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The synthesis of an isosteric-isoelectronic analogue of prekinamycin, an N-
cyanobenzo[b]carbazoloquinone 2.1, is described. The key steps include a Vilsmeier-Haack 
formylation, a regioselective bromination, a Buchwald-Hartwig cross-coupling, a palladium 
mediated oxidative cyclization and N-cyanation to furnish the target in fifteen steps in an 
overall yield of 1.6%. Subsequent bioactivity studies were conducted in which the 
cytotoxicity of various compounds on K562 cells, a human erythroleukemic cell line, 
revealed that the analogue had a similar bioactivity profile to prekinamycin. These results 
suggest that the diazo functionality may not be an absolute requirement for bioactivity. 
A study of the reactivity of nitric oxide with diphenyldiazomethane, kinamycin A and 
isoprekinamycin diacetate was undertaken. Three products were isolated from the reaction 
with diphenyldiazomethane: a nitrimine 3.7, benzophenone and, for the first time, 
dinitrodiphenylmethane 3.9. The source of the two nitrogens in the nitrimine and 
dinitrodiphenylmethane was elucidated through isotopic labeling experiments with 15N-
labeled diphenyldiazomethane. Results suggest that two separate 1,3-dipolar cycloadditions 
generating two different 5-membered intermediates via two separate [3+2] cycloadditions, 
furnishing the nitrimine and benzophenone, are occurring. Subsequent theoretical studies 
reveal that the [3+2] cycloadditions are in accord with experimental results. Further 
calculations show that the proposed intermediates and transition state structures are in good 
agreement with the product distribution and isotopic labeling studies. The kinamycins were 
found to be unresponsive to NO exposure in which theoretical calculations reveal that the 
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free energy of activation for the 1,3 dipolar cycloadditions is significantly higher for the 
natural products than for diphenyldiazomethane. 
A comprehensive theoretical study on the chemistry of the N-acetyl indole-2,3-
quinodimethanes (N-Ac IQDM 5.1) at the DFT B3LYP 6-31 G(d) level is described. 
Investigation of amide conformations of N-Ac IQDM in which good agreement between 
experimental and theoretical results is shown. Subsequent studies addressing regioselectivity 
and stereoselectivity of Diels-Alder (DA) reactions are described. FMO theory does not 
provide a rationalization for the regioselectivity observed in DA reactions of N-Ac IQDM. 
Transition state calculations were carried out to probe the regioselectivity of DA reactions of 
this system. For acrolein, Δ‡G was found not to be predictive of regiochemistry as observed 
experimentally. However, the calculated barriers, Δ‡E and Δ‡H, are in qualitative agreement 
with experimental trends in which the major regioisomer is predicted to be C-2 DA adduct. 
Methacrolein and crotonaldehyde were also examined. On comparison to acrolein, Δ‡G 
predicts that both α-substitution (i.e. methacrolein) and β-substitution (i.e. crotonaldehyde) 
increases regioselectivity for the C-2 regioisomer. Furthermore, the Δ‡E and Δ‡H data sets 
for methacrolein predicts increased regioselectivity for the C-2 adduct; the Δ‡E and Δ‡H data 
sets for crotonaldehyde predicts decreased C-2 regioselectivity. 
Efforts towards the synthesis of tetrahydrofluorenes via DA reactions of ethyl 2,3-
dimethylene-2,3-dihydro-1H-indene-1-carboxylate (6.20) and diethyl 2,3-dimethylene-2,3-
dihydro-1H-indene-1,1-dicarboxylate (6.36) are described and were generated from the 
corresponding ethyl 2-(2-(1-acetoxybuta-2,3-dien-2-yl)phenyl)acetate (6.18) and the diethyl 
2-(2-(1-acetoxybuta-2,3-dien-2-yl)phenyl)malonate (6.35), respectively. Employing various 
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solvents and bases, the carboxylate 6.20 failed to provide the desired DA adduct with methyl 
acrylate. The malonate 6.35 was synthesized by carboxyalkylation followed by a Stille cross 
coupling reaction. DA reactions with methyl acrylate were carried out in which evidence of a 
DA adduct was observed in the 1H NMR spectrum but attempts of its purification proved 
futile. DA reactions with N-phenylmaleimide provided the corresponding DA adduct in 77% 
yield. Quantum chemical calculations reveal that the two dienes 6.20 and 6.36 have termini 
that are significantly different and would suggest that FMO interactions would be a 
determining factor in the regioselectivity of Diels-Alder cycloadditions. In the case of 
acrolein, inspection of the MO coefficients predicts that the C-2 cycloadducts would be the 
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1.1 Natural Products 
1.1.1 Overview 
A natural product, by the broadest definition of the term, may be classified as any material 
that can be isolated from any living organism.1-3 Natural products may be further classified as 
products of primary metabolism or secondary metabolism although this classification is 
arbitrary.1 Generally speaking, primary metabolites would include simple sugars and 
carbohydrates, fatty acids and lipids, amino acids and proteins, nucleotides and nucleic acids 
and thus appear to be ubiquitous and essential. On the other hand, secondary metabolites 
were initially considered non-essential; however, they may have pharmacological, 
toxicological and ecological importance and thus may offer some type of advantage to the 
organism in which it is found. Most literature sources consider natural products as secondary 
metabolites only. Secondary metabolites are generally classified according to their structure 
and biosynthetic origin. 
The sheer number of reports published in the literature yearly on natural products would 
seem to reflect their immense importance to mankind. Indeed, many of these compounds 
possess potent antibiotic or anticancer activity and thus have provided the scientific 
community a strong motivation to find suitable pharmacological candidates in the ongoing 
battle against disease and infection. Almost two thirds of the known antibiotics of natural 
origin are produced by members of the genus Streptomyces4,5 with relevant examples given 
in the following discussion. 
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1.1.2 Diazo containing Natural Products 
Of the many known natural products, only a handful contain a diazo group within their 
structure, most of which are shown in Figure 1.1. Some of these are derivatives of α-amino 
acids including azaserine (1.1),6-8 6-diazo-5-oxo-norleucine (DON 1.2),9 diazomycins A and 
B (1.3 and 1.4, respectively),10 thrazarine (1.5),11-14 N-alanylazaserine (1.6)15 and alazopeptin 
(1.7).16,17 Two simpler, six-membered cyclic species are represented by SQ30,957 (1.8)18 and 
cremeomycin (1.9).19,20 Fused bicyclics are represented by four members, SF2415A1 and its 
two congeners (1.10, 1.11 and 1.12)21,22 as well as lagunamycin (1.13).23,24 The tetracyclic 
kinamycins (1.14, 1.15 and 1.16)25-33 and the related lomaiviticins (1.17 and 1.18),34 a 
dimeric form of the kinamycins, have been also been reported. With the exception of 1.6, 1.8, 
1.17 and 1.18, all of these diazo-containing natural products were isolated from Streptomyces 
sp. 
Recently, the lomaiviticins 1.17 and 1.18 were shown to possess profound cytotoxicity for 
a number of cancer cell lines.34 This demonstration of such potent toxicity has re-stimulated 
interest in the kinamycin group of natural products. The group of natural products 














1.2 The Kinamycins and related compounds 
1.2.1 Historical Background 
The kinamycins are a family of natural products that have a long and storied history. The 
first public disclosure of their existence was presented by Omura and co-workers on 
September 19th, 1969 at the 169th Scientific Meeting of the Japan Antibiotics Research 
Association, Tokyo, Japan. Subsequently, the same group provided the first literature account 
of the kinamycins in 1970, in which four active components, namely kinamycin A, B, C and 
D were described (Figure 1.2), isolated from the soil bacterium Streptomyces murayamaensis 
sp. nov. Hata et Ohtani as an orange crystalline substance.25 They possessed anti-bacterial 
activity, largely against Gram-positive bacteria and less so against Gram-negative bacteria. 
Initial spectroscopic studies provided evidence of a quinone and a nitrile or isonitrile 
functional group. A subsequent report described kinamycin A and C as yellow needles and 
kinamycin B and D as orange needles and through various chemical and spectroscopic 
studies, the Omura group was able to confirm the presence of both ester and phenolic 
functional groups as well as to verify the quinone and the apparent nitrile/isonitrile 
moieties.26 Furthermore, kinamycins A and C demonstrated lower activity against Gram-
positive bacteria than kinamycins B and D. An anticancer activity profile was provided in 
which kinamycin C afforded some increase in survival against Ehrlich ascites carcinoma and 
sarcoma-180 in mice, whereas kinamycin D did not. 
Further reports by Omura’s group provided a structure for kinamycin C consistent with 
data provided by chemical modification studies27 and together with a single crystal X-ray 
structure of the p-bromobenzoate derivative,28 permitted these workers to establish the  
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stereochemistry of the D ring. The authors proposed “… a structure with a nitrile or isonitrile 
group attached to N atom on pyrrole [sic] ring was presumed…” and upon liberation of 
ammonia but not formic acid with the treatment with 30% KOH the “…kinamycins were 
confirmed to have a nitrile group...”27 and support their findings that “…a cyano group is 
bonded to the N atom of the pyrrole ring, which is rather unusual in an antibiotic…”28 The 
likelihood of the diazo functionality was not considered presumably owing to its perceived 
inherent instability and that few natural products containing the diazo group were known at 
the time. The other kinamycins, A, B, and D “…were assumed to have difference in the 
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number and position of functional groups in the D ring from NMR, IR and mass spectra...”27 
The fifth report from the Omura group described more extensive chemical modification 
studies and the UV, IR, NMR and mass spectrometric data29 and corroborated those authors' 
findings from their earlier investigations. From these five seminal reports by the Omura 
group, those workers concluded that these compounds contained the cyanamide functionality 
and thus the kinamycins were assigned as N-cyanobenzo[b]tetrahydrocarbazoloquinones. 
Later, the application of long range heteronuclear COSY experiments by the Gould group 
provided the fully assigned proton and carbon spectra for kinamycin D and appeared to 
confirm the structures assigned to the kinamycins.35 
The significance of these proposed structures is that they provided the spark that ignited the 
efforts towards elucidating the biosynthesis of these compounds and consequently their 
syntheses from which arose some speculation that the kinamycins were not N-
cyanocarbazoles as originally described. It would be some 24 years after Omura’s initial 
report that the kinamycins would be assigned their true identity as 
diazobenzo[b]fluorenes30,31 thus again reigniting investigative efforts towards their synthesis 
as well as their mechanism of action. The following discussion will give a brief account of 
this journey that provides a unique and interesting story of the kinamycin group of natural 
products. 
1.2.2 Overview of the Kinamycins and related Benzofluorenes 
All kinamycins contain a diazo group which is not acid sensitive, an anomalous feature as 
the diazo group is typically unstable towards acidic conditions.36 This behavior has been 
justified in previous studies by our group here at Waterloo, which have revealed the 
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diazonium ion character of isoprekinamycin (IPK).37,38 Kinamycins are 
diazobenzo[b]fluorenes with the exception of IPK, which is a diazobenzo[a]fluorene. The 
benzo[b]fluorenes and the benzo[a]fluorenes structures are rarely found in nature.32 In the 
kinamycins first isolated by the Omura group, the A-ring is a phenol, the B-ring is a p-
benzoquinone and the C-ring is diazo-cyclopentadiene, features common to all kinamycins. 
Kinamycins A-D are distinguished by the substitution pattern of the D-ring. There are now 
sixteen known members of this class of secondary metabolites that possess a cyclohexene D 
ring with four contiguous stereocenters that are hydroxyl substituents and/or acyloxy 
substituents and combinations thereof. Three other members possess an epoxide within the 
saturated D ring and both PK and IPK possess aromatic D rings. The numbering of atoms of 
all derivatives of benzo[b]fluorene metabolites is consistent with the standard numbering of 
the benz[a]anthraquinone biosynthetic precursors39 at the recommendation made by Gould30 
and by the conventions of Chemical Abstracts and applies to the benzo[a]fluorenes as well.33 
Table 1.1 provides the structures of the kinamycins and related members. 
 Kinamycins possess strong activity against Gram-positive bacteria and less against Gram-
negative bacteria and moderate to significant antitumor activity. Protein, DNA and cellular 
inhibition studies have also been reported on various cell lines. Naturally produced 
kinamycins originate from either Streptomyces sp. or Actinomycetes sp. and in some cases 






Table 1.1: Original and revised structures of the kinamycins and related natural products. 
 
Name (year first reported) R1 R2 R3 R4 Source 
kinamycin A 1.14a (1970) H Ac Ac Ac a 
kinamycin B 1.14b (1970) H H Ac H a 
kinamycin C 1.14c (1970) Ac Ac H Ac a 
kinamycin D 1.14d (1970) H Ac H Ac a,b 
kinamycin E 1.14e (1989) H H H Ac a 
kinamycin F 1.14f (1989) H H H H a 
kinamycin G 1.14g (1989) Ac Ac COi-Pr Ac c,d 
kinamycin H 1.14h (1989) Ac Ac H COi-Pr c,d 
kinamycin I 1.14i (1992) Ac COi-Pr H COi-Pr d 
kinamycin J 1.14j (1973) Ac Ac Ac Ac semi-synthetic 
kinamycin K 1.14k (1992) Ac Ac COi-Pr COi-Pr d 
kinamycin L 1.14l (1989) H Ac H H a 
FL-120A 1.14m (1994) H Ac COi-Pr Ac b 
FL-120C 1.14n (1994) H Ac H COi-Pr b 
FL-120C´ 1.14o (1994) H Ac H COEt b 
FL-120D´ 1.14p (1994) H H H COi-Pr b 
prekinamycin 1.15 (1994) - - - - a,e 
isoprekinamycin 1.16 (1989) - - -  a 
FL-120B 1.19a (1994) Ac - - - b 
FL-120B´ 1.19b (1994) COi-Pr - - - b 
ketoanhydrokinamycin 1.20 (1989) - - - - a 
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a. Streptomyces murayamaensis sp. nov. Hata et Ohtani (ATCC 21414) 
b. S. chattanoogensis subsp. taitungensis (strain IY2-13/CCRC 15124) 
c. S. saccharothrix (strain M1293-N4) 
d. unidentified Actinomycete sp. (strain A83016) 
e. S. murayamaensis mutant MC2. 
 





Despite the fact that benzofluorenes are infrequently found in nature,32 examples other than 
the kinamycins have been reported and are shown in Figure 1.3. These include the stealthins 
(1.21),40,41 kinafluorenone (1.22),42 kinobscurinone (1.23),43 cysfluoretin (1.24),44 
seongomycin (1.25),45 the fluostatins A (1.26a), B (1.26b),46,47 C (1.26c), D (1.26d), 
E(1.26e),48,49 the momfulvenones (1.27)50 and shikometabolins A (1.28) and B (1.29).51 
Some of these structures such as stealthin C 1.21c and kinobscurinone 1.23 are significant as 
they are implicated as intermediates in kinamycin biosynthesis.4 
1.2.3 Reassessment of Kinamycin nomenclature 
Presently, there is some confusion in the literature regarding kinamycin nomenclature. 
Their corresponding structural assignment(s) as well as their origin has been recognized. In 
particular, the 1997 review by Gould32 reports structures that have been incorrectly named, 
most notably with kinamycins G, H and I, perhaps owing to clerical errors during 
transcription. These corrected structures are shown in Table 1.1. A brief review of the 
pertinent primary literature to correct the assumed errors is given below. 
In 1989, Isshiki and coworkers isolated 3-O-isobutyrylkinamycin C and 4-O-deacetyl-4-O-
isobutyrylkinamycin C,52 designated as kinamycins G and H, respectively, in Gould’s 1997 
review. Shortly thereafter in 1992, Smitka and coworkers also isolated 3-O-
isobutyrylkinamycin C and 4-O-deacetyl-4-O-isobutyrylkinamycin C, as well a new 
kinamycin, A83016A53 designated kinamycin I by Gould. However the structure of 3-O-
isobutyrylkinamycin C reported by Smitka et al. did not match the structure by the same 
name described by Isshiki et al. and this apparently new compound is assigned the name 
kinamycin K  (1.14k) for the purposes of this thesis. This error made by Smitka regrettably 
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was reproduced by Gould in his review. Gould had assigned kinamycin J (1.14j) as a natural 
kinamycin, whereas in fact it has never been isolated from microbial fermentation broths and 
has only been generated from semi-synthetic29 or synthetic preparations.54 In 1989, Seaton 
and Gould isolated a kinamycin corresponding to structure 1.14l but identified it only as 
“PY1” in that report.55 For the purposes of this thesis, structure 1.14l is named kinamycin L. 
The structure reported for kinamycin A by Gould as well as by others, is also in error and is 
corrected in Table 1.1.  These observations along with the ensuing corrections have also been 
reported by N. Chen from this laboratory.56 
1.2.4 Structural reassignment of the Kinamycins 
1.2.4.1 The Kinamycins are diazobenzo[b]fluorenes and not N-cyanobenzo[b]carbazoles 
The early work by the Omura group had proposed the kinamycins as N-
cyanobenzo[b]carbazoles.25-29 However, investigations by several laboratories, including our 
own, would call into question the validity of the cyanamide functionality. The uncertainty 
regarding the cyanamide moiety was supported by several studies detailed below. 
 1n 1988, Gould and coworkers observed the 13C NMR resonance at 78.5 ppm for the 
“cyanamide carbon” of a 15N-enriched sample of kinamycin D.57 The anomalously large 
upfield shift of ~30 ppm for the cyanamide functionality could not be explained by the 
authors but was attributed to possible electronic effects of the indoloquinone.30,32 Earlier 
studies by Omura and coworkers found the corresponding 13C NMR resonances for 1.30 and 
1.31 to be 119.4 and 117.8 ppm, respectively (Figure 1.4).58 In 1990, the synthesis of various 
N-cyanoindoles 1.33 in this laboratory provided 13C NMR chemical shifts between 105-108 
ppm and IR data for νCN in the range 2237-2245 cm
-1. As well, N-cyanoindoloquinones 1.34 
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and 1.35 gave 13C NMR shifts of 104.7 ppm and 103.6 ppm, respectively.59  Then in 1993, 
Echavarren's total synthesis of what was thought to be prekinamycin 1.3660 gave 
spectroscopic data that did not correspond to what Gould claimed was prekinamycin (later 
found to be isoprekinamycin33,61,62) isolated from fermentation broths of S. murayamaensis.55 
Although the structures and corresponding spectroscopic data provided by Echavarren in that 
report have been drawn into question31 (see section 1.4.1) it nonetheless fueled speculation 
about the validity of the kinamycin structure originally proposed by the Japanese group.  
Figure 1.4: 13C NMR spectroscopic assignments of selected cyanamides. 
 
  
The efforts by our group here at Waterloo, as well as Gould and Echavarren, hastened 
speculation that the cyanamide functionality should be reconsidered. This culminated in the 
simultaneous disclosure by our group here at Waterloo and Gould’s group at Oregon, that the 




Scheme 1.1: Mithani and Dmitrienko’s synthesis of 1.48. 
 
 
S. Mithani in this laboratory accomplished a regioselective synthesis of the N-
cyanobenzo[b]carbazoloquinone 1.48 via a regioselective Diels-Alder reaction and a Pd-
induced cyclization as the key steps (Scheme 1.1).31 The cyano carbon gave rise to 13C NMR 
resonance at 105 ppm and an IR band at 2253 cm-1, consistent with the N-cyanoindoles 
mentioned earlier. This was in contrast to the observations by Gould for kinamycin D (78.5 
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ppm)57 and prekinamycin diacetate (83.71 ppm)55 (later shown to be isoprekinamycin 
diacetate33,61,62). Thus the spectroscopic characteristics of the target of Mithani’s syntheses 
showed that the kinamycin(s) could not be N-cyanocarbazoloquinones and that clearly, other 
alternatives must be considered. 
In the second report, Gould and coworkers were able to crystallize the (+)-α-
methylbutyrate derivative of kinamycin D 1.49 and subsequent X-ray diffraction studies 
demonstrated that the diazo group had a significantly better statistical fit to the data set than 
the cyanamide group (Figure 1.5).30 Furthermore, it was pointed out by the Waterloo group31 
that the 13C NMR resonances of a number of known diazo compounds63 exhibited chemical 
shifts in the 60-80 ppm region. For example, the diazo carbon signal for 9-diazofluorene 1.50 
is observed at 63.2 ppm which compares favorably with kinamycin D at 78.5 ppm. 
These milestone achievements by the group here at Waterloo and that of Gould at Oregon 
clearly designated the kinamycins as diazobenzo[b]fluorenes. This in turn provided a new 
motivation for the synthesis of kinamycins as well as simpler diazo containing compounds, 
which in turn would generate new efforts towards determining their biological basis of 
action. 





1.2.4.2 Isoprekinamycin is a diazobenzo[a]fluorene 
In 1996, the first reported total synthesis of prekinamycin 1.15 was achieved by Hauser and 
Zhou.61 Unexpectedly, it was found that the spectral properties of Hauser’s synthetic target 
were not identical to those reported by Seaton and Gould in 1989, a compound named P1,55,64 
that Gould had arbitrarily designated “Cpd A”.62 During this time, spectroscopic studies 
undertaken by the Gould lab62 found there were small differences in the IR, 1H NMR and 
HPLC-PDA data between Cpd A and the synthetic prekinamycin provided by Hauser and 
Zhou. Furthermore, that same study found that the synthetic sample matched yet another 
metabolite (named “Cpd B”) from extracts of S. murayamaensis mutant MC2 and upon 
isolation of Cpd B from fermentation broths, produced identical UV-Vis spectra with 
synthetic prekinamycin. Ensuing HPLC-coinjection produced a single peak and subsequent 
purification established Cpd B as prekinamycin, leaving the identity of Cpd A unclear. 
The issue was finally resolved by a collaborative effort by this group here at Waterloo and  
P. Proteau at Oregon State.33 Using extensive 2D NMR techniques (HSQC, HMBC) and ab 
initio M.O. calculations, compound A was recognized as a diazobenzo[a]fluorene 1.16, a 
6,5,6,6 tetracyclic species isomeric with prekinamycin and Cpd A was given the name 
isoprekinamycin (IPK). The ring system in IPK is related to that in the fluostatins A 1.26a 
and B 1.26b.47 Treatment of IPK with Rh2(OAc)4 produced a deazotized product compatible 
with any of the structures 1.51, 1.52 or 1.53 (Figure 1.6) but all were incongruous with nOe 
and HMBC NMR results. Ab initio calculations showed 1.51 was particularly unfavorable 
and it was concluded that IPK was not a diazobenzo[b]fluorene. The definitive evidence was 
provided by sodium borohydride treatment, deazotization and acetylation of IPK furnishing 
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the tetraacetate derivative 1.54 which was now amenable to conventional NMR techniques. 
Thus, the identity of Cpd A was revealed as the benzo[a]fluorene isoprekinamycin 1.16 and 
is in fact, the corrected structure of the compound first described by Gould in 1989 (named 
P1 in that report), which had been inadvertently assigned the prekinamycin structure.55 
Figure 1.6: Possible structures obtained from the deazotization of isoprekinamycin. 
 
 
The co-occurrence of both 1.15 and 1.16 within the same bacterial cell suggest the 
possibility an enzyme catalyzed rearrangement such that a reversible hydration, 1,2-C shift 
and dehydration sequence occurs (Scheme 1.2).33 This group has suggested further that 1.15 
and 1.16 are variants of the same pharmacophore.38 






1.3.1  Initial studies: derivation of the carbon skeleton and oxidative elaboration of 
the D-ring 
The elucidation of the biosynthesis of the kinamycins was largely accomplished by Gould 
and co-workers and has been reviewed in 1997.32 In 1976, the first report on the biosynthesis 
of the kinamycins was described by Omura and coworkers in which those workers fed both 
sodium [1-13C] and [2-13C]acetate to separate cultures of S. murayamensis and isolated 
kinamycin D.58 From cultures supplied with sodium [1-13C]acetate exclusively and using IR 
methods, they observed a shift from 2155 cm-1 to 2139 cm-1 of kinamycin D apparently due 
to 13C enrichment of the apparent “cyanamide carbon” [sic] (diazo group) from the C-1 of 
acetate. 
In 1985 and 1986, Sato and Gould published two separate reports establishing the skeleton 
of the kinamycins was derived entirely from acetate and that the D-ring was functionalized 
via acetate and molecular oxygen.65,66 This was accomplished, in part, by feeding sodium [1, 
2-13C2]acetate 1.57 to the fermentation broths of S. murayamaensis yielding a mixture of 
kinamycins C and D (Scheme 1.3, top panel). Further purification afforded kinamycin D 1.58 
enriched at all carbons by an average of 3.1% and with the exception of C-3´ (2.5% 
enrichment), all showing coupling to at least one carbon. Subsequently, the orientation of 
each acetate in kinamycin C and D was revealed by assimilation of [2-2H3, 1-
13C]acetate 
1.59. The source of the oxygens and thus the oxidative elaboration of the D-ring was shown 
by assimilation of [1-13C,1,1-18O2]acetate 1.61 and 
18O2 1.63 in separate experiments. These 
two 18O experiments led the authors to suggest the sequence of events that is consistent with 
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the observed stereochemistry and isotopic labeling as described in the bottom panel of 
Scheme 1.3. 
Scheme 1.3: Gould’s biosynthetic studies of kinamycins C and D. 
 
 
Furthermore, Sato and Gould suggested two intermediates; a substituted 2,4,5-
trihydroxynaphthalene 1.73 (to afford a juglone species 1.74) and a substituted toluic acid 
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1.76, derived from two different polyketide intermediates 1.72 and 1.75, respectively, 
furnishing the kinamycins (Scheme 1.4). In both of those reports, the authors did not observe 
the 13C NMR resonance of the “cyanamide carbon”, contradicting the earlier report by 
Omura. The absence of the "cyanamide carbon" signal was attributed to quadrupolar 
relaxation by the two nitrogens directly attached to the "cyanamide carbon". Thus the 
origin(s) of the “cyanamide carbon” remained unknown. 
Scheme 1.4: Gould’s early proposal for the biosynthesis of the kinamycins. 
 
 
1.3.2 Advanced studies: dehydrorabelomycin from a decaketide intermediate 
In 1987, Seaton and Gould reported their unsuccessful attempts to support their hypothesis 
shown in Scheme 1.439 the suggestion of which came from two notable observations, the first 
of which was the failure to isolate labeled kinamycin D from bacterial cultures fed various 
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deuterated hydroxynaphthalenes (1.73) and hydroxynaphthoquinones (1.74). Secondly, 
isolation of other metabolites, one of which was dehydrorabelomycin 1.80 (a 
benz[a]anthraquinone) as dark green needles, previously obtained from the acid-catalyzed 
dehydration of rabelomycin 1.79 in a separate study.67 The in vivo generation of 1.80 
suggested an alternative biosynthesis (Scheme 1.5) to that shown in Scheme 1.4. To this end, 
1.80 was heated in the presence of deuteriotrifluoroacetic acid in a sealed tube in the absence 
of oxygen to produce [2,4,5,9,11-2H5] dehydrorabelomycin 1.81 and was subsequently fed to 
fermentation broths of S. murayamaensis. Compound 1.81 was recovered with no change in 
deuterium content and kinamycin D 1.83 enriched at C-7, C-5, and C-3´ was also isolated, 
thus establishing dehydrorabelomycin 1.80 as a key intermediate in the biosynthesis of 
kinamycin D. It was proposed that subsequent oxidative cleavage of the C-ring, excision of 
C-5 and C-6, and insertion of nitrogen yield the tetracycle 1.82, a benzo[b]carbazole (proof 
of which Gould claims was obtained as the cyanamide derivative of 1.82, albeit in small 
quantities with incomplete characterization). The observation of deuterium retention at C-3´ 
but not at C-1´ of 1.83 was fully consistent with the intermediacy of the hydroquinone 1.77. 









Scheme 1.5: Gould’s revised biosynthesis of the kinamycins. 
 
 
Further research towards determining the origin of the “cyanamide carbon” was pursued by 
feeding S. murayamensis with (15NH4)2SO4.
57 Surprisingly, the 13C NMR spectrum displayed 
a doublet of doublets at 78.5 ppm (J = 5.4, 21.2 Hz), which permitted the determination of 
the biosynthetic origin of the “cyanamide carbon”. A review of 13C NMR spectra of non-
isotopically labeled kinamycin samples showed a small singlet at this chemical shift, almost 
overlapped by the CDCl3 resonance that had previously been assumed to arise from a minor 
impurity. Subsequently, separate feedings with [1-13C]acetate and [2-13C]acetate, showed a 
2.7% enrichment of the “cyanamide carbon” of 1.85 obtained from the [2-13C] acetate 
feeding (Scheme 1.6). The isolation and characterization of 1.36 from other parallel studies55 
allowed Gould to propose that the cyanamide carbon originated from C-5 of 1.85 by way of 
oxidative ring cleavage and nitrogen insertion to give the pyridinone 1.86 (a 
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benzo[b]phenanthridine). Ring contraction/rearrangement was suggested to generate what 
was thought to be 13C-labeled prekinamycin 1.87. 
The synthesis of 1.88b and the corresponding pyridinone 1.86 were reported in 199268 and 
two years later Gould reported the detection of 1.88b in a UV-mutant of S. murayamaensis 
MC2.69 The first naturally occurring benzo[b]phenanthridine to be isolated was 
phenanthroviridin 1.88a and its aglycon 1.88b from Streptomyces viridiochromogenes DSM 
3972.70 
Scheme 1.6: Gould’s proposal for the origin of the “cyanamide” carbon. 
 
 
1.3.3 New metabolites, gene cloning, enzymes and the implications with respect to 
biogenesis 
The 1989 report that had identified the alleged prekinamycin (see Section 1.2.4) also 
identified a number of potential key intermediates including keto-anhydrokinamycin 1.20, 
and kinamycins F 1.14f and E 1.14e.55 Other metabolites such as kinobscurinone 1.2343 and 
stealthin C 1.21c41 were isolated and were shown to be intermediates in kinamycin 
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biosynthesis. The then recent structural revision of the kinamycins as diazo compounds 
required a new biosynthetic proposal as shown in Scheme 1.7. Subsequently the cloning and 
heterologous expression of genes from the kinamycin biosynthetic pathway of S. 
murayamaensis was reported to provide stealthin C but not the full kinamycin system that 
incorporated the diazo group.4 This report also identified kinafluorenone 1.22 and 
seongomycin 1.25 as shunt metabolites. A kinamycin acetyltransferase (KAT I, MR> 669 
kDa), a membrane-associated multifunctional enzyme was identified and was shown to 

















Scheme 1.7: Gould’s current biosynthetic proposal for the kinamycins. 
 
 
Other genes identified were the gene for cleaving the C-ring as well as the gene(s) for 
introducing the first (internal) nitrogen of the diazo group; although 1.23 had been detected 
in cultures of S. murayamaensis, the precise target of the amination had yet to be identified. 
Should 1.23 be the amination substrate, then the glutamine or ammonia dependent 
amidotransferases are worthy of consideration whereas 1.91 would invoke the pyridoxamine 
phosphate-dependent transaminases (Scheme 1.8).4 
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Scheme 1.8: Possible enzyme participation in kinamycin biosynthesis. 
 
 
1.3.4 Proposal for the source of the terminal nitrogen of the diazo group 
Although the introduction of the first nitrogen seems likely from the possibilities presented 
in Scheme 1.8, experimental evidence is still lacking. As well, the source of the terminal 
nitrogen in the diazo group has yet to be identified. Two avenues exist for the incorporation 
of the diazo function, one of them being the involvement of a hydrazine intermediate.72 The 
occurrence of enzymes believed to oxidize aryl hydrazines to aryl diazonium salts have been 
reported,73 but the existence of a hydrazine species in the kinamycin biosynthesis has yet to 
be reported. Another possibility that has been raised in the Waterloo group but not as yet 
published is the involvement of nitric oxide in some capacity. Speculation in this regard is 
fueled by the well known behavior of soil bacteria to convert nitrate to ammonia in a series 
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of redox reactions with the production of nitric oxide (NO).74 These observations have led 
this laboratory to speculate that the possibility of N-nitrosation events that may occur with 
NO and stealthin C as the likely target. This notion bodes well with the known behavior of 
stealthins as potent radical trapping agents40 and with the lack of biochemical and genetic 
evidence, presents a viable alternative which is discussed further in Chapter 3. 
1.4 Synthesis 
1.4.1 Benzo[b]carbazoloquinones syntheses and related chemistry 
Much of the biosynthesis discussed in the preceding section provided the impetus to 
synthesize the natural products, intermediates and/or analogues. This eventually led to the 
major structural revision that the kinamycins are noted for, from N-
cyanobenzo[b]carbazoloquinones to diazobenzo[b]fluorenequinones. This period carries 
several reports on efforts towards synthesizing the kinamycins as benzo[b]carbazoles and 
related chemistry.59,60,68,75-83 The discussion of the synthetic approaches directed towards the 
kinamycins will only include those synthetic efforts up until 1994, when the kinamycins were 
still considered carbazoles. Discussion on more recent advances in carbazole synthesis will 
be presented in Chapter 2. The number of reports in the literature describing syntheses of 
carbazoles and their derivatives is extensive and it is beyond the scope of this thesis to 
describe them in detail. For this purpose, one can consult the extensive and comprehensive 
reviews written by Knolker84-87 and Gallagher.88 
Efforts from this laboratory towards the syntheses of various N-cyanoindoles59 (Scheme 
1.9) were an important step towards the structural reassignments of the kinamycins (Section 
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1.2.4). The indoloquinones 1.34 and 1.35 were envisioned as BC ring synthons in Diels-
Alder reactions. 
Scheme 1.9: Dmitrienko’s synthesis of N-cyanoindoles and N-cyanoindoloquinones. 
 
 
Using the N-cyanoindoles-4,7-diones provided in the aforementioned report allowed this 
laboratory to pursue the construction of the ABC rings of the kinamycins via Diels-Alder 
reactions (Scheme 1.10).75 These studies were initiated based on an understanding of the 
regioselectivity of Diels-Alder reactions provided by FMO analysis89,90 with the knowledge 
that C-1´-alkoxy or acyloxy dienes should provide the requisite regioisomer. In practice it 
was found that 1-acetoxybutadiene 1.98a or 1-trimethylsilyloxybutadiene 1.98b led to a ~2:1 
mixture of adducts that were unstable, decomposing to 1.100 and 1.101 as an inseparable 
mixture, precluding structural characterization that would allow confirmation of the 
regioselectivity predicted by FMO analysis. Using 1-methoxy-1,3-cyclohexadiene 1.102 as 
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the diene, afforded adduct 1.103 in 76% yield as the endo product, which upon enolization 
and oxidation followed by a thermal retro Diels-Alder, furnished 1.105 in 19% yield over 
three steps. 
Scheme 1.10: Dmitrienko’s synthesis of benzoannulated indoloquinones. 
 
 
The first regioselective synthesis of the kinamycins as tetrahydrocarbazoles was 
accomplished by Murphy and coworkers78 using their bromoquinone enamine annulation 
methodology.91 Using naphthoquinones 1.106 and N-benzyl enamino ketones 1.107, they 
obtained the desired regioselective annulation, furnishing tetrahydrobenzo[b]carbazole-
1,6,11 triones 1.108 in modest yields (Scheme 1.11). Aromatization afforded the 
benzo[b]carbazoloquinones 1.109. There were neither efforts towards the synthesis of the N-
cyano compounds nor any mention of their biological testing in this report. This may be 
attributed to the fact that N-benzylindoles are resistant to standard N-debenzylation methods 





Scheme 1.11: Murphy’s synthesis of 1.109. 
 
 
Using a Stille cross-coupling of the 5-methoxy-2-bromojuglone (1.110) with the aryl 
stannane 1.111, Echavarren and coworkers reported the total synthesis of the N-
cyanobenzo[b]carbazole 1.36, the assumed structure of prekinamycin (Scheme 1.12).60 
However, the proposed structures and their corresponding assignments in that report must be 
viewed with caution. We have observed a disagreement of the assignments reported by 
Echavarren with our own assignments31 and with those of others.55 As this was the first 
reported total synthesis of what was thought to be prekinamycin 1.36, it merits an in depth 
look beginning with a summary of the Echavarren synthesis as it appeared in that report, 












Scheme 1.13: Interpretation of Echavarren’s product distribution. 
 
 
Scheme 1.13 offers, in part, an interpretation of Echavarren’s analyses of their results. 
Treatment of 1.112b under catalytic conditions of H2SO4 in methanol provided the 
regioisomers 1.113a:1.114a in 1.4:1 ratio. However, thermolysis of 1.112b or treatment with 
ZnI2 in CH2Cl2 and cyclization in DMSO-d6 led to ratios of 1:3 and 1:6, respectively, in 
which they suggest that 1.114a is formed via the azetidine intermediate 1.122 by way of 
attack of the amino group at C-2 of the quinone and subsequent migration of the aryl moiety 
to C-3. Although those authors admit other mechanistic interpretations could be conceived, 
the structures as well as the regiosomeric yields are questionable. N-Benzylation of 1.114a 
was reported to produce 1.116 in quantitative yield. However, N-benzylation of 1.113a 
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produced 1.115b apparently through a novel rearrangement which also occurred upon 
standing on SiO2 affording 1.115a. 
Cyanation of 1.114a was reported to furnish 1.118 in quantitative yield, but cyanation of 
1.113a to give 1.117 proceeded sluggishly apparently owing to its insolubility. Cyanation of 
1.115a required a change of solvent to DMSO to afford 1.120 in 81% yield. Deprotection 
proceeded uneventfully to furnish “prekinamycin” and its two regioisomers in 90-100% 
yield. The assignments reported for 1.36 were markedly different from those reported by 
Gould and consequently Echavarren felt that the structure described by Gould55 is a different 
structure from that of Echvarren’s synthetic target. More perplexing was the fact that the 13C 
NMR resonances assignable to the cyanamide carbon were reported to be in the range of 
115-123 ppm, whereas those observed for the N-cyanoindoles prepared in this laboratory 
were in the range 105-108 ppm. This led us to re-evaluate92 Echavarren's report and, through 
some thought, to reinterpret the experiments which then allowed a chemically reasonable 
proposal, avoiding unusual arrangements, which would explain the apparent spectroscopic 
discrepancies. 
Our interpretation of the likely product distribution involves two separate cyclizations of 
1.112b at C-3 and C-1 to give 1.113a and 1.115a, respectively, as the corresponding major 
and minor products as shown in Scheme 1.14, contrary to Echavarren's analysis (Schemes 
1.12 and 1.13). The likelihood that 1.114a exists at all is questionable and those workers 
qualify its formation from the mechanism offered in Scheme 1.13. Accordingly, the most 
likely events to occur are that 1.112b exists as two tautomers 1.112b and 1.112c in 
equilibrium, which upon pyrolysis, yield the corresponding tautomers 1.123 and 1.124, also 
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in equilibrium which undergo separate cyclizations to furnish 1.125 and 1.126, respectively. 
Tautomerization then gives the respective products observed, 1.115a and 1.113a. The 
unusual rearrangement of 1.113a to 1.115a upon exposure to silica is thus avoided and the 
reaction can be simply rationalized as a tautomerization between 1.125 and 1.115a. 




Cyanation of the “major product” thought by Echavarren to be 1.114a (but that is actually 
1.113a) proceeds without incident to give 1.117 (and not 1.118) quantitatively and appears 
reasonable. However, cyanation of the “minor product” 1.113a (which is actually 1.115a) to 
give 1.120 can be explained in terms of competing O-cyanation versus N-cyanation as shown 
in Scheme 1.15. In all likelihood, it is the O-cyano product 1.127 that arises from these 
transformations in which Echavarren has erroneously assigned the structure prekinamycin 






















Using nitroquinone 1.129a, Castedo and coworkers obtained 1.130 in 98% yield (Scheme 
1.16).80 Nitroketoester 1.128c was prepared from the nitration of the ketoacid 1.128a94 
affording 1.128b which was subsequently esterified to give 1.128c. Treatment of 1.128c in 
refluxing aqueous methanolic sodium hydroxide produced nitro-quinone 1.129a in which the 
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authors propose a mixed Claisen condensation followed by oxidation of the cyclized product. 
Reduction of the nitro moiety was carried out with NaBH4 in isopropanol which underwent 
cyclization to afford a red-coloured compound 1.130. The other possibility 1.131 was ruled 
out as the N-methyl derivative of the red product did not undergo a benzilic acid 
rearrangement as observed for pontevedrine,95 a natural product containing an ortho quinone 
functionality. 
Scheme 1.16: Castedo’s synthesis. 
 
 
Knölker and O’Sullivan reported a four step synthesis of a 7-deoxyprekinamycin 1.139, 
incorporating a Pd-promoted oxidative coupling as the key step (Scheme 1.17).81 This 
isomeric analogue of prekinamycin represented a possible alternative to the proposed 
structure of prekinamycin. The IR band for the cyano group was found at 2252 cm-1 and is in 
good agreement with spectroscopic data reported by the Dmitrienko group.59 The mechanism 
proposed is electrophilic attack on the Pd (II) species by the aromatic ring to give an σ-
arylpalladium (II) complex 1.135. Insertion of the quinone double bond generated the σ-
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alkylpalladium complex 1.136, which after β-elimination provides 1.137. Although at the 
time 1.139 presented an appropriate analogue, no ensuing biological studies were reported. 
Scheme 1.17: Knölker and O’Sullivan’s synthesis of 7-deoxyprekinamycin. 
 
 
1.4.2 Diazobenzo[b]fluorenequinone syntheses 
1.4.2.1 Hauser and Zhou’s synthesis of Prekinamycin 
The first reported synthesis of the kinamycins as diazobenzo[b]fluorenes was by Hauser 
and Zhou in 1996,61 using their phthalide annelation methodology96 as the key step, 
furnishing prekinamycin 1.15 in nine steps as shown in Scheme 1.18. The highlight of the 
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synthesis was the condensation of the anion of the phthalide sulfone 1.143 with indenone 
1.142 to afford the benzo[b]fluorenone 1.144 regiospecifically. As discussed in Section 1.2.4, 
this report led to the realization that the compound (Cpd A) to which the structure 1.15 had 
been assigned must have a different structure, eventually shown to be 1.16 by the Waterloo 
and Oregon State groups. 
Scheme 1.18: Hauser and Zhou’s synthesis of prekinamycin. 
 
 
1.4.2.2 Birman’s synthesis of Prekinamycin 
More recently, Birman and coworkers accomplished a total synthesis of prekinamycin in 
2007, shown in Scheme 1.19.97 This relied on the dianion 1.147 attacking the biselectrophile 
1.148 regioselectively, furnishing the fluorenone 1.149 in modest to good yields. 
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Condensation of the fluorenone with mesyl-hydrazine produced the hydrazone 1.150 in high 
yield. Global deprotection and oxidation provided the target prekinamycin in five steps. 
 
Scheme 1.19: Birman’s synthesis of prekinamycin. 
 
 
1.4.2.3 Porco’s synthesis of Kinamycin C 
The first enantioselective synthesis of any kinamycin was accomplished by Porco and 
coworkers when they reported the total synthesis of kinamycin C in 2006.98 Porco’s synthesis 
is shown in Scheme 1.20 with the synthesis of two fragments 1.159 and 1.163 and the 
subsequent Stille coupling of these fragments illustrated in Scheme 1.21. 
Synthesis of 1.159 begins with regioselective methylation of 1.152 followed by reduction 
to provide 1.153 (Scheme 1.20a). Subsequent oxidation, transketalization and silyl protection 
gave quinone monoketal 1.154. Modified Baylis-Hillman conditions provided access to 
1.155, which provided the necessary handle for the impending hydroxyl directed asymmetric 
nucleophilic epoxidation, which furnished 1.156 in 94% yield and 90% ee. Diastereoselective 
reduction followed by selective mesylation of the primary alcohol afforded 1.157, which 
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underwent reductive demesylation to give 1.158. Removal of the cyclic ketal using K-10 clay 
gave the requisite epoxy enone 1.159. Access to naphthylstannane 1.163 was provided by O-
alkylation of 1.160, reduction and O-alkylation of 1.161 to give naphthylbromide 1.162 
which underwent stannylation producing the requisite arylstannane 1.163 (Scheme 1.20b). 
The Stille coupling of 1.159 and 1.163 proceeded at a modest 70% yield producing 1.164, 
which underwent diastereoselective reduction and epoxide opening to give 1.165 (Scheme 
1.21). Acylation and deprotection of the TBDMS silyl ether furnished 1.166, which 
underwent subsequent oxidations using TPAP and then sodium chlorite affording the 
carboxylic acid 1.167. Ring closure was executed by employing TFAA, furnishing the 
tetracycle 1.168 with the serendipitous regioselective cleavage of two MOM groups. 
Cleavage of the remaining MOM group and oxidation in air using Pd/C gave ketoquinone 





















Scheme 1.21: Porco’s enantioselective synthesis of kinamycin C (continued). 
 
 
1.4.2.4 Ishikawa’s synthesis of (±)-O-methyl Kinamycin C 
In 2007 Ishikawa’s group reported the synthesis of racemic O-methyl-kinamycin C.99,100 
Acetylation and oxidative bromination of 1.171 afforded quinone 1.172, which was 
deacetylated and O-methylated to give 1.173 (Scheme 1.22). Reduction and O-methylation 
gave the trimethoxy bromonaphthalene 1.174, which upon treatment with n-BuLi and DMF 
produced naphthaldehyde 1.175. Knoevenagel reaction of 1.175 with malonic acid under 
sonication followed by catalytic hydrogenation gave naphthalenepropanoic acid 1.176. Ring 
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closure by an intramolecular Friedel-Crafts reaction provided the benzoindanone which was 
oxidized to the indenone 1.177 using IBX, providing the dienophile for the impending Diels-
Alder reaction. The cycloaddition with the Danishefsky-type diene 1.178 gave adduct 1.179, 
which, when treated with CSA followed by air oxidation in the presence of KF, provided 
enone 1.180 in three steps at 48% yield. 





The hydroxyl group at C-4a provided the necessary handle for the diastereoselective syn-
dihydroxylation using OsO4-TMEDA, giving the cis, cis-triol 1.181. Global silylation 
afforded 1.182 which underwent a Rubottom oxidation using mCPBA and allowed to 
isomerize to the desired 1α-siloxyketone 1.183. Global deprotection was executed using 
methanol-water, furnishing 1.184. 
Scheme 1.23: Ishikawa’s synthesis of (±) O-methyl-kinamycin C (continued). 
 
 
Acetylation of 1.184 gave 1.185 which underwent a diastereoselective reduction with 
tetramethylammonium triacetoxyborohydride to give the trans-diol 1.186 (Scheme 1.23). 
Manganese dioxide converted any over-reduced product back to 1.186. Ketalization gave 
1.187 and subsequent dehydration using Burgess’s reagent furnished 1.188. Deprotection, 
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acetylation and installation of the diazo functionality produced (±)-O-methyl-kinamycin C 
1.190. 
1.4.2.5 Nicolaou’s synthesis of Kinamycins C, F and J 
In 2007, Nicolaou’s group reported the enantioselective syntheses of kinamycins C, F and 
J.54 The synthesis begins, as shown in Scheme 1.24, with the allylation of 2-bromojuglone 
1.160 under radical conditions to provide 1.191. This compound underwent O-benzylation, 
reduction, and O-methylation to afford 1.192. Isomerization under basic conditions and 
oxidative cleavage gave the bromonaphthaldehyde 1.193. 





The chiral enone 1.194 underwent conjugate addition of a methyl group and trapped as the 
silyl-enol ether. The subsequent Saegusa oxidation furnished 1.195. The diastereoselective 
oxidation of the olefin with OsO4 and protection as the acetonide gave 1.197. The Saegusa 
oxidation sequence was re-iterated and a regiospecific iodination afforded the iodo-enone 
1.199. 
Scheme 1.25: Nicolaou’s enantioselective syntheses of kinamycins C, F and J (continued). 
 
 
Fragments 1.193 and 1.199 were coupled under modified Ullman conditions to give 1.200. 
Using the Rovis catalyst 1.201 in a benzoin-like reaction, the benzo[b]fluorenone 1.202 was 
obtained. The alcohol was acetylated and the acetoxy group was reductively cleaved using 
 
 47 
samarium iodide in the presence of methanol and then Et3N, migrating the double bond into 
conjugation. Allylic oxidation with selenium dioxide provided the allylic alcohol 1.203. 
Deprotection of the TBS and acetonide groups, acetylation and debenzylation gave 
fluorenone 1.204, in which the phenolic hydroxyl was TBS protected, installation of the 
hydrazone moiety and subsequent CAN oxidation furnished the TBS-protected kinamycin C 
1.205. A series of deprotections and acetylations provided the natural products kinamycins C, 
F and J. 
1.4.2.6 Dmitrienko’s biomimetic approach to construction of the D-ring 
Porco’s, Ishikawa’s and Nicolaou’s syntheses illustrated different approaches to the 
construction of the highly oxygenated D-ring. Using a simple model system, N. Chen in this 
laboratory has successfully demonstrated a three-step diastereoselective elaboration of the D-
ring using a biomimetic approach (Scheme 1.26).101 Epoxidation of 2-methyl-1,4-
naphthoquinone 1.206 with hydrogen peroxide under basic conditions gave epoxy-diketone 
1.207. This epoxy-diketone was reduced with NaBH4 with high diastereoselectivity, owing to 
steric shielding by the protic solvent via H-bonding with the epoxide, consequently 
promoting hydride approach trans to the epoxide oxygen, producing 1.208. Ring-opening of 
the epoxide was achieved with Me4NBH(OAc)3 with high regio- and diastereoselectivity. 
The mechanism is thought to be analogous to that reported by Caron and Sharpless for ring 
opening of epoxy alcohols with Ti(OiPr)4.
102 It is thought that the Lewis acid reacts initially 
with the alcohol to provide a tethered Lewis acid that then facilitates epoxide ring opening. In 
the case of 1.208, two complexes form, 1.209a and 1.209b, which react further to form the 
cyclic complex 1.210. The selectivity is attributed to the cyclic complex 1.210 in which the 
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boron serves as an intramolecular Lewis acid to assist with epoxide ring opening by the 
nucleophile via backside attack at the less crowded C-2 to provide 1.211. 
 
Scheme 1.26: Dmitrienko’s biomimetic approach to the synthesis of the D-ring. 
 
 
1.4.2.7 Dmitrienko’s total synthesis of Isoprekinamycin 
W. Liu in this laboratory accomplished the first total synthesis of isoprekinamycin 
employing a Suzuki coupling as a key step.38 Synthesis of the AB ring synthon is shown in 
Scheme 1.27. The substituted indanone 1.213 was synthesized from the commercially 
available dihydrocoumarin 1.212. Dibromination and then DBU-induced 






Scheme 1.27: Dmitrienko’s total synthesis of isoprekinamycin. 
 
 
The D-ring synthon was prepared from the o-iodoarylbenzyl alcohol 1.215 which was 
converted to the nitrile 1.216 and then to the boronate 1.217 using a Pd coupling with pinacol 
borane (Scheme 1.28). The Suzuki coupling proceeded uneventfully to give 1.218 in 85% 
yield. 
Scheme 1.28: Dmitrienko’s total synthesis of isoprekinamycin (continued). 
 
 
Cyclization of 1.218 required modified conditions, reducing the ketone first by using a 
combination of n-BuLi and DIBAL affording 1.221 which was then treated with LDA and 
upon aqueous workup gave a mixture of 1.222 and 1.219 formed from partial air oxidation. 
The mixture was O-alkylated and the nitrile hydrolyzed to the amide 1.224 with concomitant 
oxidation to the ketone using K2CO3/H2O2. Using modified Hofmann conditions the amide 
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was transformed to the carbamate 1.225 which was hydrolyzed to the aniline 1.226 and 
diazotized to afford 1.227. Deprotection with BCl3 provided the target 1.16 in 64% yield. 
 




1.4.2.8 Herzon’s enantioselective synthesis of Kinamycin F 
Most recently, Herzon and coworkers have described an enantioselective synthesis of 
kinamycin F in twelve steps (Scheme 1.30).103 Employing a Birch reduction and a 
subsequent Sharpless asymmetric dihydroxylation followed by protection as the ketal (three 
steps in 48%) provided the key chiral building block 1.230 to produce kinamycin F. 




1.5 Mechanism of Action Studies 
1.5.1 Moore’s proposed mechanism for the N-cyanobenzo[b]carbazoles 
Prior to 1994, kinamycins were thought to be cyanamides and appropriately it was felt that 
the mechanism of action (MOA) was analogous to that of the mitomycins, the well-known 
DNA bis-alkylating agents, as suggested by Moore in 1977.104 Both the mitomycin and 
kinamycin structures contain an indoloquinone incorporating appropriately positioned 
leaving groups and consequently Moore speculated that kinamycin C could be a reductively 
activated alkylating reagent. 
Mitomycin C, a clinical chemotherapy agent, is a known DNA cross-linking agent under 
reducing conditions in which the generally accepted mechanism is shown in Scheme 
1.31a.105,106 Thus, reduction of the quinone 1.238 to the dihydroquinone 1.239 and expulsion 
of the angular methoxy group provides 1.240 and tautomerization gives 1.241. The aziridine 
ring is now induced to open and consequently provides the vinylogous quinone methide 
1.242, the incipient electrophile for a nucleophilic species such as N-2 of the deoxyguanosine 
nucleoside.107-111 Next, the expulsion of the carbamate moiety generates vinylogous iminium 
ion 1.244, another electrophilic site for nucleophilic attack. Oxidation back to the quinone 
species may be an obligatory step to prohibit the release of DNA. 
It was reasonable to suggest that kinamycin C (unrevised structure) might undergo similar 
chemistry, wherein reduction and the loss of two acetates gives 1.249, a double Michael 
acceptor and is a potential bis-alkylating agent (Scheme 1.31b). Moore’s original hypothesis 
did not implicate the cyanamide group in the mechanism. In this context, it is worth pointing 
out that the bioreductive activation of the kinamycins cannot be overlooked as either 
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cyanamides or as diazo compounds as the diazo group is isosteric and isoelectronic with the 
cyanamide group. The speculation that the diazo group is implicated in the mechanism has 
been borne out by studies of kinfluorenone 1.20, lacking the diazo group, displays no 
detectable antibiotic activity against B. subtilis ATCC 6633, an organism very sensitive to 
the kinamycins.42 




1.5.2 Model diazo compounds 
Studies using simple aryl diazo compounds were the first reports to appear related to the 
mechanism of action of the kinamycins. Jebaratnam and Arya proposed potential reactive 
intermediates that may arise from 9-diazofluorene 1.253 which may go on to cleave DNA via 
three potential pathways: (a) the loss of N2 to generate a carbocation (b) the reduction and 
loss of N2 to generate a radical anion (c) the oxidation and loss of N2 to generate a radical 
cation (Scheme 1.32).112 The cleavage of pBR322 DNA in the presence of cupric acetate led 
those workers to speculate that DNA cleavage may result from the acetoxy radical 1.256. 
Carbenes as mediators of DNA cleavage were ruled out as all reactions were performed in 
the dark, but authors did not preclude the possible intervention of copper-carbenoid species. 
The nature of the mechanism responsible for DNA cleavage remains speculative and may 
involve more reactive oxygen-centered radicals generated from carbon-centered radicals and 
molecular oxygen. The other possibility is that the cuprous ions generated from the oxidation 
of 1.253 with cupric acetate generates reactive-oxygen species (ROS) such as Cu(I)-oxygen 
or Cu(I)-hydroxyl radical, which then are able to effect H-atom abstraction and to eventually 
cleave DNA.113 Maiya and coworkers have reported the generation of carbenes by 
photoirradiation of 1.253;114 however there are no reports which suggest kinamycins are 







Scheme 1.32: Early mechanistic studies with simple aryl diazo compounds. 
 
 
Zaleski and coworkers demonstrated 1.257 is an effective DNA photocleaving agent in the 
absence of oxygen using visible light (Scheme 1.32).115 Electrophoretic studies showed DNA 
cleavage at concentrations ranging from 12.5 to 200 μM. Subsequent spectrophotometric 
experiments suggest that metal-ligand redox chemistry may play an active role in the 
activation of the diazo group, possibly generating a diazonium cation prior to N2 release and 
electrochemical studies were invoked to support their hypothesis. The suggestion that the 
quinone moiety of kinamycin C serves as an internal redox switch to facilitate release of N2 
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is intriguing; however, reports on parallel studies using kinamycin C by these workers have 
yet to appear. These studies are difficult to extrapolate to the kinamycins, in which reports 
describing their photo-activation are lacking. Indeed, no requirement for light has been noted 
in any subsequent DNA cleavage studies with the kinamycins. Both of these reports by 
Zaleski et al. and Jebaratnam and Arya implicate Cu+2 as a species involved in DNA 
cleavage; however, a biological surrogate has yet to be identified. 
1.5.3 Mechanism studies using Kinamycins and closely associated models 
1.5.3.1 Dmitrienko: increased diazonium character correlates with increased electrophilicity 
and biological activity 
R. Laufer from this laboratory has pursued studies aimed at gaining insight into potential 
mechanistic pathways in which the kinamycins exert their biological activity.37 This was 
accomplished in part by the synthesis of the IPK model 1.262 employing a Suzuki coupling 
(Scheme 1.33). 





Previous reports in other laboratories on o- and p-quinodiazides116 and aryl diazonium 
ions117,118 suggest that their biological activity is elicited via aryl radicals that are able to 
chemically modify nucleic acid residues. More specifically, aryl diazonium ions 1.263 have 
been shown to undergo nucleophilic attack at the terminal nitrogen, generating the aryl 
radical 1.265 upon the subsequent release of N2 via homolytic cleavage reactions (Scheme 
1.34).119 Nucleophilic attack by the C-6 amino group and/or the C-2 amino group of adenine 
or guanine, respectively, on aryl diazonium ions precedes aryl radical formation, furnishing 
labelled triazenes which then, upon release of N2, provide radicals which can then react with 
nucleic acid residues in a number of established pathways. Thus, the kinamycins may elicit 
some of their biological effects via sp2 radicals that can chemically modify nucleic acid 
residues in a similar manner. 
Scheme 1.34: Nucleophilic attack on an aryl diazonium species to elicit aryl radicals. 
 
 
Data from this laboratory showed that the IR stretching frequency of the diazo group in 
compound 1.262 was 57 cm-1 lower than in IPK 1.16 which was reproduced well by ab initio 
calculations (52 cm-1) and also revealed a shorter N-N bond length in IPK compared to 
1.262. This suggests IPK possesses an enhanced diazonium ion character that is thought to be 
a consequence of the intramolecular hydrogen bonding network, shown as the resonance 
contributor illustrated in Figure 1.7. This would render the terminal nitrogen of the diazo 
group more electrophilic and consequently more susceptible to nucleophilic attack. 
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Figure 1.7: Resonance depicted in IPK confers diazonium character to the diazo group. 
 
 
This trend was reproduced well for a number of model compounds in a series of 
calculations whose results are shown in Table 1.2. These calculations revealed an even 
higher diazonium ion character in the N-N bond of the kinamycins as well as in the 
simplified model of lomaiviticin A 1.268. To this end, IPK and 1.262 were subjected to 
conditions that would test their relative electrophilicities (Scheme 1.35), the results of which 
indicated the higher degree of electrophilicity of IPK, consistent with IR studies and ab initio 
calculations. Complete conversion of IPK to 1.271 and 1.272 within 9 hours at 0 °C was 
observed, whereas a negligible reaction of 1.262 was observed after 17 hours. Thus the 
kinamycins and the closely related lomaiviticins may be activated towards nucleophilic 













Compound Calculated ν (cm-1) Calculated N-N (Å) 
9-diazofluorene 1.253 1906 1.133 
2,1-naphthoquinodiazide 1.269 2056 1.111 
1.262 2087 1.108 
1.266 2101 1.107 
1.267 2125 1.105 
IPK 1.16 2139 1.103 
Kinamycin B 1.14b 2188 1.099 
1.268 2212 1.097 











Scheme 1.35: Experimental conditions to test relative electrophilicities of IPK and 1.262.37 
 
 
1.5.3.2 Feldman: a one electron reduction to afford an aryl radical 
Feldman and Eastman have used prekinamycin derivatives in studies aimed at elucidating 
other pathways that may furnish DNA damaging reactive species.120-123 They propose a one 
electron reduction that generates an aryl radical 1.277 capable of causing DNA lesions.124,125 
Under standard radical generating conditions using Bu3SnH as a one electron donor in the 
presence of AIBN and heated in benzene at 80 °C they were able to isolate the phenyl adduct 
1.279 from dimethyl prekinamycin 1.273 (Scheme 1.36). The authors suggest that this 
chemistry serves as a model for a single electron reduction for the activation of the 






Scheme 1.36: Feldman and Eastman’s MOA studies of dimethyl prekinamycin. 
 
 
The exact nature of the reactive intermediate that preceded the formation of adduct 1.279 
was addressed through a suite of experiments using 1:1 molar mixtures of benzene and a 
series of electron-rich and electron-deficient aromatic solvents. The increased relative rates 
of aromatic solvent addition with 1.273 (an accelerating effect of most substituents relative to 
H) as well as o:m:p ratios (additions that place radical density on the substituent-bearing 
carbon) suggested a radical aromatic substitution mechanism, ruling out electrophilic 
aromatic substitution processes. 
In separate experiments using increasing concentrations of Bu3SnH, they isolated the 
reduced product with no change observed in the ratio of aromatic trapping products 
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consistent with the apparent radical addition mechanism. Although this study provides 
convincing evidence of a C-11 radical as well as insight into the intrinsic reactivity of 
prekinamycin under abiological radical-inducing conditions, it is difficult to extrapolate those 
findings to the biological environment in which the kinamycins are inherently associated 
with and to draw any relevant conclusions. 
1.5.3.3 Melander: a two electron activation by thiols 
Melander and coworkers have also explored kinamycin activity through DNA cleavage 
assays.126,127 Initial studies under conditions using DTT, NADPH, or NaCN revealed that 
plasmid DNA was cleaved by kinamycin D only in the presence of DTT, albeit at high 
concentrations of 1 M (Scheme 1.37).126 This study also identified a small number of 
substituted 9-diazofluorene derivatives that also recapitulated the activity of kinamycin D. 
Scheme 1.37: Melander’s experiment in which DTT activation of kinamycin D was 
observed. 
 
A follow-up study addressed the abnormally high concentrations of DTT, employing 
glutathione (GSH) at more biologically relevant concentrations, and DNA cleavage was 
observed in a time, temperature and concentration dependent manner.127 Sulfides are 
recognized sources of 2e– equivalents and thus it is unlikely that a 1e– reduction is occurring. 
Calculations revealed that the LUMO resides within the quinone moiety and appropriately, 
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reduction to the hydroquinone would ensue upon exposure to GSH. Consequently, there are 
two mechanistic pathways that may furnish species capable of DNA scission (Scheme 1.38). 
Nucleophilic attack on the distal nitrogen of the diazo group would lead to an aryl radical that 
may go on to cleave DNA in a number pathways previously mentioned (vide supra). The 
other would invoke protonation at the diazo carbon and the subsequent expulsion of N2 
provides the ortho quinone methide, a good electrophile, although alkylating events in 
themselves do not necessarily lead to DNA cleavage.128,129 





The most recent efforts from Melander suggest that, in the presence of a reducing agent at 
low pH, kinamycin D is capable of generating reactive oxygen species, which are then able 
to damage DNA.130 
1.5.3.4 Skibo: Quinone Methide of Prekinamycin 
Recently, Skibo and coworkers have carried out physical organic chemistry experiments 
aimed at identifying a possible mode of action of prekinamycin.131 In particular, this group 
has prepared prekinamycin and a number of analogues with the diazo carbon atom enriched  
with 13C and have subjected these to catalytic hydrogenation to mimic a two electron 
reduction that might occur in vivo. This has allowed them to detect certain intermediates that 
are reactive and possibly electrophilic. This group suggests that their observations are 
consistent with the formation of an ortho-quinone methide intermediate 1.287a upon 
reductive dediazoniation of prekinamycin 1.15 which can exist in equilibrium with a 
deazotized quinone 1.287b (Scheme 1.39). It is postulated further that those prekinamycin 
analogues that favour the ortho-quinone methide tautomer over the quinone tautomer are 
more likely to act as electrophiles with DNA bases as nucleophilic partners in conjugate 
addition reactions. Such alkylated DNA is then suggested to be unstable with respect to 
elimination reactions that ultimately effect cleavage of the DNA-backbone, thus rationalizing 
anticancer and antimicrobial activity on the basis of bioreductive activation of the 
prekinamycin system in vivo to create electrophilic species that can alkylate DNA leading 





Scheme 1.39: Skibo's postulate of protonated o-quinone methide intermediates as DNA 
alkylating reagents. 
 
There are a number of interesting, but somewhat troubling aspects to the proposals by the 
Skibo group in regard to the mechanism of action of prekinamycin and, by implication, of the 
kinamycins, the lomaiviticins and IPK. In the case of IPK 1.16, hydrodediazoniation yields 
an aromatic system rather than an ortho-quinone methide so that the Skibo mechanism 
cannot be operative in that case (Scheme 1.40a). Thus, to accept the Skibo mechanism for 
biological activity one needs to assume that, despite their structural similarity, IPK and 
prekinamycins must act by different mechanisms. The Skibo mechanism also invokes an 
unusually high basicity for the ketone carbonyl group oxygen atom (pKa ~7) wherein the 
non-protonated ortho-quinone methide is argued to be unreactive as an electrophile and must 
first be O-protonated. Why such a carbonyl group would be so basic is not clear. 
In the case of the momofulvenones 1.27, which incorporate an ortho-quinone methide 
system of the type invoked by the Skibo group, the enolic OH is very acidic and such 
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systems exist in their conjugate base form at physiological pH (Scheme 1.40b). Likewise, the 
presence of the keto group in ring D of the lomaiviticins 1.17 is likely to cause the 
corresponding ortho-quinone methide to exist in its deprotonated form at pH 7 which would 
make the system unable to function as an electrophile (Scheme 1.40c). Thus, the Skibo 
mechanism for mode-of-action of prekinamycin is unlikely to be the mode of action of the 







1.5.4 Advanced studies: Dmitrienko’s efforts towards understanding the mechanism 
of the cytotoxicity of the Kinamycins 
In recent years, our group here at Waterloo has established a collaboration with Dr. Brian 
Hasinoff in the Faculty of Pharmacy at the University of Manitoba, aimed at more in depth 
kinamycin MOA studies through various cell culture and enzyme assay techniques.38,132-134 
The first study,132 in a effort to determine the mechanism by which the kinamycins exert 
their cytotoxicity towards cancer cells, revealed that both kinamycins A and C possessed 
potent cell growth inhibitory growth effects on both Chinese hamster ovary (CHO) and 
human K562 leukemia cells, with kinamycin A observed to be the more potent of the two. 
Cell cycle analysis revealed that kinamycin A induced a G1/S cell cycle block on CHO cells, 
but, unusually, after the cells had passed through one full cell cycle and was attributed to 
using non-synchronized cells. Appropriately, studies using synchronized cells indicated that 
kinamycin A does not directly act on cell components necessary for exiting G0/G1 or entering 
S phase. Parallel studies using unsynchronized K562 cells showed no G1/S block for both 
kinamycin A and C although cell cycle comparisons were difficult to assess, either as a 
consequence of synchronization in CHO cells and/or inherent differences between CHO and 
K562 cells. Kinamycins A and C also induced apoptosis (programmed cell death) in K562 
cells, with the latter exhibiting higher potency. Both kinamycin A and C inhibited the 
decatenation activity (i.e. nicking and separating strands of DNA) of human topoisomerase 
IIα, but were found not to be poisons of this enzyme, as is etoposide. However, kinamycin A 
and C inhibition of topo II-catalytic activity did not correlate with cell growth inhibitory 
effects. Topoisomerase IIα is an enzyme intimately involved in DNA replication and 
transcription in which it alters DNA topology by the catalyzing the passing of intact ds-DNA 
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through a transient double-stranded fracture made in the other ds-DNA helix. This relieves 
torsional stress caused by native supercoiled DNA, thus allowing the normal processes of 
replication to ensue. Etoposide, an in-use clinical anticancer agent, is believed to exert its 
cytotoxicity by stabilizing the covalent topoisomerase II-DNA adduct. Lastly, both of these 
drugs were observed not to cross-link DNA nor produce damaging DNA double-stranded 
breaks. It was speculated that the kinamycins may be targeting sulfhydryl residues of 
topoisomerase-IIα as a mode of their inhibitory action and this is supported by two 
observations. Firstly, the inhibitory activity of the kinamycins rested upon the fact whether 
they were pre-incubated with DTT. Pretreatment of kinamycins with DTT protected 
topoisomerase IIα activity. Secondly, topoisomerase-IIα has been shown to be sensitive to 
sulfhydryl-reactive drugs such as cisplatin and quinones. The NCI antitumor SOM cluster 
analysis database was used to identify potential kinamycin C target(s) and projected a region 
that has not been assigned a function as of yet. This suggests that kinamycin C exercises its 
cell growth inhibitory activity on a cellular target unlike other known anticancer compounds. 
A follow-up study133 with kinamycin F showed that this drug weakly bound to calf thymus 
DNA and induced a small amount of nicking of pBR322 DNA by itself. However, in the 
presence of GSH, substantial increases of nicked DNA were seen with an increase in time but 
were attenuated when DMSO, catalase or deferoxamine was added. In K562 cell studies, 
kinamycin F promoted ss-DNA breaks but chemical reagents that were added to the cell 
culture media to either increase or decrease GSH levels did not seem to have an effect upon 
kinamycin F induced DNA strand breaks. However, kinamycin F inhibited the decatenation 
ability of topoisomerase IIα and was more potent then both kinamycins A and C by roughly 
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an order of magnitude but did not act as a poison similar to kinamycins A and C. Reducing or 
increasing levels of GSH increased or decreased kinamycin cytotoxicity respectively, an 
observation contrary to the cell-free study. The IC50 value of 0.33 μM over a 72 h window is 
similar to kinamycins A and C at 0.31 and 0.37 μM, respectively and suggests that metabolic 
deacetylation by intracellular esterases might be obligatory and may play a role in the 
delayed entry into a G1/S block observed with kinamycins A and C. 
This study showed that kinamycin F bound to DNA weakly and that DNA damage was 
greatly enhanced in the presence of GSH and that GSH promoted nicking of DNA occurred 
in an iron-, hydrogen-peroxide- and hydroxyl radical-dependent manner. Kinamycin F 
reacted with GSH in a complex manner suggesting that its cytotoxicity may be modulated by 
GSH. Treatment of K562 cells that either increased or decreased intracellular GSH levels 
resulted in decreased and increased kinamycin F cytotoxicity, respectively; however, DNA 
damage in K562 cells as elicited by kinamycin F was independent of GSH levels. EPR 
spectroscopy revealed the presence of semiquinone and phenoxyl free radicals that may go 
on to produce protein and DNA damaging species. Most recently, kinamycin F was observed 
to selectively downregulate cyclin D3 in K562 leukemia cells at the transcription level. This 
is the first indication that the kinamycins may not function simply by damaging DNA but 
might have a specific biological target associated with the induction of apoptosis.134 
Lastly, the bioactivity of isoprekinamycin was recently reported in which the growth 
inhibition of CHO and K562 cell lines was observed and that isoprekinamycin diacetate was 




1.6 Concluding remarks 
The kinamycins, first reported as N-cyanobenzo[b]carbazoloquinones but then reassigned 
as diazobenzo[b]flourenequinones, have been the subject of intensive work with recent 
studies emerging on the total synthesis and the mechanism of action of these natural 
products. 
The following work described in this thesis is primarily aimed at those aspects that focus 
on the mechanism of action and particularly the diazo group's role in the bioactivity.  This is 
addressed by the total synthesis of a prekinamycin analogue, an N-
cyanobenzo[b]carbazoloquinone and the subsequent bioactivity studies, presented in Chapter 
2. Chapter 3 addresses the notion of the possible protective/scavenging role the kinamycins 
may play upon exposure of the host bacteria to nitric oxide (NO). Structural elucidation 
studies together with theoretical work provide a distinction between diazo groups found in 
the kinamycins to that of simpler diaryl diazo compounds. Chapter 4 reports on the synthetic 
efforts aimed at improving Diels-Alder cycloadditions of the indole-2,3-quinodimethanes 
(IQDM) which would permit access to tetrahydrocarbazoles, the BCD ring of potential 
kinamycin analogues. The corresponding theoretical descriptions of these Diels-Alder 
reactions of the IQDM are presented in Chapter 5. In Chapter 6, synthetic efforts towards 
tetrahydrofluorenes are presented which would permit access to the BCD ring system of the 
kinamycins. 
The intent of this work was to provide some insight into the identity of the 
pharmacophore(s) required for the kinamycins to elicit their bioactivity. As well, it is hoped 
that future studies of kinamycin analogues synthesized from methods developed and 
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presented in this thesis, may contribute towards identifying the cellular target(s) necessary 
























Synthesis of an Isosteric-Isoelectronic Analogue of Prekinamycin 
and Evaluation of its Bioactivity 
2.1 Introduction 
The previous chapter provided a detailed historical account of the kinamycins in which the 
structural revisions reported by our group and others established the kinamycins as 
diazobenzo[b]fluorenes. Benzo-annulated fluorenes are structures rarely found in nature32 
and only a small number of reports on their biological activity exist. A recent literature 
search uncovered 128 references regarding biological studies associated with benzofluorenes, 
of which 108 references focused on the benzo[b]fluorenes (August 2009 Scifinder Scholar). 
The majority of these reports focused on tobacco, petroleum, soil, foodstuffs, wastewater, 
waste incinerators and so forth and addressed toxicological, carcinogenic, mutagenic, and 
ecological/environmental issues. Only a handful of these studies reported on antibacterial 
and/or anticancer activity and this reflects the paucity of information on this class of 
compounds as potential therapeutic agents. The kinamycins and lomaiviticins are the only 
known diazobenzo[b]fluorenes with the latter possessing very potent DNA damaging activity 
and cytotoxicity.34 The biological evaluation of the kinamycins with a focus on the 
mechanism and mode of action is an ongoing endeavor in this laboratory.37,38,132-134 
Benzo[b]carbazoles represent only a small subset of the carbazole family.84,87 The 
carbazoles constitute a large family of alkaloids in which many compounds have 
demonstrated biological activity.84-87 To date, very few reports have appeared on the activity 
of the benzo[b]carbazoles, none of which have focused on the cyanamide analogues of the 
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kinamycins, despite previous synthetic efforts towards these compounds.60,81,83,93 
Historically, owing to the confusion surrounding the kinamycins, the principal interest early 
on was firmly establishing the structure of the kinamycins and consequently efforts towards 
structural revision were of paramount interest whereas detailed bioactivity studies appeared 
to be of lesser significance. 
2.2 An Isosteric-Isoelectronic Analogue of Prekinamycin 
Most studies have focused on the chemical reactivity of the diazo group in relation to the 
bioactivity of the kinamycins.37,38,112,115,124-127 An idea that has not been addressed is the 
notion that the mode of action (i.e. inhibition) may be a consequence of a complementary fit 
to a biological receptor rather than the intrinsic chemical reactivity of the diazo moiety. This 
could conceivably be tested by abrogating the potential chemical reactivity of the diazo 
group while still keeping the overall size and electronic distribution intact. An isosteric-
isoelectronic replacement that would also afford the vinylogous resonance of the lone pair at 
C-11 with the quinone moiety would be the ideal candidate. All of these attributes are 
conveniently found within the N-cyano functionality as an isosteric-isoelectronic replacement 
of the diazo group (Figure 2.1) and that bioactivity of the kinamycins may be approached 








Figure 2.1: 2.1 as an isosteric-isoelectronic analogue of prekinamycin 2.2. 
 
In light of the many studies that propose a role of the diazo group, parallel studies have yet 
to appear for the cyanamide analogues of the kinamycins. Replacing the diazo group with a 
cyanamide would seem obvious and thus would permit insight into the diazo group’s role, if 
any, in the biological activity of the kinamycins. Thus, the primary motivation for the 
synthesis of 2.1 was to initiate biological studies not only to assess the importance of the 
diazo group, but also to evaluate benzo[b]carbazoloquinones in general which may be helpful 
in identifying the pharmacophore(s) responsible for the biological properties of the 
kinamycins and lomaiviticins. Ultimately, this novel information might facilitate drug design 
towards potential therapeutic agents. 
2.3 Synthesis 
2.3.1 Introduction 
Benzo-annulated carbazole ring systems are found very rarely in nature.84,87 
Benzo[b]carbazoles and their quinoid counterparts have been synthesized by several groups: 
Grinev,135 Kametani,136 Thomson,137 Snieckus,138 Kano,139 Gribble,140-145 Moody,146,147 
Liebeskind,148 Sha,149 Ley,150 Kreher and Dyker,151 Bergman,152 Pindur,153-155 Bittner,156 
Suginome,76,157 Hoornaert,158 Murphy,78 Molina,159 Brown,160 Echavarren,60,93 Castedo,80 
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Srinivasan,82 Vollhardt,161 Knölker,81,83 Dmitrienko,31 Kucklander,162,163 Koomen,164 
Åkermark,165,166 Markgraf,167 Cheng,168 Kirsch,169 Shi and Wang,170 Kobayashi,171 Black,172 
Schmittel,173 Estevez,174-179 Miki,180 Mal,181,182 Bowman,183 Mohammed,184 Xu185 and 
Fagnou186 and have been reviewed elsewhere.84-88 Only four of these studies have reported 
bioactivity data162-164,168 with molecular modeling studies155,187,188 also described. Reports of 
biological studies on 2.1 or its derivatives have yet to appear in the literature. 
Previous synthetic efforts from this laboratory towards the N-
cyanobenzo[b]carbazoloquinones were described in Chapter 1 (Sections 1.2.4 and 
1.4.1).31,59,75 The methods developed in this laboratory towards the synthesis of 
indoloquinones were subsequently employed in Diels-Alder reactions. Using this strategy, a 
total synthesis of 2.4 was accomplished by S. Mithani in nine steps with an overall yield of 
19% (Scheme 2.1).31 Although this synthesis adequately provided material that was vital in 
that structural elucidation study, future synthetic efforts towards this natural product 
analogue would require a revision of the synthesis. When this project began, the only reports 
pertaining to the synthesis of benzo[b]carbazoloquinones were studies in which the syntheses 
were plagued by low yields, nitrogen substituent issues and targets that lacked the 
appropriate A and D ring substitution pattern owing to either simplified or symmetrical 
precursors used in the early stages of the synthesis. Potentially any biological data obtained 
from these compounds would be better understood in light of parallel data provided by 2.1. 
There are only two studies that have reported the synthesis of 2.1;60,93 however, the earlier 
study by Echavarren provided incorrect assignments for the proposed structure of 2.1 that 
subsequently were corrected in their later report as discussed in Section 1.4.1. A drawback of 
 
 76 
the studies by the Echavarren group is that they suffered from regioselectivity issues during 
cyclization. 
Scheme 2.1: Mithani’s target N-cyanobenzo[b]carbazoloquinone 2.4 obtained from 2.3. 
 
With respect to Mithani’s carbazole synthesis of 2.4, two issues of concern were to be 
addressed. First, was to shorten the lengthy linear sequence and secondly to avoid 
stoichiometric amounts of metals used (i.e. palladium) in the oxidative ring closure, with the 
hopes of implementing a catalytic step at this point. Retrosynthetic considerations indicate 
that 2.1 could be generated from a functionalized naphthylamine which in turn comes from 
readily available 1,5-dihydroxynaphthalene 2.18 (Scheme 2.2). The key disconnections 
suggest that an oxidative cyclization, a condensation, a Buchwald-Hartwig cross-coupling 
and acylation with appropriate functional group transformations might be appropriate to 
obtain the target. In Scheme 2.2, the cyanamide moiety is introduced in the later stages of the 
synthesis. However, introduction of the cyanamide at an earlier stage might expedite the 
synthesis and appropriate exploratory efforts towards the cross-coupling of cyanamide to aryl 







Scheme 2.2: Retrosynthetic analyses of 2.1. 
 
 
2.3.2 Attempts towards Buchwald-Hartwig couplings of cyanamide to aryl halides 
Reports employing carbon-carbon and carbon-heteroatom bond forming methods have 
undergone a surge in recent years owing to the many advances in transition metal-mediated 
cross-coupling reactions.189-193 It was envisioned that cyanamide might be coupled to an aryl 
halide directly providing expedient access to the desired functionality thus abrogating the 
necessary steps of coupling with an ammonia surrogate, hydrogenolysis and N-cyanation 
(Scheme 2.3). Discussion of this chemistry with Professor Buchwald revealed that the  
Buchwald group had never attempted such a coupling of an aryl halide with a cyanamide. 
This represented several obstacles, of which one was a lack of a literature precedent for 
coupling cyanamide as carbon-nitrogen bond forming methods are generally restricted to 
amines and amides. The ortho substitution pattern represented another challenge inherent to 
the synthesis, with some literature accounts reporting sensitivity to ortho substituents.194 
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Lastly, the use of relatively inexpensive copper catalysts compared to palladium catalysts 
was also a consideration and consequently studies using simple model systems were initiated 
employing copper reagents. 
Scheme 2.3: Potential synthetic routes to access 2.7 via Buchwald-Hartwig couplings. 
 
2-Bromoanisole (2.14) represents an appropriate model for the naphthyl halide 2.5 shown 
in Scheme 2.3. The Buchwald group reported the coupling of 2-bromoanisole with 
benzamide in 84% yield.195 This experiment was repeated under the same conditions, and a 
59-71% isolated yield was obtained (Scheme 2.4). A small increase in the yield was observed 
when using copper iodide that had been purified.196 
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Scheme 2.4: Buchwald-Hartwig coupling of o-bromoanisole and benzamide. 
 
Encouraged by this result, those conditions were then extrapolated to the coupling of 
cyanamide in which some of the experimental parameters were varied (Table 2.1). The 
spectroscopic assignments of 2.18 were established by an independent synthesis employing 
o-anisidine and cyanogen bromide. In all cases, inspection of the 1H NMR spectrum of the 
crude material revealed no trace of 2.18. and in some of these cases, a complex mixture 
resulted (entries 3, 5-7). In the end, it was found that these conditions were of little synthetic 
value. To this date, studies on metal catalyzed cross-coupling reactions employing 
cyanamide remains an unexplored area.197 The failure of the cyanamide couplings meant that 
the more conventional approach to the synthesis of the AB synthon would be required using 










Table 2.1: Attempted Buchwald-Hartwig couplings of cyanamide with o-bromoanisole. 
 
Entry CuI (eq.) Ligand (eq.) K2CO3 (eq.) Solvent Additives Results 
1 0.01 0.11 2.1 Dioxane nil a 
2 0.01 0.11 2.1 Dioxane nil a 
3 0.1 1.1 2.1 Dioxane nil b 
4 0.1 1.1 2.0 Dioxane 0.2 KI a 
5 0.1 1.1 2.0 Toluene 0.2 KI b 
6 0.5 5.5 2.1 Dioxane nil b 
7 0.1 1.1 5.1 Toluene nil b 
a. starting materials recovered. 
b. complex mixture. 
2.3.3 Synthesis of the N-cyanobenzo[b]carbazoloquinone analogue of Prekinamycin 
The synthesis of 2.1 relies on the condensation of an AB ring synthon with 5-
methylcyclohexane-1,3-dione as the D ring, and subsequent carbon-carbon bond formation 
between the B and D rings producing the C ring pyrrole, thereby furnishing the tetracycle 
(Scheme 2.2). 
Efforts towards the synthesis of 2.1 began with 2.19 which was O-methylated affording 
2.20 in nearly quantitative yield (Scheme 2.5).198,199 Using procedures reported by 
Rapoport,200 installation of the C-1 hydroxyl was accomplished under Vilsmeier-Haack 
conditions producing aldehyde 2.21 and a subsequent Baeyer-Villiger oxidation to afford the 
formate 2.22 which, after methanolysis, yielded naphthol 2.23 in 54% yield over three steps. 
The formate 2.22 obtained from the Baeyer-Villiger oxidation invariably contained a 
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persistent impurity even after extensive washing and chromatography and was thought to be 
m-chlorobenzoic acid. Alternative procedures using potassium fluoride201 showed modest 
increases in purity of the crude product after aqueous workup but gave a lower yield of 83%. 
Another procedure in which dichloromethane was replaced by ethyl acetate202 did not resolve 
any of these issues, producing a yield of 59%. A small portion that had been extensively 
washed was loaded onto a column of silica which afforded a few fractions that were of 
sufficient purity to permit full characterization. Regioselective bromination of 2.23 produced 
2.24 and subsequently O-methylated to afford the trimethoxy-bromonaphthalene 2.25 in 49% 
yield over six steps and provided the key intermediate for the impending Buchwald-Hartwig 
cross-coupling. 
Scheme 2.5: Synthesis of 2.25. 
 
 
Although this route provided sufficient amount of the requisite material, a shorter route to 
2.25 or analogue thereof was recognized. Reports on the rapid and easy access to halogenated 
naphthoquinones200,203-207 are known as are reports of Stille,60,77,93,208 Suzuki-Miyaura,209,210 
and Castro-Stephens/Sonogashira211,212 cross-couplings using bromo-naphthoquinones that 
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potentially could be translated into Buchwald-Hartwig couplings, thus significantly reducing 
the overall number of steps to access the quinoid analogue of 2.25, making this an attractive 
route. To this end, exploratory efforts in this lab were pursued by an undergraduate student T. 
Rybak to test the feasibility of Buchwald-Hartwig couplings of bromo-naphthoquinones as 
well as other strategies (Scheme 2.6). 
Scheme 2.6: Possible synthetic routes for the amination of bromo-naphthoquinones. 
 
Juglone (2.28)213 was obtained in 37% yield from 2.19 (Scheme 2.7) which was then 
brominated to afford dibromo-dihydrojuglone 2.29214 which was stable and did not aromatize 
to the hydroquinone. Efforts towards regioselective dehydrodehalogenation of 2.29 included 
exposure to silica gel214 and refluxing in ethanol,203,207,215 as described in the literature and 
DBU-induced elimination. Exposure of 2.29 to silica gel chromatography returned mostly 
starting material with small amounts 2.30 and 2.31. Alternatively, conditions of refluxing 
ethanol provided a quantitative yield of the two regioisomers 2.30 and 2.31 as an inseparable 
mixture even after repeated attempts at chromatography, as well as a small quantity of the 
ethoxy-juglone 2.32, isolated in 7% yield in a separate experiment under identical conditions. 
Others have also reported the generation of 2.30 and 2.31 obtained from refluxing 2.29 in 
ethanol.200 Efforts at fractional crystallization207 also proved futile. Attempts at 
dehydrohalogenation using DBU produced a complex mixture in which large amounts of 
DBU were observed even after extensive washings with a saturated solution of ammonium 
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chloride. Efforts towards 2.30 will be pursued as a future endeavor as it is an important 
intermediate that has potential use within the synthetic program for the kinamycins in this 
laboratory. 
Scheme 2.7: Production of 2.29 and attempts of its regioselective dehydrohalogenation. 
 
 
Assignment of the two regioisomers, 3-bromojuglone (2.30) and 2-bromojuglone (2.31), 
was based on previous work in other laboratories. The synthesis of the acetate of 2.30 (m.p. 
148 °C) was accomplished by Wheeler and Scott216 (initially mistaken to be acetate of 2.31). 
The unambiguous synthesis of the acetate of 2.31 (m.p. 158 °C) by chromic acid oxidation of 
2,4-dibromo-5-acetoxy-1-naphthol was accomplished by Carter et al. In the present study, 
examination of a pure mixture of 2.30 and 2.31 did not indicate which regioisomer was 
produced in excess. However, Brimble et al.214 and Tietze et al.215 have both indicated that 
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2.30 is produced in excess of 2.31 when conditions of refluxing ethanol were employed. 
Thus, the observations of both Brimble and Tietze were used in the present study to facilitate 
assigning the signals in the 1H NMR and 13C NMR spectra of a pure mixture of the 
regioisomers to the respective compound. 
During this investigation, it was also observed that the 13C NMR assignments reported for 
C-2 (142.40 ppm) of 2.30 by Brimble214 did not match ours and initially, albeit erroneously, 
we had assigned this resonance to C-2 of 2.31 (assigned as 140.90 ppm by Brimble). Further 
structural elucidation studies of a pure mixture of the two regioisomers was accomplished by 
comparison to reports made by others (vide supra) in conjunction with extensive NMR 
studies including JMOD, COSY, HMQC and HMBC NMR experiments which permitted the 
assignment of C-2 of 2.30 to 139.26 ppm, corresponding to Tobinaga’s assignment at 139.29 
ppm.207 Despite the unsuccessful attempts of producing 2.30 in adequate amounts, access to 
material readily available in this laboratory by other methods provided 2.33 (Scheme 2.8) 
and subsequently permitted exploratory efforts into different amination strategies. The 
oxidation of 2.25 using ceric ammonium nitrate (CAN) furnished 2.33 in 61% yield as shown 
in Scheme 2.8. 
 





Reports on the direct coupling of ammonia to aryl halides217-221 have appeared in recent 
years and in particular the study by Xia and Taillefer220 was compelling owing to the readily 
available and inexpensive catalyst system used in that report. That system performed well for 
either electron rich or electron poor aryl iodides and bromides, but the observation that 
electron poor aryl bromide systems worked well provided the motivation to pursue this 
strategy with the bromo-naphthoquinone system 2.33. Those authors reported an 85% yield 
of m-methoxyaniline 2.35 from m-bromoanisole 2.34. In our hands, we obtained a 26% yield 
(Scheme 2.9a) but felt that the low yield may be offset by the fewer number of steps taken in 
the synthesis of aminonaphthoquinones 2.27. As well, traditional palladium cross-couplings 
using ammonia surrogates would also be explored. Under conditions reported by Buchwald 
using benzophenone imine as the ammonia equivalent,222 a 31% isolated yield (two steps) of 
2.37 was obtained (Scheme 2.9b) where those authors reported an 87% isolated yield. Having 
achieved modest yields using these couplings on model systems, attention was then turned to 
8-methoxy-2-bromojuglone 2.33 (Scheme 2.10) with the hopes of using the chemistry 










Scheme 2.9: Copper and palladium catalyzed cross-couplings of bromoanisoles. 
 
 
Initial studies under conventional Buchwald-Hartwig conditions (0.68% Pd2(dba)3, 1.87% 
BINAP, 1.3 eq. NaOtBu, toluene, 85 °C) provided a small amount of product as observed in 
the 1H NMR spectrum of the crude residue. Increasing the loadings of the catalyst and ligand 
to 10 mol% and 30 mol%, respectively, afforded 2.38 in 17% isolated yield (Scheme 2.10). 
Under modified conditions, changing the base to cesium carbonate and the solvent to DMF, 
the isolated yield dropped to 9%. For this system employing cesium carbonate and DMF, the 
isolated yields doubled from 4% to 9% when the catalyst (2.7 mol% to 5 mol%) and ligand 
(15 mol% to 30 mol%) loadings were doubled. Disappointingly, the copper system produced 
a complex mixture. With the desired target produced in low yields, these cross-coupling 
conditions were of little synthetic value, thus our focus turned to other strategies. 
Recognizing that 2.33 is amenable to addition-elimination conditions223-227 attempts using 
2.36 failed to provide 2.38, instead isolating the vinyl ether 2.39 in 11% yield, analogous to 
the earlier result that gave 2.32. Despite these low yields, we were able to demonstrate that 
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these cross-couplings using these substrates are indeed feasible. To the best of our 
knowledge, there are no reports on couplings of imines with halogenated naphthoquinones 
and thus this is the first demonstration of a Buchwald-Hartwig cross-coupling employing 
these types of systems. 
Scheme 2.10: Various amination attempts towards the synthesis of 2.38. 
 
Based on the realization that 2.33 is a poor substrate under various cross-coupling 
conditions, it was decided that further attempts at installing the amino group would be 
explored using the aromatic system 2.25 with copper reagents. Kwong and Buchwald have 
reported the coupling of primary amines to aryl bromides in high yields using copper iodide 
and N,N-diethylsalicylamide 2.41 as the ligand.228 In this study low yields and recovery of 
starting material were observed (Scheme 2.11). Unsure of whether the catalyst-ligand 
combination or the substrate was the cause of the low yields, the experiment was repeated as 
shown in Scheme 2.4 replacing 2.14 with 2.25. A yield of 8% of 2.43 (Scheme 2.11c) 
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suggested that the substrate 2.25 was intrinsically unsuitable with these copper reagents for 
reasons unknown and this approach was abandoned in favor of the use of palladium reagents. 
 
Scheme 2.11: Attempted copper catalyzed cross-couplings of aryl bromides 2.14 and 2.25. 
 
 
The palladium catalyzed coupling produced a yield of 86% with the model system 2.14 
(Scheme 2.12a) but when 2.25 was employed under similar conditions, small amounts of the 
reduced arene 2.45, identified by GC-MS analysis (m/z = 218, M+), was observed along with 
the desired coupled product 2.44 as an inseparable mixture even after repeated 





Scheme 2.12: Palladium catalyzed cross-couplings of aryl bromides. 
 
 
Other phenol protection strategies were investigated with the hopes of resolving the 
reduced arene from the coupled product and to increase the yield of 2.46. A one pot 
reduction-acetylation92 of 2.33 gave 2.47 in 95% yield (Scheme 2.13a). The cross-coupling 
of 2.47 under similar conditions as described in Scheme 2.12a, failed to provide the desired 
target 2.48 (Scheme 2.13b). Analysis of the 1H NMR spectrum of a chromatographic fraction 
revealed it to be a mixture of what was thought to be 2.50 as the major component with a 
small amounts of 2.47 and 2.49 as well as 2.51 obtained in a separate fraction indicating 
deacetylation had occurred. The results of these studies hastened efforts towards other routes 
that would provide 2.46 in an efficient manner. 
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Scheme 2.13: Synthesis of 2.47 and subsequent use in Buchwald-Hartwig couplings. 
 
 
The strategy of using benzophenone imine (2.36) as the ammonia surrogate was revisited 
as shown in Scheme 2.14. Coupling of 2.25 with 2.36 proceeded uneventfully producing 2.52 
which, after hydrogenolysis, gave the requisite naphthylamine 2.46 in a gratifying 78% yield 
over two steps. Condensation of 2.46 with 2.53 afforded anilinoketone 2.54 and subsequent 
oxidative ring closure84,229 produced the tetracycle, the benzo[b]tetrahydrocarbazole 2.55. 
Annulation typically gave yields of 27-36%. Several attempts were made to increase the 
yields by varying the time, temperature and the amount of oxidant. Substituting 
trifluoroacetic acid (TFA)229 for acetic acid resulted in recovered starting material. In the end 
it was found that two equivalents of palladium acetate provided the best yields at 46-51%. N-
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Cyanation using phenyl cyanate230 proceeded smoothly to give 2.56 and subsequent 
oxidation to the quinone 2.57 occured in 95% yield. 
 





Access to 2.58 and 2.61 (obtained from 2.56 and 2.57, respectively) was desired as there 
was interest in the implications that the cyclohexenone moiety (D-ring) may have on the 
bioactivity in comparison to that of the target 2.1 and the natural product 2.2. Attempts at 
global deprotection of 2.56 using BCl3 resulted in recovery of starting material (47%) as well 
as a mono-deprotected species, presumably 2.59 (13% yield) owing to the possible directing 
effect afforded by the D-ring carbonyl. Owing to this fact, it was felt that the 1,4-quinone 
moiety of 2.57 should facilitate deprotection and since the plan was to obtain 2.57 in any 
event, various demethylation conditions were attempted on 2.57. The use of five equivalents 
of BBr3 led to a complex mixture, but when the Lewis acid was scaled back to two 
equivalents, 2.60 and 2.61 were observed, although in low yields. The appearance of 2.60 led 
us to believe a disproportionation reaction was occurring in which 2.57, acting as a hydride 
source, furnished the hydroquinone 2.60. Alternative strategies using BBr3 with DDQ, BCl3 
and pyridinium·HCl gave complex mixtures. 
The remaining steps of silylation, aromatization and deprotection are shown in Scheme 
2.15. Enolization of the keto-D-ring was achieved by silylation of 2.57 to give the silyl enol 
ether 2.62 and subsequent aromatization with DDQ afforded 2.63. Global deprotection with 








Scheme 2.15: The remaining steps of the synthesis towards 2.1. 
 
 
2.4 Other reported syntheses of Benzo[b]carbazoloquinones 
During the time in which the synthesis of 2.1 was undertaken, a number of reports 
illustrating different approaches towards benzo[b]carbazoloquinones (also known as 
indolonaphthoquinones) have appeared. Most notably are the recent efforts by Estevez and 
coworkers.178,179 Their early strategy relied on a Heck coupling of n-butyl vinyl ether with 
either o-bromophenylacetic acid 2.64174,176 or o-bromobenzoic acid 2.66175 that displayed 
novel regioselectivity under either modified (TlOAc added) or classical Heck conditions, 
affording the α-arylation product 2.65 and 2.67, respectively (Scheme 2.16). They attributed 
the high α-regioselectivity to the chelating effect of the carboxymethyl group231 which differs 
from the mechanism proposed by Cabri.232 The goal of these early efforts was accessing the 
3-hydroxy-2-aminophenyl-1,4-naphthoquinones 2.68, the requisite synthetic intermediate 
also used by others60,80,93 in the construction of benzo[b]carbazoloquinones. Depending on 
experimental conditions access to the benzo[a]carbazoles was also possible, providing a 
divergent synthetic strategy.177 Admittedly, Estevez has acknowledged experimental 
difficulties owing to the early preparation of naphthoquinone subunit,177 and may be due to 
purification issues, a problem also encountered in this laboratory (vide supra). 
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Scheme 2.16: Estevez’s efforts towards the synthesis of 2.69 using Heck chemistry. 
 
Recognizing the lack of available methods for preparing functionalized 
tetrahydrocarbazoles, Estevez employed a Michael addition of naphthalene 2.70 to nitrosugar 
2.71 followed by an intramolecular Henry reaction of 2.74 providing 2.75 as the key step 
towards the synthesis of 2.79 (Scheme 2.17). The conjugate addition of the lithionaphthalene 
derived from 2.70 to both faces of the nitroethylene moiety of 2.71 produced a mixture of 
epimers 2.72 and 2.73 in a 4.7:1 ratio in which stereoselectivity was due to preferential attack 
at the si face of the double bond and was confirmed by X-ray studies. Removal of the 
acetonide protecting group produced the furanose 2.74, which under basic conditions (i.e. 









Scheme 2.17: Estevez’s synthesis of the benzo[b]tetrahydrocarbazoloquinone 2.79. 
 
The high degree of stereoselectivity achieved for the Henry reaction is illustrated in 
Scheme 2.18. The reaction of 2.80 (in equilibrium with 2.74) furnishes a mixture of the 
nitrocyclohexanes 2.75 and 2.82 via the corresponding transition states 2.83 and 2.81, 
respectively. It is proposed that that compounds 2.75 and 2.82 are interconvertible by a retro-
Henry reaction via 2.80. Thus 2.75 is favored over 2.82 as 2.75 is the more 
thermodynamically stable product. Reduction, oxidation and cyclization complete the 






Scheme 2.18: Diastereoselectivity of the Henry reaction producing 2.75. 
 
A subsequent study by Estevez using nitrocyclohexene 2.85 illustrates another method by 
which 1,2,3,4-tetrahydro-5H-benzo[b]carbazole-6,11-dione 2.90 could be accessed (Scheme 
2.19). The diastereomeric pair 2.86 and 2.87 was subjected to Nef reaction conditions 
producing 2.88 which was oxidized to the quinone 2.89 and treated with ammonium acetate 
in glacial acetic acid to give the heteroannulated target 2.90. 
These methods by Estevez illustrate two different approaches at introducing a cyclohexene 
D-ring providing tetrahydrobenzo[b]carbazoles which, in the former case, can be highly 
functionalized. The interest of these authors in producing compounds such as 2.79 and 2.90 
is ultimately to access the corresponding N-cyano derivatives for the purpose of biological 









2.5.1 Introduction and Background 
The occurrence, isolation and structure elucidation of natural carbazoles has created great 
interest as potential therapeutic agents owing to their vast display of pharmacological activity 
which in some cases, has been observed to be extremely high.87 This in turn has provided the 
motivation to synthesize various analogues of these natural products with the goal of 
attaining more desirable biological properties than the parent compound. Many of the 
carbazoles isolated from Nature range from the simpler tricycles to more elaborate systems in 
which there is extensive structural variation around the carbazole nucleus. The large body of 
reports focused on the activity of carbazoles precludes the presentation of a comprehensive 
overview here; however, there is some merit in discussing a select few representative 




2.5.2 Bioactivity of Pyrido[4,3-b]carbazoles and Indolo[2,3-a]pyrrolo[3,4-c]carbazoles 
Of the carbazoles, members of the pyrido[4,3-b]carbazole 2.91 and indolo[2,3-
a]pyrrolo[3,4-c]carbazole 2.92 families encompass a large group of therapeutically useful 
antitimour agents and are either currently employed in the clinical environment or are in 
various stages of clinical development (Figure 2.2).87 





A representative member of the family 2.91, ellipticine 2.93 is one of the most well known 
carbazoles.233 Displaying potent cytotoxicity against a number of tumours and leukemias, 
ellipticine is too toxic to be of therapeutic use. However elliptinium 2.94 (celiptium®, NSC 
264-137) an ellipticine analogue, has been used in cancer chemotherapy since its introduction 
in 1977.234-238 In the 1980’s, second generation ellipticine-derived anti-tumour reagents were 
developed, some of which demonstrate better activity than 2.94.239,240 The mechanism of 
action of ellipticine and its derivatives is not well understood, but it is believed that more 
than one mechanism is operative in vivo.241 Ellipticine as well as its derivatives, intercalate 
DNA with cytotoxicity observed as a consequence of DNA strand cleavage associated with 
the enzyme DNA topoisomerase II.87 Human DNA topoisomerase II is an enzyme intimately 
involved in DNA replication in which catenation (interlinking two circular DNA strands) and 
decatenation (separation of two circular DNA strands), supercoiling and relaxation, knotting 
and unknotting take place.242 Thus, topoisomerase II cleaves and rejoins DNA strands. 
Eukaryotic topoisomerases II only relax supercoils and do not generate them and are able to 
hydrolyze ATP. The corresponding complements in prokaryotes, also known as DNA 
gyrases, have been studied extensively. The DNA gyrases catalyze the stepwise negative 
supercoiling of DNA with concomitant hydrolysis of ATP. This manifests as double-stranded 
breaks in the DNA, an important step in DNA replication and occurs with all topoisomerase 
II enzymes, regardless of origin. Topoisomerase II bonds to the 5-phosphate on adjacent 
DNA strands via tyrosine, four base pairs apart forming the DNA-enzyme complex. The 
stabilization of this complex owing to its interaction with certain drugs such as 2.93, form the 
cleavable complex which then lead to the cleavage of double-stranded DNA. Thus, inhibiting 
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this enzyme selectively kills proliferating cells and consequently topoisomerase II is the 
target of widely used cancer drugs. 
The second group, the indolo[2,3-a]pyrrolo[3,4-c]carbazole 2.92, possess anti-tumour 
properties which may be due to DNA intercalation, topoisomerase inhibition, and inhibition 
of protein kinases of which several representatives of this group are in clinical trials.87 They 
have been classified broadly into two groups based on their structure and mechanism of anti-
tumour activity. The first group are inhibitors of DNA topoisomerase I and do not possess 
kinase inhibitory activity. Rebeccamycin 2.95 and its derivatives are found here.243,244 The 
other group includes the protein kinase C inhibitors such as staurosporine 2.96245,246 and its 
derivatives. 7-Oxostaurosporine 2.97 showed activity against K562 cells, a human 
erythroleukemia cell line.247 Another isolate, BE-13793C 2.98 displayed strong activity 
against human topoisomerase I and II.248 These observations are significant in the context of 
the activities reported for the kinamycins presented in Chapter 1, Section 1.5.4. Examples of 
the quinolino[4,3-b]carbazole-1,4-quinone (indolophenanthridine) family are represented by 
calothrixin A 2.99 and calothrixin B 2.100 and deserve mention on the basis of structural 
features that extend the ellipticine skeleton and incorporate the 1,4-quinone moiety as well as 
their unique activity profile in which the growth inhibition of chloroquin-resistant strain of 







2.5.3 Bioactivity of Benzo[b]carbazoles 
2.5.3.1 Early reports 
Gribble reported the potential bifunctional DNA intercalating agent 2.101 (Figure 2.3).141 
Pindur has performed extensive molecular modeling studies on benzo[b]carbazoles 
intercalating with DNA155,187,188 and found that 2.102 possessed cytostatic activity against 
L1210 leukemia cells. Kucklander’s earlier efforts found 2.103 was active against a variety 
of colon and lung cancers.162 Later studies revealed that 2.104 and 2.105 possessed marked 
potency against specific melanoma and leukemia cell lines.163 Strikingly, 2.105 bearing a 
quinone methide, displayed activity that was comparable to clinically established anticancer 
agents such as amsacrine or mitomycin C. Those authors attribute the potent anticancer 
activity of 2.105 to its ability to intercalate DNA, a phenomenon not observed with 
compounds 2.104. Koomen observed 2.106 to have low cytostatic activity which suggested 
the presence of the pyridine nitrogen found in ellipticine 2.93 was essential for antitumour 
activity.164 Cheng synthesized 2.107 with varying substitution patterns but in all cases only 














2.5.3.2 Bioactivity studies from this laboratory 
The results from the testing of the growth inhibition of K562 cells by two cyanamide 
analogues prepared in the present study as well as by prekinamycin and kinamycin F are 
shown in Table 2.2. The details of the cellular inhibition assay are given elsewhere.133 The 
IC50 value is a measure of how much of a particular substance is needed to inhibit a given 
biological process by 50% compared to that of a control group. Stated otherwise, the IC50 is 
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the measure of the effectiveness of a compound at inhibiting a biological/biochemical 
function by 50%. 
Inspection of Table 2.2 reveals that kinamycin F is the most active compound with an IC50 
range ~0.3-0.7 µM. The cyanamide compound 2.57, an earlier synthetic precursor of 2.1, is 
the least bioactive with an IC50 range of ~21-49 µM. Further inspection of Table 2.2 reveals 
that entries 1 and 2 indicate that prekinamycin is slightly more active than the cyanamide, 
whereas entry 3 indicates the opposite scenario with the cyanamide demonstrating slightly 
higher activity than prekinamycin. Taken together, entries 1-3 would suggest 2.1 and 2.2 
possess comparable biological activity owing to the tight range of data (i.e. within the same 
order of magnitude) but does not imply that activity is necessarily elicited by the same 
mechanism. This observation raises the question of what role the diazo function has with 
respect to mechanism of action (MOA) and what the putative intracellular target or targets 
might be. These results have obvious implications in regard to the design of kinamycin 
analogues as well. We have suggested that the cytotoxicity of kinamycin F is due in part to 
the unique conformation of the polyhydroxylated D-ring, which has been shown to increase 
the diazonium ion character of the diazo group.101 In this context, the results presented in 
Table 2.2 raise the issue of whether kinamycin F is a more potent inhibitor than its 







Table 2.2: The growth inhibition of K562 cells (IC50 µM) for selected compounds. 
 
   IC50 (µM) 
Entry  Trial 2.57 2.1 2.2 2.108 
1 Control 1 46.7 ± 4.8 13.9 ± 1.0 10.7 ± 1.1 0.728 ± 0.063 
2 " 2 49.2 ± 8.9 11.9 ± 2.7 8.46 ± 1.5 0.429 ± 0.071 
3 " 3 44.0 ± 12.4 14.6 ± 1.9 22.2 ± 2.1 0.536 ± 0.112 
4 " 4 21.3 10.9 na 0.356 
5 " 5 na na na 0.333 ± 0.02a 
6 OTC 1 na 5.23 ± 1.56 4.30 ± 1.92 0.36 ± 0.08 
7 BSO 1 9.48 ± 3.85 4.60 ± 0.92 5.88 ± 2.47 0.37 ± 0.06 
n.a.: not available; a. previous literature value (Ref. 133); OTC: (-)-2-oxo-thiazolidinecarboxylic acid (OTC); BSO: buthionine sulfoximine. 
 
Data shown in entries 6 and 7 were collected from conditions in which cultures were 
exposed to (-)-2-oxo-4-thiazolidinecarboxylic acid (OTC) and buthionine sulfoximine (BSO) 
before exposure to any of the compounds listed in Table 2.2. OTC and BSO increase and 
decrease, respectively, the intracellular concentrations of glutathione (GSH), an 
endogenously produced antioxidant containing a thiol functional group. Previous work by 
our laboratory has shown that kinamycin F, when incubated with GSH, is reductively 
activated to cleave DNA in vitro. In cell culture studies, however, raising intracellular GSH 
levels by exposure to OTC or lowering GSH levels with BSO did not affect the cytotoxicity 
of kinamycin F,133 although the standard errors in such measurements are relatively large. 
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If direct, bimolecular reaction of GSH and GS were to be involved in either the activation 
or deactivation of these compounds in whole cells, one might have expected a significant 
influence of intracellular GSH levels on IC50 measurements. It is possible, however, that 
GSH/GS are involved but in an enzyme catalyzed process involving glutathione-S-
transferase (GST). GST catalyzes the reaction of GSH with exogenous electrophilic species 
and thus serves to detoxify such compounds, although with certain compounds the 
"detoxification" process leads to actual activation of compounds into cytotoxic forms (e.g. 
certain enediynes). It is possible that the [GSH] remains substantially in excess of the KM for 
GSH such that the GST-catalyzed reaction remains saturated with respect to GSH over the 
entire range that [GSH] is varied in the whole cell experiments using OTC or BSO. 
 
The results presented in Table 2.2 also invite theoretical studies that may lend insight into 
the reactivity of these compounds. Quantum chemical calculations were undertaken on 2.1, 
2.2 and GS 2.109b at the DFT B3LYP 6-31 G(d) level of theory. Figure 2.4 illustrates the 
respective HOMOs and LUMOs of 2.1 and 2.2 and their corresponding energy levels. These 
data are partially reiterated in Figure 2.5 in which the frontier molecular orbital energies of 
2.1, 2.2 and 2.109b are shown. Inspection of the HOMO energies reveals that the HOMO of 
cyanamide 2.1 is 9.9 kcal·mol-1 lower in energy than that of prekinamycin 2.2. As well, 
inspection of the LUMOs reveals that the LUMO of 2.1 is 4.8 kcal·mol-1 lower in energy 
than that of 2.2. The Gibbs free energy (G) was retrieved for 2.1 (-1102.150580 a.u.) and for 
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2.2 (-1102.130649 a.u.), indicating that the cyanamide analogue is thermodynamically more 
stable than prekinamycin by 12.5 kcal·mol-1. 
 
Figure 2.4: The HOMO and LUMO of 2.1 and 2.2 and their corresponding energy levels 
(eigenvalues) generated at the DFT B3LYP 6-31 G(d) level (1 a.u. = 627.5095 kcal·mol-1). 
2.2 HOMO E = -0.20806 a.u.
2.2 LUMO E = -0.12671 a.u. 
2.1 HOMO E = -0.22381 a.u. 
2.1 LUMO E = -0.13435 a.u.
 
Intracellular concentrations of GSH 2.109a can be as high as 10 mM.250 The pKa of the 
thiol moiety of GSH is 8.66251 and at physiological pH (6.8 to 7.4), ~1-5% would exist 
ionized as the thiolate, GS 2.109b (Scheme 2.20). In general, it is the thiolate form of GSH 
that is the predominant nucleophilic species rather than the thiol (Figure 2.6). Unpublished 
data obtained from studies conducted by N. Chen from this laboratory, in which kinamycin F 
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was allowed to react with GSH, suggest that kinamycin F, possessing an electrophilic diazo 
moiety, is attacked by GSH at the terminal nitrogen, furnishing an azo adduct. Subsequently, 
it may be envisioned that in the biological milieu, the azo adduct, upon homolysis, produces 
molecular nitrogen and an aryl radical, presumably leading to cell death via a number of 
potential pathways (Scheme 2.21) and is discussed in the context of Figure 2.7 (vide infra). 
 
Figure 2.5: Frontier molecular orbital energies (a.u.) of cyanamide 2.1, prekinamycin 2.2 







































Scheme 2.21: Possible interaction of GSH with kinamycin F. 
 
 
If frontier orbital interactions are important in the nucleophilic addition of GS to these 
systems, then 2.2 is expected to be more reactive since the GSHOMO-2.2LUMO gap is smaller 
than the GSHOMO-2.1LUMO energy gap (Figure 2.5). On the other hand, if electron transfer is 
important, the lower LUMO for 2.1 would suggest a higher electron affinity (EA) and a 
greater tendency of 2.1 to accept an electron in a single electron transfer (SET). That is, 2.2 is 
more electrophilic but 2.1 has a higher electron affinity. This may suggest that compounds of 
the N-cyanocarbazole series may be more prone to the formation of free radicals including 
oxygen free radicals (i.e. S + 3O2  S·+ + 3O2·  ·OH, ·OOH, etc.) than are the 
kinamycins. Further ground state quantum chemical calculations on kinamycin F 2.108 and 
its hypothetical cyanamide analogue 2.110 were pursued to investigate this query (Figure 
2.7). Indeed, 2.110 has lower LUMO (5.5 kcal·mol-1), while 2.108 possesses a significantly 
larger coefficient at the terminal nitrogen than 2.110. The difference in free energies (G) 
predicts that the 2.110 should be more stable than 2.108 by 11.6 kcal·mol-1. Taken together, 
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these data parallel the same trend as found for comparisons of the electronic properties of 2.1 
and 2.2. 
Figure 2.7: The LUMO of 2.110 and 2.108 and their corresponding energy levels 
(eigenvalues) generated at the DFT B3LYP 6-31 G(d) level (1 a.u. = 627.5095 kcal·mol-1). 
2.110 LUMO E = -0.13076 a.u. 2.108 LUMO E = -0.12198 a.u.
 
 
In order to probe the electronic differences between 2.1 and 2.2 further, an electrostatic 
potential energy (ESP) surface for both 2.1 and 2.2 was generated. Figure 2.8 displays the 
ESP surface of 2.1 and 2.2, inspection of which reveals some notable observations. For the 
most part, the gross molecular electron distribution is relatively similar with a few key 
differences. Firstly, the terminal nitrogen of the cyano moiety of 2.1 possesses more electron 
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density than that of the terminal nitrogen of the diazo group of 2.2 and intuitively, of course, 
one would not expect the terminal nitrogen of the cyanamide group to be electrophilic. In 
general, it is assumed that the EA is approximated by the negative reciprocal of a molecule's 
LUMO energy.252,253 From this perspective, 2.1 would be a better electron acceptor owing to 
its lower energy LUMO and hence higher EA. The low electron density found at the terminal 
nitrogen of the diazo group of 2.2 fits well with the previous observations made by others 
from this laboratory of the electrophilic character of the diazo group of the kinamycins.38,199 
Secondly, the phenolic oxygens of prekinamycin display more electron density and, hence, 
more partial negative charge than that of the cyanamide. This may be a consequence of the 
increase in hydrogen bonding to the quinoid oxygens of the B-ring. If this is indeed the case, 
the difference in the O-H bond length of 2.1 and 2.2 would indicate this quality. Indeed, 
inspection of the bond lengths reveals stronger H-bonding to the quinoid oxygens in 2.2 than 












Figure 2.8: The electrostatic potential (ESP) surfaces of 2.1 and 2.2 generated at the DFT 
B3LYP 6-31 G(d) level (isoval 0.0004) and range from ±30.8 kcal·mol-1 for 2.1 and ±26.3 
kcal·mol-1 for 2.2. Regions coloured red indicate negative values of the ESP and regions 
















Figure 2.9: Bond lengths (Å) as observed in the minimized structures of 2.1 and 2.2 
obtained at the DFT B3LYP 6-31 G(d) level. 
 
It is possible that multiple interactions with various targets contribute to the activity of 
prekinamycin 2.2 and the cyanamide analogue 2.1. These include: 
1. Electron transfer to generate a radical anion which might then interact directly with 
DNA or first 3O2 leading to oxygen radicals which then go and cleave DNA. This is possible 
for 2.1 and 2.2 but is more likely for 2.1 owing to its lower LUMO. 
 
 
2. Reaction with biological nucleophiles such as DNA bases or thiol groups on protein 




3. Non-covalent binding to a biological receptor which is possible for both 2.1 and 2.2. 
However, as indicated from the ESP data, both 2.1 and 2.2 have somewhat different 
electronic character that might lead to significantly different affinity for the target. In the case 
of kinamycin F, a recent study involving this laboratory has revealed that kinamycin F may 
be specifically targeting a protein involved in transcription of cyclin D3, one of a group of 
proteins involved in the cell cycle. The contribution of such an interaction to the overall 
MOA of kinamycin F is unlikely to be the consequence of a non-selective DNA cleavage 
event.134 A non-covalent or possibly a covalent binding to such a protein target by kinamycin 
F or one of its metabolites might explain the cytotoxicity since the diminution of cyclin D3 
levels is known to induce apoptosis (programmed cell death). It is not yet known if similar 
effects on cyclin D3 levels are induced by prekinamycin, isoprekinamycin or the 
lomaiviticins. 
One interpretation of the comparable cytotoxicity of 2.1 and 2.2 is that for 2.1, the  electron 
transfer MOA makes a better contribution to the cytotoxicity effect, whereas for 2.2 the 
reaction with biological nucleophiles may be more important. Another interesting 
observation is the very low activity of the ketone 2.57. In the kinamycin series, the dimeric 
analogues called the lomaiviticins possess such a keto group and are very active in DNA 
cleavage experiments under reducing conditions and are highly cytotoxic to cancer cells; 
more so than the monomeric kinamycins that lack the keto group. It is not clear, however, if 
the O-methyl group might play a role in the low activity of 2.57. A more direct assessment of 
the influence of the keto group is the comparison of both the diazo and the cyanamide 
version of the phenols 2.61 and 2.111. Compound 2.61 is potentially available from our 
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synthetic efforts and compounds such as 2.111 may be accessible via the excellent total 
synthesis approach reported recently from the Herzon group.103 Ground state chemical 
calculations indicate that the LUMO of 2.61 is 2.6 kcal·mol-1 lower than that of 2.111, while 
2.111 possesses a significantly larger coefficient at the terminal nitrogen than 2.61. The 
difference in free energies (G) predicts that the 2.61 should be more stable than 2.111 by 
15.5 kcal·mol-1. These data parallel, in similar fashion, the two other data sets; the 2.1/2.2 
series and 2.110/2.108 series. 
Figure 2.10: The LUMO of 2.61 and 2.111 and their corresponding energy levels 
(eigenvalues) generated at the DFT B3LYP 6-31 G(d) level (1 a.u. = 627.5095 kcal·mol-1). 






This study has afforded some insights into the behavior of the kinamycins group of 
antibiotics through the synthesis and subsequent biological studies of its N-cyanocarbazole 
analogues. The data presented here has cast some light on the role of the diazo group of the 
kinamycins with respect to its bioactivity profile and draws questions about its relevance 
where so many others have implicated its importance. Synthetic studies of kinamycin 



















The Reactivity of Nitric Oxide with Diazo compounds: Structure 
and Mechanism 
3.1 Introduction 
Nitric oxide (NO) is a small stable radical whose biological importance is reflected by its 
role in a number of physiological and pathophysiological states.74,254,255 Owing to the 
intrinsic importance of NO to biological systems, the generation, use and clearance of NO is 
tightly regulated. Indeed, the mechanisms by which NO is generated and regulated in vivo by 
mammalian systems has been well established.74,254,255 Regulatory mechanisms in 
prokaryotic systems have also been well studied and the means by which bacteria and related 
organisms deal with NO are becoming clearer.256-258 
 
Figure 3.1: Representative members of the kinamycin family. 
 
 
Our laboratory has a long standing interest in the kinamycin group of natural products 
(Figure 3.1), particularly the synthesis of,31,37,38,101 as well as the biological evaluation and 
mechanism of action of the parent compounds and their analogues.37,38,101,132-134 The 
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kinamycins, originally designated as N-cyanobenzo[b]carbazoles but later found to be 
diazobenzo[b]fluorenes,30,31 are among only a handful of natural products known to contain 
the diazo functionality.6-9,19,25-34,259-272 
Several studies have attempted to elucidate the reactivity of the diazo moiety in the context 
of biological activity. Jeberatnam and Arya demonstrated the DNA cleaving ability of the 
model compound 9-diazofluorene under oxidizing conditions with Cu(OAc)2.
112 In another 
model study, Eppley et al. were able to show that bis(9-diaza-4,5-
diazafluorene)copper(II)nitrate photocleaved DNA under anaerobic conditions in the 
presence of light115 although there is no evidence to indicate the light is involved in the 
biological activity of the kinamycins. Studies by Feldman and Eastman, under non-biological 
conditions, suggested that the one electron reduction to the semiquinone affords, after 
nitrogen expulsion, an sp2 radical at C-11 that is implicated in DNA damage via a number of 
potential mechanistic pathways.124,125 In that study, prekinamycin was exposed to 
Bu3SnH/AIBN in toluene at 80 °C, where Bu3SnH served as the one electron surrogate, 
generating the sp2 radical species, which subsequently undergoes radical aromatic 
substitution with the aromatic solvent. Electrophilic aromatic substitution was ruled out when 
they examined 1:1 mixtures of either electron poor or electron rich aromatic solvents and 
benzene and measured the relatives rates of incorporation as well as the o,m,p ratios. 
Melander’s group has shown that under reducing conditions using a high concentration of 
DTT, simple analogues as well as kinamycin D cleave DNA.126 In a later report using 
glutathione at biologically relevant concentrations, they were able to show a time, 
temperature and concentration dependence on DNA cleavage.127 Melander suggested a two 
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electron reduction of the quinone to the quinol from which arise two potential pathways for 
DNA cleavage. The first pathway describes a nucleophilic attack at the terminal nitrogen of 
the diazo moiety, furnishing a radical species which then can damage DNA. The second 
pathway involves protonation and subsequent loss of N2, providing the orthoquinone methide 
which may serve as a DNA alkylating agent, although DNA cleavage by this pathway has yet 
to be reported as alkylation itself does not lead to DNA cleavage.128,129 
Our laboratory has shown previously that the diazo group of isoprekinamycin is 
diazonium-like and thus possesses electrophilic character and hence should be activated 
toward attack by nucleophiles at the terminal nitrogen of the diazo group.37 More recently, 
we have demonstrated that kinamycins A and C (3.1a, 3.1b) are inhibitors, but not poisons, 
of topoisomerase IIα and are potent cell growth inhibitors.132 Furthermore, we have also 
shown that kinamycin F 3.1c, the deacetylated form of the kinamycins, is able to cleave some 
DNA on its own with increased cleavage in the presence of glutathione, albeit slowly under 
either condition.133 The total synthesis of isoprekinamycin 3.3a was recently accomplished in 
our laboratory and was shown to cause significant growth inhibitory effects on CHO and 
K562 cells.38 The discovery of the lomaiviticins by the Wyeth group,34 a dimeric form of the 
kinamycins that displayed very potent cytotoxicity against several cancer cell lines and 
consequently has intensified interest surrounding the mode of action of the kinamycins. 
The efforts described above have largely centered on (i) elucidating the reactivity of the 
diazo group in simple aryl diazo compounds as well as the kinamycins themselves requiring 
(ii) some type of redox dependent activation to (iii) generate as of yet, an unidentified 
intermediate(s) that is directly or indirectly involved in DNA cleavage. The more recent 
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enzyme inhibition and cytotoxicity studies by our own laboratories have added to the 
kinamycin bioactivity database, but the mechanistic interpretation of the exact events that 
lead to these observations remain speculative and await further studies. DNA cleavage is just 
one of the many possible modes in which the kinamycins may elicit their cytotoxicity. Most 
recently, kinamycin F was observed to selectively downregulate cyclin D3 in K562 leukemia 
cells at the transcription level and suggests that the kinamycins may not function simply by 
damaging DNA but might have a specific biological target associated with the induction of 
apoptosis.134 Despite these intensive efforts, the focus of kinamycin research for the most 
part has been directed towards DNA cleavage and thus other biochemical events in which the 
kinamycins are intimately involved with may have been overlooked. These biological 
processes include but are not limited to immunity and protection; regulation, sequestering 
and chaperoning; signaling, trafficking, communication and so forth and may involve some 
well known biological participants. 
One obvious candidate is nitric oxide, which is known to mediate a host of physiological 
processes.74,254,255 Reports on the reactivity of the kinamycins with NO are nonexistent; 
however, studies focusing on the reactivity of NO with diazo compounds are known although 
no experimental evidence addressing mechanism has been offered. Appropriately, 
mechanistic studies of NO with simple diazo compounds and the parallel experiments using 
the kinamycins would be justified. The data obtained from these studies would lend insight 
into the diverse reactivity of the diazo moiety, thus providing a fundamental understanding of 
NO reactivity with simple and more complex diazo compounds. 
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The first known studies on the reactivity of diazo compounds with NO was reported by 
Kirmse and coworkers in which diphenyldiazomethane was exposed to NO.273,274 The 
products, identified only by IR spectroscopy and elemental analysis, were a 
diphenylnitrimine, benzophenone and nitrous oxide (N2O) with no other data supplied. 
Chapman and Heckert repeated the same studies undertaken by Kirmse in an effort to 
identify the nature of any intermediates.275 Their observation of an alkylideneaminoxyl 
radical (also known as an iminoxyl radical and incorrectly assigned as a nitroxyl radical by 
the authors) by ESR studies support Kirmse’s earlier suggestion of the involvement of the 
radical species, but offered little in evidence and few experimental details. In this context, it 
occurred to us that the kinamycins may be NO scavengers and thus the kinamycins might 
exist as a possible protective mechanism employed by Streptomyces murayamensis. More 
recently, it has been shown through extensive calculations by the Houk group, that the 
reactivity of NO is dramatically increased upon dimerization in the presence of an aromatic 
scaffold276 and in some part, this may reflect events at the cellular level. These studies 
encouraged us to begin our own investigations into the reactivity of kinamycins as well as 
simpler diaryl diazo compounds with NO. 
A discussion pertaining to the reactivity of NO with diphenyldiazomethane is given below 
in which the formation of three products, namely N-(diphenylmethylene)nitramide, 
benzophenone and for the first time a minor component, namely dinitrodiphenylmethane, are 
observed. A mechanistic model is given that is supported by both isotopic labeling studies as 
well as quantum chemical calculations. As well, the intrinsic lack of reactivity of kinamycin 
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A and isoprekinamycin diacetate towards NO is shown and a rationale is offered based on 
molecular modeling studies interpreted through the framework of the mechanistic model. 
 
3.2 Results and Discussion. 
3.2.1 Exposure of Diphenyldiazomethane to Nitric Oxide and characterization of its 
products 
Our initial objective was to reproduce the chemistry under the conditions reported earlier274 
with diphenyldiazomethane exposed to NO and to firmly establish the identity of all products 
from that reaction. Diphenyldiazomethane 3.5a was synthesized according to standard 
literature procedures in near quantitative yield (Scheme 3.1).277 
 
Scheme 3.1: Synthesis of diphenyldiazomethane 3.5. 
 
 
A NO generating apparatus (see Experimental) was employed to expose 3.5a to NO,278 
typically over 16 to 20 hour period. The production of NO was confirmed by a positive test 
result in the Griess assay.279-281 The crude reaction mixture was concentrated under reduced 
pressure and purified by flash silica gel column chromatography to afford three products, 
nitrimine 3.7, benzophenone 3.8 and a previously unidentified product, 
dinitrodiphenylmethane 3.9, shown in Scheme 3.2. As well, a small solvent effect was 
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observed (Table 3.1). Initially we failed to isolate 3.9 owing to the small quantity produced 
and that analytical TLC (similar Rf values) and 
1H NMR (overlapping spectra) data were not 
diagnostic. Earlier reports provide no mention of 3.9, in all likelihood for the same reason. 
Scheme 3.2: Exposure of diphenyldiazomethane to NO furnishing the corresponding 
products. 
 
Table 3.1: Product distribution of nitrimine 3.7 and benzophenone 3.8 under different 
solvent conditions. 





 (% yield) 
Benzene 2.3 (53) 1 (23) 
50/50 
Benzene/Cyclohexane
3.1 (58) 1 (19) 
Cyclohexane 3.6 (66) 1 (18) 
 
X-ray structures. Single crystal X-ray structures were obtained for 3.7 and 3.9 and are 
shown in Figure 3.2. X-ray structures of other nitrimines have been determined282-295 
including derivatives of guanidines,282,283,292 imidazolidines,288,291,295 thiazoles,290 
triazines289,293 and pyridyl284-287 systems. A selected summary of bond lengths and bond 
angles appear in Tables 3.2a and 3.2b, respectively of imidazolidine 3.11295 and 
camphorimine 3.12294 derivatives and 3.7. The 2-nitriminoimidazolidine 3.11 shows a planar 
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nitroguanidine moiety and a slightly bent imidazolidine ring. This is in contrast to the "bent 
orthogonal" shape observed in both N-dinitrocamphorimine 3.12 and nitrimine 3.7, in which 
both species have the nitro moiety orthogonal to the imine moiety. 
 
Figure 3.2. Single crystal X-ray structures of nitrimine 3.7 (left) and 
dinitrodiphenylmethane 3.9 (right). Structures were generated using Mercury 2.2 (carbon = 













Table 3.2a: Selected bond lengths for nitrimines 3.11, 3.12 and 3.7 in angstroms (Å). 
 
Bond 3.11 3.12 3.7 
N(3)-O(1) 1.237(1) 1.24(2) 1.232(3) 
N(3)-O(2) 1.238(1) 1.20(2) 1.234(2) 
N(3)-N(4) 1.339(1) 1.461(9) 1.447(2) 
N(4)-C(5) 1.353(1) 1.273(7) 1.309(3) 
C(5)-C/N(6) 1.326(1) 1.511(8) 1.503(3) 
C(5)-C/N(7) 1.324(1) 1.498(8) 1.506(3) 
 
Table 3.2b: Selected bond angles (in degrees) for nitrimines 3.11, 3.12 and 3.7. 
Bond Angle 3.11 3.12 3.7 
O(1)-N(3)-O(2) 121.5(1) 128(1) 125.9(2) 
O(1)-N(3)-N(4) 115.0(1) 115(1) 115.6(2) 
O(2)-N(3)-N(4) 123.5(1) 117(1) 118(2) 
N(3)-N(4)-C(5) 117.9(1) 113.8(5) 115.4(2) 
N(4)-N(5)-C/N(6) 117.1(1) 130.4(5) 125.4(2) 
N(4)-N(5)-C/N(7) 132.3(1) 120.7(5) 114.8(2) 
 
The identity of 3.9 initially proved to be elusive as standard spectroscopic techniques could 
not unequivocally identify it and was established only through X-ray studies. Initial 
inspection of the 13C NMR spectrum revealed four well resolved resonances with a fifth 
barely visible signal that was initially attributed to an impurity in the deuterated chloroform 
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solvent. We repeated the NMR experiment using deuterated dichloromethane and increased 
the relaxation delay (2 to 10 sec) over a 36 hour acquisition window and observed a small 
signal at 127.5 ppm. This resonance observed by us matches that reported by others296 but 
with no mention of the low intensity of this signal. Levy et al. have noted that 13C nuclei 
attached to 14N nuclei often exhibit broad resonances in the 13C NMR spectrum.297 
3.2.2 Mechanistic proposal 
Once the identity of all products was firmly established, the focus then turned towards 
elucidating the mechanistic pathway(s) that produce the observed products. A reasonable 
mechanistic proposal has been offered in which nucleophilic attack by the diazo compound 
3.13 on NO occurs which, after expulsion of N2, furnishes an iminoxyl radical 3.15 which 
then can combine with NO to afford the N-nitrosonitrone 3.17 from which the nitrimine 3.18, 
ketone 3.19 and nitrous oxide 3.10 are generated (Scheme 3.3).274 During the time that we 
undertook our investigation, a significant report was published by Houk and coworkers on 











Scheme 3.3: Ionic-type mechanism for attack of diazo species 3.13 on NO. Reproduced 
from reference 274 with modifications. 
 
 
From that report, several key findings emerged one of which was that the equilibrium 
constant for dimerization of 2NO  N2O2 increases by a factor of 150 in the presence of 
aromatic solvents. It was also found that N2O2 possesses a lower lying LUMO than NO and 
that it is N2O2, rather than NO, that is the reactive electrophile in reactions. This carries 
mechanistic implications and in the context of this report, we felt we could offer other 
mechanistic possibilities other than that originally proposed by Kirmse and coworkers. In 
Houk’s report, a [4+1] cycloaddition (chelotropic trapping) of phosphine 3.20 with N2O2 
generated the dioxadiazaphosphole 3.22 and subsequently undergoes a [3+2] cycloreversion 
producing phosphine oxide and nitrous oxide as shown Scheme 3.4a. By analogy to this 
reaction of 3.20 with N2O2, 3.5a may react with N2O2 in a similar fashion as shown in 
Scheme 3.4b, although it is not immediately clear how benzophenone 3.8 or 
dinitrodiphenylmethane 3.9 are generated by this pathway. On the other hand, it is well 
known that diazo compounds, acting as 1,3 dipoles, can participate in [3+2] cycloadditions 
(Scheme 3.5).298 Depending on the regioselectivity of the [3+2] cycloaddition of N2O2 with 
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3.5a, either 3.7 or 3.8 may be produced via pathway A or pathway B, respectively. It is also 
conceivable that 3.9 is produced at a point where pathway A bifurcates at 3.26. Here, 3.26 
may proceed on to generate 3.7 or undergo homolytic cleavage to furnish NO and the 
corresponding iminoxyl radical, which upon recombination, produces a dinitroso compound 
which can be oxidized further to furnish 3.9. Thus, these different pathways are able produce 
the observed products via [4+1] or [3+2] cycloadditions. 
 











Scheme 3.5: Two possible regio-[3+2] cycloaddition pathways of N2O2 with 
diphenyldiazomethane to furnish nitrimine 3.7, benzophenone 3.8 and 
dinitrodiphenylmethane 3.9. The free energies of activation (Δ‡G) are given in kcal·mol-1 and 
were calculated at the DFT B3LYP 6-31 G(d) level of theory. 
 
a. see discussion in section 3.2.4. 
3.2.3 15N-labeling and NO exposure: Insight into Mechanism 
Hence experiments were conceived that might lend support to or refute either of the 
mechanistic possibilities shown in Schemes 3.4 and 3.5. One of the simplest means to 
investigate both the mechanism and thus the origin of the nitrogens in both the nitrimine 3.7 
and the dinitrodiphenylmethane 3.9 would be best approached by using doubly-labeled 15N-
diphenyldiazomethane 3.5b. Retrosynthetically, the 15N,15N-labeled diazo compound would 
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be obtained from the 15N,15N-labeled hydrazone, which in turn would be obtained from the 
parent ketone and 15N,15N-labeled hydrazine. Owing to the expense of 15N,15N-labeled 
hydrazine, optimization of the conditions to obtain the labeled hydrazone was required. 
Using unlabeled hydrazine, the number of equivalents of hydrazine was reduced to 1.25 
relative to benzophenone in refluxing ethanol (Mg/I2) over 72 hours to obtain the hydrazone 
in almost quantitative yield. It is imperative that the ethanol solvent used be rigorously dried 
under refluxing conditions of magnesium and iodine. Having established optimum conditions 
for the hydrazone synthesis, condensation of the 15N,15N-labeled hydrazine with 
benzophenone generated the 15N,15N-labeled hydrazone 3.4b in 51% yield which was 
subsequently oxidized to the 15N,15N-labeled diphenyldiazomethane 3.5b in 91% yield as 
described earlier (Scheme 3.6). The azine 3.29 was easily resolved from 3.4b 
chromatographically and was recovered in 44% yield. 
 






The 1H NMR spectra of 3.4a and 3.4b, the unlabeled and 15N-labeled hydrazone, 
respectively, appear identical in the aromatic region of the spectrum indicating that there is 
no coupling between either one of the two nitrogens and an aromatic proton ( i.e. 4J(15N1H) 
or 5J(15N1H) are not observed). However, in the 1H NMR spectrum of 3.4b, the amino 
protons show coupling to the terminal nitrogen to give a doublet (1J(15N1H)  = 77.3 Hz and is 
typical for sp3 nitrogen299) but not a doublet of doublets as coupling to the imino nitrogen is 
not evident (i.e. 2J(15N1H) is not observed). The observation of matching 1H NMR spectra in 
the aromatic region is also observed for 3.5a and 3.5b indicating no coupling between either 
of the two nitrogens to an aromatic proton. A direct comparison of the 1H NMR spectra of 






Inspection of the 13C NMR spectra of the 15N-labeled compounds provides useful data on 
the structural and conformational heterogeneity of these compounds. In the 13C NMR 
spectrum of 3.4b, the two quaternary phenyl carbons display different chemical shifts and 
couplings indicative of hindered rotation as well as different orientation relative to the lone 
pair on the sp2 imino nitrogen. A dd at 138.4 ppm with couplings of 9.1 and 2.4 Hz and a dd 
at 132.9 ppm with couplings of 2.3 and 2.0 Hz were observed. The configuration of these two 
carbons at the C=N double bond can be determined from the magnitude of the coupling 
constants,300 where couplings of 7-13 Hz are assigned to carbons syn the lone pair (and thus 
the carbon at 138.4 ppm) and couplings of 1-3 Hz are assigned to carbons anti to the lone 
pair (and thus the carbon at 132.9 ppm).301 Furthermore, it has been shown that C-N 
couplings are attenuated when the aromatic ring is twisted out of coplanarity with the C=N 
bond.302,303 The chemical shift of the imino carbon (149.1 ppm) is typical for phenyl 
hydrazone304 and the coupling of 6.3 Hz is in reasonable agreement with 7.2 Hz reported for 
benzaldehyde phenylhydrazone.305 This analyses can also be applied to 3.29, although one of 
the quaternary carbons fails to show any couplings at all. The 13C NMR spectrum of 3.5b 
appears straightforward with no conformational issues where the chemical shifts and 








Table 3.3: 15N NMR chemical shifts and couplings for 3.4b, 3.29 and 3.5b. 
 
 Observed 15N 
chemical shift (ppm)a 
Couplings (Hz) 
3.4b 320.37, 106.16 JNN = 12.4 Hz 
3.29 353.05 na 
3.5b 439.96, 304.86b JNN = 9.6 Hz 
a. Referenced to 15N-formamide at 112.82 ppm in DMSO d6 (equivalent to ammonia at 0 ppm) 
b. Literature value = 438.8, 302.7 ppm (see reference 306,307). 
 
Table 3.3 shows the 15N NMR chemical shifts and couplings of the 15N-labeled materials 
and are representative for compounds of their class.308 The 15N NMR spectrum of 3.5b has 
the internal nitrogen assigned to the upfield resonance and the terminal nitrogen is assigned 
the more deshielded resonance as reported by others.306,307 
With the labeled material in hand it was then exposed to NO as described earlier, affording 
the same three products as described previously. The nitrimine and dinitrodiphenylmethane 
were observed to lack any 15N enrichment as shown by 15N NMR, 13C NMR, IR and HRMS-
EI, indicating that the [4+1] mechanism shown in Scheme 3.4 is not occurring and that the 






Scheme 3.7: Mechanistic manifold illustrating three possible pathways that generate 3.7, 
3.8 and 3.9. The free energies of activation (Δ‡G) are given in kcal·mol-1 and were calculated 




a. see discussion in section 3.2.4. 
 
With this new evidence in hand, a novel mechanistic proposal could be envisioned. Scheme 
3.7 illustrates a comprehensive mechanistic manifold that shows the reaction of 3.5b with 
N2O2 in a [3+2] cycloaddition to afford the cycloadduct 3.25b which then undergoes a [3+2] 
cycloreversion furnishing the N-nitrosonitrone 3.26, a common intermediate from which the 
nitrimine 3.7 (Pathway A), benzophenone 3.8 (Pathway B′) and dinitrodiphenylmethane 3.9 
(Pathway A′) might be produced. The proposed manifold also accounts for the lack of 15N-
labeling in 3.7 and 3.9, consistent with our observations from the 15N-labeling experiments. 
Nitrous oxide (N2O), produced in Pathway B′ is most likely consumed as an oxidant, 
furnishing 3.9 from dinitrosodiphenylmethane 3.31, either in a separate [3+2] cycloaddition 
or ionic type of mechanism. To the best of our knowledge, there are no known examples of 
1,3 dipolar cycloadditions of N2O with a nitroso species. As well, nitric oxide may react with 
3.5b in a radical fashion generating dinitrosodiphenylmethane 3.31 (Scheme 3.8) which 
would then go on to furnish dinitrodiphenylmethane 3.9. However, in light of Houk’s report 
and in conjunction with the well-known behavior of diazo compounds in cycloadditions as 
well as our own observations, we suggest that the mechanisms shown in Schemes 3.5 and 3.7 
are more appropriate. 
 




Insight into these mechanistic possibilities was addressed by theoretical methods. The 
reaction channels shown in Schemes 3.4, 3.5, 3.7 and 3.8 are the subject of quantum 
chemical calculations and is the focus of the following discussion. 
3.2.4 Quantum chemical calculations 
The periselectivity of the [4+1] chelotropic process versus the competing [3+2] 
cycloaddition manifold as well the regioselectivity of the two [3+2] cycloadditions can be 
addressed through theoretical calculations. Quantum chemical calculations of structures and 
energies were accomplished using the Gaussian 03 suite of software programs.309 The 
geometry of the reactants, intermediates, products as well as the transition state structures 
(TSs) for the various processes in Scheme 3.7 were fully optimized at the hybrid density 
functional B3LYP level of theory310,311 employing the 6-31G(d) basis set.312 All calculations 
were carried out in the gas phase at T = 298.15 K and P = 1 atm. Vibrational analysis 
confirmed that the TSs manifested as a single imaginary frequency (i.e. vibrational mode). 
The intrinsic reaction coordinate procedure (IRC)313,314 was followed upon acquisition of the 
TSs to connect the TSs with the two closest minima and to confirm that this saddle point was 
a representative TSs for the indicated reaction. The corresponding zero point energy 
corrections were calculated using the same theoretical platform for all optimized structures 
but were not scaled.315 Chapter 5 provides detailed information on the theoretical platform 
used in this study. 
FMO interactions. The frontier molecular orbital (FMO) energies of the two reactants 
3.5a and 3.21 are shown in Figure 3.3. There are two possible interactions shown: 
HOMOdipole-LUMOdipolarophile and HOMOdipolarophile-LUMOdipole. From this illustration, the 
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HOMOdipole-LUMOdipolarophile would indicate the reactivity of this cycloaddition is governed 
by this interaction owing to the smaller energy gap, should this reaction be FMO controlled. 
According to Sustmann’s classification of 1,3-dipoles, the reaction of the HOMOdipole of 
diphenyldiazomethane with the LUMOdipolarophile of N2O2 is a Type 1.
316 
 
Figure 3.3: Frontier molecular orbital energies (a.u) for the 1,3-dipolar cycloaddition of 
diphenyldiazomethane 3.5a (dipole, black) with N2O2 3.21 (dipolarophile, red) obtained at 



























Periselectivity: [4+1] versus [3+2]. The periselectivity of the two cycloaddition processes 
can be addressed through FMO theory and the free energy surfaces (FES) constructed from 
the reactants and their corresponding cycloadducts and their associated energy barriers. 
The ground state energies of the first intermediate in each of the three individual pathways, 
namely cycloadducts 3.24, 3.25 and 3.27 and the corresponding free energy of activation, 
‡G, (TS1, TS3, and TS6, respectively) are shown in Table 3.4. Barriers were obtained for 
3.5a+3.213.25 (TS3, Δ‡G = 20.61 kcal·mol-1) and 3.5a+3.213.27 (TS6, Δ‡G = 22.29 
kcal·mol-1). Despite many repeated attempts, a transition state structure (TSs) could not be 
located for 3.5a+3.213.24 (TS1). The notion that 3.24 may not be generated by a 
pericyclic process, but rather through an ionic-type mechanism producing a zwitterionic 
intermediate is shown in Scheme 3.9. Although the energy minimum structure for 3.37 was 
successfully obtained from our calculations, location of the corresponding TSs for this 
reaction channel was denied despite repeated attempts. 
 








Table 3.4: The relative ground state energies (E, H, G) of 3.24, 3.25 and 3.27 and the 
corresponding free energies of activation (Δ‡G) for the indicated pericyclic reaction obtained 
at the DFT B3LYP 6-31 G(d) level. 
 
Adduct Energy 








Ef, Hg, Gh 
(a.u.)d 
Energy barriers 







































a., b., c. Energies are taken from minimized structures and are a) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), b) the 
electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), c) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 
d. One atomic unit (a.u.) = 627.5095 kcal/mol. 
e. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 12-36 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
f., g., h. Energies are taken from transition state structures and are f) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), g) 
the electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), h) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 
i. Δ‡E (= Δ‡E0), j. Δ‡H, k. Δ‡G in kcal/mol. 
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Table 3.4 also reveals another important aspect regarding the two pericyclic processes. The 
ground state energy of cycloadduct 3.24 is 10.71 and 20.35 kcal·mol-1 higher in energy than 
cycloadducts 3.25 and 3.27, respectively (See Figure 3.3). Perhaps more importantly, the 
ground state energy of 3.24 is slightly higher than the free energy of activation observed with 
TS3 and TS6 by 2.04 and 0.36 kcal·mol-1, respectively. Thus, the relatively high energy of 
3.24 compared to that 3.25 and 3.27 may suggest that its corresponding TS may not be 
accessible and that the genesis of the chelotropic product 3.24 may not be feasible on kinetic 
grounds. An alternative explanation is that TS1 exists as a low lying barrier with respect to 
3.24 such that the reverse reaction, (i.e. the chelotropic extrusion: 3.243.5a+3.21) occurs 
instantaneously only to refurbish the reactants which then proceed on to the other reaction 
channels. This data alone would suggest that the two [3+2] cycloadditions are the dominant 
possible pericyclic reaction channels (Pathways A and B of Scheme 3.5) and is corroborated 












Figure 3.4: The free energy of activation (Δ‡G) of the two regio-[3+2] cycloadditions of 
3.5a with 3.21 furnishing adducts 3.25 (highlighted in green) and 3.27 (highlighted in red). 
The relative free energy (ΔGr) is given for 3.24, 3.25 and 3.27. All calculations are at the 






TS6 ‡G = 22.3 kcal/mol














Regioselectivity of [3+2]. The energy barrier of these two regio-[3+2] cycloadditions is 
shown in Figure 3.4. The ΔΔ‡G of the two [3+2] cycloadditions is 1.69 kcal·mol-1 (TS3 and 
TS6) and provides a good indication of the relative yield of 3.7 to 3.8 (Table 3.1). From the 
Δ‡G given in Table 3.4, the regioselectivity can be estimated by the Eyring relationship (see 
Chapter 5), which indicates a ~17:1 ratio for 3.25:3.27. Although this result is in qualitative 
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agreement with the product distribution given in Table 3.1, it is clearly at odds with the 
experimental result of 2.3-3.6:1 (3.7:3.8) and may suggest that the other reaction channels 
have implications on the relative yields of the three products. It is also conceivable that a 
cycloreversion is occurring (i.e. 3.25  3.5a + 3.21) which refurbishes the reactants which 
than proceed onto the other reaction channel, TS6, generating the cylcoadduct 3.27 (pathway 
B) which goes on to provide benzophenone. 
Table 3.5 shows the FMO coefficients and energies of both reactants 3.5a and 3.21 
calculated at the DFT B3LYP 6-31 G(d) level. Reactions in which the orbitals are closest in 
energy and maximal bond overlap in the transition state will occur with a concomitant 
lowering of the energy barrier.319-323 Inspection of Table 3.5 shows that for the HOMO of 
diphenyldiazomethane, the largest coefficients reside on the termini of the dipole (C-1 and N-
3) with the N-3 coefficient possessing a marginally higher magnitude over the C-1 
coefficient. In the LUMO of 3.21, the coefficients of nitrogen and oxygen are also of 
comparable magnitude with the nitrogen (N-1 and N-2) slightly larger than those of oxygen 
(O-3 and O-4). Thus FMO theory would predict that the orbital(s) N-3 of 
diphenyldiazomethane and the orbital(s) N-1 (or N-2) of NO would afford the greatest orbital 
overlap in the transition state, generating 3.27 in the process (and hence 3.8) as the major 
product as shown in Scheme 3.5, although the regioselectivity would be predicted to be very 
slight. As mentioned above, the relative differences in the magnitudes of the C-1 and N-3 
coefficients within the HOMO of 3.5a are so small it could be argued that both cycloadducts 
3.25 and 3.27 would be produced in relatively equal amounts if the reaction were FMO 
controlled. Thus other means were sought to rationalize the regioselectivity. 
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Table 3.5: FMO energies (a.u.) and orbital coefficients of 3.5a and 3.21 obtained at the 
DFT B3LYP 6-31 G(d) level. 
LUMO 3.5a LUMO 3.21
HOMO 3.5a HOMO 3.21
 
Diphenyldiazomethane 3.5a 
  Energy (a.u.) Orbital Coefficient 
HOMO  -0.19138 C1 2pz -0.33530 
C1 3pz -0.25995 
N2 2pz -0.14499 
N2 3pz -0.12382 
N3 2pz 0.34587 




 Energy (a.u.) Orbital Coefficient 
LUMO -0.12539 N1 2pz 0.36885 
N1 3pz 0.34232 
N2 2pz 0.36894 
N2 3pz 0.34238 
O3 2pz -0.33762 
O3 3pz -0.30675 
O4 2pz -0.33771 
O4 3pz -0.30680 
 
Inspection of TSs may offer insight into these regioselectivity issues. Early reports have 
indicated that significant bending of the dipole must occur to facilitate the cycloaddition.324-
326 Early work by Houk and coworkers suggested that dipole bending may be implicated in 
the regioselectivity of 1,3 dipolar cycloadditions.327 The MOs in the bent dipole may differ 
significantly from those of the linear dipole this could conceivably have an outright influence 
on regioselectivity.328 However calculations by the Houk group on diazomethane revealed 
only small changes in the relative magnitudes of the coefficients and energies of the π MOs 
of linear and bent dipoles. 
The notion that the activation barrier (Δ‡E) is the sum of distortion (Δ‡Ed) and interaction 
energies (Δ‡Ei) has been used to rationalize 1,3-dipolar cycloadditions
329-331 and has also 
been applied in rationalizing endo vs. exo selectivity of Diels-Alder reactions.332-335 
Furthermore, other studies have indicated that distortion energies influence barrier 
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heights.336,337 More recently, high level ab initio calculations have led to the proposal of the 
distortion/interaction reactivity model by Houk.329,330 Those reports show that there was a 
direct correlation between the activation energy and the energy required to distort the dipole 
and dipolarophile into the TS geometries but devoid of any interaction between the dipole 
and dipolarophile. This observation has also been reported by others.338 Indeed, examination 
the transition state structures TS3 and TS6 is completely consistent with these observations. 
The C-1---N-2---N-3 bond angles of 3.5a were retrieved and were found to be 143.49° (TS3, 
Δ‡G = 20.6 kcal·mol-1) and 135.85° (TS6, Δ‡G = 22.3 kcal·mol-1) indicating that there is 
more distortion in the dipole of TS6 compared to TS3 and is in qualitative agreement with 
Houks observations (Figure 3.5). 
Inspection of the TSs of TS3 reveals an asynchronous cycloaddition. Examination of the 
vibrational mode corresponding to the imaginary frequency (IF = -337.7 cm-1) indicates this 
motion is principally between the diazo carbon (C-1) of 3.5a and the nitrogen (N-1) of the 
NO dimer 3.21. Asynchronousity may also be measured by calculating the difference in bond 
lengths between the two developing bonds (d). Thus N-3---O-3 (2.3329 Å) subtract C-1---
N-1 (1.9317 Å) gives a d = 0.4012 Å. Examination of the TSs of TS6 also reveals an 
asynchronous cycloaddition in which the vibrational mode corresponding to the imaginary 
frequency (IF = -320.3 cm-1) indicates the principal motion is between N-3 of 3.5a and N-1 
of 3.21. The Δd = 0.4576 Å, indicating advanced bond formation between N-3 and N-1 
(1.7099 Å) over that of N-3 and O-3 (2.1675 Å). The IRC reveals minima closely resembling 
the reactants and products. Figure 3.5 shows the TS complexes for TS3 and TS6 with the 
relevant geometrical data. 
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Figure 3.5: Transition state structures of TS3 and TS6 obtained at the DFT B3LYP 6-31 









Table 3.6: Energies of all reactants, cycloadducts and intermediates in Pathways A, A′, B 
and B′ calculated at the DFT B3LYP 6-31-G(d) level. 
Structure 
Energy 




















































































  3.39 -1745.586152 
-1745.552641 
-1745.653472 
a., b., c. Energies are taken from minimized structures and are a) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), b) the 
electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), c) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 
d. One atomic unit (a.u.) = 627.5095 kcal/mol. 










Free Energy Surface. The 1,3 dipolar cycloadditions serve as a gateway to the four 
reaction channels A, A′, B and B′ which together comprise a mechanistic manifold that 
furnishes the three products 3.7, 3.8 and 3.9. A theoretical investigation into these pathways 
(shown in Schemes 3.5 and 3.7) would provide detailed information on structure, mechanism 
and energetics. 
Table 3.6 provides the ground state electronic energy (E), enthalpy (H) and free energy (G) 
for all reactants, intermediates and products of the four reaction channels, pathways A, A′, B 
and B′. From those structures the appropriate transition state calculations were accomplished 
to acquire the corresponding energy barriers (activation energy Δ‡E, enthalpy of activation 
Δ‡H, free energy of activation Δ‡G) shown in Table 3.7. The free energy of activation (Δ‡G) 
was then used to construct the free energy surfaces (FES) for pathways A, B and B′ and are 
shown schematically in Figures 3.6 and 3.7. The FES for pathway A′ is not schematically 
represented but is discussed later on. The reaction channels described in Scheme 3.8 were not 
obtained in spite of many repeated attempts and will not be discussed any further. The 










Table 3.7: Energies and energy barriers for reaction channels calculated at the DFT 
B3LYP 6-31 G(d) level. 
Reaction Channel TSsa IFb 
Energy 
Ec, Hd, Ge 
(a.u.)f 
Energy barrier 
Δ‡E,g Δ‡H,h Δ‡Gi 
(kcal·mol-1) 
3.5a + 3.21  3.24 TS1 na na na 
3.24  3.7 TS2 na na na 





























































3.30a  3.7 
 
 



























3.31  3.32 TS13 na na na 





































a. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 12-48 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
b. IF = imaginary frequency in reciprocal centimeters and are not scaled (Ref. 315). 
c., d., e. Energies are taken from transition state structures and are c) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), d) 
the electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), e) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 
f. One atomic unit (a.u.) = 627.5095 kcal/mol. 
g. Δ‡E (= Δ‡E0), h. Δ‡H, i. Δ‡G in kcal/mol. 















Figure 3.6: The FES of the reactants 3.5a and 3.21 generating products 3.7 and 3.8 
















































Figure 3.7: The FES of the reactants 3.5a and 3.21 generating products 3.7 and 3.8 








































Pathway A: Nitrimine. The cylcoadduct 3.25 generates the N-nitrosonitrone 3.26 and N2 
(TS4 ‡G = 0.09 kcal·mol-1) and appears to be thermodynamically driven (see Scheme 3.5 
and Figure 3.6). The one step transformation of 3.26 to nitrimine 3.7 (TS5 ‡G = 32.7 
kcal·mol-1) provided a TSs that appeared to be consistent with the product. Examination of 
the vibrational mode appeared to correspond with the bond making/breaking process. 
However, the intrinsic reaction coordinate (IRC) for this calculation did not converge and 
appeared ambiguous. Incidentally, this TSs appeared to be identical to that obtained for the 
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conversion of 3.26 to the O-nitrosooxime 3.30a (TS9 ‡G = 32.7 kcal·mol-1) described in 
pathway A and is corroborated by the energy values found in Table 3.7. These results 
provided the impetus to locate new TSs and accordingly the computational parameters were 
changed to a tighter grid search to provide a second TSs and an IRC profile that was 
consistent with the calculation of interest. However, the barrier ‡G (85.8 kcal·mol-1) is not 
consistent for reactions carried out at ambient conditions. Thus other reaction channels were 
considered. The nitrone 3.26 provided the O-nitrosooxime 3.30a/3.30b (TS9, TS10 
respectively) which in turn furnish 3.7 (TS11a, TS11b respectively) and represents another 
route by which the nitrimine 3.7 may be accessed. The pathway of TS9 to TS11 would be 
considered to make a very small contribution to the overall pathway owing to the higher 
energy barriers. It is conceivable that other reaction channels exist (such as an intermolecular 
oxidative process) some of which are shown in Scheme 3.10 but were not explored owing to 
time constraints in the present thesis. Efforts towards identifying other reaction channels in 
pathway A that are consistent with experimental results are the focus of ongoing studies. 
Pathway A′: Dinitrodiphenylmethane. Generation of the N-nitrosonitrone 3.26 provides 
access to four different reaction channels (TS5, TS9, TS10 and TS15). Three of these have 
been discussed already TS5, TS9 and TS10 with TS15 found in pathway B′. An equilibrium 
is most likely established between 3.30a and 3.30b but it is 3.30b that furnishes 3.31 (TS12 
‡G = 29.9 kcal·mol-1). Attempts at using 3.30a to access the reaction channel that would 
furnish 3.31 were denied. The reaction channel TS13 did not converge and consequently the 
entire FES for pathway A′ could not be completed and hence is not shown. Of special 
interest, the cycloreversion of 3.32 to 3.33 (TS14 ‡G = -0.11 kcal·mol-1) is the only reaction 
 
 156 
channel found in this study that is barrierless. These types of reactions are typical of carbene 
and/or radical reactions. The extrusion of molecular nitrogen and the formation of the nitro 
moiety are thermodynamically driven but the negative energy barrier may be describing other 
effects that are not immediately apparent. Descriptions of barrierless reactions are found 
throughout the literature the majority of which focus on carbenes and radicals with very few 
reports on closed shell molecules. An alternative explanation is that an intermediate exists 
that has not been identified and possesses a lower energy than that for the TSs. This 
possibility has been described by others.339 This would then provide a positive value for the 
energy barrier. Furthermore, Wang and Weitz also note that a negative ‡G is likely due to 
errors in the DFT calculation. The assumption of harmonic vibrational modes can also 
introduce errors in the calculation of the enthalpy, entropy and zero point energy corrections 
and thus the most suitable interpretation is that ‡G is small. The idea of hidden 
intermediates and hidden transition states has been reported by others.340 Efforts focused on 
resolving this issue is the subject of further studies. 
Pathway B: Benzophenone. This pathway constitutes the major pathway by which 
benzophenone is produced. The acquired TSs were unremarkable. The TSs of TS7 and TS8 
(‡G = 5.3 and 0.8 kcal·mol-1, respectively) provide barriers consistent with room 
temperature reactions. 
Pathway B′: Benzophenone. This may be considered the minor pathway that produces 
benzophenone. TS15 (‡G = 37.2 kcal·mol-1) is the kinetic bottleneck in this pathway. The 
nitrone 3.26 is presumably able to generate all three products but it is the only intermediate 
identified in this study that produces the nitrimine 3.7. However, production of the nitrone 
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3.26 also contributes to the production of benzophenone 3.8 and hence a small amount of 
3.26 may be available to contribute to pathway B′ that would otherwise be available for 
pathways A and A′. The generation of the N-nitrosooxaziridine 3.34 furnishes 3.28a (TS16 
‡G = 14.5 kcal·mol-1) which presumably undergoes a conformational change to give 3.28b 
which then produces benzophenone (TS8 ‡G = 0.8 kcal·mol-1) in the same manner already 
described for pathway B. Benzophenone could not be accessed employing 3.28a. The TSs 
obtained for the reaction channel TS17 (‡G = 1.5 kcal·mol-1) appeared identical to the TSs 
for TS8 as shown by their respective energies and thus TS17 may represent a variation of the 
reaction channel TS8. Efforts are ongoing to address these issues. 
Other intermediates were considered in the manifold but were not obtained owing to non-














Scheme 3.10: Possible reaction channels that may generate 3.7 and 3.8. 
 
 
3.2.5 Kinamycin A and Isoprekinamycin diacetate 
Having satisfied our query about the nature of the nitric oxide reactivity with 
diphenyldiazomethane, we then eagerly turned our attention towards the kinamycin group of 
natural products. Under the same conditions employed in the diphenyldiazomethane 
experiments, kinamycin A and isoprekinamycin diacetate were exposed to nitric oxide. We 
recovered both species from the reaction quantitatively without any indication of chemical 
modification as observed by 1H and 13C NMR spectroscopy. This led us to undertake some 
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calculations which may explain the lack of reactivity of kinamycins towards NO whilst 
simpler model diaryl diazo compounds react. The ground state energies of the natural 
products and simple diazo compounds were examined. Although we have established that the 
regioselectivity of N2O2 with diphenyldiazomethane is not FMO controlled, FMO 
interactions will contribute to the activation energy. The HOMO of both kinamycin A (-
0.24573 a.u.) and isoprekinamycin diacetate (-0.22680 a.u.) were examined and found to be 
significantly lower than that of diphenyldiazomethane by 33.8 and 21.4 kcal·mol-1, 
respectively. As well, the free energy of activation (‡G) for the corresponding [3+2] 
cycloadditions were found to be significantly larger and that acquisition of the 5-membered 
intermediates 3.38 and 3.39 would appear to be inaccessible on kinetic grounds (Scheme 
3.11). Furthermore, the other scenario in which the interaction of the HOMO of N2O2 (-
0.21127 a.u.) with the LUMO of either kinamycin A (-0.13487 a.u.) or IPK diacetate (-
0.12084 a.u.) indicate that these interactions would be of lesser importance owing to the 
larger energy gaps than that of the HOMO of diphenyldiazomethane with the LUMO of N2O2 
as described in Figure 3.3. These observations would appear to justify the lack of reactivity 













3.2.6 A Proposal for the source of the terminal nitrogen of the Diazo group 
Certain species of bacteria found in the soil are known to convert nitrate to ammonia with 
the production of nitric oxide via a sequence of redox reactions.74 The group of natural 
products known as the stealthins have been shown to be potent radical trapping agents.40,41 
One member, stealthin C, has been isolated from fermentation broths of S. murayamaensis 
which has led the Waterloo group to speculate that N-nitrosation events may occur within the 
organism that, through a series of chemical reactions, generate the diazo group furnishing 

















Diphenyldiazomethane reacts with nitric oxide to produce three products nitrimine 3.7, 
benzophenone 3.8 and a previously unidentified product, dinitrodiphenylmethane 3.9 via two 
separate [3+2] cycloadditions, supported by isotopic labeling experiments and theoretical 
studies. As well we observed that the natural products kinamycin A and isoprekinamycin 
diacetate were found to be unresponsive to nitric oxide exposure. This lack of reactivity was 
supported by theoretical studies. This suggests that the kinamycins are not NO scavengers 
and that their biological role interpreted through the context of the diazo group remains 
speculative. Other ongoing studies that are addressing the mode of activity of the kinamycins 
















Diels-Alder Reactions of Indole-2,3-quinodimethanes and Related 
Chemistry 
4.1 Introduction 
The highly reactive cis-diene o-quinodimethane 4.1 (o-QDM) also known as o-xylylene or 
o-quinododimethide and 2,3-dimethylene-2,3-dihydro-1H-indole, the so-called indole-2,3-
quinodimethane (IQDM) 4.2 have been the focus of extensive research over many years 
owing to their synthetic value due in part to the variety of methods available to generate 
them. 
Figure 4.1: The structures of o-QDM 4.1 and IQDM 4.2. 
 
4.2 Background and Overview 
4.2.1 o-QDM 
In 1910, Finkelstein reported the isolation of 1,2-dibromobenzocyclobutene 4.5 upon 
treating α,α,α′,α′-tetrabromo-o-xylene 4.3 with sodium iodide (Scheme 4.1).341 It was 
assumed that the o-QDM 4.4 was generated and this was subsequently confirmed by Cava et 
al. who reported the trapping of 4.4 in a Diels-Alder reaction with N-phenylmaleimide, 





Scheme 4.1: The early experiments of Finkelstein and Cava. 
 
 
Owing to the synthetic potential of 4.1, others have reported alternative methods for 
generating o-QDM, some of which are shown in Scheme 4.2. There are six major 
classifications based on the precursor and method employed to generate o-QDM and these 
have been reviewed elsewhere:344-346 
1. 1,4-elimination of α,α′-substituted o-xylenes 4.9 induced by: 
a. thermal eliminations. 
b. reductive eliminations. 
c. base-catalyzed eliminations. 
d. ion-induced catalyzed eliminations. 
2. Diels-Alder-cycloreversions of 4.10 and are typically lactones or azo compounds, where 




3. Chelotropic extrusion from 4.11 and are typically sulfones or ketones, where X−Y = 
(SO2) and (C=O), respectively. 
4. Thermolysis of benzocyclobutenes 4.12. 
5. Photo-enolization of o-methylbenzaldehydes 4.13 (X = O) and/or photo-rearrangement 
of o-methylstyrenes 4.13 (X = CH2). 
6. From o-xylylene-metal complexes 4.14. 
Scheme 4.2: Methods of generating o-QDM 4.1. 
 
 
More recently, Kitagaki347 has reported the generation of o-QDM 4.18 and its use in Diels-
Alder (DA) reactions, prepared in situ from ene-bis(propargyl alcohols) 4.15 and 
benzenesulfenyl chloride to produce the ene-bis(propargyl sulfenate) 4.16 which undergoes a 
[2,3]-sigmatropic rearrangement to afford the ene-bis(sulfinylallene) 4.17 (Scheme 4.3). 
Subsequently, a 6π electrocyclization of 4.17 furnishes the o-QDM 4.18 for the ensuing 
intramolecular Diels-Alder (IMDA) cycloaddition to give a one-pot construction of the 
polycyclic adduct 4.19. In addition to the obvious benefit of a single pot preparation of the 
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polycycle, this method also possesses the intrinsic advantage of avoiding high temperatures 
required by the many of the methods illustrated in Scheme 4.2. Kitagaki has also 
demonstrated the use of this method in intermolecular cycloadditions.348 




In 1964, Plieninger et al., extending the ideas put forth by Finkelstein and Cava et al., 
reported the generation of indole-2,3-quinodimethane 4.21 in situ from pyranoindole 4.20 
and demonstrated its reactivity in [4 + 2] cycloadditions as shown in Scheme 4.4.349 The 
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adduct 4.22 was characterized only by elemental analysis and no further reports were issued 
by the Plieninger group on this chemistry. 
Scheme 4.4: Plieninger’s generation of IQDM and use in Diels-Alder reactions. 
 
 
The access to various heterocycles using IQDM chemistry has been demonstrated in the 
syntheses of several natural products such as aspidospermidine 4.23,350,351 kopsanone 
4.24,352,353 staurosporinone 4.25,354,355 and 16-methoxytabersonine 4.26356 (Figure 4.2). 
IQDM chemistry could be potentially applied to the syntheses of akuammicine 4.27357-365 and 
tubotaiwine 4.28366-368 as well as the vinca alkaloids, vindoline356,369 and vinblastine370,371 
(not shown). 
Magnus and coworkers have made extensive use of intramolecular Diels-Alder reactions 
employing IQDMs in the synthesis of complex indole alkaloids.350-356,370,372 In particular, the 
general applicability of this method towards the syntheses of the Aspidosperma alkaloids was 
first demonstrated by Magnus350,372 who reported the total synthesis of the natural product dl-
aspidospermidine 4.23,351 by generating an IQDM in situ which undergoes an intramolecular 
Diels-Alder reaction as the key step (Scheme 4.5). The desired cis-fused geometry of the 
ring-junction between the piperidine and cyclohexane rings was attributed to the exo (E) 
transition state 4.31. 
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Figure 4.2: Natural products accessible through IQDM chemistry. 
 
 
Scheme 4.5: The key step of Magnus’ total synthesis of dl-aspidospermidine. 
 
 
Methods for generating 4.2 are shown in Scheme 4.6 and have been reviewed 
elsewhere.346,373-375 Recent reports employing 4.38 and 4.39 by Mukai and coworkers376,377 
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and Fuwa and Sasaki,378,379 respectively, as IQDM progenitors have extended the synthetic 
scope of IQDM chemistry. 
Scheme 4.6: Methods of generating IQDM 4.2. 
 
 
Recently, Mukai et al. have developed a novel approach to access IQDMs under mild 
conditions (Scheme 4.7a).376 The 2-allenylaniline 4.40a produces IQDM 4.41 in situ under 
basic conditions, which can then be trapped with dienophiles already present in the reaction 
vessel. When 4.40a was added slowly via syringe to solution of 4.42 in DMF and potassium 
carbonate, the adduct 4.43 was provided in 93% yield. Premixing a solution of 4.40b and 
4.42 was less efficient, providing 4.43 in 76% yield in addition to a small amount (13%) of 
the homodimer 4.44. When dimethyl maleate (not shown) was substituted for dimethyl 
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fumarate 4.42, the adduct was produced in 7% yield with an 85% recovery of 4.44, a 
significant decrease compared to the reaction with dimethyl fumarate. 
Scheme 4.7: Mukai’s generation of IQDM 4.41 and its Diels-Alder trapping. 
 
 
A subsequent report377 by those authors addressed these issues using alternative methods 
which included substituting the acetoxy group with an ethyl carbonate group (as in 4.45 in 
Scheme 4.7b). When 4.45 was refluxed with dimethyl maleate in toluene and a catalytic 
amount of potassium carbonate, the yield increased markedly to 82% with 13% of 4.44 
produced. This method worked well for a number of dienophiles, but not so for quinones. 
Realizing that allylic carbonates can produce the corresponding (π-allyl)-palladium complex 
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4.47 (or the related palladium complexes 4.48 and 4.49) when treated with Pd0 catalysts, 
those workers treated 4.45 with 5% Pd2(dba)3 in refluxing toluene to produce good to 
excellent yields of Diels-Alder adducts not accessible under basic conditions. Thus 4.45 was 
able to provide access to various targets under divergent conditions. 
Fuwa and Sasaki have also implemented Pd0 catalysis in a novel tandem intramolecular 
Heck/Diels-Alder reaction (Scheme 4.8).378 IQDM 4.41 was generated from the acyclic α-
phosphono enecarbamate 4.51 and trapped with 4.53 to provide a 1:2 ratio of 4.54a:4.54b in 
75% yield. This procedure could be modified by changing the solvent to either THF, toluene 
or acetonitrile to accommodate various dienophiles which afforded yields of 32-93%. The 
dimer 4.44 was recovered in 49% yield in the absence of a dienophile. A follow up report by 
these workers employed allenamides in place of 4.51 to generate IQDM which were then 
trapped with various dienophiles in yields of 53-93%.379 






The observation of 4.44 has provided evidence of the intermediacy of IQDM 4.41 that was 
first reported by Marinelli in 1982.380 Marinelli’s report was significant as it was the first to 
describe Diels-Alder reactions of IQDMs with unsymmetrical dienophiles. Although the 
reports mentioned here have provided a structure for the homodimer and have suggested it to 
be 4.44, there is a lack of evidence, spectroscopic or otherwise, to support this structural 
assignment. Work performed from this laboratory has revealed that the homodimer possesses 
structure 4.55 (Figure 4.3). This structure was deduced from extensive NMR studies as well 
as a single crystal X-ray study.381,382 Efforts from this laboratory towards the structural 
elucidation of the homodimer are discussed in the following sections. 
Figure 4.3: The proposed structure of the homodimer assigned to be 4.44 first reported by 
Marinelli. The structural reassignment of the homodimer to 4.55 as reported by S.F. Vice.381 
 
 
4.3 Previous work in this laboratory 
4.3.1 Early studies 
This laboratory has extensive experience with the chemistry of IQDMs.381-388 S.F. Vice 
developed the initial conditions to generate N-acetyl-indole-2,3-quinodimethane (N-Ac-
IQDM) 4.58 (Scheme 4.9).381 Heating N-acetyl-2,3-dimethyl indole 4.56 with two 
equivalents of N-bromosuccinimide in carbon tetrachloride with a 250W Brooder lamp 
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afforded 4.57 at 80% yield and in gram quantities. These conditions were later modified by 
J.Y.J. Wu in this group, changing the solvent from carbon tetrachloride to 
dichloromethane.386 Initial experiments using zinc, DMF and maleic anhydride failed to 
produce the desired adduct 4.60, instead returning 4.56 and 4.55, indicating the dimerization 
had occurred faster than the cycloaddition. It was also found that dimerization was highly 
regioselective producing a single diastereomer 4.55. Since the dimer could exist as four 
possible isomers, its structure was elucidated through extensive NMR studies on selectively 
deuterated analogues as well as by a single crystal X-ray crystallographic analysis. The 




























Figure 4.4: Four possible isomers of the homodimer and the corresponding single crystal 




Through some experimentation it was found that the generation of 4.58 from 4.57 could be 
accomplished by addition of eight equivalents of sodium iodide in acetone at room 
temperature (Scheme 4.9). However, these cycloaddition reactions suffered from poor 
regioselectivity (~3:1 for C-2 adduct:C-3 adduct) and required a large excess of dienophile to 
overcome the competing dimerization of 4.58. Theoretical investigations pertaining to the 
observed regioselectivity are discussed in Chapter 5 through quantum chemical calculations. 
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In the absence of a dienophile, only 4.55 was obtained. An independent and unambiguous 
synthesis389 of 4.62b permitted the identification of the regioisomers that are shown in 
Scheme 4.9. The rapid generation of N-Ac-IQDM 4.58 under those mild conditions 
suggested the possibility that its genesis may be observed spectroscopically at lower 
temperatures. 
The initial suite of experiments was executed by adding a solution of NaI in acetone-d6 to a 
pre-cooled (-23 °C) solution the dibromide 4.57 in a 5 mm NMR tube and observing the 1H 
and 13C NMR spectra obtained on an 80 MHz spectrometer. A brown colour was generated 
upon addition of NaI, indicative of iodine formation. Poorly resolved signals in the δ 5.5 to 
5.8 region in the 1H NMR were taken to be preliminary evidence for the formation of the N-
Ac-IQDM 4.58. Later, more detailed studies at 400 MHz provided evidence for the 
intermediacy of the diiodide 4.67 and/or monoiodomonobromides 4.68. In particular, 
recording the spectrum at -23 °C, immediately after mixing, yielded signals assignable to the 
N-Ac-IQDM vinyl hydrogens (δ 5.50, 5.55, 5.70, 5.76) as well as singlets at δ 4.82 and 5.10 
ppm that disappeared with time to be replaced by signals resulting from the dimer 4.55 as 
well as those from the N-Ac-IQDM.  
Owing to the availability of NMR instrumentation and pulse sequences that were more 
advanced than those available to S.F. Vice, these spectroscopic studies were further extended 
by S.R. White in this group using variable temperature NMR (VT 1H NMR, 500 MHz) 
techniques.385 Taken together, additional insights into mechanistic as well as 




Scheme 4.10: The probable mechanism furnishing 4.58 interpreted from NMR studies 
performed by Vice381 and White.385 
 
 
The VT 1H NMR data provided valuable insight into the conformational mobility of the 
amide moiety of 4.58 initially observed by Vice and confirmed by White and is illustrated in 
the top panel of Figure 4.5a. The -60 °C panel in Figure 4.5b shows substantial broadening of 
the H-7 and H-2αa protons indicative of a hindered conformational rotation. Thus, the NMR 
probe was cooled to -93 °C to observe the slow exchange extreme for the two rotamers 4.58a 
and 4.58b in a ratio of 2.6:1. This prevalence of rotamer 1 over rotamer 2 is addressed by 
quantum chemical calculations discussed in Chapter 5. Warming 4.58 induces dimerization 











Figure 4.5a: IQDM rotamers 4.58 and their associated spectroscopic assignments obtained 
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On the basis of chemical shift arguments, the major and minor rotamers could be assigned 
as conformers 4.58a and 4.58b, respectively. The proton H-7 of the major component (4.58a, 
rotamer 1) was assigned 8.25 ppm (d; J = 8.1 Hz) while in the minor component (4.58b, 
rotamer 2) H-7 was assigned 7.52 ppm. These assignments can be justified as H-7 is found 
within the deshielding region of the amide carbonyl of 4.58a thus shifting the resonance 
further downfield on comparison to 4.58b. The same argument can also be applied to the 
assignment for H-2αa of 4.58b to 6.26 ppm which is shifted downfield compared to that of 
4.58a at 5.21 ppm. These studies permitted the 1H NMR assignments for both rotamers as 
shown in the bottom panel of Figure 4.5a. 
Initial attempts at increasing the regioselectivity of intermolecular Diels-Alder reactions of 
4.58 were investigated by varying the indolic nitrogen substituents. The purposes of these 
studies were twofold. Purification issues had plagued the synthetic utility of this method; the 
crude product was often an inseparable mixture of the two regioisomers. Secondly, it was felt 
that the molecular orbital coefficients of the diene would be sufficiently altered by the N-
substituent such that it would invoke a high degree of regioselectivity for either the 2- or 3-
substituted tetrahydrocarbazole. Alternatives to replace the acetyl moiety were trifluoroacetyl 
(CF3CO-), tert-butoxycarbonyl (t-Boc), trifluoromethanesulfonyl (Tf),
381 and cyano (-CN)384 
(Table 4.1). Experiments were carried out using methyl acrylate as the dienophile under 
those conditions described in Scheme 4.9. Disappointingly, only a marginal improvement 
was observed even for the highly electron withdrawing substituents, trifluoroacetyl and 
triflyl. The cyanamide system was found to dimerize more readily than the N-acetyl system, 
making Diels-Alder trapping with dienophiles difficult. Owing to these observations 4.57 
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would be used in all successive studies due to its ease of preparation and handling as well as 
its stability. 
 Table 4.1: The observed regioselectivity of DA reactions of IQDMs generated from 4.57. 
 
Entry R C2:C3 (%) 
1 COCH3 (Ac) 70:30 
2 COCF3 75:25 
3 SO2CF3 (Tf) 71:29 
4 CO2tBu (t-Boc) 66:34 
5a CN 70:30 
a. Conditions: TEAI in CH2Cl2. 
 
4.3.2 Advanced Studies 
Hence attention was turned to other avenues at increasing the regioselectivity, one of which 
was to employ Lewis acids. The theoretical descriptions pertaining to the observed regio- and 
stereochemistry of Diels-Alder reactions and have been summarized in several key 
reports.90,320,390-393 The effect of Lewis acids on the acceleration,394 and enhancement of 
regio- and stereo-control395 is well documented. The early synthetic efforts of Vice employed 
DMF as the solvent and the VT NMR studies by White indicated that 4.58 was stable 
between 30-35 °C in acetone. However, many Lewis acids owing to their oxophilic character 
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are not compatible with these solvents. Vice had initially screened Lewis acid compatible 
solvents and the corresponding source of soluble iodide and found tetra-butylammonium 
iodide (TBAI) in dichloromethane worked well. 
Accordingly, new and improved conditions were later defined by J.Y.J. Wu386 and are 
shown in Scheme 4.11. Generation of 4.58 from 4.57 was accomplished upon adding 4.57 
via syringe to a solution of eight equivalents of TBAI in CH2Cl2 at room temperature and 
trapping 4.58 with an excess of 4.53 affording a quantitative yield of 4.63. 
Scheme 4.11: Wu’s initial experiments defining conditions for LA-catalyzed reactions.386 
 
 
This demonstrated that Lewis acid catalysis was indeed feasible and the next suite of 
experiments was executed under these newly defined conditions. The IQDM was generated 
as before but in the range of -23 to -30 °C and was stable at this temperature, abrogating 
dimerization which in turn permitted a significant decrease in the amount of dienophile 
required. The temperature was then dropped to -78 °C and two equivalents of either 4.69 or 
4.70 and one equivalent of Lewis acid were added. A significant increase in the 
regioselectivity was observed, especially in the reaction using SnCl4 at -94 °C (13.5:1 for 
4.72a:4.72b) as shown in entry 6 of Table 4.2. 
Several other key observations also came from this work. In the absence of Lewis acids no 
Diels-Alder adducts were observed and consequently only dimer was generated. Lower 
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temperatures led to higher regioselectivity and the amount of dienophile required was 
decreased by an order of magnitude. In a later study, using β-substituted-α,β-unsaturated 
enals (e.g. trans-pentenal 4.74), an absolute requirement for strong Lewis acids such as 
BF3·OEt2 and low temperatures (-94 °C) provided satisfactory regiocontrol at 9:1 (C-2:C-3) 
but the yields were moderate at 44%. Non-aldehyde type dienophiles such as ketones and 
esters provided regioselectivities lower than observed for the enals. 
Table 4.2: Wu’s experimental conditions of Lewis acid catalyzed DA reactions of β-
unsubstituted-α,β-unsaturated enals and N-Ac-IQDM 4.58. 
 








1 4.69 4:1 2:1 -30 SnCl4 4:1 nd 
2 " 2:1 " -78 " 9:1 57-68 
3 " 4:1 " -30 ZnCl2 4:1 nd 
4 " 4:1 " -30 BF3 3.5:1 nd 
5 4.70 2:1 " -78 SnCl4 11:1 68 
6 " 2:1 " -94 " 13.5:1 47 
nd: not determined 
 
These seminal studies indicated that further explorations using Lewis acids would be 
appropriate to widen the synthetic scope. Having established methods that could potentially 
provide the C-2-substituted tetrahydrocarbazole in excess of the C-3 regioisomer (13.5:1), 
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issues regarding stereoselectivity could now be addressed. Accordingly, both chiral catalysts 
and chiral auxiliaries were investigated. 
Corey’s tryptophan-derived oxazaborolidine chiral Lewis acid catalyst 4.73396 provided 
ee’s up to 82% when using 4.70. However, poor enantioselectivity (16% ee) was achieved 
when using 4.74. 
Scheme 4.12: Wu’s stereoselective Diels-Alder reactions of N-Ac-IQDM using 4.73. 
 
 
It was anticipated that other chiral catalysts such as Hawkins' aromatic alkyldichloroborane 
4.76397,398 and/or MacMillan’s chiral imidazolidinones 4.77399 (Figure 4.6) would provide 
adduct 4.75 with high ee’s. Efforts using enantiopure 4.76 were not pursued as racemic 4.76 
was used in the initial studies to probe whether it could efficiently catalyze Diels-Alder 





Figure 4.6: Racemic alkyldichloroborane 4.76 and chiral imidazolidinone 4.77. 
 
Thus attention was turned to Evan’s chiral oxazolidinones.400 The β-substituted-α,β-
unsaturated acyl chiral oxazolidinones 4.78 provided high diastereoselectivity. After removal 
of the chiral auxiliary, up to 96% ee was observed (Scheme 4.13). Crystals were obtained for 
4.79a and 4.80a and the ensuing X-ray diffraction studies permitted assignment of the two 
chiral centres (C-2 and C-3) to the R configuration. Of paramount importance was that the 
regioselectivity could be controlled, affording either the C-2 or C-3 regioisomer in excess of 
the other by using either TiCl4 or Et2AlCl, respectively. It was felt that reactions which used 
the titanium reagents were FMO controlled whereas the reactions using aluminum reagents 
were charge controlled. This suggestion is one of the issues that are addressed in Chapter 5 in 
which theoretical calculations are invoked to provide insight into the processes governing 
regioselectivity. The auxiliary employed in these studies was the only method used that was 









Scheme 4.13: Wu’s stereoselective Diels-Alder reactions of N-Ac-IQDM using 4.78. 
 
 
A drawback with the TiCl4 mediated reactions were the low isolated yields (23%). One 
assumption was that the iodine generated in the reaction was reacting with N-Ac-IQDM 4.58 
producing 4.67. Thus 1,3-propanedithiol was added to the reaction mixture to quench the 
iodine and the yields were observed to increase to 68% as well as the regioisomeric ratio 
increased to 4.4:1 (C-2:C-3). Although this was a substantial increase in the yield, there were 
no further attempts employing other sequestering reagents. Recent efforts towards alternative 








4.4 Efforts towards optimizing Diels-Alder reactions of N-acetyl Indole-2,3-
Quinodimethanes and its Application in Total Synthesis of Kinamycin 
Analogues 
4.4.1 Oxygenated IQDMs 
One of the very early strategies employing IQDMs in synthesis was to access and 
implement substituted IQDMs in natural product synthesis. Of particular interest was the 
oxygen substituted IQDM 4.82 and in the presence of the appropriately substituted 
dienophile 4.83 and chiral Lewis acid (vide supra) could in principle provide carbazole 4.84 
with four contiguous stereocentres (Scheme 4.14a). This in turn could be applied to the 
multistep synthesis of kinamycin analogues (Scheme 4.14b). This strategy would allow the 
introduction of the oxygen substituents at an earlier stage rather than later. Thus one of the 
early goals of this laboratory was to develop methods using oxygenated IQDMs384 that would 
permit easy access towards the multistep synthesis of these analogues. 
Scheme 4.14: Proposed synthesis of carbazoles and kinamycin analogues. 
 
Early exploratory efforts were initiated by O.M. Jakiwyzk using lactone 4.87384  (Scheme 
4.15) with the belief that the access to 4.87 would be straightforward owing to previous work 
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in this laboratory preparing pyranoindoles.383 At the time these studies were performed there 
were no reports on the synthesis of the kinamycins which were still thought to be benzo-
annulated carbazoles. In practice it was found that preparation of 4.88 was plagued by 
substantial quantities of unanticipated side products, tedious purification and recovery of 
significant amounts of starting material which, taken together, provided low yields of the 
desired target. Strategies for synthesizing the regioisomer 4.91 had advanced as far as 4.90 
but never fully materialized beyond this stage. The inherent disadvantage to using 4.88 or 
4.91 was the requirement of elevated temperatures to generate IQDMs for their use in Diels-
Alder reactions. These conditions would preclude the use of Lewis acids and low 
temperatures described in section 4.2.2 and therefore this route was not pursued for the 
purposes of this thesis. 
 







4.4.2 Synthetic efforts towards oxygenated N-acetyl Indole-2,3-Quinodimethanes 
Owing to the limitations described above, new strategies toward oxygen substituted 
IQDMs were attempted in the present study. It was realized early on that α-bromoether 4.92 
would be unstable and difficult to handle (Scheme 4.16). However the corresponding α-
bromoacetate 4.93 may be stable owing to the stabilizing electron withdrawing effect of the 
carbonyl moiety. Hence efforts towards 4.93 were developed with 4.56. 
Scheme 4.16: The potential generation of oxygen substituted IQDM 4.94 from 4.93. 
 
 
The diacetoxy indole 4.95 was synthesized from 4.57 in 65-73% yield (Scheme 4.17a).401 
Attempts at bromination of 4.95 produced a complex mixture in which a number of products 
were evident as indicated by analytical TLC. This was corroborated by the 1H NMR 
spectrum of the crude residue which revealed novel peaks at 10.41 and 10.21 ppm as well as 
a number of peaks in the 3.86-6.61 ppm range with the diminution and/or absence of peaks in 
various capacities assigned to the methylene, acetoxy and acetamide groups of 4.95. The 
crude material was dissolved in a small amount of CH2Cl2 for the purposes of purification via 
chromatography in which the evolution of gaseous fumes of acetic acid occurred. A number 
of fractions were procured which permitted the identification of two compounds; 4.57 
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isolated in 5-6% yield and 4.96 (or its regioisomer) in 8-13% yield as shown in Scheme 
4.17a. On several occasions, a separate fraction was routinely found to contain an inseparable 
mixture of what was thought to be 4.98 and 4.100. Inspection of the 1H NMR spectrum of 
this fraction provided chemical shifts of 10.22, 6.61, 5.57, 2.10 ppm and is consistent with 
4.98. In the same spectrum, peaks were also observed at 5.54, 4.77, 2.80, 2.07 ppm and are 
consistent with 4.100. The signal at 6.61 ppm was assigned to either the hydroxyl proton or 
indolic nitrogen proton. An aliquot of this sample was then subjected to GCMS analysis 
providing mass to charge ratios for the molecular ions 217 and 201, consistent with structures 
4.98 and 4.101, respectively (Scheme 4.17b). It was assumed that under the thermal 
conditions provided by the GCMS instrumentation, 4.100 furnishes 4.101 by intramolecular 
displacement of acetate. As well, ions at m/z of 173 and 215, consistent with 4.97 and 4.99, 
respectively, were also observed routinely and can be justified by the same thermal processes 
of the GCMS experiment. In the end this sequence was repeated several times to firmly 
establish the identity of as many compounds as possible. Since access to oxygenated IQDMs 










Scheme 4.17: a) Attempted bromination of 4.95; b) Possible compounds generated via the 
thermal process of the GCMS experiment. 
 
 
Compound 4.93 was not isolated and its generation could not be satsfactorily determined. 
Thus it was anticipated that the tri-acetoxy system 4.102 might better serve our purposes to 
obtain oxygenated IQDMs and thus efforts towards obtaining 4.102 were pursued (Scheme 
4.18). It was felt that the generation of the diiodide 4.67 may in turn produce 4.58 in situ 
(which would dimerize to 4.55) but in the end this resulted in quantitative recovery of 
starting material. Attempts at acetoxylation using lead tetra-acetate or diacetoxy iodobenzene 
also resulted in recovery of large amounts of starting material. These exploratory studies 
provided some insight into the synthesis of substituted IQDMs and other routes of obtaining 
materials able to generate 4.94 or its analogues will be pursued in the future. 
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Scheme 4.18: Attempts at iodination and acetoxylation of 4.95. 
 
 
4.4.3 Efforts towards increasing product yields of Lewis-acid catalyzed Diels-Alder 
reactions of N-acetyl Indole-2,3-Quinodimethanes 
Wu had demonstrated several advances of using Lewis acid catalyzed Diels-Alder 
reactions of IQDMs to access substituted tetrahydrocarbazoles in a highly regioselective and 
stereoselective manner (Section 4.2.2). In the case with TiCl4 catalyzed reactions using chiral 
β–substituted-α,β-unsaturated N-acyl oxazolidinones, the product yield increased 
dramatically upon the addition of 1,3-propanedithiol. The excess iodine in the reaction may 
have reacted with 4.58 catalyzed by TiCl4 as shown in Scheme 4.19a. As well, any acid 
produced by the dithiol reagent was scavenged by the tertiary amine  (Scheme 4.19b). The 
amine salt may, in turn, act as a Brønsted acid which is deprotonated by 4.58 furnishing 




Scheme 4.19: Proposed degradation pathways of IQDM 4.58. 
 
 
Thus a small number of iodine and acid scavenging reagents (Figure 4.7) were investigated 
with the aim to increase the yields in the presence of any Lewis acid with the additive. These 
included 1,8-bis(dimethylamino)naphthalene (Proton-spongeTM) 4.105,402 N,N-
dimethylaniline (4.106),403 the substituted pyridine 4.107404 and the dithiol 4.103. 
Figure 4.7: Proton/Iodine scavenging reagents. 
 
The yields of the SnCl4 catalyzed reactions were moderate (47-68%) but gave high 
regioselectivities (Table 4.2) and accordingly efforts towards increasing these yields began 
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with these tin catalyzed reactions (Table 4.3). The first attempts using acrolein 4.69 with the 
dithiol 4.103 and the substituted pyridine 4.107 produced only the dimer 4.55 and it was 
assumed that the thiol reagent was attacking acrolein leaving 4.58 in solution, furnishing the 
known dimer 4.55 upon workup. Thus attention was turned towards methacrolein 4.70 and 
the experiment repeated under the same conditions which afforded 49% yield of the desired 
adducts. The use of 4.105 produced the highest regioisomeric ratio (entry 3) whereas 
employing 4.106 provided the highest yield at 61% (entry 4). 
Table 4.3: Diels-Alder SnCl4 catalyzed reactions of 4.58 with additives. 
 











1 4.69 2:1 2:1 2:1 (4.103) + 
1:1 (4.107) 
0b 100 
2 4.70 2:1 2:1 2:1 (4.103) + 
1:1 (4.107) 
49 (11.3:1) 16 
22c 
3 4.70 2:1 2:1 2:1 (4.105) 57 (21:1) 27 
4 4.70 2:1 2:1 1:1 (4.106) 61 (17:1) 27 
5 4.70 4:1 2:1 2:1 (4.105) 39 (16:1) 30 
a. regioisomeric ratios were obtained by integrating the aldehydic protons from the chromatographically pure sample containing both 4.72a 
and 4.72b as an inseparable mixture. 
b. as estimated by inspection of the proton NMR spectrum of the crude product. 
c. isolated yield. 
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From these studies it was clear that the use of these additives did not provide the desired 
adducts in high yields. The factors contributing towards these low yields may not be those 
that were initially anticipated. Further studies towards resolving these issues will need to be 
addressed in the future. 
Synthetic efforts towards optimizing Lewis acid catalyzed Diels-Alder reactions of N-
acetyl-indole-2,3-quinodimethanes remains an ongoing interest in this laboratory and may be 
supported by studies at the theoretical level. Indeed, high level quantum chemical 
calculations may provide insight into many of these observations and from this, issues 
regarding regioselectivity, stereoselectivity and reactivity may be better understood. The 
following chapter provides an in-depth discussion of quantum chemical calculations 
performed on the chemistry of N-acetyl-indole-2,3-quinodimethanes which in almost all 
cases, has shown good agreement for many of the experimental observations discussed in this 
chapter. 
4.4.4 Studies employing Mukai’s method to generate N-substituted Indole-2,3-
Quinodimethanes 
As outlined in the overview, one of the inherent advantages of Mukai’s method is the mild 
conditions used to generate IQDMs and thus we were compelled to reproduce this chemistry 
with the goal in mind that this chemistry may be extended to carbocyclic systems and 
ultimately the kinamycins (Scheme 4.20). This chemistry is described in Chapter 6 and will 
not be discussed any further here. 
In the spirit of reproducibility, this chemistry was re-iterated with three goals in mind. The 
first goal was to reproduce Mukai’s results before any attempts of the carbocyclic system 
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4.109 would be investigated. Secondly, if this chemistry could be repeated without difficulty 
then interest in substituting the Boc group with acetyl as the N-substituent and then probing 
Diels-Alder reactions under Lewis-acid friendly conditions just described would be 
appropriate. Thirdly, owing to significant advances in NMR and X-ray technology within the 
last 25 years, a suite of in depth spectroscopic studies as well as a higher resolution single 
crystal X-ray structure of 4.55 were in order. 
Scheme 4.20: a) Mukai’s method to generate tetrahydrocarbazoles b) potential extension to 
carbocyclic systems to furnish benzo-annulated tetrahydrofluorenes. 
 
 
Efforts towards 4.40 began with procedures described by Marshall and Palovich405 to 
furnish 4.114 as shown in Scheme 4.21. Propargyl alcohol 4.112 was silylated to afford 
4.113 in 98% yield which underwent hydroxymethylation under strongly basic conditions. 
Quenching with paraformaldehyde provided 4.114 in 89% yield. Activation of the alcohol 
4.114 proceeded uneventfully to furnish the mesylate 4.115 in 89% yield.406 The 
allenylstannane 4.116 was furnished by SN2′ displacement of 4.115 by a tin-copper reagent 
produced in situ, in a moderate yield of 58%. 
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Scheme 4.21: Synthesis of allenylaniline 4.40. 
 
 
With a good quantity of 4.116 in hand it was decided to utilize some of this material in two 
separate Stille cross-coupling reactions. The first cross-coupling reaction employed the Boc-
protected aniline 4.117a (obtained from 2-iodoaniline in 78% yield407) and the second 
coupling reaction used the acetanilide 4.117b (obtained from 2-iodoaniline in 91% yield408) 
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which provided the allenylanilines 4.118a and 4.118b in 76% and 83% yield, respectively. 
Deprotection of 4.118a using TBAF as described by Mukai376 did not provide the requisite 
alcohol, instead cyclization to 4.119 occurred in 86% yield. It appears that the fluoride ion, 
acting as a base, deprotonated the aniline furnishing 4.119. The experiment was repeated 
with strict adherence to literature protocol only to find cyclization had repeated itself. The 
material 4.118a was identical to that used as reported by Mukai, yet it was puzzling that there 
was no mention of cyclization reported by those workers. Ironically, an earlier publication by 
Mukai explicitly illustrates the use of TBAF to access indoles from the corresponding 2-
allenylanilines.406 Thus other methods of deprotection were sought, preferably under mild 
acidic conditions with the hopes of abrogating any deprotonation. Reports of desilylation of 
TBS ethers under very mild conditions have been reported by Perumal using KHSO4 in 
aqueous methanol.409 When this method was employed using 4.118a, the alcohol was 
furnished in high yield which in turn was acetylated to give 4.40a in a gratifying 81% yield 
over two steps. The same procedure was then applied to 4.118b to produce 4.40c in 56% 
yield over two steps. Both 4.40a and 4.40c were produced in eight steps with an overall yield 
of 22% and 19%, respectively. 
The next objective was to repeat the Diels-Alder reaction employing 4.40a with dimethyl 
fumarate as described by Mukai.376 In that report, 4.40a was added via syringe over a two 
hour period, to a solution of 4.42 and potassium carbonate in DMF at 0 °C, furnishing the 
adduct 4.43 in 93% yield with no trace of 4.44 (which is actually 4.121) (Scheme 4.7). In 
practice, this experiment was repeated only to find small amounts of product with large 
amounts of starting material recovered. It was decided to allow the reaction mixture to warm 
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to room temperature and to use a longer reaction time. Under these conditions 4.43 was 
obtained in 71% isolated yield. No traces of 4.121 were observed in the 1H NMR spectrum of 
the crude material. Having satisfied ourselves that the reaction was indeed feasible, concerns 
now turned towards increasing the yields. Thus, the experiment was repeated with the 
modification that 4.40a and 4.42 were dissolved in DMF, cooled to 0 °C and then K2CO3 was 
added and stirred overnight, warming to ambient temperature. We were pleased to recover a 
quantitative yield of 4.43 with a very small amount of the dimer 4.121 (Scheme 4.22a). 
Scheme 4.22: Repeat of Mukai’s experiment under new conditions. 
 
 
The next step was to probe if these reaction conditions were conducive to Lewis acid 
catalysis. Dichloromethane was the solvent of choice owing to the precedent already 
established and the bases DBU and Hünig’s base (diisopropylethylamine) were used for these 
initial explorations. A quantitative recovery of starting material was observed for the reaction 
employing Hünig’s base (Scheme 4.22b). Conditions using DBU resulted in 3% recovery of 
4.40a and 4% of 4.121 as well as a small amount of unidentified material was produced but 
its identity was not pursued (Scheme 4.22c). These efforts described above have provided 
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some insight into the feasibility of using 4.40a to generate IQDM under Lewis acid friendly 
conditions. 
Efforts towards obtaining the dimer 4.55 using methods outlined in Schemes 4.9 and 4.11 
failed to provide material suitable to grow crystals for the purpose of X-ray diffraction 
studies. In practice, using TBAI in CH2Cl2 to generate 4.55 provided material that appeared 
to be sensitive to deuterated solvents required for NMR studies. It was found that 4.55 
obtained under those conditions appeared colorless as an ethereal solution but appeared as a 
pale yellow solution in CDCl3 or CD2Cl2, suggesting decomposition of the product upon 
standing. It is possible that this material contained traces of TBAI and air oxidation of I 
might lead to formation of I2 and reaction of I2 with the dimer might be the cause of the  
apparent instability. Upon standing in deuterated solvents, the dimer slowly decomposed 
over time and it was felt that the iodine reacted with the dimer promoting its decomposition 
via deacetylation. All attempts to purify 4.55 from iodine were ineffective. Despite the fact 
that preparations of 4.55 were insufficiently pure, in one instance, crystals were obtained 
from these efforts from which the ensuing single crystal X-ray study revealed an 
anomalously high density around C6/C7 and C7′ suggestive of a small amount (~1%) of 








Figure 4.8: The initial X-ray structure of 4.55. 
 
 
Later on, another analysis of the crystal structure data revealed that the iodine occupancy at 
these coordinates was less than the statistical standard deviation. The original suggestion of 
iodine could be conceivably attributed to artifacts such as twinning. In any event, all methods 
involving iodine and metals were abandoned in favor of using 4.40a and 4.40c which 
provided yields of 98% and 78% for 4.121 and 4.55, respectively. From this, crystals of 4.55 
were obtained from diethyl ether and were suitable for a single crystal X-ray study shown in 
the bottom panel of Scheme 4.23 (Appendix D). The very close spectroscopic similiarity of 






















4.5 Future efforts: Towards stereoselective induction using Yamamoto's BLA 
catalyst and/or Corey’s oxazaborolidine catalyst 
One of the early goals of the work intended to be in this thesis was to initiate new methods 
that would allow stereoinduction in Diels-Alder reactions employing 4.58. The β-substituted 
α,β-unsaturated enals used in attempted cycloadditions with 4.58 were found to be 
unreactive. A solution to this problem was provided by the Evan's auxiliary which gave good 
diastereoselectivities; however, efforts at installing and removing the oxazolidinone were 
laborious and time consuming. Consequently, the result of these efforts provided the 
motivation to pursue other catalyst systems. There are a number of appropriate catalysts 
available,410,411 but future studies would employ either Yamamoto's BLA 4.122412 or Corey's 
oxazaborolidine 4.123413-416 (Figure 4.8) in efforts towards enantioselective Diels-Alder 
reactions of 4.58. 










A Theoretical Investigation into the Chemistry of the N-acetyl 
Indole-2,3-Quinodimethanes: A Quantum Chemical Study 
5.1 Introduction 
The preceding chapter provided experimental observations of the chemistry of N-
acetylindole-2,3-quinodimethane (N-Ac-IQDM) 5.1, in which amide rotamer conformations 
as well as regioselectivity and stereoselectivity studies of Diels-Alder reactions with 5.1 were 
described. This chapter provides the corresponding quantum chemical calculations as an 
extension of those studies as a continuation of our long-standing interest in IQDM chemistry. 
A brief review of the computational methods employed and previous computational studies 
on IQDMs is given in the discussion below. 
Figure 5.1: N-acetylindole-2,3-quinodimethane. 
 
 
5.2 Theoretical investigation of IQDM by others 
Pindur and coworkers were the first to describe the chemistry of IQDMs by computational 
methods using MNDO,375 π-SCF417 and AM1418 calculations. The HOMO of 5.1, 5.2 and 5.3 
and the corresponding molecular orbital (MO) coefficients as reported by Pindur are shown 




 Figure 5.2: The HOMO of IQDMs 5.1, 5.2, 5.3 as calculated by Pindur. 
 
 
Experimentally, Pindur employed 5.4 to generate the benzoyl IQDM 5.3 which was 
trapped with dienophiles methyl vinyl ketone (MVK) 5.5, methyl acrylate 5.6 and acrolein 
5.7 (Table 5.1). The results of the cycloaddition reactions using methyl acrylate and 
acrolein418 were consistent with Vice’s and Jakiwczyk’s results;381,382,384 however, the 
reaction with MVK was perplexing and contradicted the results from this laboratory. Where 
Vice had obtained a 1:3 ratio of 5.8a to 5.8b, Pindur’s laboratory reported a 4:1 ratio.417,419 
Pindur has rationalized the regioselectivity through the use of Frontier Molecular Orbital 
theory:90 
“…The heterocyclic diene reactivity of 5.2 is primarily determined by the 2-
aminobutadiene structural unit. Our MNDO calculations on the parent compound 5.2 have 
shown that the [4πs + 2πs]-cycloaddition reactions with electron-poor dienophiles are 
HOMOdiene-LUMOdienophile controlled processes and that the peri- and regioselectivities found 
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in the numerous experimental syntheses can be predicted satisfactorily from the HOMO 
topologies of 5.1…”375 
Table 5.1: Summary of Pindur’s studies of Diels-Alder reactions with IQDM 5.3. 
 




1 Methyl vinyl ketone 5.5 5.8a:5.8b = 4:1 59 
2 Methyl acrylate 5.6 5.9a:5.9b = 1:3 22 
3 Acrolein 5.7 5.10a:5.10b = 1:3 8 
 
Pindur’s MNDO studies predict, albeit erroneously, the 3-substituted-1,2,3,4-
tetrahydrocarbazoles to be the major product and are clearly at odds with results from our 
laboratory and others380 in which the 2-substituted-1,2,3,4-tetrahydrocarbazole were found to 
be the major product. S.R. White from this laboratory repeated these calculations employing 
the MNDO Hamiltonian as per Pindur’s study, as well as the AM1, PM3 and MINDO/3 
methods and obtained energies and MO coefficients markedly different from those reported 
by Pindur. White's results are shown in Figure 5.3.385 
The discrepancy between White’s MNDO results and those of Pindur is surprising. It is 
possible that the data set reported by Pindur was obtained from structure(s) in which a full 
geometry optimization was not performed. The possibility also exists that the MINDO/3 
Hamiltonian was inadvertently used for this study and seems plausible when one compares 
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Pindur’s results with White's results from the MINDO/3 calculations. In practice it was found 
that the MINDO/3 method was unsuitable to describe the structure and chemistry of 5.2 and 
hence was abandoned. The results of the MNDO, AM1 and PM3 calculations provide MO 
coefficients at the termini that are closer together in magnitude than those reported by Pindur 
and indicate a modest preference for the C-3-substituted carbazole, if the reaction is assumed 
to be FMO controlled. A later study by Pindur417 attributed the low degree of regioselectivity 
to small differences in the HOMO coefficients of the terminal carbon atoms of the 2-
aminobutadiene unit. 
Figure 5.3: Energy and selected MO coefficients of the HOMO of 5.2 calculated with the 
MNDO, MINDO/3, PM3 and AM1 Hamiltonian as reported by S.R. White. 
 
 
The HOMO-1 was calculated for 5.2 at the MNDO level and is shown in Figure 5.4. The 
coefficients at C-3 and C-3α are 0.23 and 0.30, respectively, whereas C-2 and C-2α do not 
contribute to this molecular orbital. Hence the HOMO-1 is governed by a styrene-like 
contribution of the IQDM. Interaction of the HOMO-1diene with the LUMOdienophile would 
favor the C-2-substituted carbazole generated from the Diels Alder trapping of 5.2 with 
dienophiles. However, this interaction is less important than that between the HOMOdiene 
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with LUMOdienophile as the strength of orbital interactions is inversely proportional to the 
difference in energy between the orbitals (i.e. -8.325 eV for the HOMO gives a stronger 
interaction than the HOMO-1 at -9.203 eV). 
 
Figure 5.4: The HOMO-1 of 5.2 calculated at the MNDO level by S.R. White. 
 
 
Intrigued by these results, these computational studies were then extended to the N-Ac-
IQDM 5.1. Figure 5.5 shows the HOMO and HOMO-1 energies and coefficients for both 
rotamers of 5.1. Again, the HOMO indicates a slight preference for the C-3-substituted 
carbazole with the larger eigenvectors manifesting at the C-2α terminus. Much like the 
HOMO-1 of the parent system 5.2, the HOMO-1 of 5.1a and 5.1b shows a similar topology 
with negligible coefficients at C-2 and C-2α and substantial coefficients at C-3 and C-3α 
giving the familiar styrene-like MO. The energetically favorable interaction with the 
LUMOdienophile (i.e. p-orbitals at centres with coefficients that are relatively large preferably 
interact with another) predicts the C-2-substituted-1,2,3,4-tetrahydrocarbazoles as the major 
product. However, these interactions would be considered to be much less important than the 
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HOMOdiene-LUMOdienophile interaction. As it has already been shown, the eigenvalues and 
eigenvectors are heavily dependent on the theoretical platform used to describe these 
systems. 
Figure 5.5: Energies and selected MO coefficients of the HOMO and the HOMO-1 for 
5.1a and 5.1b calculated at the AM1 level by S.R. White. 
 
 
Owing to this confusion, R. Laufer from this laboratory initiated higher level ab initio 
studies, abandoning the oft-used semi-empirical approaches. High level calculations with 
lower basis sets such as the 3-21 G basis set gave results similar to those obtained with the 
semi-empirical methods. However, use of the 6-31G(d) basis set generated coefficients at the 
termini that were essentially equal and hence could not be used to explain the regioselectivity 
through FMO theory. The HOMO-1 calculated at this level revealed topologies similar to 
S.R. White's studies and might contribute a modest influence towards the regioselectivity. 
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Additionally, transition state (TS) calculations were undertaken and found to be predictive of 
the observed regioselectivity (Scheme 5.1). Accordingly, this approach was also used in 
computational studies described later in this chapter. In the studies by R. Laufer from this 
laboratory, only the N-formyl IQDM was employed for the TS calculations and not the N-
acetyl IQDM 5.1. Furthermore, conformations were restricted to s-trans acrolein and a single 
rotamer of the diene (i.e. R1). 
Scheme 5.1: TS calculations of the Diels-Alder cycloaddition of s-trans acrolein and N-
formyl-IQDM calculated at the DFT B3LYP 6-31G(d) level by R. Laufer. 
 
 
Thorough and extensive theoretical investigations of cycloadditions employing 5.1 
describing the influence of IQDM amide conformation, dienophile conformation and facial 
approach have yet to be reported. Additionally, the Lewis acid catalyzed versions of these 
cycloaddition reactions have not been extensively pursued. A major goal of the work 
presented in this chapter is to evaluate a computational method(s) that effectively describes 
the chemistry of the IQDMs from experiment and then to implement those method(s) for 
successive studies in an effort to describe issues of regioselectivity and stereoselectivity. This 




5.3 Quantum Chemical Calculations of the N-acetylindole-2,3-quinodimethanes 
at the DFT B3LYP 6-31G(d) level 
5.3.1 Background 
The discrepancies found between the results reported by Pindur and our own laboratory 
provided the impetus to initiate a thorough in-depth theoretical study to address some of 
these ambiguities and to establish an appropriate computational method that effectively 
describes the behavior and reactivity of the IQDMs. This would be accomplished in part by 
reiterating calculations previously accomplished by others from this laboratory as well as 
those already reported in the literature. The subject of these quantum chemical calculations 
presented in this chapter is based on the experimental work reported in Chapter 4. 




Theoretical descriptions of Diels-Alder reactions are found throughout the literature. 
Additionally, there have been considerably more computational studies of o-QDMs 
compared to IQDMs of which only a handful have utilized quantum chemical 
calculations.420-423 The only computational studies of IQDMs have been reported by Pindur 
and more recently by Tsoleridis.424 The studies by Tsoleridis and coworkers focused on 1,3-
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dipolar cycloadditions of aryl nitrile oxides to both of the exocyclic double bonds of IQDMs, 
generating dispiroisoxazolines 5.13 (Scheme 5.2). These experimental results were then 
followed up by computational studies at the AM1 level in which those authors' proposed 
mechanism was supported by FMO arguments and transition state calculations. Interestingly, 
one of the products isolated in that study (5.14) was “…a remarkable indole quinodimethane 
dimerization and cycloaddition product…” generated from two different cycloaddition 
processes: the [4+2] cycloaddition of one IQDM with the C-3/C-3α exocyclic bond of 
another IQDM; the other, a [3+2] cycloaddition of the nitrile oxide with the other exocyclic 
double bond (C-2/C-2α). This product 5.14 is another example of which dimerization has 
occurred with complete regioselectivity. Furthermore, this product appears to have been 
generated by the same regioselective processes that govern the genesis of the homodimer of 
5.1 as reported by Vice, discussed in Chapter 4. 
To date, high-level quantum chemical calculations on the IQDMs have yet to appear. 
Studies employing the hybrid density functional B3LYP and the 6-31G(d) basis set have 
given excellent descriptions of Diels-Alder reactivity and selectivity despite its 
limitations.334,425-435 More recently, Houk and coworkers have reported on the Diels-Alder 
reactions of butadiene with a series of dienophiles using Corey’s cationic oxazaborolidine 
catalyst411,413-416 in which the computational results showed excellent agreement with the 
experimental results with respect to stereoinduction and enantiomeric ratio.436 In this context, 
it was anticipated that calculations using this theoretical platform would be appropriate with 




5.3.2 Quantum Chemical Calculations: Ab Initio and Density Functional Theory 
All quantum mechanical methods depend on solving the Schrödinger equation. Ab initio 
literally translated means “from the beginning” and these types of calculations use purely 
theoretical approaches to compute chemical structures, their properties, and reactivity. There 
are different levels of theory of which one of the most frequently used is Hartree-Fock (HF) 
which calculates the wavefunction to determine structure, properties and reactivity. Other ab 
initio approaches include Moller-Plesset perturbation theory (MP2, MP3, MP4), 
Configuration Interaction (CIS, CISD), Multi-Configuration SCF (MCSCF, CASSCF) and 
Coupled Cluster Theory (CCSD, CCSD(T)). These are called post-SCF methods that are 
typically applied after a standard ab initio method to correct for deficiencies in the HF 
method. 
On the other hand, Density Functional Theory (DFT) uses a functional (a function of a 
function) to relate the electron density to the quantum mechanical description of the system 
(i.e. that there is a one-to-one mapping from the ground state electron density to the ground 
state electronic wavefunction). This is based on the Hohenberg-Kohn theorem,437 which 
states that all the ground-state properties of a system are functions of the charge density and 
thus enables one to write the total electronic energy as a function of the electron density. In 
other words, the properties, structure and reactivity of a system are related to its electron 
density rather than the wavefunction (i.e. HF methods). In practice the DFT method often 
reduces computational cost considerably while giving results that are as good, and in some 
cases better, than those obtained using HF methods. 
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Computational methods are generally stated by the level of theory followed by the basis set 
used (e.g. HF 6-311+G*, MP2 aug-cc-pVTZ, CBS-QB3, etc). A basis set is the set of 
functions that are used in linear combinations to create the molecular orbitals. In a very 
qualitative way, these basis functions can be thought of as approximating the atomic orbitals 
centered on the atoms. 
All computational studies presented in this thesis were performed at the DFT level of 
theory employing the hybrid density functional B3LYP310,311 (Becke three-parameter Lee-
Yang-Parr exchange-correlation functional) and the 6-31G(d) basis set438 (a valence double-
zeta polarized basis set) using the suite of programs accessible in the commercially available 
software package Gaussian 03 by Gaussian Inc. (Copyright  1994-2003, Gaussian, Inc)309 
installed on a desktop computer running the Linux operating system. Unless otherwise stated, 
all calculations were carried out in the gas phase at T = 298.15 K and P = 1 atm. 
5.3.3 Theoretical Investigation of the Conformational Mobility of the N-Acetyl-Indole-
2,3-Quinodimethanes 
Calculations were initiated with the aim of using the variable temperature NMR (VT 
NMR) work performed by S.R. White as the first model study to assess the predictability at 
the DFT B3LYP 6-31 G(d) level of theory. The observation of a 2.6:1 ratio of 5.1a:5.1b at -
93 °C (Chapter 4 Section 4.3.1) indicated a hindered conformational change that manifested 
as the deshielding of the H-7 proton and H-2αa protons in the 1H NMR spectrum. Using this 
data one can calculate an experimental value for the corresponding energies of the two 
rotamer populations (Table 5.2). According to Gibbs free-energy relationship (equation 5.1), 
the difference in the ground state energy between these two rotamers is: 
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 (5.1)   Δ°GR1R2 = -RTlnKeq 
    Δ°G R1R2 = -(1.98588 e
-3 kcal·K-1·mol-1) (180K)·ln(2.6) 
    Δ°G R1R2 = -0.34 kcal·mol
-1 
Next, the ground state energy minimum structures of both rotamers were computed. These 
calculations are called minimizations as the computation locates a geometry that is consistent 
with the corresponding energy value to be a minimum based on several criteria of the 
algorithm employed by the software program. Thus a minimized structure may be thought of 
as a structure possessing the most relaxed geometry. These calculations revealed that 5.1a 
was 0.75 (ΔE), 0.75 (ΔH) and 0.67 (ΔG) kcal·mol-1 lower in energy than 5.1b and is in 
reasonable agreement with the experimental value of 0.34 kcal·mol-1. The modest difference 
between these two values may possibly be attributed to the experimental conditions 
employing deuterated acetone whereas the computations are carried out in the gas phase. 
Using the value -0.67 kcal·mol-1 and substituting into equation 5.1: 
 
(5.1)    Δ°GR1R2 = -RTlnKeq   
    -0.67 kcal·mol-1= -(1.98588 e-3 kcal·K-1·mol-1) (180K)·lnKeq 
    lnKeq = 1.874 
    Keq = 6.52 
 
This value is in reasonable agreement with the value of 2.6 obtained from VT NMR study. 




Table 5.2: Experimental and calculated rotamer populations and ground-state energies of 
N-Ac-IQDM rotamers 5.1a and 5.1b. Computations were accomplished at the DFT B3LYP 
6-31G(d) level at -93 °C (180K). 
 
Rotamer population R1 R2 
experimental 2.6 1 
theoretical 6.5 1 
Relative energy ΔG (kcal·mol-1)   
experimental 0 0.34 
theoretical 0 0.67 
 
 
These computational results correspond with the VT NMR study and thus provide 
assurance on the predictability of this method to pursue transition state (TS) studies. 
Accordingly, the free energy of activation (‡G) for rotation of the amide moiety was 
calculated. From the VT NMR studies, a ratio of 2.6:1 at -93°C with peak coalescence 
occurring at -50°C was observed. From equation 5.2,439 the activation barrier for R1R2 
could be calculated. Two different values are given for ν depending on whether one uses H-




 (5.2) ‡Gc = 2.3 RTc [10.32 + log(Tc/kc)]; where kc = ν/2 
  = 2.3(8.314472 J·K-1·mol-1)(223K) [10.32 + log(223K/(365 or 525)/2)] 
  = 4264.492689 [10.32 + log(223K/810.826 or 1166.256 Hz] 
  = 4264.492689 [10.32 + log(0.275 or 0.1912)] 
  = 4264.492689 [10.32 + (-0.5606 or -0.7185)] 
  = 4264.492689 [9.759 or 9.6015] 
  = 41618.79 or 40945.57 J·mol-1 
  = 41.61879 or 40.94557 kJ·mol-1 
  = 9.94 or 9.78 kcal·mol-1 
 
Next, the corresponding computation for the transition state  structure (TSs) of the rotation 
of the amide moiety was accomplished. The free energy of activation provided Δ‡GR1R2  of 
10.06 kcal·mol-1 and is in excellent agreement with the experimental value of 9.78-9.94 











Figure 5.6: Computed activation energy (Δ‡E), enthalpy of activation (Δ‡H) and free 
energy of activation (Δ‡G) and the experimental free energy of activation (Δ‡G) for the 
rotation of the amide moiety of 5.1. The bottom panel shows the respective TSs (DFT 




By providing reasonably accurate quantitative data on both structure and energies, these 
two model studies provided a good assessment of the computational method employed such 
that examination of Diels-Alder reactions of 5.1 could now be pursued and this is the focus 





5.3.4 Theoretical Investigation of Diels-Alder Reactions of the N-Acetyl-Indole-2,3-
Quinodimethanes. 
In their analyses of the outcomes of Diels-Alder reactions of 5.3, Pindur and coworkers had 
rationalized the regioselectivity in terms of FMO theory using semi-empirical calculations. 
The use of FMO theory as a predictive tool for such phenomena is well established amongst 
the organic chemistry community. However, other approaches may be used to rationalize 
chemo-, regio- and stereoselectivity should FMO theory fail to adequately predict the 
outcome of such reactions. Particularly, the use of transition state theory (TST), wherein the 
free energy of activation (Δ‡G) may be calculated which then may be applied to the analyses 
























A number of criteria were established for both the diene and dienophile and are 
summarized in Figure 5.7. Both rotamers would be invoked in these studies to investigate if 
the two different conformations have implications on selectivity and is one issue that has not 
been explicitly addressed before. This is particularly important for reactions carried out under 
low temperature conditions. The choice of dienophiles would begin with the simple 
unsubstituted, unsymmetrical system, acrolein 5.7. The effect of dienophile conformation (s-
trans vs. s-cis) on selectivity would also be evaluated. Should these calculations parallel 
experimental results, then evaluation with the α-substituted species methacrolein 5.15 and the 
β-substituted series trans-2-butenal (crotonaldehyde) 5.16, both in their s-cis and s-trans 
conformations would be pursued. These dienophiles are chosen to probe the sensitivity of 5.1 
to structural and conformational differences of the dienophile. Diastereoselectivity issues 
would be addressed by endo versus exo docking of the dienophile in TS calculations. Taken 
together, this data can provide useful information on feasibility of using various dienophiles 
in Diels-Alder reactions with 5.1 to construct substituted carbazoles as well kinamycin 
analogues. 
5.3.4.1 Acrolein 
Appropriately, minimizations of 5.1, 5.7 and the corresponding Diels-Alder adducts 5.17 
and 5.18 were performed and from these calculations, the ground state electronic energy, 
enthalpy and free energy (E, H, G respectively) were retrieved and are given in Table 5.3. 
Only one enantiomer of each adduct was minimized due to the fact that the diene 5.1 is 
achiral and hence facial selectivity issues are non-existent in TS calculations. Separate 
adducts were calculated with respect to amide rotations (e.g. C2R1 and C2R2) even though 
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they represent the same product (in this case the C-2 regioisomer). This was accomplished so 
that TS calculations are focused on the appropriate reaction channel, the Diels-Alder 
reaction, and not bond rotation. If this were not so, then these conditions could compromise 
the calculation as the mathematical algorithms implemented in the software will in effect be 
looking for two transitions states in a single calculation. Thus it becomes a mandatory 
stipulation that the reactants have the same conformation as the products with the only 
differences being the loci at which bond formation (or cleavage) takes place. Obviously, this 
condition does not apply if the conformational change is the desired reaction path of 
investigation. The success of these calculations requires that close attention be paid to issues 
of conformation from bond rotation, sterics, Van der Waals contacts and so forth. 
Focusing on the free energy values, G, examination of Table 5.3 reveals several 
observations: 
1. Rotamer 1 (5.1a) is more stable than rotamer 2 (5.1b) by 0.62 kcal·mol-1 as described in 
the preceding discussion (vide supra). 
2. Acrolein is more stable in its s-trans conformation (5.7a) than its s-cis conformation 
(5.7b) by ~1.6 kcal·mol-1. 
3. Rotamer 2 adducts (5.17b, 5.18b) are more stable than the corresponding rotamer 1 
adducts (5.17a, 5.18a) by ~0.3-1.6 kcal·mol-1. 
4. The adducts are more stable when the CHO group is in the axial conformation compared 





Table 5.3: The energies (a.u.) and relative energies (kcal·mol-1) of N-Ac-IQDM and 
acrolein and their corresponding Diels-Alder adducts obtained at the DFT B3LYP 6-31G(d) 





































































4 5.18a -785.570122 (eq.) 
-785.553830 (eq.) 
-785.613601 (eq.) 





















a., b., c. Energies are taken from minimized structures and are a) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), b) the 
electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), c) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 
d. One atomic unit (a.u.) = 627.5095 kcal/mol. 
e, f. The abbreviations eq. and ax. refer to the cyclohexene ring conformation in which the CHO group is in an equatorial and axial 
orientation, respectively. 
 
The frontier molecular orbital (FMO) energies of the two reactants N-Ac-IQDM 5.1 and 
acrolein 5.7 are shown in Figure 5.8. There are two possible interactions: HOMOdiene-
LUMOdienophile and HOMOdienophile-LUMOdiene. From this illustration, the HOMOdiene-
LUMOdienophile would indicate the reactivity of this cycloaddition would be governed by this 









Figure 5.8: Frontier molecular orbital energies (a.u) for the [4πs+2πs] cycloaddition of 5.1 
with 5.7 calculated at the DFT B3LYP 6-31G(d) level. The four black solid lines indicate the 
four possible lowest energy HOMO-LUMO interactions of the HOMO of N-Ac-IQDM 5.1 




















One atomic unit (a.u.) = 627.5095 kcal/mol. 
 
Table 5.4 and Table 5.5 show the FMO energies and corresponding MO coefficients of 5.1 
and 5.7, respectively. The MO coefficients of both 5.1a and 5.1b are very similar at the 
termini; -0.25/0.25 (5.1a) and 0.28/-0.27 (5.1b) for C-2α/C-3α as shown in Table 5.4 (2pz 
orbital only). This is in contrast to those reported by Pindur in which AM1 calculations gave 
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-0.38 for C-2α and 0.34 for C-3α. As previously stated, it would appear that Pindur’s 
calculations do not provide the correct HOMO topology of 5.1 as initially reported, leading 
to erroneous conclusions on regioselectivity provided by FMO arguments derived from those 
calculations. Inspection of Table 5.5 reveals the largest MO coefficients are on C-3′ of 
acrolein. It has been argued that, in some instances of dienes where the 2p orbital coefficients 
are too close in magnitude to determine regioselectivity of Diels-Alder reactions, the so 
called "secondary orbital" interactions may be the determining factor. For example, in the 
DA reaction of 1-methylbutadiene with methyl acrylate, the 2p orbital coefficients at C-1 (-
0.531) and C-4 (0.534) are very similar, but the coefficient at C-2 (-0.456) is significantly 
greater than that at C-3 (0.350) (Scheme 5.3).440 
 
Scheme 5.3: Secondary orbital interactions as a determining factor in the regioselectivity 
of Diels-Alder cycloadditions of 1-methylbutadiene with methyl acrylate. 
 
 
In this case it has been argued that the reaction is still FMO controlled with a preferential 
stabilizing interaction in an endo-transition state between the C-2 2p orbital and that of the 2p 
orbital on the activating group carbon of the dienophile (i.e. C-1). That secondary FMO 
interactions cannot explain the regioselectivity in the case of the DA reactions of the N-acetyl 
IQDM's is indicated by a comparison of the HOMO coefficients at C-2 (-0.11178) and at C-3 
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(0.11187) of rotamer 1. Thus, FMO theory does not provide a rationalization for the 
regioselectivity observed in DA reactions of IQDMs. Taken together, this suggests that there 
would be negligible differences in the regioselectivity of these DA reactions. Thus other 
means were sought to rationalize the regioselectivity. To this end, TS calculations were 




















Table 5.4: FMO energy (a.u.) and orbital coefficients of the HOMO of N-Ac-IQDM 5.1a 
and 5.1b obtained at the DFT B3LYP 6-31G(d) level.a 
 
5.1a (R1) 
  Energy (a.u.) Orbital Coefficient 
HOMO  -0.20403 C2α 2pz -0.25128 
 C2α 3pz -0.21190 
 C2 2pz -0.11178 
C3 2pz 0.11187 
C3α 2pz 0.25534 
C3α 3pz 0.21680 
a. The 6-31 G(d) basis set is a polarized basis set in which d functions have been added to heavy atoms (atoms other than H and He). 6-31 
G(d) is a split valence (double zeta) basis set that uses six Gaussians for the core orbitals (6 Cartesian d functions) and a 31G split valence 
shell. In the 6-31 G(d) basis set, the "6" is the number of primitive Gaussian type orbitals representing the core orbitals, whereas the "31" 
indicates how many functions the valence orbitals are split into and how many primitive Gaussian type orbitals are used for their 
representation. In other words, the numbers before the G indicate the s and p functions in the basis (i.e. 6-31), whereas the polarization 
function is placed after the G (i.e. d). In molecular modeling language, 6-31 G(d) is simply known as a valence double-zeta polarized basis 
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set. The purpose of the extra functions is to increase flexibility of the basis set and thus produce more realistic wavefunctions (Ref. 441-
444). 
 
Table 5.4 (continued) 
 
5.1b (R2) 
  Energy (a.u.) Orbital Coefficient 
HOMO  -0.20119 C2α 2pz 0.28030 
C2α 3pz 0.23003 
C2 2pz 0.14873 
C2 3pz 0.10694 
C3 2pz -0.12729 
C3α 2pz -0.27298 





Table 5.5: FMO energy (a.u.) and orbital coefficients of the LUMO of acrolein 5.7a and 
5.7b obtained at the DFT B3LYP 6-31G(d) level. 
 
5.7a 
  Energy (a.u.) Orbital Coefficient 
LUMO  -0.06504 C1 2pz -0.33525 
C1 3pz -0.30754 
C2′ 2pz -0.21578 
C2′ 3pz -0.27339 
C3′ 2pz 0.37601 







Table 5.5 (continued) 
 
5.7b 
  Energy (a.u.) Orbital Coefficient 
LUMO  -0.06835 C1 2pz -0.34179 
C1 3pz -0.32196 
C2′ 2pz -0.19995 
C2′ 3pz -0.26879 
C3′ 2pz 0.36256 








Transition state calculations were pursued to obtain the energy barriers (electronic 
activation energy Δ‡E, enthalpy of activation Δ‡H, free energy of activation Δ‡G) for these 
cycloadditions and to acquire structural information (Table 5.6). Some general remarks can 
be made upon examination of the TS structures and their corresponding free energies of 
activation (Δ‡G). Both geometrical and energetic issues are considered: 
1. Inspection of all TS structures (TSs) reveals an asynchronous cycloaddition owing to 
differences in bond lengths of the two incipient bonds. 
2. The s-cis TSs are more asynchronous than the corresponding s-trans TSs as revealed by 
a larger difference in bond length between the two developing bonds (e.g. TS2 vs. TS4). As a 
measure of asynchronicity, one can calculate the difference in the length of the two 
developing bonds, d: (C-3α-C-3′)-(C2α-C2′) = d (or alternatively, (C-3α-C2′)-(C2α-C-3′) 
= d). This is accomplished for the s-trans TSs and for the s-cis TSs (data not shown). Thus 
d is larger in the s-cis TSs than in the s-trans TSs, hence, more asynchronicity is observed 
in the s-cis TSs. 
3. In all cases, a lower energy barrier (i.e. the most stable TS) is achieved by s-cis acrolein, 
the higher energy conformation of acrolein, as shown in Table 5.3, an example of which is 
TS2 compared to TS4. Others have described that, for unsymmetrical dienophiles, the more 
asynchronous the TS, the lower the energy barrier.445,446 
4. All s-trans TSs are endoselective (e.g. TS1 vs. TS2) and this observation has also been 
reported by others.334,447-449 Endoselectivity has been justified in several reports, including 
the "maximum accumulation of unsaturation" by Alder,450 secondary orbital 
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interactions,322,390,440,451,452 dipole-dipole,453 charge-transfer,454 electrostatic455 and steric 
interactions392 as influencing factors.  
5. Rotamer 1 furnishes C-2 adducts with lower barriers than that for the corresponding C-3 
adduct (e.g. TS1 vs. TS5). However, rotamer 2 and s-trans acrolein is marginally selective 
for the C-2 adduct (e.g. TS9 vs. TS13; TS10 vs. TS14) whereas s-cis acrolein is not selective 
at all. 
6. As a general conclusion, the conformation of acrolein (s-trans vs. s-cis) has greater 
implications on the activation barrier than its approach (endo vs. exo; an example of which is 
TS5 vs. TS6 compared to TS5 vs. TS7). Furthermore, all s-cis TSs are more stable (i.e. lower 
energy) than the corresponding s-trans TSs (e.g. TS2 vs. TS4); all endo TSs are more stable 
than the corresponding exo TSs (e.g. TS15 vs. TS16), with one exception (TS7 vs. TS8). 
7. Δ‡G is typically 10-15 kcal·mol-1 higher than Δ‡E and is typical for bimolecular 
reactions in which the entropy raises the free energy barrier relative to the electronic barrier 
alone.456 
8. Considering Δ‡G, the C-3 regioisomer is predicted to be in slight excess of C-2 (i.e. 
TS11 compared to TS15). However, further inspection of Δ‡E and Δ‡H, predict 
regioselectivities of ~6:1 (C-2:C-3) that are in accord with experimental observations 
presented in Chapter 4  (vide infra). 
9. Acquisition of TS3 was denied despite many repeated computational attempts. However, 
based on the data presented in Tables 5.10 and 5.11 for methacrolein and crotonaldehyde, 
respectively, it may be reasonably assumed that the barrier for TS3 is higher than that for 
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TS11, and thus TS11 may be assumed to possess the lowest energy barrier for the C-2 
adduct. 
Table 5.6: Selected structural data and energies of TS structures of Diels-Alder reactions 
of N-Ac-IQDM and acrolein obtained at the DFT B3LYP 6-31G(d) level.a 
TS for DA Adduct TSs 
IFb 

























































Table 5.6 (continued) 
TS for DA Adduct TSs 
IFb 


































































Table 5.6 (continued) 
TS for DA Adduct TSs 
IFb 
































































Table 5.6 (continued) 



































































a. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 8-12 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
b. IF = imaginary frequency in reciprocal centimeters and are not scaled (Ref. 315). 
c. Δ‡E (= Δ‡E0), d. Δ‡H, e. Δ‡G in kcal/mol. 
f. Eelec. + ZPE (= E0), g. H = E0
 
+ Hcorr, h. G = E0
 
+ Gcorr in a.u. (1 a.u. = 627.5095 kcal/mol). 
 
The most important observation from the VT NMR studies of 5.1 (S.R. White in this 
group) was the conformational preference for R1. The use of low temperatures employed by 
Wu as described in Chapter 4 would favor the R1 conformation and hence may justify the C-
2 regioselectivity. The regioselective outcome is the weighted average of all TSs combined, 
each of which is described in Table 5.6. 
A simple estimate of regioselectivity can be shown as the arithmetical difference between 
the free energy barrier for a C-2 adduct and a C-3 adduct obtained from representative 
transition states. First, one must identify the lowest activation barriers in this data set that 
furnishes the C-2-substituted and the C-3-substituted carbazoles. These are TS11 (Δ‡G = 
23.133 kcal·mol-1) and TS15 (Δ‡G = 23.099 kcal·mol-1), respectively. This gives a difference 
of ~0.033 kcal·mol-1 (i.e. ΔΔ‡G= 32.63 cal·mol-1). The two products of the Diels-Alder 
reaction are kinetic. That is, the ratio of products is a function of the ratio of kinetic rate 
constants, kC3/kC2. Therefore, using the Eyring relationship, equation 5.3: 
(5.3)    k = κ(kbT/h)e
(-Δ‡G/RT) 
    kC3/kC2 = e
(-ΔΔ‡G/RT) 
    kC3/kC2 = e
[-32.63 cal/mol/(1.98588 cal/K·mol) (298K)] 




Taking the absolute value of the exponent; 
    kC3/kC2 = e
|-0.055| 
    kC3/kC2 = e
0.055 
    kC3/kC2 = 1.06 
 
From these calculations, the C-3 regioisomer is predicted to be the major product as it has 
the lower Δ‡G, although the selectivity is marginal. From the Erying rate law, the calculated 
TS energies give selectivities of 1.06:1 (i.e. ~1:1 for C-3:C-2) which do not agree with the  
experimental results from this lab. However, when one compares the Δ‡E and Δ‡H values for 
TS11 and TS15 and calculates the corresponding ΔΔ‡E = 1.039 kcal·mol-1 and ΔΔ‡H = 1.085 
kcal·mol-1, the C-2 regioisomer is predicted to be the major product, giving a regioselectivity 
of 5.79:1 and 6.26:1, respectively (i.e. ~6:1 for C-2:C-3 using equation 5.3 and substituting 
ΔΔ‡E and/or ΔΔ‡H for ΔΔ‡G). These data are in reasonable agreement with the experimental 
results of Diels-Alder reactions of N-Ac-IQDM with acrolein (~3:1 ratio for C-2:C-3). The 
reason(s) for the discrepancy between calculated and experimental results are not clear. 
At this time, the qualitative differences between the energy barriers listed in Table 5.6 
should be made obvious. The Δ‡E data set provides the potential energy barrier and thus 
represents the minimum energy pathway (MEP) connecting the reactants to the products on 
the potential energy surface (PES),457-459 also known as the hypersurface. The PES has 3N-6 
degrees of freedom for an N-atom system (N > 3 atoms). Δ‡E is the electronic energy 
difference between reactant and transition state and is the most important contribution to Δ‡G 
and is the most difficult to calculate accurately.460 It is important to realize that no 
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thermodynamic corrections have been applied to Δ‡E. The PES helps to define the scope of 
each elementary reaction and the MEP facilitates understanding the nature of a transition 
state structure, TSs, (not to be confused with the transition state, vide infra) and is just one 
representative of the population of molecules passing from reactants to products.461 More 
specifically, the TSs is saddle point associated with particular molecular structure and is a 
stationary point on the energy surface,462 where the first derivative of the energy function is 
zero with respect to all coordinates and one (and only one) negative second derivative of the 
energy463,464 (i.e. a single negative eigenvalue of the Hessian matrix and is often referred to 
as the imaginary frequency for motion over the saddle point465). Finally, Δ‡E differs Δ‡H by 
RT (vide infra).466 
On the other hand, the Δ‡G data set represents the free energy surface and in effect, hovers 
above the PES, in which the transition state (also known as the "activated complex"), an 
ensemble of species that populate a range of energy levels in the vicinity of a saddle point on 
the PES, can be found.462,467 It is the free energy of populations of molecules that almost 
always govern the kinetics and equilibria of reacting systems, not the potential energy of 
single molecules.467 The TSs is a specific entity with a definite structure; the transition state 
is a thermodynamic concept in which a N-atom system is a surface with 3N-7 degrees of 
freedom.462 The position of the TS is thought to be the at the maximum of the PES 
(electronic energy surface) but in actuality it should be the maximum of the Gibbs free 
energy surface (ΔG).468 The contribution(s) to the free energy of activation (Δ‡G) from 
sources other than the potential energy difference (Δ‡E) must taken into consideration, 
including differences in entropy, thermal energy, zero point vibrational energy (ZPVE), and 
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the PV term.462 Thus entropy plays a role and consequently the geometry of the TS will 
depend on temperature.469 Variational TS theory470-472 is one such approach that is used to 
address this issue. 
The salient points are summarized here. The total internal thermal energy (Etot) is made up 
of the internal energy due to translation, rotational motion, vibrational motion and electronic 
motion, given by: 
 
(5.4)    Etot = Et + Er + Ev + Ee 
 
The thermal corrections (not shown) applied to the Enthalpy and the Gibbs Free Energy 
and are given by: 
(5.5)   Hcorr = Etot + kBT  (= thermal correction to enthalpy) 
(5.6)   Gcorr = Hcorr - TStot  (= thermal correction to Gibbs free energy) 
 
Applying these corrections gives the electronic and thermal enthalpy (H) and the electronic 
and thermal free energies (G), equations 5.9 and 5.10, respectively. As well, the zero point 
vibrational energy (ZPVE) corrected electronic energy (E0, equation 5.7) is shown: 
 
(5.7)  E0 = Eelec + ZPVE (= sum of electronic and zero point Energies) 
(5.8)  Etot = Etransl + Erot + Evib + E0 (= sum of electronic and thermal Energies) 
(5.9)  H = Etot + RT (= E0 + Hcorr = sum of electronic and thermal Enthalpies) 
(5.10) G = H - TS (= E0 + Gcorr = sum of electronic and thermal free Energies) 
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Thus the energy barriers are calculated as: 
(5.11) Δ‡E0 = (Eelec + ZPVE)TS - (Eelec + ZPVE)reactants = Activation energy 
(5.12) Δ‡H = (E0 + Hcorr)TS - (E0 + Hcorr)reactants = Activation enthalpy 
(5.13) Δ‡G = (E0 + Gcorr)TS - (E0 + Gcorr)reactants = Free energy of Activation 
 
Disagreement between theory and experiment can be justified by either by the theoretical 
approach or some intrinsic source of error of which there can be many. Firstly, one of the 
major assumptions is that of non-interacting particles and that the system under study 
behaves as an ideal gas. Some error can be expected from this assumption. Secondly, and 
related to aforementioned gas phase calculation scenario is that solvent effects are not 
explicitly included in the calculations for the present study. This has a pronounced effect on 
energy barriers where it has been shown that the inclusion of solvent effects can give results 
opposite of those acquired in the gas phase. This is dealt with more in depth in the discussion 
on Lewis acid catalyzed DA reaction of IQDMs (Section 5.3.5). 
In this study of DA reactions with N-Ac IQDM and acrolein, the computational method has 
not provided a prediction of regioselectivity that is consistent with the experimentally 
observed result. Clearly some further computational effort in this area is required before 
reliable predictions of regioselectivity of D-A reactions of N-Ac-IQDM are possible. 
Although time constraints preclude the possibility of pursuing this issue further in the context 
of the present thesis, it is worth considering briefly various issues that might be addressed in 
future work. The methodology employed in this study has been employed very successfully 
in making predictions of reactivity and stereoselectivity in numerous Diels-Alder reactions in 
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both the gas and condensed phase, most notably by the Houk333,436 and Paddon-Row 
groups.473 The failure to give an accurate prediction in the present work suggests that 
consideration be given to the unique nature of the diene in this work. 
The ground state calculations of 5.1a and 5.1b, R1 and R2, respectively, indicate a slight 
twisting about the amide group as well as the diene portion suggesting that there might be a 
small facial selectivity issue in DA reactions of N-Ac-IQDMs. Such subtle effects may play a 
role in the ‡G between the two TSs that provide the C-2 adduct, which in this instance, is 
less than 0.1 kcal·mol-1 (i.e. if one compares TS4 and TS11, TSs in which R1 and R2 are 
invoked, respectively, furnishing the C-2 adduct). Owing to this very small difference, it may 
be suggested that TS calculations be carried out using minimized structures that possess bond 
angles and dihedral angles that are "opposite" of the those minimized structures employed in 













Figure 5.9: The transition state structures of TS11 and TS15. 
 
 
Figure 5.9 shows two TS structures from the aforementioned calculations, TS11 and TS15. 
In both cases advanced bond development occurs between C-3′ of acrolein and either C-3α 
(TS11) or C-2α (TS15) of N-Ac-IQDM and thus are asynchronous. Examination of the 
vibrational mode corresponding to the imaginary frequencies (TS11 = -398 cm-1; TS15 = -
405 cm-1) indicates this motion is principally between C-3α and C-3′ (TS11) and C-2α and C-
3′ (TS15) and is another measure of asynchronous character. A further means to characterize 
asynchronousity is to measure the pyramidalization at each of the sp2 carbon centers. This 
may be accomplished by summing all of the bond angles of the atom in question. In TS11, C-
3α is 351.8° and C-3′ is 351.4° which is more advanced upon comparison to C-2α at 359.3° 
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and C-2′ at 359.8°. In TS15, C-2α is 351.1° and C-3′ is 351.0° and the other pair, C-3α and 
C-2′, display angles of 359.2° and 359.8°, respectively. Here the pyramidalization manifests 
principally at C-2α and C-3′. Other sophisticated studies to further characterize transition 
states such as Wiberg bond indices474 and/or NBO analysis475 (which has shown to be a more 
reliable than Mulliken population analysis476), were not pursued. 
Thus quantum chemical studies of Diels-Alder cycloadditions of N-Ac-IQDM with 
acrolein provides reasonably accurate data on structure and energies. Whereas Δ‡G was 
found not to be predictive of regiochemistry, the calculated barriers Δ‡E and Δ‡H parallel 
experimental trends previously accomplished by others in this group and elsewhere. 
Evaluation of both α- and β-substituted systems could now be pursued and are discussed 
below. 
5.3.4.2 Methacrolein and Crotonaldehyde 
Table 5.7 shows the ground state energies of the reactants and products for cycloadditions 
of methacrolein and crotonaldehyde and display the same trends as found for acrolein: 
1. Dienophiles are more stable as their s-trans conformation. 
2. Rotamer 2 adducts are more stable than rotamer 1 adducts. 
The frontier molecular orbital (FMO) energies for methacrolein 5.15 and crotonaldehyde 
5.16 are shown in Figures 5.10 and 5.11, respectively along with 5.1. There are two possible 
interactions: HOMOdiene-LUMOdienophile and HOMOdienophile-LUMOdiene. Both methacrolein 
and crotonaldehyde are similar to acrolein in which the HOMOdiene-LUMOdienophile indicates 
the reactivity of this cycloaddition is governed by this interaction owing to the smaller energy 
gap, should the reaction be FMO controlled. The HOMO-LUMO gap has also slightly 
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increased on comparison to the acrolein data set and is corroborated by the energetic data 
presented in Tables 5.10 and 5.11, should the reaction be FMO controlled. 
Table 5.8 and Table 5.9 show the FMO energies and corresponding MO coefficients of 
5.15 and 5.16, respectively. Taken together and disregarding sterics for the moment, this 
would indicate that methacrolein and crotonaldehyde are similar to acrolein in that there 
would be negligible differences in the regioselectivity of DA reactions, if FMO interactions 
were the determining factor. 
 
Table 5.7: The energies (a.u.) and relative energies (kcal·mol-1) of methacrolein and 





























































































a., b., c. Energies are taken from minimized structures and are a) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), b) the 
electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), c) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 







Figure 5.10: Frontier molecular orbital energies (a.u) for the [4πs+2πs] cycloaddition of 5.1 
with 5.15 calculated at the DFT B3LYP 6-31G(d) level. The four black solid lines indicate 
the four possible lowest energy HOMO-LUMO interactions of the HOMO of N-Ac-IQDM 






























Figure 5.11: Frontier molecular orbital energies (a.u) for the [4πs+2πs] cycloaddition of 5.1 
with 5.16 calculated at the DFT B3LYP 6-31G(d) level. The four black solid lines indicate 
the four possible lowest energy HOMO-LUMO interactions of the HOMO of N-Ac-IQDM 





























Table 5.8: FMO energy (a.u.) and orbital coefficients of the LUMO of methacrolein 5.15a 
and 5.15b obtained at the DFT B3LYP 6-31G(d) level. 
 
5.15a 
  Energy (a.u.) Orbital Coefficient 
LUMO  -0.05841 C1 2pz -0.35619 
C1 3pz -0.33111 
C2′ 2pz -0.20650 
C2′ 3pz -0.26688 
C3′ 2pz 0.36160 







Table 5.8 (continued) 
 
5.15b 
  Energy (a.u.) Orbital Coefficient 
LUMO  -0.06105 C1 2pz -0.36376 
C1 3pz -0.34793 
C2′ 2pz -0.19326 
C2′ 3pz -0.26085 
C3′ 2pz 0.34078 








Table 5.9: FMO energy (a.u.) and orbital coefficients of the LUMO of crotonaldehyde 
5.16a and 5.16b obtained at the DFT B3LYP 6-31G(d) level. 
 
5.16a 
  Energy (a.u.) Orbital Coefficient 
LUMO  -0.05479 C1 2pz -0.33810 
C1 3pz -0.31455 
C2′ 2pz -0.19776 
C2′ 3pz -0.24853 
C3′ 2pz 0.38941 







Table 5.9 (continued) 
 
5.16b 
  Energy (a.u.) Orbital Coefficient 
LUMO  -0.05843 C1 2pz -0.34484 
C1 3pz -0.32729 
C2′ 2pz -0.18148 
C2′ 3pz -0.24729 
C3′ 2pz 0.37562 








TS calculations involving methacrolein and crotonaldehyde were carried out in a manner 
identical to that used for DA reactions of acrolein, the results of which are shown in Tables 
5.10 and 5.11, respectively. Some general trends are observed upon inspection of the TS 
structures and their corresponding barriers (Δ‡G) and, in many respects, a similar pattern 
emerges to that of acrolein: 
1. Inspection of all TSs reveals an asynchronous cycloaddition. 
2. The s-cis TSs are more asynchronous than the corresponding s-trans TSs as shown by 
the larger difference in bond length between the two nascent bonds (e.g. TS17 vs. TS19; 
TS33 vs. TS35). 
3. In all cases, a lower energy barrier is achieved by the s-cis conformer of the dienophile 
(e.g. TS18 vs. TS20), the higher energy conformations of these dienophiles. 
4. All cycloadditions with methacrolein and crotonaldehyde possess larger energy barriers 
than the corresponding cycloadditions with acrolein with crotonaldehyde possessing the 
largest energy barriers of the three dienophiles (TS1 vs. TS17 and TS33). This reflects the 
effect of β-substitution of the dienophile in [4+2] cycloadditions. 
5. The s-trans TSs for methacrolein are endoselective (e.g. TS17 vs. TS18). This is not the 
case with crotonaldehyde in which half of the s-trans TSs possess lower barriers than their 
exo counterparts (e.g. TS33 vs. TS34 compared with TS37 vs. TS38). 
6. Of the TSs with methacrolein, lower barriers are observed in six instances of endo 
approach and two instances of exo approach of the eight cognate TS pairs (e.g. TS17 with 
TS18). With crotonaldehyde, lower energy barriers are observed with three endo approaches 
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and five exo approaches of the eight cognate TS pairs (e.g. TS33 with TS34). This is likely 
an indication of the steric contribution to the diastereofacial approach of the dienophile. 
7. For methacrolein, both rotamer 1 and rotamer 2 furnish C-2 adducts with lower barriers 
than that for the corresponding C-3 adducts. This is somewhat true of crotonaldehyde with 
two exceptions (TS41 with TS45; TS42 with TS46). Upon comparison to acrolein, 
substitution in the α position increases regioselectivity for the C-2 regioisomer and is true of 
methacrolein (vide infra). 
8. As a general conclusion, the conformation of methacrolein and crotonaldehyde (s-trans 
vs. s-cis) has greater implications on the energy barrier than their approach (endo vs. exo) 
with two exceptions (TS17 and TS18 compared to TS17 and TS19; TS21 and TS22 
compared to TS21 and TS23). 
9. Considering Δ‡G, the regioselectivity is predicted to be ~4.4:1 (C-2:C-3) for 
methacrolein and ~2.3:1 (C-2:C-3) for crotonaldehyde. Furthermore, Δ‡E and Δ‡H together 
predict regioselectivities of ~8.2-8.5:1 (C-2:C-3) for methacrolein and ~2:1 (C-2:C-3) for 
crotonaldehyde (vide infra). 
 
Using the Eyring relationship (equation 5.3), the regioselectivity of these cycloadditions 
with methacrolein and crotonaldehyde can be illustrated. In the methacrolein data set (Table 
5.10), the lowest activation barriers in this data set that furnishes the C-2-substituted and the 
C-3-substituted carbazoles are TS27 (Δ‡G = 24.882 kcal·mol-1) and TS31 (Δ‡G = 25.752 
kcal·mol-1), respectively. This gives a difference of ~0.87 kcal·mol-1 (ΔΔ‡G = 870.4 cal·mol-
1) furnishing kC2/kC3 = ~4.35. In the crotonaldehyde data set (Table 5.11), the lowest 
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activation barriers in this data set that furnishes the C-2-substituted and the C-3-substituted 
carbazoles are TS43 (Δ‡G = 27.918 kcal·mol-1) and TS48 (Δ‡G = 28.407 kcal·mol-1), 
respectively. This gives a difference of ~0.49 kcal·mol-1 (ΔΔ‡G = 489.5 cal·mol-1) which 
provides kC2/kC3 = ~2.29. 
In summary, on comparison to the acrolein data set (Table 5.6), the ΔΔ‡G predicts that both 
α-substitution (i.e. methacrolein) and β-substitution (i.e. crotonaldehyde) increases 
regioselectivity for the C-2 regioisomer. Furthermore, both the ΔΔ‡E and ΔΔ‡H data sets for 
methacrolein (calculations not shown) also predicts increased regioselectivity for the C-2 
adduct. However, with crotonaldehyde, both the ΔΔ‡E and ΔΔ‡H data sets indicate that β-















Table 5.10: Selected structural data and energies for TS structures of Diels-Alder reactions 
of N-Ac-IQDM and methacrolein obtained at the DFT B3LYP 6-31G(d) level.a 
TS for DA Adduct TSs 
IFb 
































































Table 5.10 (continued) 
TS for DA Adduct TSs 
IFb 


































































Table 5.10 (continued) 
TS for DA Adduct TSs 
IFb 

































































Table 5.10 (continued) 
TS for DA Adduct TSs 
IFb 


































































Table 5.11: Selected structural data and energies for TS structures of Diels-Alder reactions 
of N-Ac-IQDM and crotonaldehyde obtained at the DFT B3LYP 6-31G(d) level.a 
TS for DA Adduct TSs 
IFb 
































































Table 5.11 (continued) 
TS for DA Adduct TSs 
IFb 


































































Table 5.11 (continued) 
TS for DA Adduct TSs 
IFb 

































































Table 5.11 (continued) 
TS for DA Adduct TSs 
IFb 


































































a. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 8-12 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
b. IF = imaginary frequency in reciprocal centimeters and are not scaled (Ref. 315). 
c. Δ‡E (= Δ‡E0), d. Δ‡H, e. Δ‡G in kcal/mol. 
f. Eelec. + ZPE (= E0), g. H = E0
 
+ Hcorr, h. G = E0
 
+ Gcorr in a.u. (1 a.u. = 627.5095 kcal/mol). 
 
Figure 5.12: The transition state structures of a) TS27 and TS31; b) TS43 and TS48. 
 
 
Figure 5.12 shows the relevant TS structures obtained from the methacrolein data set (TS27 
and TS31) and the crotonaldehyde data set (TS43 and TS48). Akin to acrolein, advanced 
bond development occurs between C-3′ of the dienophile and C-3α (TS27; TS43) or C-2α 
(TS31; TS48) of N-Ac-IQDM, consistent with asynchronicity. Asynchronicity was further 
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supported upon examination of the vibrational mode corresponding to the imaginary 
frequencies (TS27 = -394 cm-1; TS31 = -399 cm-1; TS43 = -417 cm-1; TS48 = -427 cm-1). 
This revealed that the principle motion is between C-3α and C-3′ (TS27; TS43) or C-2α and 
C-3′ (TS31; TS48). 
In analogous fashion to that of acrolein, pyramidalization is evident at the relevant reacting 
loci: TS27 shows C-3α = 351.4°, C-3′ = 351.3° and is advanced over that of C2α = 359.5°, 
C-2′ = 359.8°; TS31 shows C-2α = 350.5°, C-3′ = 350.8° and is advanced over that of C3α = 
359.5°, C-2′ = 359.8°; TS43 shows C-3α = 350.2°, C-3′ = 349.3° and is advanced over that of 
C2α = 359.2°, C-2′ = 359.7°; TS48 shows C-2α = 351.2°, C-3′ = 348.9° and is advanced over 
that of C3α = 358.5°, C-2′ = 359.4°. 
Thus far, this investigation into the chemistry of N-Ac IQDM has revealed important 
structural and energetic data and has reproduced experimental trends reasonably well. In the 












5.3.5 Theoretical Investigation of Lewis acid catalyzed Diels-Alder Reactions of the N-
Acetyl-Indole-2,3-Quinodimethanes 
The effect of Lewis acids on Diels-Alder cycloadditions is well known.394 Studies by Wu 
revealed a 3.5:1 selectivity for BF3-catalyzed cycloadditions of acrolein and N-Ac-IQDM 
(Chapter 4). Although the regioselectivity is only marginally enhanced over that of the non-
catalyzed reactions, it was felt that investigation into conditions that use Lewis acids would 
be initiated with boron-type Lewis acids for two reasons. Firstly, there is no precedent in this 
laboratory of computational efforts towards Lewis acid-catalyzed reactions. Hence, these 
initial efforts are exploratory and using one of the simplest Lewis acids would be an 
appropriate ruler to assess these types of calculations. Secondly, owing to the low atomic 
masses of boron and fluorine there is a substantially reduced computational cost upon 
comparison to using transition metal catalysts, making this an attractive choice for initial 
computational study. Computations in which SnCl4 was used were not accommodated by the 
6-31G(d) basis set and consequently these studies were abandoned. 
This section focuses on two different projects. Firstly, calculations of BF3 complexes of the 
three dienophiles 5.7, 5.15 and 5.16 were accomplished. The corresponding cycloadditions of 
BF3-acrolein with N-Ac-IQDM are then presented and discussed. Secondly, computations on 
the aluminum and titanium-oxazolidinone catalyzed cycloadditions would be investigated. 
As discussed in Chapter 4, regioselectivity could be controlled, affording either the C-2 or C-






Table 5.12: The energies (a.u.) and relative energies (kcal·mol-1) of BF3-complexed 
acrolein, methacrolein and crotonaldehyde and their corresponding Diels-Alder adducts 





Table 5.12 (continued) 
Entry Structure Energy 


















































































































































































a., b., c. Energies are taken from minimized structures and are a) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), b) the 
electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), c) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 
d. One atomic unit (a.u.) = 627.5095 kcal/mol. 
e, f. The abbreviations eq. and ax. refer to the cyclohexene ring conformation in which the CHO group is in an equatorial and axial 
orientation, respectively. 
 
5.3.5.1 BF3-catalyzed Diels-Alder cycloadditions with Acrolein 
Table 5.12 shows the energy data of the BF3-complexed dienophiles acrolein, methacrolein 
and crotonaldehyde and their corresponding cycloadducts. The anti s-trans conformers 5.7c, 
5.15c and 5.16c are the lowest energy forms in their respective data sets. Of interest are the 
anti s-cis conformers 5.15e and 5.16e which are lower in energy than the syn s-trans 
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conformers 5.15d and 5.16d, respectively, reflecting the contribution of allylic interactions to 
the ground state energies. As well, rotamer 2 adducts are more stable than the rotamer 1 
adducts in all instances. 
The FMO energies of N-Ac-IQDM and BF3-complexed acrolein are shown in Figure 5.13. 
As in the cases with acrolein, methacrolein and crotonaldehyde, the lowest energy interaction 
is that of the HOMO of 5.1 with the LUMO of 5.7c, 5.7d, 5.7e and 5.7f (HOMOdiene-
LUMOdienophile). The most important observation is that the LUMO energies are lowered 
considerably from ~0.065 a.u. to ~0.12 a.u. upon Lewis acid complexation (cf. Figure 5.13 to 
Figure 5.8). Accordingly, this should give lower activation barriers than the non-catalyzed 
versions, thus increasing the rate of reaction if these reactions are FMO controlled. 
Table 5.13 shows the FMO energies and corresponding MO coefficients of 5.7c, 5.7d, 5.7e 
and 5.7f. The largest coefficients reside on C-1. The coefficients have increased at C-1, 
decreased at C-2 and are virtually unchanged at C-3 upon comparison to the values presented 
in Table 5.5. The relative difference in magnitude between the eigenvectors has increased 
between C-2 and C-3 (cf. Table 5.5). Hence, the difference between the eigenvectors at C-2 
and C-3 should attribute to increased asynchronicity and thus regioselectivity, owing to the 
“big-big” FMO interactions. As well, stereoselectivity (endo:exo) should also increase due to 
the increase of the C-1 eigenvector (i.e. the carbonyl carbon is more polarized). 
Consequently, stronger secondary orbital interactions with the diene should exist, thus 
increasing endoselectivity. However, as previously stated, FMO theory does not provide a 
rationalization for the regioselectivity observed in DA reactions of IQDMs and thus there 
would be negligible differences in the regioselectivity of these DA reactions, despite the 
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marked effect of Lewis acids. Many theoretical studies have attempted to explain the effect 
of Lewis acids on Diels-Alder reactions with respect to regio- and stereoselectivity. The 
following discussion focuses on transition state calculations of BF3-catalyzed cycloadditions 
of acrolein and N-Ac-IQDM. 
Figure 5.13: Frontier molecular orbital energies (a.u.) for the [4πs-2πs] cycloaddition of 5.1 
with 5.7c, 5.7d, 5.7e, and 5.7f calculated at the DFT B3LYP 6-31G(d) level. In each case, the 
black solid lines indicate the lowest possible energy interaction of the HOMO of N-Ac-















































































Table 5.13: FMO energies (a.u.) and orbital coefficients of the LUMO of BF3-complexed 
acrolein 5.7c, 5.7d, 5.7e and 5.7f obtained at the DFT B3LYP 6-31G(d) level. 
 
  5.7c 5.7d 5.7e 5.7f 
Energy (a.u.) 
LUMO 
 -0.12047 -0.11784 -0.12440 -0.11831 
 Orbital Coefficient 
 C1 2pz -0.39198 -0.40099 -0.39467 0.39720 
 C1 3pz -0.34617 -0.35640 -0.35396 0.35662 
 C2′ 2pz -0.16124 -0.15153 -0.14935 0.12202 
 C2′ 3pz -0.19118 -0.17792 -0.19077 0.16929 
 C3′ 2pz 0.37813 0.37547 0.36597 -0.34533 
 C3′ 3pz 0.40801 0.40145 0.41423 -0.36953 
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Transition state calculations were undertaken on BF3-catalyzed reactions of acrolein and N-
Ac-IQDM, the results of which are shown in Table 5.14. There are thirty-two possible 
reaction channels producing four products (two when one does not take into consideration 
rotation of the amide carbonyl) and TS calculations were attempted on all thirty-two 
channels. Of these, twenty-two transition state structures were obtained. Despite several 
attempts, there were ten reaction channels that did not converge. For many of these, non-
convergence could be attributed to steric issues. The corresponding reactions of methacrolein 
and crotonaldehyde were not pursued owing to time constraints. 
Inspection of structural and energetic data (Δ‡G) from Table 5.14 reveals the following 
trends: 
1. The BF3-catalyzed DA reactions with acrolein are more asynchronous than the 
corresponding uncatalyzed DA reactions with acrolein (Table 5.5) with Δd > 1.0 Å in one 
case (TS78). This trend has been reported by others for catalyzed DA reactions with other 
dienes.334,395,449,477 
2. On comparison to the uncatalyzed DA reactions, the Δ‡G for the BF3-catalyzed DA 
reactions of acrolein are significantly reduced. These observations have also been reported by 
others.334,449,477 Examination of the Δ‡E data set reveals that, in some cases, this decrease is 
by an order of magnitude (e.g. TS1 vs. TS51). 
3. The s-trans TSs are endoselective regardless of the coordination of BF3. 
4. The lowest energy barriers for each of the four data sets found in Table 5.14 are with the 
s-cis conformation (5.7e, 5.7f) and exo approach (TS56, TS62, TS70) and endo approach 
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(TS77). Salvatella and coworkers reported that the endo s-cis was the most stable TS found 
in studies of BF3-acrolein and butadiene.
334 
5. Rotamer 1 (5.1a) furnishes C-2 adducts with lower energy barriers than the 
corresponding C-3 adducts (e.g. TS50 compared to TS58). On the other hand, rotamer 2 
(5.1b) furnishes C-3 adducts with lower activation energies than the corresponding C-2 
adducts (e.g. TS65 compared to TS73). 
6. Rotamer 1 (5.1a) furnishes C-2 adducts with lower barriers than rotamer 2 (5.1b) does 
(e.g. TS50 compared to TS66). A corollary to this is that rotamer 2 furnishes C-3 adducts 
with lower barriers than rotamer 1 (e.g. TS57 compared to TS73). 
7. All s-cis TSs are more stable (i.e. lower energy) than the corresponding s-trans TSs with 
one exception (TS51 compared to TS55); all endo TSs are more stable than the 
corresponding exo TSs with one exception (TS55 compared to TS56). 
8. From the twenty-two available data sets, the Δ‡G predicts the C-2 adduct to be the major 
product at ~8.7:1 (C-2:C-3) predicting a higher regioselectivity than the uncatalyzed reaction 
and is in general agreement with experimental results from this lab with acrolein and other 
dienophiles. Furthermore, the Δ‡E and Δ‡H data sets predict ~3:1 regioselectivity (C-2:C-3). 
There are two barrierless reactions TS56 and TS77 (i.e. negative Δ‡E of -2.25 and -1.59 
kcal·mol-1, respectively). The corresponding Δ‡G are 11.525 (TS56) and 12.803 kcal·mol-1 
(TS77). These two cases, TS56 and TS77, in which both the Δ‡E and Δ‡H are negative (i.e. 
barrierless) and the Δ‡G is positive have also been observed by others and almost always 




Bickelhaupt remarked that the first step in a reaction is the exothermic formation of a 
"reactant complex", the occurrence of which is a typical feature of gas phase calculations 
and, upon solvation, the complexation becomes less important and may disappear altogether 
in the condensed phase.478 Although the TSs are higher in energy than the corresponding 
reactant complexes, they may be below the reactants and thus appear as negative activation 
energies. However, negative activation barriers do not imply a "barrierless" reaction. The 
reaction is also governed by a statistical or entropic "bottleneck" as one goes from the 
separate unbound starting materials to the tightly bound transition state. This "bottleneck" is 
associated with the decrease in the number of available quantum states (translational, 
rotational, and vibrational) on going from the reactants to transition state. Upon solvation, 
these barriers become positive. The effect of differential solvation of the reactant(s) and the 
transition state can induce a negative activation energy to become a positive one. 
Furthermore, one may also observe a reversal of activation energies of two competing 
reactions, such that the selectivity for one reaction over another in the gas phase may be 
reversed upon solvation. Indeed, this phenomena has been shown by Evanseck and 
coworkers study of DA reactions employing the bis(oxazoline) Cu(II) catalyst with an achiral 
N-acroyloxazolidinone.332 Houk and coworkers study of DA reactions employing Evans' 
chiral N-acyloxazolidinone auxiliary catalyzed by Me2AlCl has also shown negative Δ
‡E 
values and positive Δ‡G values.333 Inspection of TS56 and TS77 follow these trends outlined 
above. 
The lowest activation barriers in this data set that furnishes the C-2-substituted and the C-3-
substituted carbazoles are TS56 (Δ‡G = 11.525 kcal·mol-1) and TS77 (Δ‡G = 12.803 
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kcal·mol-1), respectively. This gives a difference of ~1.28 kcal·mol-1 (i.e. ΔΔ‡G= 1277.6 
cal·mol-1), which gives kC2/kC3 = ~8.66. The Δ
‡E and Δ‡H values for TS56 and TS77 provide 
the corresponding ΔΔ‡E = 0.65 kcal·mol-1 and ΔΔ‡H = 0.68 kcal·mol-1 and predicts the C-2 





















Table 5.14: Selected structural data and energies of TS structures of Diels-Alder reactions 
of N-Ac-IQDM and BF3-complexed acrolein obtained at the DFT B3LYP 6-31G(d) level.
a 
TS for DA Adduct TSs 
IFb 













































































































Table 5.14 (continued) 
TS for DA Adduct TSs 
IFb 






























































 TS61 na anti, s-cis na 
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Table 5.14 (continued) 
TS for DA Adduct TSs 
IFb 






























































 TS69 na anti, s-cis na 
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Table 5.14 (continued) 
TS for DA Adduct TSs 
IFb 






























































 TS77 3.15310 anti, s-cis -1.599 
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na syn, s-cis 
exo, bottom 
na 
a. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 12-24 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
b. IF = imaginary frequency in reciprocal centimeters and are not scaled (Ref. 315). 
c. Δ‡E (= Δ‡E0), d. Δ‡H, e. Δ‡G in kcal/mol. 
f. Eelec. + ZPE (= E0), g. H = E0
 
+ Hcorr, h. G = E0
 
+ Gcorr in a.u. (1 a.u. = 627.5095 kcal/mol). 
 
Experimentally, the regioselectivity of the uncatalyzed reaction is 3:1 in favour of the C-2 
regioisomer, whereas the theoretical analysis predicts a nearly equal yield of C-2 and C-3 
products. In the BF3-catalyzed process, the regioselectivity observed experimentally is 3.5:1 
in favour of the C-2 isomer whereas the theoretical analysis predicts a 8.7:1 ratio of C-2 to C-
3 regioisomers. It is feasible that, in solution, the Lewis acid is complexing with the amide 
carbonyl of 5.1 and it is these conditions that are representative of what is occurring in 
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solution as shown in Scheme 5.4. Owing to time constraints, transition state calculations of 
the scenarios presented in Scheme 5.4 were not pursued but will be the focus of follow up 
computational studies in the near future. Finally, the ΔΔ‡E and ΔΔ‡H data sets (calculations 
not shown) indicate decreased regioselectivity upon comparison to the acrolein data set. 
 











Figure 5.14: The transition state structures of TS56 and TS77. 
 
 
Figure 5.14 shows the TS structures for TS56 and TS77. Asynchronicity manifests as 
advanced bond development between C-3′ and C-3α (TS56) or C-3′ and C-2α (TS77) and is 
corroborated by vibrational mode corresponding to the imaginary frequencies (TS56 = -236 
cm-1; TS77 = -289 cm-1) in which the principle motion is between C-3′ and C-3α (TS56) or 
C-3′ and C-2α (TS77). Further examination gives the following pyramidalization data: TS56 
shows C-3α = 356.1°, C-3′ = 354.6° and is advanced over that of C2α = 359.9°, C-2′ = 
359.9°; TS77 shows C-2α = 353.9°, C-3′ = 354.4° and is advanced over that of C3α = 359.9°, 
C-2′ = 359.9°. 
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5.3.5.2 Diels-Alder cycloadditions of Aluminum and Tin acroyloxazolidinones 
Wu's studies employing chiral aluminum and titanium (R,E)-4-benzyl-3-(pent-2-
enoyl)oxazolidin-2-one 5.23386 revealed either the C-2 or C-3 regioisomer could be produced 
in excess of the other and was attributed to either a possible FMO or charge controlled 
reaction, respectively (Scheme 5.5). These types of issues can be potentially explored by 
computational studies. 
Scheme 5.5: Wu’s stereoselective Diels-Alder reactions of N-Ac-IQDM using 5.23. 
 
 
Before this investigation began it was imperative that the correct metal-oxazolidinone 
structures used in TS calculations were consistent with structures obtained from structural 
elucidation studies on Evans' auxiliary-metal chelates.479-481 More recently, Houk and 
coworkers have computationally examined Diels-Alder reactions involving the 
oxazolidinone-containing dienophile with Me2AlCl catalyst 5.26 (Figure 5.15).
333 
Furthermore, it was felt that molecular modeling studies would be initiated in this laboratory 
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using the achiral acrylates 5.27 and 5.28 as this would reduce computational costs 
considerably. Then, time permitting, studies would be pursued with the chiral 3-pent-2-
enoyloxazolidin-2-ones 5.23. 
 
Figure 5.15: Achiral aluminum and titanium oxazolidinones. 
 
 
Table 5.15 shows the relevant energy data of aluminum and titanium N-acyloxazolidinone 
5.27 and 5.28, respectively and their corresponding adducts. All dienophiles (5.27, 5.28, 
5.29, 5.30) are more stable in their s-cis conformation ("b" series). Rotamer 2 cycloadducts 










Table 5.15: The energies (a.u.) and relative energies (kcal·mol-1) of aluminum and 
titanium N-acyloxazolidinones and their corresponding Diels-Alder adducts obtained at the 




Table 5.15 (continued) 
Entry Structure Energy 





























































































































































a., b., c. Energies are taken from minimized structures and are a) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), b) the 
electronic, zero point and thermal enthalpies (i.e. H = E0 + Hcorr), c) the electronic, zero point and thermal free energies (i.e. G = E0 + 
Gcorr). 
d. One atomic unit (a.u.) = 627.5095 kcal/mol. 
 
The FMO energies of N-Ac-IQDM and of aluminum and titanium N-acyloxazolidinone 
5.27 and 5.28, are shown in Figures 5.16 and 5.17, respectively. The lowest energy 
interaction is that of the HOMO of 5.1 with the LUMO of 5.27 and 5.28 (HOMOdiene-
LUMOdienophile). An important observation is that the LUMO energies of 5.27 are lowered 
considerably from ~-0.065 a.u. observed for acrolein to ~-0.25 a.u. and is lower in energy 
than the HOMO of 5.1, demonstrating the powerful Lewis acid effect of Et2AlCl. With 5.28, 
the LUMO is lowered to that observed previously with BF3 (cf. Figure 5.16 to Figure 5.8 and 
Figure 5.13). Consequently, a lowering of the activation barrier would occur as compared to 




Tables 5.16 and 5.17 shows the FMO energies and corresponding MO coefficients of 5.27 
and 5.28, repectively The largest coefficients reside on C-1. The coefficients have increased 
at C-1 (exception 5.28b) and decreased at C-2 and C-3 upon comparison to the values 
presented in Table 5.5. Stereoselectivity (endo:exo) and regioselectivity may increase owing 
to the bulky auxiliary but can only be determined by a thorough in depth theoretical study. 
The following discussion focuses on transition state calculations of aluminum and titanium 


















Figure 5.16: Frontier molecular orbital energies (a.u.) for the [4πs + 2πs] cycloaddition of 
5.1 with 5.27 calculated at the DFT B3LYP 6-31 G(d) level. The four black lines indicate the 
four possible lowest energy HOMO-LUMO interactions of the HOMO of N-Ac IQDM 5.1 




























Figure 5.17: Frontier molecular orbital energies (a.u.) for the [4πs + 2πs] cycloaddition of 
5.1 with 5.28 calculated at the DFT B3LYP 6-31 G(d) level. The four black lines indicate the 
four possible lowest energy HOMO-LUMO interactions of the HOMO of N-Ac IQDM 5.1 



























Table 5.16: FMO energy (a.u.) and orbital coefficients of the LUMO of 5.27a and 5.27b 
obtained at the DFT B3LYP 6-31G(d) level. 
 




 Orbital Coefficient Orbital Coefficient 
 C1 2py 0.30483 C1 2pz 0.39499 
 C1 2pz -0.28420 C1 3pz 0.32165 
 C1 3py 0.26417 C2′ 2pz 0.10543 
 C1 3pz -0.22253 C2′ 3pz 0.14401 
 C2′ 2py 0.08412 C3′ 2pz -0.33979 
 C2′ 3py 0.11499 C3′ 3pz -0.36451 
 C3′ 2px -0.16115   
 C3′ 2py -0.22918   
 C3′ 2pz 0.15745   
 C3′ 3px -0.15433   
 C3′ 3py -0.25817   




Table 5.17: FMO energy (a.u.) and orbital coefficients of the LUMO of 5.28a and 5.28b 
obtained at the DFT B3LYP 6-31G(d) level. 
 




 Orbital Coefficient Orbital Coefficient 
 C1 2pz -0.29649 C1 2pz -0.32624 
 C1 3pz -0.24840 C1 3pz -0.27017 
 C2′ 2pz -0.07996 C2′ 2pz -0.12758 
 C2′ 3pz -0.13269 C2′ 3pz -0.17755 
 C3′ 2px -0.16106 C3′ 2pz 0.30238 
 C3′ 2py -0.08334 C3′ 3pz 0.34700 
 C3′ 2pz 0.15883   
 C3′ 3px -0.16783   
 C3′ 3py -0.12347   





Table 5.18: Selected structural data and energies of TS structures of Diels-Alder reactions 
of N-Ac-IQDM 5.1 and 5.27 and 5.28 obtained at the DFT B3LYP 6-31G(d) level. 
TS for DA Adduct TSs 
IFb 






































a. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 48-60 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
b. IF = imaginary frequency in reciprocal centimeters and are not scaled (Ref. 315). 
c. Δ‡E (= Δ‡E0), d. Δ‡H, e. Δ‡G in kcal/mol. 
f. Eelec. + ZPE (= E0), g. H = E0
 
+ Hcorr, h. G = E0
 
+ Gcorr in a.u. (1 a.u. = 627.5095 kcal/mol). 
 
Despite many repeated attempts, acquisition of only two TSs were obtained for the DA 
adducts listed in Table 5.15. This precludes any analysis and subsequent comparison of the 
reversal of regioselectivity provided by the aluminum and titanium catalysts as discussed in 
Chapter 4. The reasons no TSs were obtained for the C-3 adducts are not immediately clear. 
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No obvious steric clashes were observed during modeling efforts for TS calculations for the 
C-3 adducts and casual inspection of TS81 and TS82 with input files for the corresponding 
C-3 TS calculations confirms this. The C-2 adducts were obtained using the s-cis 
conformation (5.27b, 5.28b) with an exo approach. This approach seemed appropriate for C-
3 TSs and was pursued, yet modeling efforts were denied despite repeated attempts. Houk 
and coworkers' study of DA reactions of siloxydienes and silylated dienes with N-
acyloxazolidinones catalyzed by Me2AlCl found that an exo approach with the dienophile in 
the s-cis conformation gave barriers that were completely consistent with the experimentally 
observed diasteroselectivity.333 In that study, it was found that exo selectivity was due to the 
result of more severe reactant distortions, overwhelming the more favorable interaction 
energies in the endo TS. The notion that the activation barrier (Δ‡E) is the sum of distortion 
(Δ‡Ed) and interaction energies (Δ
‡Ei) has been used to rationalize endo vs. exo selectivity
332-
335,478 and has also been applied in rationalizing 1,3-dipolar cycloadditions.329-331 Whether 
this type analysis can be applied to rationalize the reversal of regioselectivity with the 
catalysts 5.27 and 5.28 remains to answered by future modeling experiments. 
The experimental results obtained by J.Y.J. Wu from this laboratory provided the primary 
motivation for the computational work on Lewis acid catalyzed reactions employing 5.27 and 
5.28 in efforts towards elucidating a cause for the reversal of selectivity. Despite insufficient 
data that would allow insight into the reversal of regioselectivity provided by 5.27 and 5.28, 
others have shown that a reversal of stereoselectivity can be obtained simply by employing 
Et2AlCl or TiCl4 ("stereodichotomy").
482,483 Currently, there is a paucity of information 
regarding the effect of different Lewis acids on regioselectivity. 
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The TS82 is more asynchronous (d = 0.91857 Å) but it possesses higher barriers 
compared to that of the TS81 (d = 0.88865 Å). Thus it would appear that one cannot predict 
relative energy barriers based on Δd data alone when comparing two different metal 
catalysts. This is further supported upon inspection of the analogous BF3-catalyzed version 
(TS70) in which Δd = 0.97351 nm and a Δ‡G = 14.577 kcal·mol-1. These reactions are not 
FMO controlled and thus rules out the argument of a closer HOMO-LUMO gap influencing 
energy barriers of 5.1 and 5.27 compared to that of 5.1 and 5.28 (c.f. Figures 5.16 and 5.17). 

















Figure 5.18: The transition state structures of TS81 and TS82 
 
 
Figure 5.18 shows the TS structures for TS81 and TS82. Asynchronicity is observed as 
advanced bond development between C-3′ and C-3α and is further supported upon 
examination of the vibrational mode corresponding to the imaginary frequencies (TS81 = -
256 cm-1; TS82 = -352 cm-1) in which the principle motion is between C-3′ and C-3α. The 
pyramidalization data is as follows: TS81 shows C-3α = 354.4°, C-3′ = 354.5° and is 
advanced over that of C2α = 359.7°, C-2′ = 359.9°; TS82 shows C-3α = 352.9°, C-3′ = 




A thorough in depth theoretical study of the N-acetyl indole-2,3-quinodimethanes (N-Ac 
IQDM) has been accomplished. Calculations at the DFT B3LYP 6-31 G(d) level of theory 
have provided insight into conformational populations of the N-Ac IQDM, its Diels-Alder 
cycloadducts and the associated energy barriers of corresponding transition state structures 
(TSs). 
Good agreement was observed for the description of the rotamer populations and energy 
barriers for amide rotation of N-Ac IQDM. The potential energy surface and free energy 
surface was described through extensive TS calculations of DA reactions with acrolein in 
which ΔΔ‡G failed to predict the experimentally observed regioselectivity. Calculations that 
are not representative of experimental conditions (e.g. temperature issues, gas phase vs. 
solvent inclusion, etc.) may have implications on these results. However, ΔΔ‡E and ΔΔ‡H 
data sets was found to be predictive of the regioselectivity observed experimentally. 
The ΔΔ‡G predicts that both α-substitution (i.e. methacrolein) and β-substitution (i.e. 
crotonaldehyde) increases regioselectivity for the C-2 regioisomer. Furthermore, both the 
ΔΔ‡E and ΔΔ‡H data sets for methacrolein predicts increased regioselectivity for the C-2 
adduct. However, with crotonaldehyde, both the ΔΔ‡E and ΔΔ‡H data sets indicate that β-
substitution diminishes C-2 regioselectivity. 
The ΔΔ‡G data set with BF3-acrolein predicts increased regioselectivity over that of the 
non-catalyzed version as per experimental evidence; however, it is overestimated by the 




ΔΔ‡H data sets (calculations not shown) indicate decreased regioselectivity upon comparison 
to the acrolein data set. 
Limited data obtained from transition state calculations of aluminum and titanium N-
acyloxazolidinone-catalyzed cycloadditions with N-Ac-IQDM could not provide insight on 
the reversal of regioselectivity observed experimentally by J.Y.J Wu from this laboratory. 
Future computational efforts will be directed towards calculations in which solvent effects 
and temperature corrections are to be included to address issues of selectivity and the 


















Efforts towards the Synthesis of Substituted Tetrahydrofluorenes 
through Diels-Alder Reactions of 2,3-Dimethylene Indene 
Carboxylates and Malonates 
6.1 Introduction 
Chapter 4 illustrated the generation and use of N-acetyl-indole-2,3-quinodimethanes (N-
Ac-IQDM) 6.2 in Diels-Alder cycloadditions to access carbazoloquinones 6.4 which in 
principle could furnish kinamycin analogues (Scheme 6.1a). This chapter presents synthetic 
efforts towards 6.6, the bis-methylene carbocyclic analogues of the N-Ac-IQDM and their 
use in Diels-Alder reactions to generate substituted tetrahydrofluorenes and ultimately the 
kinamycins (Scheme 6.1b). The purpose of these studies is to provide an efficient route to 6.7 
that parallels the potential IQDM route to the carbazole 6.4. 






A proposed synthetic plan is outlined in Scheme 6.2 illustrating the generation of 6.11 
which could provide the diazofluorene 6.12. The chemistry used to obtain 6.9 has already 
been discussed in Chapter 4. Hence efforts have focused on optimizing conditions for X 
(halogen, triflate, etc.), EWG (carboxylate, malonate, nitrile, etc.) and OLG (mesylate, 
acetoxy, carbonate, etc.) of 6.8 and 6.10 to provide the most expedient access to 6.12. 





6.2.1 Ethyl 2-(2-(1-acetoxybuta-2,3-dien-2-yl)phenyl)acetate 
Efforts towards 6.10 were initiated using the ethyl ester of 2-iodo-phenylacetic acid 6.14 
produced from 2-iodophenylacetic acid 6.13 in 99% yield and was subsequently employed in 
a Stille cross-coupling to furnish 6.16 in 82% yield. Deprotection and acetylation provided 




Scheme 6.3: Synthesis of 6.18. 
 
 
With sufficient amounts of 6.18 in hand, optimization of conditions suitable for Diels-
Alder reactions was pursued. Reactions using methyl acrylate 6.19, DBU, NaH or NaOtBu in 
either CH2Cl2 or CH3CN were investigated (Table 6.1). Dichloromethane was explored first. 
Use of DBU in CH2Cl2 returned starting material, whereas using NaH led to total 
decomposition of starting materials and products. Sodium tert-butoxide gave a complex 
mixture as indicated by analytical TLC, 1H NMR and GCMS analysis. These attempts were 
repeated in acetonitrile in which the use of DBU did not provide the desired adduct 6.21, but 
instead produced the eneyne 6.22 in 21% yield with a 27% recovery of the starting material 
(Pathway 1 Scheme 6.4). A separate fraction contained an inseparable mixture of what was 
thought to be 6.20, 6.21 and/or 6.23 as inferred from GCMS data obtained from the crude 
residue that provided a m/z for molecular ions 214 and 300 (Pathway 2 Scheme 6.4). The 1H 
NMR spectrum of this fraction provided two sets of what appeared to be overlapping 
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doublets centered at ~5.80 and ~5.40 ppm and is consistent with the olefinic protons of the 
diene moiety of either 6.20 and/or 6.23. As well, multiplets observed between ~2.2 and ~3.2 
ppm can be tentatively assigned to the methylene protons of the substituted cyclohexene ring 
of 6.21 and/or the α and β carbons of the ester moiety of 6.23. 
Table 6.1: Attempted optimization of Diels-Alder reactions of 6.18 with 6.19. 
 





of 6.18 (%) 
1 CH2Cl2
a DBU (1.1) rt/31 h 
NaH (6.9) rt/44 h 
NaOtBu (1.1) rt/4 h 
trace 6.22 by 1H NMR 
nil 






b DBU (2.2) rt/12 h 
 
NaH (3.2) rt/2.5 h 
 
NaOtBu (1.1) rt/1.5 
complex mixture: 6.22 (21); 
6.20, 6.21 and/or 6.23 (trace)d 
6.22 by 1H NMR; 
complex mixture 







a. Using 1.1 equivalents of 6.19. 
b. Using 2 equivalents of 6.19. 
c. m/z = 228, 242, 286, 300, 314 obtained from GCMS analysis of the crude residue. 
d. Inferred from m/z obtained from GCMS analysis. 
e. 6.18 observed in the proton NMR of the crude residue. 
 
It was anticipated that stronger bases such as NaOtBu and/or NaH may provide the desired 
adduct; however, in practice both of these bases produced complex mixtures. Use of NaH 
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resulted in the complete consumption of 6.18, generating small amounts of 6.22 as observed 
in the 1H NMR spectrum of the crude residue. Employing NaOtBu generated small amounts 
of 6.22 but also returned a large quantity of 6.18. A quantitative workup was not pursued and 
further efforts of using 6.18 in cycloaddition reactions were abandoned. 
Scheme 6.4: Attempted Diels-Alder reactions of allenyl phenyl acetate 6.18. 
 
 
One possible route of decomposition is that the starting materials may be consumed by 
oligomerization via an anionic route (Scheme 6.5a). Deprotonation could occur at either the 
benzylic position or the acetoxy group of 6.18 generating the corresponding enolates which 
would then add to methyl acrylate, eventually leading to polymerization. Ketene generation 
was felt to be another possible route of decomposition; however, esters typically afford the 
corresponding enolates whereas ketenes are not generally considered. Hence, a control 
experiment was conceived in which the acetoxy group was replaced by the pivaloyl group to 
confirm or refute decomposition by pathway 2. Treatment of 6.25 with DBU in ACN 
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provided a 51% recovery of starting material and 13% yield of the eneyne (Scheme 6.5b) 
with little evidence of a cycloadduct appearing in the 1H NMR spectrum of the crude residue. 
Although the recovery of starting material had almost doubled in this instance, it is not clear 
that enolate generation contributed to the decomposition of 6.18 as its corresponding alcohol 
was never recovered from any of the experiments listed in Table 6.1. In any event, it was 
determined that 6.18 was not suitable as a diene precursor presumably owing to the low 


















Scheme 6.5: a) Possible decomposition of 6.18 via oligomerization b) Attempted 
cycloadditions using pivalate 6.25. 
 
 
These initial studies provided some evidence for the generation of 6.20 despite the fact that 
cycloadducts could not be isolated in pure form or fully characterized. This would suggest 
that the cycloaddition process is not as facile as hoped and this is borne out by the fact that 
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This is in contrast to the N-Ac IQDM which dimerizes readily as discussed in Chapter 4. As 
previously stated, a possible reason for the failure of the desired reactions to occur may be 
competing deprotonation pathways (i.e. Pathway 1 and 2, Scheme 6.4) which in turn may 
furnish a low concentration of 6.20. Upon the formation of 6.20 it is reasonable to expect that 
in the presence of excess base, a second deprotonation event even more facile than the first 
occurs at the benzylic position of 6.20 and the resultant anion may subsequently add in a 1,4 
addition to 6.19, generating 6.23 rather than the producing the desired cycloadduct 6.21. 
These concerns invited quantum chemical calculations that are the focus of discussion found 
later on in this chapter. 
6.2.2 Diethyl 2-(2-(1-acetoxybuta-2,3-dien-2-yl)phenyl)malonate 
It was decided that increasing the acidity of the benzylic protons while providing only a 
single such proton in the precursor might be helpful to achieve the desired process. This 
might be accomplished via a malonate or similar alternative. Efforts towards synthesis of the 
malonate 6.27 were envisioned as a deprotonation of 6.16 under basic conditions and 
quenching with a suitable carboxyalkylation reagent (Table 6.2). However, in practice it was 
found this was not as straightforward as initially envisioned. Carboxyalkylation reagents such 
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as diethyl carbonate (DEC), ethyl chloroformate (ECF) and methyl magnesium carbonate 
(MMC) were all utilized but none gave the desired malonate. Using NaH with either DEC or 
ECF returned starting material. Employing DBU and LDA with ECF also returned starting 
material. Using MMC in DMF gave a complex mixture in which the homodimer 6.26 (and 
fragments thereof) in varying amounts was observed from data obtained from GCMS 
analyses. Several different experiments were executed in which the reaction time and 
amounts of MMC were allowed to vary consistently producing the same profile of products. 
When the amount of NaH was increased to eight equivalents in DEC, a brown turbid mixture 
was produced within five minutes of its addition. The reaction was allowed to stir for fifty 
minutes and after workup and purification, three separate fractions were obtained containing 
6.28, 6.29 and 6.26 (Scheme 6.6). This experiment was repeated several times, consistently 
generating the same products. The desired malonate 6.27 was never isolated in any of these 
reactions. 




Table 6.2: Attempts at carboxyalkylation of 6.16. 
 










of  6.16 (%) 
1 DECa NaH (2.6) DEC rt/17 h nil 95 






3 ECFb NaH (5) ECF rt/39 h nil >100 
4 
 
THF LDA (1) ECF (2) 0°Crt 
/25 min 
nil >100 
5 ACN DBU (4.9) ECF (1.5) rt/19 h nil >100 






a. DEC = Diethyl carbonate. 
b. ECF = Ethyl chloroformate. 
c. MMC = Methyl magnesium carbonate. 
d. Inferred from m/z of 398, 400, 414, 428 obtained from GCMS analysis obtained from four different trials. 
 
A pathway that might furnish these products is shown in Scheme 6.7. Deprotonation of 
6.16 generates 6.20a which is in equilibrium with 6.20b, the incipient electrophile for 6.16 
producing 6.30 in the process. Aqueous workup provides the products 6.28 and 6.29. A 
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single diastereomer was observed for 6.28, whereas two diastereomers of 6.29 were observed 
as an inseparable mixture. The Diels-Alder reaction of 6.20a provides two diastereomers 
and/or regioisomers of the homodimer 6.26 as an inseparable mixture. Isolation and 
characterization of these three products provided confirmation that the diene 6.20 had been 
generated, but apparently not the malonate 6.27. Clearly, a new direction towards synthesis 
of the malonate was in order. 




a. All of the spectroscopic data is consistent with the assignment of the structure as the mixture of diastereomers 6.26 except for the 
presence of four signals in the δ 164.6-165.4 range in the Carbon 13 NMR spectrum. If the structure 6.26 is correct, two of the Carbon 13 
signals in that range must arise from unidentified impurities. 
 
The structures of 6.28, 6.29 and 6.26 were elucidated through standard spectroscopic 
means using 1D NMR (1H, 13C, JMOD) and 2D NMR (COSY, HMQC, HMBC) as well as 
LRMS obtained from GCMS analyses. The correlations permitted the assignment of the 
proposed structures of 6.28 and 6.29 and are shown in Figure 6.1. In particular, signals 
observed for 6.28 in which the COSY spectrum shows correlations for H-1′ (δ 2.82-
2.77/1.53-1.47) to H-1 (δ 3.43, dd) and to H-2′ (δ 4.35). The HMBC spectrum shows 
correlations for H-2′ to the ester carbonyl (δ 165.1) and correlations for H-2α (δ 2.40) to C-1 
(δ 52.6). This in contrast to 6.29 in which correlations are not observed in the COSY 
spectrum of H-1 (δ 4.12, 4.02) to H-1′ and appears as singlets in the 1H NMR spectrum 
(overlapped by signals from the ester methylene moieties). As well, the HMBC spectrum 
show correlations of H-1 (δ 4.12, 4.02) to the ester carbonyl (δ 170.78, 170.75), a correlation 
of H-1′ (δ 3.32-3.26, 2.93, 2.87) and H-2′ (δ 4.40) to the ester carbonyl (δ 173.7, 173.6) and a 










Figure 6.1: Selected 2D NMR correlations of 6.28 and 6.29. 
 
 
Generating the malonate 6.32 first followed by the Stille cross-coupling provided the 
desired target but this route was plagued by low yields and tedious purification (0.7% over 
nine steps, Scheme 6.8). In particular, purification of 6.33, the product obtained from the 
cross-coupling reaction, consistently produced unreacted starting materials and unknown by-
products that remained even after repeated chromatography. A small amount of 6.33 was 
eventually acquired for purposes of characterization. On one occasion, it was found that 
desilylation of an incompletely purified portion of 6.33 to afford its corresponding alcohol 
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was a sufficient means to adequately remove the unwanted impurities. However, this method 
was found to be irreproducible often leading to an inseparable mixture. 
 













Table 6.3: Diels-Alder cycloadditions of 6.35 with 6.19. 
 












1a K2CO3 (1.1) 
DMF 
6.19 (1.2) rt/9.5 h nilb nil ~50 
2a DBU (1.1) 
CH2Cl2 
6.19 (1.1) rt/9 h nilb nilc ~50 
3 DBU (1.1) 
CH2Cl2 




4 DBU (1.0)e 
CH2Cl2 




5 DBU (2)e 
CH2Cl2 
6.40 (20) rt/14.5 h 77 % of 6.41 
a. 6.36 not isolated but is suggested by δ 5.28, 5.06 in proton NMR and m/z 286 (M+) in GCMS of crude residue. 
b. Trace amount observed by GCMS analysis only. 
c. Trace of 6.37 not isolated but is suggested by m/z 372 (M+) in GCMS of crude residue. 
d. 1.5:1 ratio of 6.37:6.38 as observed by proton NMR. 
e. DBU in dichloromethane added via syringe over 2 h period. 
f. 1.3:1 ratio of 6.37:6.38 as observed by proton NMR. 
 
With a small amount of 6.35 in hand, exploratory efforts into Diels-Alder reactions could 
now be pursued using the approach described by Mukai.376 This approach failed to generate 
6.37 and instead produced the homodimer 6.38 (Entry 1, Table 6.3). All other attempts 
employed DBU in CH2Cl2 (Entry 2-4, Table 6.3). Using one equivalent of DBU and one 
equivalent of 6.19 produced 6.38 in 45% but failed to generate the cycloadduct 6.37 (Entry 
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2). It was felt that the generation of 6.38 may be due in part to the work-up, particularly 
during rotary evaporation of the solvent at elevated temperatures. The experiment was 
repeated, increasing the number equivalents of methyl acrylate 6.19 to ~20 and the solvent 
was removed via a gentle stream of nitrogen. For the first time, a chemical shift observed at δ 
3.69 appeared in the 1H NMR spectrum of the crude residue and was assigned to Me of the 
ester moiety of 6.37. This provided initial evidence of a cycloadduct in an estimated 1.5:1 
ratio of 6.37:6.38 from the 1H NMR spectrum (Entry 3). Adding DBU via syringe over a two 
hour period failed to increase the amount of 6.37 and provided essentially the same results 
(Entry 4). Furthermore, attempts at separating 6.37 from 6.38 proved futile. One possible 
route leading to the generation of the homodimer 6.38 is that DBU might be attacking methyl 
acrylate in a 1,4-conjugate addition which may go on to polymerize in situ. This would 
deplete the pool of dienophile available to react with diene 6.36, leaving the diene to react 
with itself, consequently generating the dimer in the process. Although the structure assigned 
to the homodimer is shown to be 6.38, further spectroscopic studies (i.e. H2BC) could not 
unequivocally assign its structure and it is possible that its regioisomer 6.39 may be an 
alternative. Future studies will attempt to confirm the structural assignment of the 





Thus attention turned towards employing a suitable alternative dienophile for the purposes 
of obtaining a cycloadduct that could easily be resolved from 6.38 and in good amounts. N-
phenylmaleimide 6.40 satisfied this criterion and provided the desired cycloadduct 6.41 in 
77% yield which was easily separated from 6.38 (Scheme 6.9). 
 
Scheme 6.9: Cycloaddition reaction of 6.35 with 6.40 to furnish 6.41. 
 
 
The procurement of 6.41 provided confirmation of the generation of 6.36 and thus the 
potential use of 6.35 in cycloaddition reactions. However, it appears that the utility of 6.35 
might be limited by the need for the use of highly reactive dienophiles such as 6.40 at 
ambient conditions. Alternative strategies that would make use of 6.18 and/or 6.35 are 
discussed below. 
6.2.3 Future synthetic efforts 
The use of Lewis acids and an appropriate non-nucleophilic base at low temperatures that 
could make the use of the allenyl phenyl acetate 6.18 is one such avenue has not yet been 
explored which may avoid the need to use the malonate 6.35 (Scheme 6.10a). Another 
alternative is using the  quinone 6.43, which would permit facile deprotonation with a weak 
base and subsequent cyclization in situ. This then might be extended to the naphthoquinone 
 
 322 
system 6.46 that could potentially furnish kinamycin analogues 6.7 (Scheme 6.10b). The 
malonate 6.35 might be amenable to other types chemistry that do not require acids or bases. 
This chemistry might be better pursued at elevated temperatures using palladium-catalyzed 
cycloadditions with carbonate 6.47 or a similar alternative (Scheme 6.10c). 
 





6.3 Quantum chemical calculations 
Theoretical calculations described here were pursued in an identical manner to those 
presented in Chapter 5. Table 6.4 shows the energies of 6.20 and 6.36 and their 
corresponding cycloadducts obtained with acrolein. 
 
Table 6.4: The energies (a.u.) and relative energies (kcal·mol-1) of carboxylate 6.20, 
malonate 6.36 and acrolein and their corresponding Diels-Alder adducts calculated at the 







Entry Structure Energy 









































































































a., b., c. Energies are taken from minimized structures and are a) the electronic and zero point energies (i.e. E = Eelec + ZPE = E0), b) the 




d. One atomic unit (a.u.) = 627.5095 kcal/mol. 

























Figure 6.3 illustrates the FMO energies of 6.20 and 6.35 and acrolein. If these reactions are 
FMO controlled, the HOMOdiene-LUMOdienophile would indicate the reactivity of Diels-Alder 
cycloadditions of 6.20 and 6.36 are governed by these interactions due to the smaller energy 
gap. 
Figure 6.3: Frontier molecular orbital energies (a.u.) for the [4πs + 2πs] cycloaddition of 
6.20 and 6.36 with acrolein obtained the DFT B3LYP 6-31 G(d) level. The four black solid 
lines indicate the four possible lowest energy HOMO-LUMO interactions of the HOMO of 

























Table 6.5 and 6.6 show the FMO energies and corresponding coefficients of 6.20 and 6.36, 
respectively. Unlike the N-Ac IQDM in which the terminal coefficients were essentially 
identical (see Chapter 5), the two dienes 6.20 and 6.36 have termini that are significantly 
different and thus would suggest that FMO interactions would be a determining factor in the 
regioselectivity of Diels-Alder cycloadditions. In the case of acrolein, inspection of the MO 
coefficients indicates that the C-2 cycloadducts would be the major regioisomer. 
Furthermore, the coefficients are markedly different at C-2 and C-3, especially in the case of 
the malonate 6.36, such that secondary orbital interactions may also play a role in such 
cycloadditions. 
Transition state calculations were undertaken in a manner identical to that described in 
Chapter 5 the results of which are shown in Tables 6.7 and 6.8 for 6.20 and 6.36, 
respectively. These calculations were pursued in an effort to provide insight into structure, 












Table 6.5: FMO energy (a.u.) and orbital coefficients of the HOMO of 6.20 calculated at 
the DFT B3LYP 6-31 G(d) level. 
 
6.20 
 Energy (a.u.) Orbital Coefficient Orbital Coefficient 
HOMO -0.21249  C2α 2px -0.06584 C3 2pz 0.20168 
  C2α 2pz -0.22102  C3 3px 0.04606 
  C2α 3px -0.04566 C3 3pz 0.12553 
  C2α 3pz -0.17404 C3α 2px 0.10422 
  C2 2px  -0.04281 C3α 2py -0.01656 
  C2 2pz -0.14155 C3α 2pz 0.32964 
  C2 3px -0.03079 C3α 3px 0.08489 
  C2 3pz -0.09299 C3α 3py -0.01188 




Table 6.6: FMO energy (a.u.) and orbital coefficients of the HOMO of 6.36 calculated at 
the DFT B3LYP 6-31 G(d) level. 
 
6.36 
 Energy (a.u.) Orbital Coefficient Orbital Coefficient 
HOMO -0.21347  C2α 2py -0.10319 C3 2pz 0.18760 
  C2α 2pz -0.19429 C3 3py 0.06443 
  C2α 3py -0.08129 C3 3pz 0.11579 
  C2α 3pz -0.14913 C3α 2py 0.16426 
  C2 2pz -0.12688 C3α 2pz 0.30344 
  C2 3pz -0.07546 C3α 3py 0.13491 






Consideration of transition state structures (TSs) and their corresponding energy barriers 
reveal important information on these systems. In many instances the data presented in 
Tables 6.7 and 6.8 reveal similar trends as for the N-Ac-IQDM (Table 5.6, Chapter 5): 
1. Inspection of all TSs reveals an asynchronous cycloaddition. 
2. In all cases, the s-cis TSs are more asynchronous than the corresponding s-trans TSs as 
evidenced by a larger Δd. 
3. In all cases, a lower energy barrier is achieved with s-cis acrolein. 
4. All s-trans TSs are endo selective for both the carboxylate 6.20 and the malonate 6.36 
(e.g. TS83 vs. TS83). 
5. Generally speaking, the conformation of acrolein (s-trans vs. s-cis) has greater impact on 
the energy barrier than its approach (endo vs. exo). For example, compare TS83 vs. TS84 to 
TS83 vs. TS85 (exception: TS103 vs. TS104 compared to TS103 vs. TS105). All s-cis TSs 
are more stable (lower in energy) than the corresponding s-trans (e.g. TS104 vs. TS106). All 
s-trans endo TSs are more stable (lower in energy) than the corresponding exo TSs. 
6. For the carboxylate series, the TSs which possess the lowest Δ‡G are TS85 and TS90 for 
the C-2 and C-3 adduct, respectively to give ΔΔ‡G = 2.43 kcal·mol-1 predicting 60:1 (C-2:C-
3) and agrees with the qualitative interpretation that FMO arguments provide. Consideration 
of Δ‡E and Δ‡H predict C-2:C-3 of 51:1 and 46:1, respectively. 
7. For the malonate series, the TSs which possess the lowest Δ‡G are TS102 and TS106 for 
the C-2 and C-3 adduct, respectively to give ΔΔ‡G = 3.76 kcal·mol-1 predicting 576:1 (C-
2:C-3) and agrees with the qualitative interpretation that FMO arguments provide. 
Consideration of Δ‡E and Δ‡H predict C-2:C-3 of 184:1 and 145:1, respectively. 
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Table 6.7: Selected structural data and energies of TS structures of Diels-Alder reactions 
of 6.20 and acrolein obtained at the DFT B3LYP 6-31 G(d) level. 
TS for DA Adduct TSs 
IFa 
































































Table 6.7 (continued) 

























































Table 6.7 (continued) 
TS for DA Adduct TSs 
IFa 























































Table 6.7 (continued) 






































a. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 8-12 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
b. IF = imaginary frequency in reciprocal centimeters and are not scaled. 
c. Δ‡E (= Δ‡E0), d. Δ‡H, e. Δ‡G in kcal/mol. 
f. Eelec. + ZPE (= E0), g. H = E0
 
+ Hcorr, h. G = E0
 






Table 6.8: Selected structural data and energies of TS structures of Diels-Alder reactions 
of 6.36 and acrolein obtained at the DFT B3LYP 6-31 G(d) level. 
TS for DA Adduct TSs 
IFa 
































































Table 6.8 (continued) 




















































a. Each TS calculation was carried out using the Synchronous Transit-Guided Quasi-Newton Method (QST2 or QST3, Ref. 317,318) using 
Gaussian 03 rev. B.04 or C.02 implemented on a desktop computer running Linux OS (Redhat). TS calculations times were typically 8-12 
hours in duration. All structures reported here as TSs exhibit only one imaginary frequency. The imaginary vibrations were animated with  
Gaussview 3.09 or 4.1 to determine if they were in qualitative agreement with the bond-making/bond-breaking processes associated with 
the reaction of interest. In each case, intrinsic reaction coordinate (IRC, Ref. 313,314) calculations were performed to determine that the 
observed TS could be linked reasonably to the assumed reactant and product geometries. 
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b. IF = imaginary frequency in reciprocal centimeters and are not scaled. 
c. Δ‡E (= Δ‡E0), d. Δ‡H, e. Δ‡G in kcal/mol. 
f. Eelec. + ZPE (= E0), g. H = E0
 
+ Hcorr, h. G = E0
 
+ Gcorr in a.u. (1 a.u. = 627.5095 kcal/mol). 
 
Figure 6.4 shows the relevant TS structures obtained from the carboxylate data set (TS85 
and TS90) and the malonate data set (TS102 and TS106). Advanced bond development 
occurs between C-3′ of the dienophile and C-3α (TS85; TS102) or C-2α (TS90; TS106) of 
the corresponding diene, consistent with asynchronicity. Asynchronicity was further 
supported upon examination of the vibrational mode corresponding to the imaginary 
frequencies (TS85 = -399 cm-1; TS90 = -455 cm-1; TS102 = -408 cm-1; TS106 = -449 cm-1). 
This revealed that the principle motion is between C-3α and C-3′ (TS85; TS102) or C-2α and 
C-3′ (TS90; TS106). 
Pyramidalization is evident at the relevant reacting loci: TS85 shows C-3α = 350.9°, C-3′ = 
350.0° and is advanced over that of C2α = 359.4°, C-2′ = 359.9°; TS90 shows C-2α = 352.2°, 
C-3′ = 351.2° and is advanced over that of C3α = 358.2°, C-2′ = 359.1°; TS102 shows C-3α 
= 350.9°, C-3′ = 349.1° and is advanced over that of C2α = 359.3°, C-2′ = 359.9°; TS106 

























This work described in this chapter has provided the foundation for future experimental 
studies of Diels-Alder reactions of 2,3-dimethylene carboxylates and malonates with suitable 
dienophiles as a potential synthetic strategy towards the kinamycin group of natural products. 
Additionally, quantum chemical calculations indicate that these reactions are expected to be 
highly regioselective. Future synthetic efforts will assess the accuracy of the computational 
predictions of regioselectivity. 
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Chapter 7 Experimental 
7.1 General Procedures 
Materials and Methods. All reactions were carried out under an atmosphere of nitrogen 
and/or argon in flame-dried and/or oven-dried glassware with magnetic stirring unless 
otherwise stated. Where required, the purification of solvents and reagents was accomplished 
according to standard procedures.484 All solvents were reagent grade unless otherwise stated. 
Dichloromethane and triethylamine were distilled from calcium hydride. DMSO was distilled 
from calcium hydride under high vacuum. Tetrahydrofuran and diethyl ether were distilled 
from sodium benzophenone ketyl. Anhydrous ethanol was prepared by reacting absolute 
ethanol with magnesium and iodine as described.484 Dimethylformamide was pre-dried with 
calcium hydride and distilled under high vacuum from 3Å molecular sieves and stored over 
3Å molecular sieves. Alternatively, selected solvents were procured from the M. Braun 
Solvent Purification System, Department of Chemistry, University of Waterloo. The 
maintenance of reactions at very low temperatures for extended periods of time was 
accomplished with the Flexi Cool Immersion Cooler (KINETICS Thermal systems) with the 
cooling coil immersed in an acetone or a methanol bath pre-cooled with dry ice. 
All commercial reagents used were purchased from the Aldrich Chemical Co. or VWR 
Canada (EMD, BDH, Alfa Aesar and J.T. Baker) and were used as received unless otherwise 
stated. Reactions were monitored by analytical thin layer chromatography (TLC) with silica 
coated aluminum sheets (EMD TLC Silica gel 60 F254). Visualization was accomplished 
using UV light (254 nm) or basic KMnO4 stain. Unless otherwise stated, purification of crude 
reaction products was carried out using flash silica gel chromatography (Silicycle SiliaFlash® 
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P60 40-63 μm, 230-400 mesh) according to established procedures.485 All reported yields 
refer to chromatographically and spectroscopically pure compounds unless otherwise stated. 
Characterization Methods. In some instances, compounds previously reported in the 
literature in which the characterization data was insufficient are reported here with a more 
complete characterization data set. Melting points were obtained on a MEL-TEMP® 
apparatus (Laboratory Devices Inc., Holliston MA, USA) and are uncorrected. 1H NMR 
NMR spectra were acquired on a Brüker AC300 (300 MHz), Brüker AVANCE300 (300 
MHz) or Brüker AVANCE500 (500 MHz) spectrometer and are reported in parts per million 
(ppm) in either CD2Cl2 or CDCl3 using the solvent residual peak as the internal standard. For 
CDCl3 this was 7.24 and 77.0 ppm for 
1H NMR and 13C NMR, respectively. Data are 
reported as chemical shift in ppm, integrated intensity; peak multiplicities; coupling constants 
J (Hz) and assignment. The following abbreviations are used for reporting peak 
multiplicities: br = broad, w = weak, s = singlet, d = doublet, t = triplet, q = quartet, dd = 
doublet of doublets, dt = doublet of triplets, m = multiplet. 13C NMR spectra were broadband 
decoupled and acquired on Brüker AC300 (75.5 MHz), Brüker AVANCE300 (75.5 MHz) or 
Brüker AVANCE500 (125.8 MHz) spectrometers and are reported in ppm in CD2Cl2 or 
CDCl3, using the carbon signal of the deuterated solvent as the internal standard. 
15N NMR 
spectra were recorded on a Brüker AVANCE300 (30.4 MHz) and reported in ppm using 
external 15N-formamide in DMSO-d6 as the reference standard at 112.8056 ppm relative to 
NH3 at 0 ppm. Samples were dissolved in CDCl3 and transferred to a 5 mm NMR tube to 
which a 3 mm coaxial NMR tube was inserted containing DMSO-d6 as the lock solvent. 
Infrared spectra (IR) were recorded on a Perkin Elmer Spectrum RX I FT-IR System 
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spectrometer either as thin films on a NaCl plate, KBr pellet, or as a solution in CDCl3 using 
an IR solution cell with 0.1 mm path length and CaF2 windows. Low and high resolution 
mass spectra were recorded in electron impact (EI) mode, chemical ionization (CI) mode 
and/or electrospray ionization (ESI) mode obtained at the WATSPEC mass spectrometry 
facilities, University of Waterloo, Waterloo, Ontario, Canada. 
7.2 Experimental Procedures 
 
 
N-(2-Methoxyphenyl)benzamide (2.17). Following a known procedure,195 a two neck 
round bottom flask was charged with CuI (0.0072 g, 0.038 mmol), benzamide (0.4937 g, 4.1 
mmol), potassium carbonate (0.8408 g, 6.1 mmol), 2-bromoanisole (0.38 mL, 3.1 mmol), 
(±)-trans-1,2-diaminocyclohexane (0.04 mL, 0.33 mmol) and dioxane (0.75 mL). The 
mixture was heated at 110 °C for 24.5 hours. The solution was then allowed to cool, diluted 
with ethyl acetate and filtered through a small plug of Celite 545 and the solvent was 
evaporated in vacuo. The residue was purified by flash silica gel chromatography (6:1 
hexanes:ethyl acetate) to afford 0.4765 g (71%) of the title compound as white solid: mp 65-
66 °C (lit. value486 61-63 °C); IR (NaCl, film, cm-1) νmax 3428, 3065, 2943, 2838, 1674, 1602, 
1580, 1530, 1498, 1481, 1461, 1433, 1339, 1290, 1254, 1218, 1177, 1124, 1099, 1074, 1047, 
1027, 928, 896, 839, 796, 773, 749, 708, 691; 1H NMR (300 MHz, CDCl3)  8.53 (1H, br s, 
NH) overlapping with 8.52 (1H, dd, J = 1.8, 7.8 Hz, ArH), 7.89-7.87 (2H, m, ArH), 7.56-
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7.45 (3H, m, ArH), 7.07 (1H, ddd, J = 1.8, 7.7, 7.7 Hz ArH), 7.01 (1H, ddd, J = 1.5, 7.7, 7.7 
Hz, ArH), 6.91 (1H, dd, J = 1.5, 7.8 Hz, ArH), 3.91 (3H, s, OCH3); 
13C NMR (75.5 MHz, 
CDCl3)  164.9, 147.9, 134.9, 131.4, 128.5, 127.5, 126.7, 123.7, 120.8, 119.5, 109.7, 55.5; 
MS m/z (rel. intensity) (EI) 227 (M+, 69), 196 (4), 167 (1), 105 (100), 77 (33), 65 (3), 51 (7). 
 
 
Synthetic efforts towards N-(2-Methoxyphenyl)cyanamide (2.18). Representative 
procedure: A 10 mL round bottom flask was charged with CuI (0.0081 g, 0.04 mmol) and 
trans-1,2-diaminocyclohexane (0.040 mL, 0.33 mmol) and the mixture was stirred under 
nitrogen for 5 min. o-Bromoanisole (0.38 mL, 3.1 mmol) was added and the mixture was 
stirred for an additional 5 min. To this was added 1,4-dioxane (1 mL) and the mixture was 
stirred for 5 min. K2CO3 (0.9023 g, 6.5 mmol) was added followed by cyanamide (0.1347 g, 
3.2 mmol) and then the mixture was heated at 110 °C for 23 h. The mixture was cooled to 
ambient temperature, filtered through a small pad of silica and the solvent was evaporated on 
a rotary evaporator. The crude residue typically contained starting materials or was a 








1,5-Dimethoxynaphthalene (2.20). From a modification of a known procedure,487 a 
solution of 1,5-dihydroxynaphthalene (10.1552 g, 0.0596 mol) dissolved in acetone (850 mL) 
by vigorous stirring, was added anhydrous K2CO3 (101.1864 g, 0.732 mol) followed by 
dimethyl sulfate (84 mL, 0.888 mol). The mixture was heated at reflux (60 °C oil bath) for 22 
h. The solution was cooled to room temperature and filtered through a sintered glass funnel. 
Triethylamine (50 mL) was added to the filtrate and the mixture was evaporated to dryness 
on a rotary evaporator. The residue was taken up in dichloromethane (400 mL) and 
triethylamine (100 mL) and the mixture was stirred at room temperature for 15 min. This 
solution was then washed twice with 1 M HCl, once with brine, dried over Na2SO4, filtered 
and the solvent evaporated in vacuo to afford 11.07 g (99%) of the title compound as a brown 
solid. The crude naphthalene was typically taken to the next step without further purification: 
mp 174-176 °C (lit. value488 180-181 °C); IR (KBr, cm-1) νmax 3073, 3007, 2960, 2936, 2830, 
1592, 1509, 1469, 1453, 1401, 1342, 1267, 1083, 865, 775; 1H NMR (300 MHz, CDCl3)  
7.83 (2H, d, J = 8.3 Hz, ArH), 7.37 (2H, dd, J = 7.9, 8.3 Hz, ArH), 6.84 (2H, d, J = 7.9 Hz, 
ArH), 3.98 (6H, s, ArOCH3); 
13C NMR (75.5 Hz, CDCl3)  155.2, 126.6, 125.1, 114.2, 
104.5, 55.5; MS m/z (rel. intensity) (EI) 188 (M+, 100), 173 (57), 158 (3), 143 (7), 127 (4), 






4,8-Dimethoxy-1-naphthaldehyde (2.21). Following a known procedure,200 1,5-
dimethoxynaphthalene 2.20 (18.77 g, 0.0997 mol), toluene (20 mL) and DMF (12 mL, 0.155 
mol) were mixed together and cooled to 0 ºC. To this was added POCl3 (12 mL, 0.129 mol) 
and stirring was continued for another hour. The mixture was then heated at 110 ºC for two 
hours, cooled to room temperature and poured into 300 mL of 10% NaOH containing 100 
mL ice. The mixture was then extracted with benzene three times. The extracts were pooled, 
washed twice with 1 M HCl, twice with water, once with brine, dried over Na2SO4, filtered 
and concentrated in vacuo to furnish 19.73 g (92%) of the title compound as a light orange 
solid that was of satisfactory purity for the next step. A small amount (0.1462 g) was purified 
by column chromatography (silica, 1:1 hexanes:ether) and recrystallized from ethanol to 
furnish fine white needles: mp 127-128 °C (lit. value200 125-126 °C); IR (KBr, cm-1) νmax 
3073, 3025, 2971, 2908, 2838, 1663, 1587, 1517, 1465, 1412, 1330, 1270, 1225, 1064, 868, 
828, 801, 765; 1H NMR (300 MHz, CDCl3)  11.03 (1H, s, CHO), 8.05 (1H, d, J = 8.3 Hz, 
ArH), 7.93 (1H, dd, J = 0.7, 8.3 Hz, ArH), 7.42 (1H, dd, J = 7.9, 8.3 Hz, ArH), 7.01 (1H, d, J 
= 7.9 Hz, ArH), 6.87 (1H, d, J = 8.3 Hz, ArH), 4.03 (3H, s, OCH3), 3.99 (3H, s, OCH3); 
13C 
NMR (75.5 Hz, CDCl3)  194.6, 159.5, 156.4, 129.3, 127.7, 127.1, 125.8, 124.7, 115.3, 
107.8, 103.9, 55.9, 55.6; MS m/z  (rel. intensity) (EI) 216 (M+, 100), 215 (30), 201 (19), 185 





4,8-Dimethoxynaphthalen-1-yl formate (2.22). Following a published procedure,200 to a 
solution of naphthaldehyde 2.21 (19.61 g, 0.0906 mol) in CH2Cl2 (900 mL) was added 
mCPBA (39.3051 g at 75.7% assay, 0.172 mol). The solution was stirred vigorously at room 
temperature for 2 h 40 min. This solution was then poured into 10% Na2S2O3 (700 mL) and 
stirred for 25 min. The aqueous layer was removed and water (900 mL) was added. The 
mixture was stirred for 5 min and the aqueous layer removed. This sequence was repeated 
once more. The solution was then transferred to a separatory funnel and washed with a 10% 
solution of Na2S2O3 twice with water washings between and three washings with saturated 
NaHCO3 solution with water washings between, brine once, dried over Na2SO4, filtered and 
the solvent evaporated in vacuo producing 19.44 g (92%) of the crude formate as a brown 
solid. The crude material was employed in the next step without further purification. A small 
portion (0.5874 g) was purified by column chromatography (silica, 2:1 hexanes:ether) to 
afford 0.2248 g of the title compound as fine colourless needles: mp 136 °C (lit. value489 
137-138.5 °C); IR (NaCl, film, cm-1) νmax 2938, 1737, 1599, 1516, 1449, 1411, 1378, 1267, 
1148, 1125, 1061, 846, 789, 746; 1H NMR (300 MHz, CDCl3)  8.32 (1H, s, CHO), 7.88 
(1H, dd, J = 0.7, 8.3 Hz, ArH), 7.39 (1H, dd, J = 8.0, 8.3 Hz, ArH), 7.03 (1H, d, J = 8.3 Hz, 
ArH), 6.89 (1H, d, J = 8.0 Hz, ArH), 6.75 (1H, d, J = 8.3 Hz, ArH), 3.97 (3H, s, ArOCH3), 
3.89 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, CDCl3)  160.9, 154.9, 153.7, 138.9, 128.3, 
126.2, 119.2, 118.8, 115.0, 107.1, 103.7, 55.82, 55.78; MS m/z (rel. intensity) (EI) 232 (M+, 
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32), 204 (54), 189 (100), 174 (18), 161 (5), 146 (3), 118 (3), 102 (6); HRMS (EI) calc. for 
C13H12O4: 232.0736, found: 232.0739. 
 
 
4,8-Dimethoxynaphthalen-1-ol (2.23). Following a known procedure,200 the crude 
formate 2.22 (24.39 g, 0.105 mol) was dissolved in a 1:1 mixture of degassed MeOH/THF 
(750 mL) and stirred on ice at 0 ºC. Potassium hydroxide (17.1858 g, 0.3063 mol) was 
dissolved in methanol (150 ml), extensively degassed, cooled to 0 ºC and added to the 
formate solution that was then stirred for 1 h. The reaction was quenched with 5% aq. HCl 
(130 mL) to obtain a pH ~2, poured into water (3 L) and extracted three times with 
dichloromethane. The organic extracts were pooled, washed twice with water and dried over 
sodium sulfate, filtered through a sintered funnel and the solvent evaporated in vacuo to yield 
20.60 g of a dark brown solid. The crude naphthenol was purified by flash column 
chromatography (silica, CHCl3) furnishing 13.6464 g (64%) of the title compound as a pale 
yellow solid: mp 153-154 °C (lit. value200 155-156 °C); IR (NaCl, film, cm-1) νmax 3419, 
2942, 1631, 1514, 1446, 1412, 1288, 1071, 815, 752; 1H NMR (300 MHz, CDCl3)  8.92 
(1H, s, ArOH), 7.84 (1H, dd, J = 0.8, 8.3 Hz, ArH), 7.32 (1H, dd, J = 7.9, 8.3 Hz, ArH), 6.82 
(1H, d, J = 7.9 Hz, ArH), 6.77, 6.75 (2H, ABq, J = 8.5 Hz, H2, H3), 4.03 (3H, s, ArOCH3), 
3.92 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, CDCl3)  155.9, 148.1, 147.9, 127.8, 125.1, 
115.9, 115.5, 109.0, 106.3, 104.9, 56.1, 55.9; MS m/z (rel. intensity) (EI) 204 (M+, 82), 189 
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(100), 174 (19), 161 (5), 146 (3), 131 (2), 118 (4), 102 (5); HRMS (EI) calc. for C12H12O3: 
204.0786, found: 204.0780. 
 
 
2-Bromo-4,8-dimethoxynaphthalen-1-ol (2.24). Following a published procedure,200 a 
naphthenol solution 2.23 (12.1569 g, 0.0595 mol) in CCl4 (600 mL) was stirred vigorously at 
room temperature. A separate flask was charged with bromine (9.7463 g, 0.0609 mol) 
dissolved in CCl4 (100 mL) which was immediately transferred to a dropping funnel. The 
flask was rinsed with two separate washings of CCl4 (25 mL each) and these rinses were 
added to the dropping funnel to ensure quantitative transfer of bromine. The bromine solution 
was then added drop-wise to the stirred solution of naphthenol over the course of 2 h, after 
which stirring continued for another hour at which time a 20% solution of Na2S2O3 (800 mL) 
was added and stirred for 10 min. This solution was transferred to a separatory funnel and the 
aqueous and organic layers separated. The aqueous layer was extracted three times with 
CH2Cl2 and the extracts were pooled, washed twice with a 10% solution of Na2S2O3, once 
with water, once with brine and dried over Na2SO4, filtered and concentrated under reduced 
pressure. The same workup procedure was also applied to the CCl4 layer. The crude products 
were pooled together to give 16.7275 g (99%) of the title compound as a brown solid which 
was judged by 1H NMR to be sufficiently pure for the following step. A small portion 
(0.1814 g) was by purified by column chromatography (silica, 2:1 hexanes:ether) to afford 
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0.1519 g of a white solid as fine needles: mp 138-139 °C (lit. value200 141-142 °C); IR 
(NaCl, film, cm-1) νmax 3358, 1609, 1509, 1398, 1294, 1238, 1068, 872, 820, 798, 771, 750; 
1H NMR (300 MHz, CDCl3)  9.59 (1H, s, ArOH), 7.79 (1H, d, J = 8.3 Hz, ArH), 7.33 (1H, 
dd, J = 8.0, 8.3 Hz, ArH), 6.92 (1H, s, ArH), 6.86 (1H, d, J = 8.0 Hz, ArH), 4.03 (3H, s, 
ArOCH3), 3.90 (3H, s, ArOCH3); 
13C NMR (75.5 Hz, CDCl3)  155.1, 148.1, 144.4, 127.2, 
125.6, 116.2, 115.6, 110.1, 106.1, 102.8, 56.4, 56.0; MS m/z (rel. intensity) (EI) 284 (M+ for 
C12H11
81BrO3, 99), 282 (M
+ for C12H11
79BrO3, 100), 269 (83), 267 (85), 254 (5), 252 (6), 241 
(4), 239 (5), 226 (2), 224 (2), 187 (7), 173 (9), 159 (3), 145 (10), 129 (4), 101 (3), 89 (3); 
HRMS (EI) calc. for C12H11
79BrO3: 281.9892, found: 281.9888. 
 
 
2-Bromo-1,4,8-trimethoxynaphthalene (2.25). To a stirred solution of bromonaphthenol 
2.24 (0.9064 g, 3.2 mmol) in acetone (100 mL) was added K2CO3 (3.1869 g, 23.1 mmol) and 
dimethyl sulfate (1.8 mL, 19 mmol). The mixture was heated at reflux (60 °C oil bath) for 21 
h. The solution was cooled to ambient temperature, filtered through Celite 545 and the 
solvent evaporated on a rotary evaporator. The residue was dissolved in ether (50 mL) and 
triethylamine (5 mL) and the solution was stirred for 25 min. The solution was then washed 
with 10% HCl twice, water once, brine once and dried over MgSO4, filtered and concentrated 
in vacuo to yield 1.1554 g of dark orange brown solid that was purified by column 
chromatography (silica, 12:1 hexanes:ethyl acetate) affording 0.8775 g (92%) of the title 
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compound as a white solid: mp 81-82 °C (lit. value490 85-87 °C); IR (NaCl, film, cm-1) νmax 
2934, 1576, 1508, 1450, 1413, 1337, 1326, 1267, 1071, 1006, 970, 874; 1H NMR (300 MHz, 
CDCl3)  7.80 (1H, d, J = 8.3 Hz, ArH), 7.37 (1H, dd, J = 8.0, 8.3 Hz, ArH), 6.94 (1H, d, J = 
8.0 Hz, ArH) overlapping with 6.93 (1H, s, ArH), 3.97 (3H, s, ArOCH3), 3.93 (3H, s, 
ArOCH3), 3.83 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, CDCl3)  155.4, 151.7, 146.7, 128.1, 
126.0, 121.2, 114.9, 114.1, 108.9, 107.9, 61.6, 56.4, 55.9; MS m/z (rel. intensity) (EI) 298 
(M+ for C13H13
81BrO3, 98), 296 (M
+ for C13H13
79BrO3, 100), 283 (23), 281 (24), 253 (4), 251 
(3), 225 (3), 223 (4), 202 (57), 187 (32), 159 (11), 149 (4), 129 (8), 116 (6), 113 (4), 101 (4); 
HRMS (EI) for C13H13
79BrO3: 296.0048, found: 296.0058. 
 
 
5-Hydroxynaphthalene-1,4-dione (Juglone) (2.28). Following a known procedure,213 to a 
stirred solution of 2.19 (30.0553 g, 0.1876 mol) in acetonitrile (500 mL) was added CuCl 
(12.2495 g, 0.1237 mol). The mixture was stirred vigorously while a strong current of air was 
bubbled through for 15 h. The solution was then filtered through a Buchner funnel and the 
filter cake washed with acetonitrile. The crude product was concentrated under reduced 
pressure and was purified via Soxhlet extraction with n-heptane over 4.5 days after which the 
solution was filtered through a sintered funnel and evaporated in vacuo producing the title 
compound as an orange solid (12.06 g, 37%): mp  150-151 °C (lit. value213 154-161 °C); IR 
(NaCl, film, cm-1) νmax 1663, 1645, 1592, 1450, 1363, 1289, 1224, 1153, 1079, 857, 833, 
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746, 697, 628; 1H NMR (300 MHz, CDCl3) δ 11.89 (1H, s, ArOH), 7.65-7.58 (2H, m, ArH), 
7.27 (1H, dd, J = 2.4, 7.2 Hz, ArH), 6.93 (2H, s, H2, H3); 13C NMR (75.5 MHz, CDCl3) δ 
190.3, 184.2, 161.4, 139.5, 138.6, 136.5, 131.7, 124.5, 119.1, 114.9; MS m/z (rel. intensity) 
(EI) 174 (M+, 100) 173 (22), 158 (3), 146 (8), 118 (18), 92 (9), 63 (6). 
 
 
2,3-Dibromo-5-hydroxy-2,3-dihydronaphthalene-1,4-dione (2.29). Following a 
published procedure,214 to a stirred solution of juglone 2.28 (0.4011 g, 2.30 mmol) in CHCl3 
(5 mL) and 6 drops of acetic acid stirring at 0 °C was added slowly a solution of bromine 
(0.4045 g, 2.53 mmol) in CHCl3 (5 mL). The mixture was stirred for 2 h and then brought to 
room temperature.  The solution was concentrated under reduced pressure to give the title 
compound as a black solid (0.7546 g, 98%): 1H NMR (300 MHz, CDCl3) δ 11.40 (1H, s, 
ArOH), 7.72 (1H, dd, J = 7.4, 8.3 Hz, ArH), 7.63 (1H, d, J = 7.4 Hz, ArH), 7.34 (1H, d, J = 
8.3 Hz, ArH), 4.93, 4.90 (2H, ABq, J = 3.1 Hz, H2, H3); 
13C NMR (75.5 MHz, CDCl3) δ 
192.7, 185.7, 162.6, 140.0, 130.2, 125.4, 120.3, 112.9, 45.5, 45.4; MS m/z (rel. intensity) (EI) 
336 (M+ for C12H6
81,81Br2O3, 24), 334 (M
+ for C12H6
79,81Br2O3, 54), 332 (M
+ for 
C12H6
79,79Br2O3, 36), 255 (93), 253 (100), 174 (42), 173 (20), 146 (15), 145 (11), 120 (11), 






2-Bromo-8-hydroxynaphthalene-1,4-dione (3-bromojuglone) (2.30); 2-bromo-5-
hydroxynaphthalene-1,4-dione (2-bromojuglone) (2.31). Following a modification of 
known procedures,203,207,215 2,3-Dibromo-5-hydroxy-2,3-dihydronaphthalene-1,4-dione 2.29 
(0.5201 g, 1.56 mmol) was dissolved in ethanol (5 mL) and the solution was refluxed for 11 
min.  The solution was cooled to room temperature and concentrated under reduced pressure 
to give 0.4175 g of crude product containing the desired target 3-bromojuglone 2.30 in 
excess of the 2-bromojuglone 2.31 in ~3:1 ratio as well as trace of the vinyl ether 2.32. The 
mixture was subjected to silica gel chromatography (20:1 then 10:1 hexanes:ethyl acetate) to 
give 0.1803 g (31%) of a mixture of the two regioisomers and a small amount of the vinyl 
ether. A portion of this mixture (0.117 g) was subjected to another round of silica gel 
chromatography (15:1 hexanes:ether) to afford a pure mixture of the two regioisomers as an 
orange residue (0.0504 g, 9%). Assignment of the two regioisomers, 3-bromojuglone (2.30) 
and 2-bromojuglone (2.31), was based on previous work in other laboratories214,215 and in 
conjunction with 1H, 13C, JMOD and 2D (COSY, HMQC and HMBC) 
NMR analyses: 
2-Bromo-8-hydroxynaphthalene-1,4-dione (2.30). 1H NMR (300 MHz, 
CDCl3) δ 11.67 (1H, s, ArOH), 7.68-7.56 (2H, m, ArH), 7.44 (1H, s, H3), 
7.25 (1H, d, J = 9.0 Hz, ArH); 13C NMR (75.5 MHz, CDCl3) δ 182.8, 181.6, 162.0, 141.2, 
139.3, 137.1, 131.5, 124.7, 119.9, 113.9. 
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2-Bromo-5-hydroxynaphthalene-1,4-dione (2.31). 1H NMR (300 MHz, 
CDCl3) δ 11.73 (1H, s, ArOH), 7.70-7.58 (2H, m, ArH), 7.47 (1H, s, H3), 
7.27 (1H, d, J = 8.3 Hz, ArH); 13C NMR (75.5 MHz, CDCl3) δ 187.4, 177.2, 
161.7, 140.9, 140.2, 136.4, 130.6, 125.1, 120.9, 114.6. 
 
 
2-Ethoxy-8-hydroxynaphthalene-1,4-dione (2.32). The title compound (0.1814 g, 0.83 
mmol, 7%) was obtained from 3.8432 g of 2.29 under conditions identical to those described 
above for the production of 2.30 and 2.31: 1H NMR (300 MHz, CDCl3) δ 11.75 (1H, s, 
ArOH), 7.62-7.56 (2H, m, ArH), 7.19 (1H, dd, J = 2.8, 6.8 Hz, ArH), 6.09 (1H, s, H3), 4.07 
(2H, q, J = 7.0 Hz, OCH2CH3), 1.51 (3H, t, J = 7.0 Hz, OCH2CH3); 
13C NMR (75.5 MHz, 
CDCl3) δ 185.0, 184.1, 161.9, 159.3, 137.1, 131.9, 123.7, 118.8, 114.3, 110.7, 65.5, 13.9; MS 
m/z (rel. intensity) (EI) 218 (M+, 100), 203 (5), 189 (9), 174 (65), 162 (15), 146 (10), 121 










2-Bromo-8-methoxynaphthalene-1,4-dione (2.33). Following a known procedure,200 to a 
stirred solution of 2-bromo-1,4,8-trimethoxynaphthalene 2.25 (2.4785 g, 8.3 mmol) in 
acetonitrile (250 mL) was added a solution (75 mL) of ceric ammonium nitrate (10.3866 g, 
18.9 mmol) dissolved in water, via a dropping funnel over a 5 min period. The solution was 
allowed to stir for 10 min, diluted with water (500 mL) and extracted with CH2Cl2. The 
organic extracts were pooled, washed with water, a saturated solution of sodium bicarbonate, 
water, brine, dried over anhydrous sodium sulfate, filtered and the solvent evaporated under 
reduced pressure to afford the title compound as an orange solid (1.3669 g, 61%): mp 151-
152 °C (lit. value200 154-155 °C); 1H NMR (300 MHz, CDCl3) δ 7.70-7.67 (2H, m, ArH), 
7.41 (1H, s, ArH), 7.32-7.26 (1H, m, ArH), 3.99 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, 
CDCl3) δ 182.5, 176.1, 160.3, 142.6, 138.3, 135.5, 133.9, 119.4, 118.6, 118.1, 56.5; MS m/z 
(rel. intensity) (EI) 268 (M+ for C11H7
81BrO3, 100), 266 (M
+ for C11H7
79BrO3, 99), 237 (6), 
210 (3), 186 (32), 159 (36), 129 (34), 116 (18), 101 (16), 76 (17), 62 (11); HRMS (EI) for 
C11H7









3-Methoxyaniline (2.35). Following a modification of a procedure described by Xia and 
Taillefer,220 a Schlenk tube was charged with Cu(acac)2 (0.0295 g, 0.11 mmol), 2,4-
pentanedione (0.045 mL, 0.44 mmol) and DMF (2 mL) and degassed twice under high 
vacuum with argon purges. To this was added 3-bromoanisole (0.136 mL, 1.07 mmol) and 
Cs2CO3 (0.6968 g, 2.14 mmol) under an argon environment with another cycle of 
degassing/argon purges. To this solution was added aqueous ammonium hydroxide (0.750 
mL at 28% assay, 5.39 mmol) and the mixture was sealed, mixed well and heated at 90 °C 
for 23 h. The solution was then cooled to room temperature, quenched with a saturated 
solution of NH4Cl (2 mL) diluted with water (10 mL) and extracted three times with 
dichloromethane. The organic extracts were pooled, washed twice with water, once with 
brine, dried over Na2SO4, filtered and concentrated under reduced pressure to give 0.1009 g 
of a brown oil that was purified by flash silica gel chromatography (14:1 then 3:1 
hexane:ethyl acetate) to afford 0.0344 g (26%) of the title compound as a light brown oil: IR 
(NaCl, film, cm-1) νmax 3452, 3370, 3222, 3001, 2959, 2837, 1602, 1496, 1471, 1440, 1332, 
1292, 1207, 1159, 1038, 943, 836, 766, 689; 1H NMR (300 MHz, CDCl3)  7.05 (1H, dd, J = 
8.0, 8.1 Hz, ArH), 6.33-6.27 (2H, m, ArH), 6.23 (1H, s, ArH), 3.75 (3H, s, ArOCH3), 3.65 
(2H, br s, ArNH2); 
13C NMR (75.5 MHz, CDCl3)  160.7, 147.7, 130.0, 107.9, 103.9, 101.0, 





2-Methoxyaniline (2.37). The title compound was produced under similar conditions as 
described for 2.252.522.46. The amounts used were 0.2121 g (1.13 mmol) of 2-
bromoanisole, 0.2215 g (1.22 mmol) of benzophenone imine, 0.0023 g (0.44 mol%) of 
Pd2(dba)3, 0.0054 g (0.76 mol%) of (±)-BINAP, 0.1465 g (1.52 mmol) of NaOtBu in toluene 
(4 mL) to give 0.2310 g (73%) of a yellow oil after chromatography (silica, 10:1 
hexanes:ethyl acetate). Subsequent hydrogenolysis using 0.3034 g of Pd/C (5%) and 0.6959 
g (11.2 mmol) ammonium formate in 3.7 mL methanol furnished 0.0382 g (42%) of the title 
compound as a light brown oil after chromatography (silica, 10:1 than 3:1 hexanes:ethyl 
acetate): 1H NMR (300 MHz, CDCl3)  6.81-6.69 (4H, m, ArH), 3.84 (3H, s, ArOCH3), 3.79 
(2H, br s, ArNH2); 
13C NMR (75.5 MHz, CDCl3)  147.4, 135.7, 121.0, 118.7, 115.2, 110.4, 
55.4; MS m/z (rel. intensity) (EI) 123 (M+, 100), 108 (45), 80 (14), 69 (6). 
 
 
2-((Diphenylmethylene)amino)-8-methoxynaphthalene-1,4-dione (2.38). Following a 
known procedure,222 a 25 mL two-neck flask was charged with Pd2(dba)3 (0.0088 g, 9.61 
µmol), (±)-BINAP (0.0372 g, 0.059 mmol) and toluene (2 mL).  The mixture was degassed 
with two freeze-thaw cycles under high vacuum with argon purges. To the frozen mixture 
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was added 2.33 (0.0518 g, 0.194 mmol), benzophenone imine (0.0435 mL, 0.260 mmol) and 
NaOtBu (0.0254 g, 0.264 mmol) under argon atmosphere and the mixture was subjected to 
another round of freeze-thawing under high vacuum and then heated to 85 °C for 6 h. The 
mixture was cooled to ambient temperature, filtered through a Celite 545 pad and the 
material was concentrated under reduced pressure to yield a dark brown residue that was 
purified using flash silica gel column chromatography (3:1 hexanes:ethyl acetate) furnishing 
the title compound as a yellow residue (0.0119 g, 17%): 1H NMR (300 MHz, CDCl3)  7.69-
7.57 (2H, m, ArH), 7.51-7.48 (4H, m, ArH), 7.43-7.32 (6H, m, ArH),  7.18 (1H, d, J = 8.1 
Hz, ArH), 6.09 (1H, s, H3), 3.92 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, CDCl3) δ 196.8, 
183.2, 180.1, 160.0, 149.4, 137.6, 135.9, 135.7, 132.4, 130.1, 128.3, 119.0, 118.2, 116.2, 
103.3, 56.4; MS m/z (rel. intensity) (EI) 366 (1), 308 (2), 280 (4), 234 (1), 203 (100), 186 (9), 
176 (10), 158 (8), 147 (11), 135 (13), 130 (8), 105 (9), 76 (11). 
 
 
Synthetic efforts towards 2-((Diphenylmethylene)amino)-8-methoxynaphthalene-1,4-
dione (2.38). The following is a modification of a procedure described by Nakazumi and 
coworkers.223 To a solution of the naphthoquinone 2.33 (0.0423 g, 0.158 mmol) in ethanol (5 
mL) was added benzophenone imine (0.0265 mL, 0.159 mmol) and the solution was heated 
at 80 °C for 16 h. Potassium carbonate (0.0235 g, 0.170 mmol) suspended in ethanol (1 mL) 
was then added to the mixture and heating continued for another 5 h. The mixture was cooled 
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to room temperature and quenched with a saturated solution of NH4Cl and extracted with 
CH2Cl2. The organic extracts were combined washed with water, brine, dried over Na2SO4, 
filtered and concentrated to dryness and the residue purified by flash silica gel 
chromatography (1:1 to 1:5 hexanes:ethyl acetate) to give the side product 2.39 as a light 
brown residue (0.0042 g, 11%): 2-Ethoxy-8-methoxynaphthalene-1,4-dione (2.39a) or 2-
Ethoxy-5-methoxynaphthalene-1,4-dione (2.39b). 1H 
NMR (300 MHz, CDCl3) δ 7.78 (1H, d, J = 7.6 Hz, ArH), 
7.61 (1H, dd, J = 7.6, 8.3 Hz, ArH), 7.28 (1H, d, J = 8.3 
Hz, ArH), 6.04 (1H, s, H3), 4.03 (2H, q, J = 7.0 Hz, CH2CH3), 3.98 (3H, s, ArOCH3), 1.48 
(3H, t, J = 7.0 Hz, CH2CH3); 
13C NMR (75.5 MHz, CDCl3) δ 184.8, 180.5, 159.3, 157.7, 
134.2, 133.5, 130.0, 119.6, 118.5, 112.4, 65.0, 56.6, 13.9; MS m/z (rel. intensity) (EI) 232 
(M+, 90), 217 (62), 203 (52), 188 (53), 175 (74), 158 (40), 147 (41), 130 (32), 119 (45), 105 
(100), 89 (35), 76 (52), 69 (25), 63 (19), 50 (9). 
 
 
N-Benzyl-2-methoxyaniline (2.42). The following is a modification of a known 
procedure.491 A 25 mL two-neck flask was charged with 2-bromoanisole (0.25 mL, 2.01 
mmol), benzylamine (0.27 mL, 2.47 mmol), KOtBu (0.3786 g, 3.37 mmol) and toluene (8 
mL). The mixture was degassed with two freeze-thawing cycles under high vacuum with 
argon purges. To the frozen mixture was added (S)-BINAP (0.1077 g, 8.6 mol%) and 
Pd2(dba)3·CHCl3 (0.069 g, 6.6 mol%) under argon atmosphere and the mixture was subjected 
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to another two rounds of freeze-thawing under high vacuum and then heated to 90 °C for 
19.5 h. The mixture was cooled to room temperature, filtered through a bed of Celite 545 and 
the crude material concentrated in vacuo and purified by flash silica gel chromatography 
(15:1 hexanes:ethyl acetate) to give 0.3663 g (86%) of the title compound as a faint yellow 
oil: IR (NaCl, film, cm-1) νmax 3427, 3063, 3039, 3029, 2937, 2834, 1602, 1513, 1455, 1429, 
1346, 1297, 1247, 1222, 1177, 1126, 1050, 1028, 737, 698; 1H NMR (300 MHz, CDCl3) δ 
7.40-7.26 (5H, m, ArH), 6.83-6.77 (2H, m, ArH), 6.68 (1H, dd, J = 7.6, 7.6 Hz, ArH), 6.60 
(1H, d, J = 7.8 Hz, ArH), 4.66 (1H, br s, ArNH), 4.34 (2H, d, J = 5.7 Hz, ArCH2NH), 3.84 
(3H, s, ArOCH3); 
13C NMR (300 MHz, CDCl3) δ 146.7, 139.5, 138.1, 128.5, 127.5, 127.1, 
121.2, 116.6, 110.0, 109.3, 55.3, 48.0; MS m/z (mass intensity) (EI) 213 (M+, 100), 198 (24), 
196 (4), 180 3(), 154 (1), 136 (7), 120 (7), 106 (4),  91 (49), 65 (7), 51 (2). 
Alternative procedure using CuI: Following a known procedure,228 a 25 mL two-neck 
flask was charged with K3PO4 (0.8734 g, 3.98 mmol), N,N-diethylsalicylamide (0.0899 g, 
0.45 mmol), CuI (0.0216 mg, 0.11 mmol), o-bromoanisole (0.250 mL, 1.95 mmol) and DMF 
(1 mL) and the mixture stirred for 3 min under nitrogen atmosphere. To this was added 
benzylamine (0.33 mL, 2.99 mmol) and DMF (1 mL) and the mixture was heated at 100 °C 
for 15 h at which time another 0.8 mL of DMF was added and heating was continued for 6 h. 
The mixture was cooled to ambient temperature and filtered through Celite 545. The filtrate 
was extracted with ethyl acetate, washed with water and dried over anhydrous MgSO4 and 
filtered through Celite 545. The crude product was concentrated in vacuo to give a brown oil 
which was purified by silica gel chromatography (15:1 then 5:1 hexanes:ethyl acetate) to 
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N-(1,4,8-Trimethoxynaphthalen-2-yl)benzamide (2.43). The title compound was 
produced under similar conditions as described for 2.142.17. The amounts used were CuI 
(0.0132 g, 0.069 mmol), benzamide (0.103 g, 0.85 mmol), potassium carbonate (0.2024 g, 
1.46 mmol), bromonaphthalene (0.2065 g, 0.695 mmol), (±)-trans-1,2-diaminocyclohexane 
(0.008 mL, 0.067 mmol), 4 Å molecular sieves (0.250 g) and 1,4-dioxane (1 mL) and 
refluxed at 110 °C for 23 h. The solution was then allowed to cool, diluted with ethyl acetate 
and filtered through a small plug of Celite 545 and the solvent evaporated in vacuo. The 
residue was purified by flash silica gel chromatography (12:1 hexanes:ethyl acetate) to afford 
0.018 g (8%) of the title compound as a yellow solid: mp 139-140 °C; IR (NaCl, film, cm-1) 
νmax 3418, 2934, 2834, 1673, 1602, 1525, 1503, 1488, 1454, 1423, 1381, 1259, 1074; 
1H 
NMR (300 MHz, CDCl3)  8.96 (1H, br s, NH), 8.28 (1H, s, ArH), 7.91 (2H, m, ArH), 7.85 
(1H, d, J = 8.4 Hz, ArH), 7.58-7.49 (3H, m, ArH), 7.30 (1H, dd, J = 8.0, 8.2 Hz, ArH), 6.90 
(1H, d, J = 7.7 Hz, ArH), 4.03 (3H, s, ArOCH3), 4.01 (3H, s, ArOCH3), 3.84 (3H, s, 
ArOCH3); 
13C NMR (75.5 MHz, CDCl3)  165.3, 155.1, 151.9, 136.9, 135.1, 131.9, 129.1, 
128.9, 127.0, 125.0, 124.4, 119.6, 115.0, 107.0, 99.0, 62.4, 56.1, 55.9; MS m/z (rel. intensity) 
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(EI) 337 (M+, 100), 322 (100), 296 (6), 219 (4), 205 (5), 202 (5), 187 (4), 149 (5), 145 (3), 
105 (74), 77 (16), 57 (4). 
 
 
N-Benzyl-1,4,8-trimethoxynaphthalen-2-amine (2.44). The title compound was produced 
under similar conditions as described for 2.242.42. The amounts used were 0.1801 g (0.61 
mmol) of the bromonaphthalene 2.25, 0.080 mL (0.73 mmol) of benzylamine, 0.023 g (7.3 
mol%) of Pd2(dba)2·CHCl3, 0.0361 g (9.6 mol%) of (S)-BINAP, 0.1006 g (0.89 mmol) 
KOtBu in toluene (8 mL) to give 0.1612 g (82%) of a yellow oil after chromatography 
(silica, 4:1 hexanes:ethyl acetate) as the title compound as well as containing small amounts 
of 2.45 as an inseparable mixture: 1H NMR (300 MHz, CDCl3) δ 7.72 (1H, dd, J = 0.6, 8.4 
Hz, ArH), 7.40-7.23 (5H, m, ArH), 7.08 (1H, dd, J = 7.6, 8.4 Hz, ArH), 6.81 (1H, d, J = 7.6 
Hz, ArH), 6.46 (1H, s, ArH), 5.11 (1H, br s, NH), 4.49 (2H, s, CH2NH), 3.97 (3H, s, 
ArOCH3), 3.83 (3H, s, ArOCH3), 3.78 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, CDCl3) δ 
154.2, 152.5, 139.8, 138.6, 133.3, 128.6, 127.2, 127.1, 121.1, 120.9, 120.8, 114.9, 106.8, 
94.8, 61.1, 56.1, 55.6, 48.3; MS m/z (mass intensity) (EI) 323 (M+, 49), 308 (100), 278 (11), 
231 (2), 218 (11), 203 (9), 190 (4), 175 (2), 115 (2), 91 (13), 65 (1); HRMS (EI) calc. for 






1,4,8-Trimethoxynaphthalen-2-amine (2.46). A solution of N-Benzyl naphthylamine 2.44 
(0.0993 g, 0.31 mmol) dissolved in acetic acid (6 mL) was stirred briefly under nitrogen and 
Pd/C (10%, 0.092 g) was added. The mixture was then briefly purged with hydrogen and 
then allowed to stir for 4 h under an atmosphere of hydrogen using a balloon reservoir. The 
mixture was then filtered through Celite 545 and the solvent evaporated under reduced 
pressure. The crude material was purified by silica gel chromatography (3:1 hexanes:ethyl 
acetate) to afford 0.0185 g (26%) of a purple solid. Spectroscopic data matched that from 
other experiments producing 2.46 from 2.52. 
 
 
2-Bromo-8-methoxynaphthalene-1,4-diyl diacetate (2.47). A solution of the 
bromonaphthoquinone 2.33 (0.0993 g, 0.37 mmol), zinc powder (0.0535 g, 0.82 mmol), 
acetic anhydride (2 mL, 21.2 mmol) and triethylamine (0.14 mL, 1 mmol) was heated at 80 
°C for 11 min, cooled and filtered through a bed of Celite 545. The filtrate was then poured 
into ice cold water (60 mL) and the mixture was extracted with chloroform three times. The 
chloroform extracts were pooled, washed with water, brine and dried over anhydrous sodium 
sulfate, filtered and concentrated in vacuo to afford the title compound as a tan colored solid 
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(0.1247 g, 95%): IR (NaCl, film, cm-1) νmax 3075, 2943, 2841, 1765, 1595, 1578, 1507, 1471, 
1460, 1415, 1372, 1348, 1332, 1266, 1216, 1190, 1158, 1100, 1056, 1038, 1010, 930, 903, 
811, 784, 749, 728, 682; 1H NMR (300 MHz, CDCl3)  7.47 (1H, s, ArH), 7.41 (2H, m, 
ArH), 6.87 (1H, m ArH), 3.91 (3H, s, ArOCH3), 2.42 (3H, s, OC(O)CH3), 2.40 (3H, s, 
OC(O)CH3); 
13C NMR (75.5 MHz, CDCl3)  168.8, 167.7, 154.9, 144.1, 141.7, 128.9, 127.5, 
122.5, 120.6, 114.1, 112.9, 107.6, 56.3, 20.9, 20.7; MS m/z (rel. intensity) (EI) 354 (M+ for 
C15H13
81BrO5, 17), 352 (M
+ for C15H13
79BrO5, 17), 312 (23), 310 (23), 270 (99), 268 (100), 
255 (14), 253 (14), 231 (2), 188 (5), 173 (3), 129 (3), 102 (3), 76 (2); HRMS (EI) calc. for 
C15H13BrO5: 351.9946, found 351.9940. 
 
 
Synthetic efforts towards 2-(Benzylamino)-8-methoxynaphthalene-1,4-diyl diacetate 
(2.48). A 100 mL two-neck flask was charged with the bromonaphthalene 2.47 (0.0801 g, 
0.23 mmol), Pd2(dba)3·CHCl3 (0.0121 g, 0.023 mmol), (S)-BINAP (0.0196 g, 0.031 mmol) 
and toluene (6 mL) and was degassed with three freeze-thawing cycles with nitrogen purges. 
A separate 5 mL flask was charged with benzylamine (0.026 mL, 0.24 mmol) and potassium 
tert-butoxide (0.0258 g, 0.23 mmol) and purged with nitrogen for 10 min to which toluene (2 
mL) was added and stirred. This solution was added to the naphthalene mixture with an 
additional 4 mL of toluene added and heated to 80 °C for 16 h. The mixture was cooled to 
ambient temperature and filtered through Celite 545 and the solvent was evaporated under 
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reduced pressure to give 0.0887 g of a brown oil that was purified by silica gel 
chromatography (3:1 hexanes:ethyl acetate) to give 0.0474 g of residue. Another round of 
chromatographic purification (silica, 2:1 hexanes:ethyl acetate) gave 0.0126 g of a clear 
residue as the side product 2.51: 
N-Benzylacetamide (2.51). 1H NMR (300 MHz, CDCl3) δ 7.33-7.24 (5H, 





N-(Diphenylmethylene)-1,4,8-trimethoxynaphthalen-2-amine (2.52). Following a 
known procedure,222 a 25 mL two-neck flask was charged with bromonaphthalene 2.25 
(0.2023 g, 0.68 mmol), benzophenone imine (0.1642 g, 0.91 mmol), sodium tert-butoxide 
(0.0824 g, 0.86 mmol) and toluene (4 mL) under argon environment and the mixture was 
degassed with two freeze–thawing cycles under high vacuum with argon purges. To the 
frozen mixture was added Pd2(dba)3 (0.002 g, 0.64 mol%) and (±) BINAP (0.0073 g, 1.7 
mol%) and the mixture was freeze–thawed twice again and then heated at 85 °C for 14 h. The 
mixture was allowed to cool, diluted with ether, filtered through Celite 545 and concentrated 
in vacuo to yield a yellow oil that was purified using flash silica column chromatography 
(4:1 than 2:1 hexanes:ether) producing 0.2506 g (93%) of a bright yellow solid as the title 
compound: mp 160-162 °C; IR (NaCl, film, cm-1) νmax 3058, 2931, 2832, 1616, 1596, 1576, 
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1507, 1447, 1412, 1364, 1337, 1316, 1290, 1264, 1202, 1076, 1017; 1H NMR (300 MHz, 
CDCl3)  7.85 to 7.83 (2H, m, ArH), 7.70 (1H, dd, J = 0.6, 8.4 Hz, ArH), 7.51 to 7.40 (3H, 
m, ArH), 7.27 to 7.17 (6H, m, ArH), 6.84 (1H, d, J = 7.6 Hz, ArH), 6.17 (1H, s, ArH), 3.90 
(3H, s, ArOCH3), 3.83 (3H, s, ArOCH3), 3.69 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, 
CDCl3)  168.6, 156.2, 151.1, 141.6, 139.5, 137.7, 136.7, 130.6, 129.4, 128.8, 128.5, 128.1, 
127.8, 125.4, 123.7, 121.4, 114.7, 107.7, 101.1, 60.1, 56.7, 55.6; MS m/z (mass intensity) 
(EI) 397 (M+, 84), 382 (100), 367 (11), 352 (15), 290 (3), 280 (2), 230 (2), 191 (3), 165 (18), 
160 (3), 105 (2); HRMS (EI) calc. for C26H23NO3: 397.1678, found: 397.1668. 
 
 
1,4,8-Trimethoxynaphthalen-2-amine (2.46). Following a known procedure,222 a mixture 
of the imine 2.52 (0.2506 g, 0.63 mmol), 5% palladium on carbon (0.1616 g, 12 mol%) and 
ammonium formate (0.6806 g, 10.9 mmol) in methanol (5 mL) was heated at reflux for 1 h 
40 min. The mixture was cooled to room temperature and diluted ten-fold with 
dichloromethane. The mixture was filtered through a bed of Celite 545, washed once with 0.1 
M NaOH, dried over sodium sulfate, filtered and concentrated in vacuo to give 0.2319 g of a 
light brown solid that was further purified by flash silica gel chromatography (1:12 
hexanes:ether) to afford 0.1229 g (84%) of the title compound as a light tan solid: mp 118-
119 °C (lit. value493 125 °C); IR (NaCl, film, cm-1) νmax 3482, 3368, 2960, 1623, 1603, 1512, 
1448, 1421, 1388, 1341, 1258, 1211, 1163, 1070; 1H NMR (300 MHz, CDCl3)  7.72 (1H, 
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dd, J = 0.6, 8.3 Hz, ArH), 7.11 (1H, dd, J = 7.8, 8.3 Hz, ArH), 6.83 Hz (1H, d, J = 7.8 Hz, 
ArH), 6.40 (1H, s, ArH), 3.98 (2H, br s, ArNH2) overlapping with 3.96 (3H, s, ArOCH3), 
3.90 (3H, s, ArOCH3), 3.78 (3H, s, ArOCH3); 
13C NMR (75.5 MHz, CDCl3)  154.4, 152.2, 
136.6, 133.6, 122.5, 121.7, 121.2, 114.9, 107.2, 97.8, 60.9, 56.1, 55.6; MS m/z (rel. intensity) 
(EI) 233 (M+, 74), 218 (100), 201 (8), 173 (13), 159 (3), 145 (6), 130 (3), 116 (5), 102 (3) 




5-Methyl-3-(1,4,8-trimethoxynaphthalen-2-ylamino)cyclohex-2-enone (2.54). A 
mixture of naphthylamine 2.46 (0.0989 g, 0.42 mmol), 5-methylcyclohexane-1,3-dione 
(0.0547 g, 0.43 mmol), p-TsOH hydrate (0.0105 g, 0.055 mmol) in toluene (4 mL) was 
heated at reflux for 6 h. The solution was cooled and the solvent evaporated in vacuo. The 
residue was purified by flash silica gel chromatography (ethyl acetate) providing the title 
compound as a white solid (0.1245 g, 86%): mp 169-170 °C; IR (NaCl, film, cm-1) νmax 3226, 
2954, 1581, 1529, 1502, 1450, 1417, 1378, 1338, 1262, 1142, 1075, 1016; 1H NMR (300 
MHz, CDCl3)  7.80 (1H, d, J = 8.4 Hz, ArH), 7.31 (1H, dd, J = 7.7, 8.4 Hz, ArH), 6.89 (1H, 
d, J = 7.7 Hz, ArH), 6.83 (1H, s, ArH), 6.43 (1H, br s, NH), 5.71 (1H, s, H2), 3.96 (3H, s, 
ArOCH3), 3.91 (3H, s, ArOCH3), 3.72 (3H, s, ArOCH3), 2.49 to 2.29 (4H, m, H4, H6), 2.12 
to 2.04 (1H, m, H5), 1.12 (3H, d, J = 5.4 Hz, CHCH3); 
13C NMR (75.5 Hz, CDCl3)  198.1, 
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160.7, 155.4, 151.8, 141.1, 128.4, 126.1, 125.2, 120.4, 114.9, 107.4, 101.4, 99.9, 62.4, 56.1, 
55.9, 44.9, 38.3, 29.3, 21.0; MS m/z (rel. intensity) (EI) 341 (M+, 66), 326 (100), 310 (4), 294 
(4), 278 (3), 240 (5), 217 (5), 204 (3), 189 (2), 141 (2), 120 (6), 103 (2), 69 (3), 57 (1); 
HRMS (EI) calc. for C20H23NO4: 341.1627, found: 341.1628. 
 
 
6,7,11-Trimethoxy-3-methyl-3,4-dihydro-2H-benzo[b]carbazol-1(5H)-one (2.55). From 
a modification of procedures described by Akermark,229 a mixture of  the anilinoketone 2.54 
(0.0315 g, 0.09 mmol), palladium acetate (0.0425 g, 0.189 mmol) in glacial acetic acid (5 
mL) was heated at 95 °C for 90 min. The mixture was cooled to ambient temperature, filtered 
through a small pad of Celite 545 and the residue concentrated under reduced pressure and 
purified by column chromatography (silica, 1:7 hexanes:ethyl acetate) to furnish 0.0151 g 
(51%) of a light brown solid as the title compound: m.p.  260 °C decomposition; IR (NaCl, 
film, cm-1) νmax 3231, 3072, 2996, 2956, 2929, 2840, 1620, 1543, 1505, 1479, 1465, 1445, 
1428, 1395, 1357, 1263, 1247, 1215, 1134, 1100, 1058, 1004; 1H NMR (500 MHz, CDCl3)  
9.15 (1H, br s, NH), 7.96 (1H, d, J = 8.7 Hz, ArH), 7.27 (1H, dd, J = 7.5, 8.7 Hz, ArH), 6.79 
(1H, d, J = 7.5 Hz, ArH), 4.03 (3H, s, ArOCH3), 4.00 (3H, s, ArOCH3), 3.99 (3H, s, 
ArOCH3), 3.05 (1H, dd, J = 4.3, 16.5 Hz, H4), 2.69 to 2.63 (2H, m, H2, H4), 2.50 to 2.44 
(1H, m, H3), 2.36 (1H, dd, J = 11.7, 15.8 Hz, H2), 1.16 (3H, d, J = 6.5 Hz, CHCH3); 
13C 
NMR (125.8 MHz, CDCl3)  191.1, 155.5, 154.9, 145.4, 135.7, 130.7, 127.4, 123.2, 118.2, 
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117.0, 115.9, 112.6, 103.8, 63.7, 63.0, 55.9, 47.2, 32.2, 30.8, 21.2; MS m/z (rel. intensity) 
(EI) 339 (M+, 66), 324 (100), 310 (4), 267 (5), 239 (3), 218 (6), 186 (7), 170 (9), 142 (13), 





carbonitrile (2.56). A solution of the carbazole 2.55 (0.0174 g, 0.051 mmol), phenyl 
cyanate230 (0.040 mL, 0.37 mmol) and triethylamine (0.030 mL, 0.21 mmol) in dry DMSO 
(0.8 mL) was stirred at room temperature for 4 h after which another 2 drops of triethylamine 
(~0.012 g, 0.12 mmol) was added and stirring was continued overnight. The solution was 
then diluted with water (10 mL) and extracted with ethyl acetate three times and the organic 
extracts were pooled. The pooled extracts were washed three times with water, brine once 
and dried over Na2SO4, filtered and concentrated under reduced pressure to yield the title 
compound as a light tan solid (0.0186 g, 99%): mp 183-184 °C; IR (NaCl, film, cm-1) νmax 
2930, 2841, 2244, 1752, 1680, 1613, 1570, 1508, 1452, 1408, 1391, 1356, 1342, 1266, 1099, 
1066, 1044, 997, 967, 912, 882, 810, 761, 729; 1H NMR (CDCl3, 300 MHz)  7.92 (1H, d, J 
= 8.6 Hz, ArH), 7.39 (1H, dd, J = 7.6, 8.6 Hz, ArH), 6.89 (1H, d, J = 7.6 Hz, ArH), 4.024 
(3H, s, ArOCH3), 4.019 (3H, s, ArOCH3), 3.95 (3H, s, ArOCH3), 3.23 (1H, dd, J = 4.2, 17.5 
Hz, H4), 2.81 to 2.71 (2H, m, H2, H4), 2.66 to 2.49 (1H, m, H3), 2.42 (1H, dd, J = 11.6, 15.5 
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Hz, H2), 1.26 (3H, d, J = 6.3 Hz, CHCH3); 
13C NMR (75.5 MHz, CDCl3)  190.7, 155.9, 
154.3, 146.2, 138.3, 129.6, 128.4, 125.4, 118.8, 117.3, 116.6, 115.7, 106.3, 105.7, 64.7, 64.1, 
56.1, 47.1, 30.7, 30.2, 21.0; MS m/z (rel. intensity) (EI)  364 (M+, 99), 349 (100), 335 (4), 
322 (2), 292 (3), 264 (3), 237 (3), 182 (4), 149 (2), 126 (3), 111 (1), 69 (11), 57 (1); HRMS 
(EI) calc. for C21H20N2O4: 364.1423, found: 364.1414. 
 
 
Synthetic efforts towards 6,7,11-Trihydroxy-3-methyl-1-oxo-3,4-dihydro-1H-
benzo[b]carbazole-5(2H)-carbonitrile (2.58). A 25 mL flask was charged with carbazole 
2.56 (0.0116g, 0. 032 mmol) and CH2Cl2 (1.5 mL) and cooled to -78 °C. To this was added 
BCl3 (0.2 mL, 0.2 mmol of a 1.0 M solution in heptane) and stirred for 30 min. The colour of 
the reaction mixture changed from light yellow to orange. The flask was allowed to come to 
room temperature over the period of an hour and the mixture became a dark brown-orange. 
The reaction was quenched with ice water and extracted with CH2Cl2. The pooled organic 
extracts were washed with water twice, brine once, and dried over Na2SO4, filtered and 
concentrated in vacuo to produce 0.0104 g of a green residue. The residue was purified by 
silica gel chromatography (3:1 hexanes:ethyl acetate, then 100% ethyl acetate) to give 0.0014 






benzo[b]carbazole-5(2H)-carbonitrile (2.59). 1H NMR (300 MHz, 
CDCl3) δ 10.75 (1H, s, OH), 7.97 (1H, d, J = 8.7 Hz, ArH), 7.34 
(1H, dd, J = 7.7, 8.7 Hz, ArH), 6.91 (1H, d, J = 7.7 Hz, ArH), 4.03 (3H, s, ArOCH3), 3.99 
(3H, s, ArOCH3), 3.21 (1H, dd, J = 4.2, 17.3 Hz, H4), 2.81-2.71 (2H, m H2, H4), 2.68-2.54 
(1H, m, H3), 2.45 (1H, dd, J = 10.9, 16.3 Hz, H2), 1.26 (3H, d, J = 6.4 Hz, CHCH3); MS m/z 
(rel. intensity) (EI) 350 (99, M+), 335 (100), 308 (14), 280 (8), 264 (10), 238 (3), 207 (2), 175 




carbonitrile (2.57). Carbazole 2.56 (0.0122 g, 0.033 mmol) was dissolved in acetonitrile (1 
mL) and the solution cooled to 0 °C. To this solution was added ceric ammonium nitrate 
(0.0475 g, 0.087 mmol) dissolved in distilled water (0.3 mL), in 0.04 mL aliquots over a 5 
min period. The solution was then allowed to come to room temperature over a period of 10 
minutes and water (20 mL) was added. This mixture was extracted with CH2Cl2 four times 
and the extracts were pooled, washed with water, a saturated solution of NaHCO3, water, 
brine and dried over Na2SO4. The solution was then filtered and concentrated in vacuo to 
give the crude product as an orange solid which was purified chromatographically (silica, 2:5 
then 1:5 hexanes:ethyl acetate) to afford the title compound as an orange solid (0.0106 g, 
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95%): mp  240 °C decomposition; IR (CDCl3, cm-1) νmax 3693, 2259, 1701, 1662, 1586, 
1528, 1472, 1454, 1440, 1408, 1298, 1272, 1240, 1168, 1041, 1005, 929; 1H NMR (300 
MHz, CDCl3)  7.89 (1H, d, J = 7.7 Hz, ArH), 7.71 (1H, dd, J = 7.7, 8.4 Hz, ArH), 7.31 (1H, 
d, J = 8.4 Hz, ArH), 4.03 (3H, s, ArOCH3), 3.18 (1H, dd, J = 4.4, 17.3 Hz, H4), 2.77 to 2.66 
(2H, m, H2, H4), 2.60 to 2.49 (1H, m, H3) 2.40 (1H, dd, J = 11.4, 15.7 Hz, H2), 1.24 (3H, d, 
J = 6.4 Hz, CHCH3); 
13C NMR (75.5 MHz, CDCl3)  190.0, 177.2, 174.0, 160.7, 152.7, 
136.1, 136.0, 135.7, 124.1, 120.9, 120.5, 118.4, 118.0, 103.3, 56.6, 47.1, 30.3, 29.9, 20.9; MS 
m/z (rel. intensity) (EI) 334 (M+, 100), 321 (19), 307 (11), 292 (37), 279 (19), 264 (41), 237 
(63), 221 (5), 206 (6), 178 (4), 151 (4), 105 (6), 76 (6), 51 (2); HRMS calc. for C19H14N2O4: 
334.0954, found: 334.0951. 
 
 
Synthetic efforts towards 7-Hydroxy-3-methyl-1,6,11-trioxo-3,4,6,11-tetrahydro-1H-
benzo[b]carbazole-5(2H)-carbonitrile (2.61). A 25 mL flask was charged with 0.012 g 
(0.036 mmol) of carbazole 2.57 and CH2Cl2 (3 mL) and the solution was cooled to -78 °C. 
To this solution was added BBr3 (0.08 mL, 0.08 mmol of 1.0 M solution in CH2Cl2) and the 
mixture was stirred for 15 min. The reaction flask was removed from the CO2-acetone bath 
and allowed to warm to ~0 °C at which time the reaction was quenched with water (5 mL) 
and a saturated solution of sodium bicarbonate (1 mL). The mixture was extracted with 
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CH2Cl2 three times and pooled. The pooled extracts were washed with water twice, brine 
once, dried over Na2SO4, filtered and the solvent evaporated on a rotary evaporator to give 
0.0109 g of a yellow-green residue that was purified chromatographically (silica, 1:1 
hexanes:ethyl acetate) to furnish 0.0024 g of a yellow-green residue (20%) as the side 
product 2.60 and 0.0012 g (10%) of the title compound 2.61 as a 
yellow residue: 
6,11-Dihydroxy-7-methoxy-3-methyl-1-oxo-3,4-dihydro-1H-
benzo[b]carbazole-5(2H)-carbonitrile (2.60): IR (CDCl3, cm
-1) 
νmax 3695, 3394, 2967, 2250, 1711, 1638, 1581, 1519, 1456, 1444, 1432, 1370, 1344, 1262, 
1248, 1225, 1098, 1057, 1010; 1H NMR (300 MHz, CDCl3) δ 10.40 (1H, s, OH), 9.19 (1H, s, 
OH), 7.87 (1H, d, J = 8.6 Hz, ArH), overlapping with solvent signal 7.27 (1H, dd, J = 7.7 Hz, 
ArH), 6.80 (1H, d, J = 7.7 Hz, ArH), 4.05 (3H, s, ArOCH3), 3.13 (1H, m H4), 2.78-2.55 (3H, 
m, H2, H3, H4), 2.44 (1H, dd, J = 11.6, 16.2 Hz, H2), 1.28 (3H. d, J = 6.2 Hz, CHCH3); MS 
m/z (rel. intensity) (EI) 336 (100, M+), 321 (75), 305 (5), 292 (5), 278 (9), 264 (4), 251 (3), 
237 (5), 201 (3) 168 (4), 121(1), 71 (2). 
7-Hydroxy-3-methyl-1,6,11-trioxo-3,4,6,11-tetrahydro-1H-
benzo[b]carbazole-5(2H)-carbonitrile (2.61): IR (CDCl3, cm
-1) 
νmax 3692, 2966, 2256, 1710, 1641, 1601, 1519, 1454, 1422, 1364, 
1271, 1225, 1160, 1116, 1074; 1H NMR (300 MHz, CDCl3) δ 11.56 (1H, s, OH), 7.76 (1H, 
dd, J = 1.0, 7.5 Hz, ArH), 7.65 (1H, dd, J = 7.5, 8.2 Hz, ArH), overlapping with solvent 
signal 7.27 (1H, dd, J = 1.0 Hz, ArH), 3.21 (1H, dd, J = 4.4, 17.6 Hz, H4), 2.79-2.69 (2H, m, 
H2, H4), 2.62-2.48 (1H, m, H3), 2.41 (1H, dd, J = 11.4, 15.7 Hz, H2), 1.25 (3H, d, J = 6.4 
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Hz, CHCH3); MS m/z (rel. intensity) (EI) 320 (72, M
+), 305 (4), 278 (100), 253 (19), 250 




benzo[b]carbazole-5(4H)-carbonitrile (2.62). Following a procedure described by Mander 
and Sethi,494 N-cyanocarbazoloquinone 2.57 (0.216 g, 0.65 mmol) was dissolved in 
dichloromethane (12 mL) and the solution was cooled to 0 C. To this was added TBSOTf 
(0.24 mL, 1.05 mmol) and the mixture was stirred for 2 min. Triethylamine (0.25 mL, 1.79 
mmol) was added and was stirring continued at room temperature for 1 h. Dichloromethane 
was then added and the reaction was quenched with an excess of an ice cold solution of 
saturated sodium bicarbonate. The organic phase was dried over sodium sulfate, evaporated 
in vacuo and purified by flash silica column chromatography (2:3 hexanes:ether) to afford 
0.1025 g (35%) of the title compound as an orange solid: IR (CDCl3, cm
-1) νmax 2961, 2932, 
2860, 1679, 1652, 1619, 1586, 1509, 1471, 1439, 1418, 1365, 1339, 1279, 1253, 1235, 1186, 
1165, 1141, 1026, 1012, 994, 974, 944; 1H NMR (300 MHz, CDCl3)  7.83 (1H, d, J = 7.5 
Hz, ArH), 7.65 (1H, dd, J = 7.5, 8.2 Hz, ArH), 7.26 overlapping with CHCl3 peak (1H, d, J = 
8.2 Hz, ArH), 4.96 (1H, d, J = 3.9 Hz, H2), 4.01 (3H, s, ArOCH3), 2.95 (1H, dd, J = 7.3, 16.1 
Hz, H4), 2.88 to 2.76 (1H, m, H3), 2.55 (1H, dd, J = 9.6, 16.1 Hz, H4), 1.14 (3H, d, J = 6.8 




NMR (75.5 MHz, CDCl3)  177.7, 173.7, 160.5, 144.5, 141.9, 136.6, 135.2, 134.4, 123.4, 
120.3, 119.9, 119.0, 117.5, 110.6, 104.2, 56.5, 29.3, 28.2, 26.0, 20.7, 18.7, -4.26, -4.31; MS 
m/z (rel. intensity) (EI) 448 (M+, 1), 433 (3), 391 (100), 364 (20), 349 (12), 320 (8), 319 (4), 
292 (3), 279 (2), 262 (1), 174 (3), 149 (3), 111(1), 73 (5), 57 (3); HRMS (EI) calc. for 
C21H19O4N2Si (M




benzo[b]carbazole-5-carbonitrile (2.63). Silyl enol ether 2.62 (0.0051 g, 0.011 mmol) was 
dissolved in benzene (1 mL) and DDQ (0.003 g, 0.013 mmol) was added and stirring was 
continued for 3.5 h at room temperature. The reaction mixture was diluted with 
dichloromethane (10 mL), concentrated under reduced pressure and the residue purified by 
column chromatography (silica, 1:3 hexanes:ether) to yield a yellow solid (0.0045 g, 88%) as 
the title compound: IR (CDCl3, cm
-1) νmax 2932, 2860, 1675, 1657, 1615, 1587, 1576, 1549, 
1500, 1471, 1437, 1415, 1373, 1352, 1321, 1280, 1253, 1232, 1183, 1133, 1106, 1070, 1032, 
1014; 1H NMR (300 MHz, CDCl3)  7.89 (1H, d, J = 7.8 Hz, ArH), 7.69 (1H, dd, J = 7.8, 8.4 
Hz, ArH), 7.29 (1H, d, J = 8.4 Hz, ArH), 7.12 (1H, s, ArH), 6.72 (1H, s, ArH), 4.03 (3H, s, 
ArOCH3), 2.47 (3H, s, ArCH3), 1.05 (9H, s, SiC(CH3)3), 0.32 (6H, s, Si(CH3)2); 
13C NMR 
(75.5 MHz, CDCl3)  177.5, 175.3, 160.4, 152.3, 142.0, 141.1, 136.5, 136.3, 135.7, 122.4, 
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120.4, 118.9, 118.1, 117.5, 114.5, 105.0, 104.8, 56.5, 26.1, 22.1, 18.9, -3.8; MS m/z (rel. 
intensity) (EI) 431 (2), 405 (4), 389 (100), 374 (13), 362 (36), 346 (11), 334 (14), 332 (5), 
304 (3), 288 (2), 261 (1), 181 (3), 173 (2), 152 (1), 97(1), 73 (1), 57 (2); HRMS (EI) calc. for 
C21H17O4N2Si (M




carbonitrile (2.1). N-Cyanocarbazoloquinone 2.63 (0.0748 g, 0.168 mmol) was dissolved in 
dichloromethane (7 mL) and the solution was cooled to -78 °C. To this was added BBr3 (1.2 
mL of a 1 M solution in CH2Cl2, 1.2 mmol) and the mixture was stirred for 40 min, allowed 
to come to room temperature over a 15 min period and then quenched with an ice cold 
solution of saturated sodium bicarbonate. The mixture was diluted with dichloromethane, 
washed with water, dried over Na2SO4, filtered and the solvent evaporated in vacuo. The 
crude material was purified by flash silica gel chromatography (1:1 then 2:3 hexanes:ether) 
to afford the target compound as a blackish-purple solid (0.0181 g, 34%): IR (CDCl3, cm
-1) 
νmax 3692, 3208, 3123, 2927, 2247, 1627, 1593, 1553, 1455, 1430, 1408, 1300, 1250, 1219, 
1184, 1164, 1089; 1H NMR (500 MHz, CDCl3)  11.81 (1H, s, ArOH), 10.17 (1H, s, ArOH), 
7.82 (1H, d, J = 7.5 Hz, ArH), 7.67 (1H, dd, J = 7.5, 8.1 Hz, ArH), 7.34 (1H, d, J = 8.1 Hz, 
ArH), 7.01 (1H, s, ArH), 6.79 (1H, s, ArH), 2.49 (3H, s, ArCH3); 
13C NMR (125.8 MHz, 
CDCl3)  182.2, 179.4, 162.9, 153.1, 145.5, 140.8, 136.9, 133.2, 132.0, 126.8, 124.9, 121.4, 
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114.6, 113.7, 111.1, 104.4, 103.1, 22.5; MS m/z (rel. intensity) (EI) 318 (M+, 100), 293 (6), 
289 (3), 261 (2), 219 (3), 190 (3), 159 (3), 115 (1), 87 (2); HRMS (EI) calc. for C18H10N2O4: 
318.0641, found: 318.0645. 
 
 
(Diphenylmethylene)hydrazine (3.4a). Benzophenone (2.6839 g, 0.0147 mol) was 
dissolved in dry ethanol (60 mL, distilled from Mg/I2) under argon atmosphere. To this 
solution was added hydrazine monohydrate (1 mL, 0.0184 mol) and 4 drops of concentrated 
HCl. The solution was then refluxed at 85 °C for 72 h. The reaction mixture was cooled to 
room temperature and evaporated to dryness under reduced pressure. The residue was then 
taken up in CH2Cl2, washed sequentially with a saturated solution of sodium bicarbonate, 
water and brine and dried over Na2SO4 and the solvent evaporated in vacuo to yield 2.8315 g 
(98%) of the title compound as a white solid as: mp = 98 °C (lit. value495 98 °C); IR (NaCl, 
film, cm-1) νmax 3421, 3273, 1582, 1559, 1491, 1442, 1334, 768, 695, 652; 
1H NMR (300 
MHz, CDCl3)  7.52-7.44 (5H, m, ArH), 7.29-7.24 (5H, m, ArH), 5.41 (2H, br s, NH2); 13C 
NMR (75.5 MHz, CDCl3)  149.2, 138.4, 132.9, 129.4, 128.9, 128.8, 128.1, 126.4; MS m/z 
(rel. intensity) (EI) 196 (M+,100), 195 (34), 180 (20), 165 (33), 152 (4), 139 (3), 119 (8), 93 







Diphenyldiazomethane (3.5a). To a solution of benzophenone hydrazone (2.9939 g, 
0.0153 mol) in petroleum ether 30-60 (30 mL) was added yellow mercuric oxide (3.7108 g, 
0.0171 mol) and was vigorously shaken in the dark for 6 h. The mixture was then filtered and 
the solvent evaporated in vacuo to yield the title compound as a dark purple solid (2.9584 g, 
99%): mp = 27-28 °C (lit. value496 29-30 °C); IR (NaCl, film, cm-1) νmax 2038; 
1H NMR (300 
MHz, CDCl3)  7.41-7.36 (4H, m, ArH), 7.31-7.27 (4H, m, ArH), 7.20-7.15 (2H, m, ArH); 
13C NMR (75.5 MHz, CDCl3)  129.5, 129.1, 125.5, 125.1, 62.3; MS m/z (rel. intensity) (EI) 
194 (M+, 8) 166 (69), 165 (100), 139 (8), 115 (3), 105 (3), 82 (3), 63 (3), 51 (3); HRMS (EI) 
calc. for C13H10N2: 194.0844, found: 194.0846. 
 
 
N-(Diphenylmethylene)nitramide (3.7), Benzophenone (3.8), Dinitrodiphenylmethane 
(3.9). Diphenyldiazomethane (0.7465 g, 3.84 mmol) was dissolved in a 50/50 (v/v) solution 
of benzene/cyclohexane (70 mL) that was extensively degassed under vacuum and purged 
with N2. This solution was then purged continuously with a constant flow of nitric oxide for 
2-2.5 h. NO was generated by the slow addition of separate degassed solutions of sodium 
nitrite (93.15 g in 250 mL aqueous solution) via a dropping funnel into L-ascorbic acid 
(118.8 g in 500 mL aqueous solution) using an in-house gas generating apparatus (Appendix 
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A). The reaction flask was vented to prevent pressure buildup. The reaction flask was then 
sealed 2-3 h after the entire addition of the NaNO2 solution, and stirring continued overnight 
in the dark for another 12-14 h. The solution typically went from a deep purple to a lemon 
yellow color overnight. The crude reaction mixture was then concentrated under reduced 
pressure and the residue purified by silica gel column chromatography (5:1, 2:1 then 1:2 
hexanes:dichloromethane) to afford three products as white solids: nitrimine 0.4698 g (54%), 
benzophenone 0.1484 g (21%), and dinitrodiphenylmethane 0.0818 g (8%). 
N-(Diphenylmethylene)nitramide (3.7). mp = 64 °C (lit. value274 67-69 °C); IR (NaCl, 
film, cm-1) νmax 3063, 2846, 1561, 1490, 1447, 1292, 970, 882, 783, 691; 
1H NMR (300 
MHz, CDCl3)  7.65-7.33 (10 H, m, ArH); 13C NMR (75.5 MHz, CDCl3)  171.5, 133.3, 
133.2, 131.2, 131.1, 130.1, 128.7, 128.6, 127.8; MS m/z (rel. intensity) (EI) 226 (M+, 1), 180 
(100), 165 (4), 152 (2), 103 (3), 77 (34), 51 (11); HRMS (EI) calc. for C13H10N2O2: 
226.0742, found: 226.0741. 
Benzophenone (3.8). 1H NMR (300 MHz, CDCl3)  7.80-7.78 (4H, m, ArH), 7.60-7.55 
(2H, m, ArH), 7.49-7.44 (4H, m, ArH); 13C NMR (75.5 MHz, CDCl3)  196.7, 137.6, 132.4, 
130.0, 128.2; MS m/z (rel. intensity) (EI) 182 (M+, 94),  152 (5), 105 (100), 77 (44), 51 (16); 
HRMS (EI) calc. for C13H10O: 182.0732, found: 182.0729. 
Dinitrodiphenylmethane (3.9). mp = 75 °C (lit. value296 80.4 °C); IR (NaCl, film, cm-1) 
νmax 3069, 2892, 1585, 1563, 1496, 1450, 1319, 1227, 832, 800, 740, 693, 569; 
1H NMR 
(300 MHz, CDCl3)  7.58-7.52 (2H, m, ArH), 7.49-7.43 (4H, m, ArH), 7.40-7.36 (4H, m, 
ArH); 1H NMR (300 MHz, CD2Cl2)  7.63-7.58 (2H, m, ArH), 7.53-7.48 (4H, m, ArH), 7.42-
7.39 (4H, m, ArH); 13C NMR (75.5 MHz, CDCl3)  131.6, 131.1, 129.8, 128.6, 126.7; 13C 
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NMR (75.5 MHz, CD2Cl2) 132.1, 131.4, 130.2, 129.0, 127.5; MS m/z (rel. intensity) (EI) 212 
(79), 182 (19), 165 (100), 152 (8), 105 (81), 77 (18), 51 (5); HRMS (EI) calc. for C13H10NO2: 
212.0712, found: 212.0714. 
 
 
15N, 15N´-(Diphenylmethylene)hydrazine (3.4b). Benzophenone (2.7065 g, 0.0148 mol) 
was dissolved dry ethanol (60 mL distilled from Mg/I2) under argon atmosphere. To this 
solution was added doubly labeled 15N hydrazine monohydrate (0.9 mL, 0.0185 mol) and 4 
drops of concentrated HCl. The solution was then heated to 85 °C for 73 h during which a 
yellow color started to develop and deepen over time and was attributed to formation of the 
azine 3.29. The reaction mixture cooled to room temperature and workup as previously stated 
yielded 2.862 g of an off-white solid. Flash silica gel chromatography (5:1 hexanes:ethyl 
acetate) afforded 1.1762 g of an off-white solid identified as the azine (44%) and 1.4859 g 
(51%) of the title compound as a white solid: IR (CDCl3, CaF2, cm
-1) νmax 3412, 3083, 3063, 
3027, 1608, 1584, 1552, 1495, 1444, 1331, 1267, 1164, 1074, 1048, 1023, 951; 1H NMR 
(500 MHz, CDCl3)  7.53-7.43 (5H, m, ArH), 7.29-7.24 (5H, m, ArH), 5.42 (2H, d, 1JNH = 
77.3 Hz, =NNH2); 
13C NMR (125.8 MHz, CDCl3)  149.1 (d, 1JCN = 6.3 Hz, C=NNH2) 138.4 
(dd, JCN = 9.1 Hz, JCN = 2.4 Hz, ArC), 132.9 (dd, JCN = 2.3 Hz, JCN = 2.0 Hz, ArC), 129.4, 
128.84, 128.76, 128.07, 128.03, 126.40, 126.38; 15N NMR (30.4 MHz, CDCl3, DMSO-d6 
lock solvent)  320.4 (d, 1JNN = 12.4 Hz), 106.2 (br m); MS m/z (rel. intensity) (EI) 198 (M+, 
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100), 197 (36), 181 (21), 165 (35), 152 (5), 139 (3), 121 (8), 120 (4), 94 (7), 77 (26), 51 (9); 
HRMS (EI) calc. for C13H12
15N2: 198.0941, found: 
198.0941. 
15N,15N´-1,2-bis(Diphenylmethylene)hydrazine (3.29). 
mp = 163-164 °C; IR (CDCl3, CaF2, cm
-1) νmax 3085, 
3063, 3027, 1550, 1490, 1445, 1323, 1300, 1179, 1075, 1029, 953; 1H NMR (500 MHz, 
CDCl3)  7.49-7.24 (10H, m, ArH); 13C NMR (125.8 MHz, CDCl3)  158.8 (dd, JNC = 3.4 
Hz, JNC = 3.4 Hz, C=N) 138.2 (dd, JNC = 5.4, JNC = 5.4 Hz, ArC), 135.5, 129.5, 129.3, 
128.63, 128.61, 127.9, 127.8; 15N NMR (30.4 MHz, CDCl3, DMSO-d6 lock solvent)  
353.05; MS m/z (rel. intensity) (EI) 362 (M+, 79), 285 (100), 258 (14), 207 (5), 181 (29), 165 
(28), 105 (7), 77 (21), 51 (4); HRMS (EI) calc. for C26H20
15N2: 362.1567, found: 362.1569. 
 
 
15N,15N´-Diphenyldiazomethane (3.5b). To a solution of 15N enriched benzophenone 
hydrazone (0.6135 g, 3.09 mmol) in petroleum ether 30-60 (30 mL) was added yellow 
mercuric oxide (1.2369 g, 5.71 mmol) and the mixture was vigorously shaken in the dark for 
10.5 h. The mixture was then filtered and the solvent evaporated in vacuo to yield a dark 
purple solid (0.5539 g, 92%): IR (CDCl3, CaF2, cm
-1) νmax 1978, (NaCl, film, cm
-1) νmax 
1973; 1H NMR (500 MHz, CDCl3)  7.41-7.37 (4H, m, ArH), 7.31-7.29 (4H, m, ArH), 7.21-
7.16 (2H, m, ArH); 13C NMR (125.8 MHz, CDCl3)  129.5 (d, 2JNC = 1.4 Hz, ArC) 129.1, 
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125.6, 125.2, 62.3 (dd, 1JNC = 23.7 Hz, 
2JNC = 2.9 Hz, C=N2); 
15N NMR (30.4 MHz, CDCl3, 
DMSO-d6 lock solvent)  439.9 (d, 1JNN = 9.6 Hz), 304.9 (d, 1JNN = 9.6 Hz); MS m/z (rel. 
intensity) (EI) 196 (M+, 8), 182 (3), 166 (68), 165 (100), 139 (8), 115 (3), 105 (3), 82 (6), 63 
(3), 51 (3); HRMS (EI) calc. for C13H10
15N2: 196.0785, found: 196.0780. 
 
 
N-(Diphenylmethylene)nitramide (3.7), Benzophenone (3.8), Dinitrodiphenylmethane 
(3.9). 15N-enriched diphenyldiazomethane (0.4049 g, 2.07 mmol) was dissolved in a 
degassed solution of a 50/50 (v/v) benzene/cyclohexane (70 mL). This solution was then 
purged continuously with a constant flow of nitric oxide for 2.5 h. NO was generated by the 
slow addition of separate degassed solutions of sodium nitrite (93.15 g in 250 mL aqueous 
solution) via a dropping funnel into L-ascorbic acid (118.8 g in 500 mL aqueous solution) 
using an in-house gas generating apparatus (Appendix A). The reaction flask was vented to 
prevent pressure buildup. The reaction flask was then sealed three hours after the entire 
addition of the sodium nitrite solution, and stirring continued overnight in the dark for 
another 14 h. The solution went from a deep purple to a yellow color overnight. The crude 
reaction mixture was then concentrated under reduced pressure and purified by silica gel 
column chromatography (5:1 then 2:1 hexanes:dichloromethane) to afford three products as 
white solids: nitrimine (0.2583 g, 55%), benzophenone (0.0675 g, 18%), and 
dinitrodiphenylmethane (0.027 g, 5%) which were equivalent to the corresponding products 
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1H, 13C and 15N NMR spectra 























15N,15N´-(Diphenylmethylene)hydrazine 3.4b (1H NMR 500 MHz; 13C NMR 125.8 MHz, 
CDCl3; 



















15N,15N´-1,2-bis(Diphenylmethylene)hydrazine 3.29 (1H NMR 300 MHz; 13C NMR 75.5 
MHz, CDCl3; 



















15N,15N´-(Diazomethylene)dibenzene 3.5b (1H NMR 500 MHz; 13C NMR 125.8 MHz, 
CDCl3; 



















1-(2,3-Dimethyl-1H-indol-1-yl)ethanone (4.56). The following procedure is a 
modification of the procedure reported by Dave and Wharnoff.497 To a stirred solution of 
para-toluenesulfonic acid hydrate (0.253 g, 1.33 mmol) in acetic anhydride (300 mL) was 
added 2,3-dimethylindole (22.9981 g, 0.158 mol) and then refluxed at 130 °C for 11 h. The 
residue was cooled and the excess acetic anhydride was evaporated either by vacuum 
distillation or on a rotary evaporator. The crude material was then applied to a bed of silica 
gel and target compound was purified eluting with 30:70 ether:pet ether to furnish the title 
compound as an off-white solid (23.33 g, 79%): mp 69-70 °C (lit. value497 68-70 °C); 1H 
NMR (300 MHz, CDCl3)  7.96-7.93 (1H, m, ArH), 7.40-7.38 (1H, m, ArH), 7.25-7.22 (2H, 
m, ArH), 2.58 (3H, s, NC(O)CH3), 2.45 (3H, s, CH3), 2.13 (3H, s, CH3); 
13C NMR (75.5 
MHz, CDCl3) δ 170.1, 135.6, 132.5, 131.2, 123.7, 122.8, 118.1, 115.4, 114.9, 27.5, 14.4, 8.7; 




1-(2,3-bis(Bromomethyl)-1H-indol-1-yl)ethanone (4.57). The following procedure is a 
modification of the procedure described by Wu.386 A solution of N-acetyl-2,3-dimethylindole 
4.56 (4.0057 g, 21.4 mmol) and NBS (8.0067 g, 44.9 mmol) in CH2Cl2 (350 mL) was heated 
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at reflux using a 250 W Brooder lamp for 100 min, cooled to ambient temperature and 
filtered through Celite 545. The solution was washed twice with water, once with brine, dried 
over Na2SO4, filtered and evaporated under reduced pressure to afford 7.3664 g (99%) of the 
title compound498 as a white solid: 1H NMR (300 MHz, CDCl3)  7.75 (1H, d, J = 8.2 Hz, 
ArH), 7.68 (1H, d, J = 7.5 Hz, ArH), 7.42-7.32 (2H, m, ArH), 5.08 (2H, s, CH2Br), 4.69 (2H, 
s, CH2Br), 2.85 (3H, s, NC(O)CH3); 
13C NMR (75.5 MHz, CDCl3)  169.9, 135.8, 134.9, 
127.8, 126.2, 123.6, 120.0, 119.7, 114.7, 27.5, 23.1, 21.1; MS m/z (rel. intensity) (EI) 347 (4, 
M+ for C12H11
81Br2NO), 345 (9, M
+ for C12H11
81/79Br2NO), 343 (4, M
+ for C12H11
79Br2NO), 




(1-Acetyl-1H-indole-2,3-diyl)bis(methylene) diacetate (4.95). Following a published 
procedure,401 a round bottom flask was charged with acetic acid (20 mL), acetic anhydride (4 
mL) and zinc oxide (0.5283 g, 6.49 mmol) and stirred for 10 min. Indole 4.57 (1.5384 g, 4.46 
mmol) was added and the solution was stirred vigorously for 3.5 h at which point water (60 
mL) was added and the mixture briefly stirred. The mixture was filtered and extracted with 
ether three times. The ethereal extracts were pooled and washed with a saturated solution of 
NaHCO3 until bubbling ceased. CAUTION: abundant gas (CO2) evolution. The pooled 
extracts were dried over Na2SO4, filtered and the solvent evaporated in vacuo, producing a 
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yellow oil which was purified through a small plug (20 mL) of silica gel (2:1 hexanes:ethyl 
acetate) furnishing the target compound as a light tan-yellow solid (0.9614 g, 71%): mp 61-
62 °C; IR (NaCl, film, cm-1) νmax 1740, 1461, 1373, 1306, 1234, 1142, 1023, 962, 750; 
1H 
NMR (300 MHz, CDCl3)  7.86 (1H, d, J = 8.2 Hz, ArH), 7.68 (1H, d, J = 7.8 Hz, ArH), 
7.40-7.27 (2H, m, ArH), 5.56 (2H, s, CH2OAc), 5.36 (2H, s, CH2OAc), 2.79 (3H, s, 
NC(O)CH3), 2.05 (3H, s, OC(O)CH3), 2.03 (3H, s, OC(O)CH3); 
13C NMR (75.5 MHz, 
CDCl3)  170.8, 170.4, 169.8, 135.8, 133.4, 128.6, 125.8, 123.5, 119.9, 119.1, 114.9, 57.0, 
56.2, 27.1, 20.8; MS m/z (rel. intensity) (EI) 303 (41, M+), 278 (4), 261 (28), 243 (11), 224 
(1), 202 (27), 201 (26), 173 (8), 159 (100), 145 (31), 142 (32),  130 (18), 115 (6), 84 (10), 77 
(3), 51 (3). 
 
 
Synthetic efforts towards (1-Acetyl-1H-indole-2,3-diyl)bis(bromomethylene) diacetate 
(4.93). A solution of the bis-acetoxy indole 4.95 (1.0011 g, 3.3 mmol) in dry CH2Cl2 (120 
mL) and NBS (1.3495 g, 7.6 mmol) was heated at reflux using a 250 W Brooder lamp for 3 h 
generating a complex mixture. The solvent was evaporated under reduced pressure. The 
residue was dissolved in a small amount of CH2Cl2 at which time gaseous fumes of acetic 
acid were generated. Purification by silica gel chromatography (3:1 hexanes:ethyl acetate) 
provided the side product 4.96 (0.1107 g, 13%) as a yellow oil: 
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(1-Acetyl-2-formyl-1H-indol-3-yl)methyl acetate (4.96). 1H NMR (300 
MHz, CDCl3) δ 10.46 (1H, s, CHO), 8.39 (1H, d, J = 7.6 Hz, ArH), 7.76 
(1H, d, J = 7.9 Hz, ArH), 7.45-7.35 (2H, m, ArH), 5.76 (2H, s, CH2OAc), 
2.86 (3H, s, NHCOCH3), 2.08 (3H, s, OCOCH3); 
13C NMR (75.5 MHz, CDCl3) δ 186.4, 
170.5, 170.2, 142.5, 135.4, 126.4, 125.9, 124.9, 122.7, 120.6, 114.0, 56.1, 27.3, 20.7; MS m/z 
(rel. intensity) (EI) 259 (M+, 20), 217 (45), 199 (14), 175 (100), 157 (42), 144 (19), 129 (55), 
102 (11), 77 (6), 51 (2). 
 
 
Synthetic efforts towards increasing the yield of Diels-Alder adduct 4.71. A solution of 
2,3-bis(bromomethyl) indole 4.57 (0.1291 g, 0.37 mmol) in  CH2Cl2 (2 mL) was cooled to -
78 °C. To this was added a solution of TBAI (1.0438 g, 2.83 mmol) in CH2Cl2 (2 mL), 
stirred for 5 min and then transferred to a -30 °C bath. The temperature was permitted to rise 
to -23 °C (approximately 20 min) at which time a white precipitate disappeared and the 
solution turned brown in colour. The solution was then re-cooled to -78 °C. To this was 
added a separate solution of 1,3-propanedithiol (0.040 mL, 0.39 mmol) and 2,6-di-tert-butyl-
4-methylpyridine (0.1432 g, 0.69 mmol) in CH2Cl2 (0.5 mL) and the solution was stirred for 
30 min. Then a solution of acrolein (0.055 mL at 90%, ~0.74 mmol, filtered through a bed of 
CaSO4) in CH2Cl2 (0.5 mL) was added to the reaction mixture which was then stirred for 7 
min. To this was added SnCl4 (0.44 mL of a 1.0 M solution in CH2Cl2, 0.44 mmol) and 
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stirred for 18 h at -78 °C. The reaction mixture was quenched with a saturated solution of 
sodium bicarbonate at this temperature and permitted to come to ambient temperature at 
which time a portion of a saturated solution of NaS2O3 was added. The mixture was extracted 
with ether three times and pooled. The extracts were washed once with a saturated solution of 
NaS2O3, water once, brine once and dried over Na2SO4, filtered and the solvent evaporated in 




Synthetic efforts towards increasing the yield of Diels-Alder adduct 4.72. This 
experiment was executed under similar conditions as described above for 4.71. The amounts 
of the reagents are given and are listed in the order in which they were employed: 2,3-
bis(bromomethyl) indole (0.1322 g, 0.38 mmol), TBAI (1.0686 g, 2.89 mmol), Proton 
sponge (0.1485 g, 0.69 mmol), methacrolein (0.06 mL, 0.73 mmol), SnCl4 (0.42 mL of a 
1.0 M solution in CH2Cl2, 0.42 mmol). Silica gel chromatography (3:1 hexanes:ethyl acetate) 
afforded 0.0553 g (57%) of an inseparable mixture of the two regioisomers as a yellow solid 
in a ratio of 21:1 for 4.72a:4.72b. The ratio was obtained by integrating the aldehydic protons 
for each regioisomer. The remaining signals of the minor regioisomer were obscured. The 
following assignments apply to the C-2 regioisomer 4.72a: 1H NMR (500 MHz, CDCl3) δ 
9.58 (1H, s, CHO), 7.91 (1H, d, J = 8.1 Hz, ArH), 7.43 (1H, d, J = 7.1 Hz, ArH), 7.34-7.26 
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(2H, m, ArH), 3.50 (1H, d, J = 17.7 Hz, CH), 2.90 (1H, d, J = 17.7 Hz, CH), 2.83 (3H, s, 
NHC(O)CH3), 2.75-2.69 (2H, m, CH), 2.16-2.13 (1H, m, CH), 1.83-1.79 (1H, m, CH), 1.25 
(3H, s, CH3). 
 
 
tert-Butyldimethyl(prop-2-yn-1-yloxy)silane (4.113). Following procedures described by 
Marshall and Palovich,405 a stirred solution of propargyl alcohol (20 mL, 0.34 mol) and 
imidazole (36.09 g, 0.53 mol) in DMF (250 mL) was cooled to 0 °C and TBDMSCl (52.31 g, 
0.35 mol) was added. Stirring was continued for 5 h. The reaction was quenched with water 
and the reaction mixture was extracted with ether three times. The ethereal extracts were 
pooled, washed with water twice, brine once, dried over MgSO4, filtered and concentrated in 
vacuo to yield 57.23 g (98%) of the title compound499 as clear pale yellow oil: IR (NaCl film, 
cm-1) νmax 3314, 2931, 2860, 1473, 1369, 1257, 1099, 1005, 838, 779, 662; 
1H NMR (300 
MHz, CDCl3)  4.29 (2H, d, J = 2.4 Hz, TBDMSOCH2), 2.37 (1H, t, J = 2.4, CCH), 0.89 
(9H, s, SiC(CH3)3), 0.10 (6H, s, Si(CH3)2); 
13C NMR (75.5 MHz, CDCl3)  82.4, 72.8, 51.5, 
25.8, 18.3, -5.2; MS m/z (rel. intensity) (EI) 170 (M+, 4), 155 (3), 113 (100), 83 (63), 75 (13). 
 
 
4-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-ol (4.114). Following a published 
procedure,405 a stirred solution of the silyl ether 4.113 (34.80 g, 0.204 mol) in THF (500 mL) 
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cooled to -78 ºC was added n-BuLi (0.259 mol, 162 mL at 1.6 M) dropwise. The solution 
was stirred for 50 min, warmed to room temperature over a 50 min period and subsequently 
re-cooled to -78 ºC. Paraformaldehyde (13.4163 g, 0.447 mol) was added in five equal 
portions to the solution and stirring was continued for 25 min. The reaction mixture was 
allowed to warm to room temperature over a 2 h period with vigorous stirring. The solution 
was quenched with a saturated solution of ammonium chloride and ice. The organic and 
aqueous layers were separated, and the aqueous layer was extracted with ether twice. The 
organic fractions were pooled, washed with water twice, brine once, dried over MgSO4, 
filtered and concentrated under reduced pressure to give 38.23 g of the crude product as a 
gold oil. Silica gel chromatography (6:1 hexanes:ethyl acetate) afforded the title compound500 
as a light yellow oil (27.68 g, 68%): IR (NaCl, film, cm-1) 3361, 2934, 1466, 1367, 1257, 
1133, 1082, 1015, 838, 780; 1H NMR (300 MHz, CDCl3)  4.33 (2H, t, J = 1.7 Hz, SiOCH2), 
4.27 (2H, dt, J = 6.1, 1.7 Hz, HOCH2), 1.59 (1H, t, J = 6.1 Hz, OH), 0.90 (9H, s, SiC(CH3)3), 
0.1 (6H, s, Si(CH3)2); 
13C NMR (75.5 MHz, CDCl3)  84.1, 83.1, 51.7, 50.9, 25.8, 18.3, -5.2. 
MS m/z (rel. intensity) (EI) 143 (M+ - tBu, 13), 125 (38), 85 (5), 75 (100), 73 (7), 57 (3); (CI) 
218 (M+ + NH4, 100). 
 
 
4-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl methanesulfonate (4.115). Following 
procedures described by Mukai and Takahashi,406 a solution of the alcohol 4.114 (19.49 g, 
0.097 mol) in CH2Cl2 (350 mL) was cooled to 0 ºC. Triethylamine (26 mL, 0.187 mol) and 
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mesyl chloride (11 mL, 0.142 mol) were added and stirring continued for 40 min at 0 ºC. The 
reaction mixture was then quenched with a saturated solution of sodium bicarbonate and 
extracted three times with CH2Cl2. The pooled extracts were washed with water, brine and 
dried over sodium sulfate, filtered and concentrated in vacuo to yield the title compound501 as 
a gold oil (24.72 g, 91%): IR (NaCl, film, cm-1) νmax 3030, 2931, 2859, 1473, 1363, 1256, 
1177, 1143, 1083, 942, 836, 716, 668; 1H NMR (300 MHz, CDCl3)  4.86 (2H, t, J = 1.7 Hz, 
MsOCH2), 4.34 (2H, t, J = 1.7 Hz, SiOCH2), 3.09 (3H, s, SO2CH3), 0.87 (9H, s, SiC(CH3)3), 
0.08 (6H, s, Si(CH3)2); 
13C NMR (75.5 MHz, CDCl3)  88.5, 76.7, 57.8, 51.4, 38.9, 25.7, 




tert-Butyldimethyl((2-(tributylstannyl)buta-2,3-dien-1-yl)oxy)silane (4.116). Following 
a published procedure,406 a solution of diisopropylamine (9.0 mL, 0.064 mol) in THF (200 
mL) was cooled to 0 ºC to which n-BuLi (24.5 mL at 2.5 M, 0.061 mmol) was added and 
stirred for 30 min. Tributyltin hydride502 (16.0 mL, 0.059 mmol) was added and stirring 
continued for another 30 min. The solution turned a lemon yellow color and the temperature 
was dropped to -78 ºC. Then CuBr·SMe2 (12.3143 g, 0.059 mmol), prepared by a 
modification of the methods described by Theis and Townsend503 and Wuts,504 was added in 
several portions over 15 min and stirred for a further 30 min in which the reaction solution 
developed a deep dark red colour. The mesylate 4.115 (8.1444 g, 0.029 mmol) was dissolved 
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in THF (10 mL) and cannulated into the tin-copper mixture. The solution was kept at -78 ºC 
for 5 min and then the temperature was raised slowly to -20 ºC over the course of 2 h. The 
solution developed a deep dark blackish-blue colour over this time. The reaction mixture was 
then poured into a 10% solution of NaCN (250 mL; or alternatively 19:1 NH4Cl:NH4OH and 
stirred until deep blue) and stirred vigorously. The black precipitates were allowed to settle, 
and the mixture was filtered through glass wool twice and ether (200 mL) was added. The 
organic phase was washed with water, brine, dried over Na2SO4 and evaporated to dryness. 
The residue was purified by flash chromatography (100% hexanes) to yield 7.9752 g (58%) 
of the known allenylstannane406 as clear colorless oil: IR (NaCl, film, cm-1) νmax 2929, 2856, 
1930, 1464, 1361, 1255, 1081, 1049, 838, 802, 777, 668; 1H NMR (300 MHz, CDCl3)  
4.33-4.26 (2H, m, SiOCH2), 4.22-4.15 (2H, m, C=CH2), 1.55-0.85 (27H, m, (C4H9)3) 
overlapping with 0.89 (9H, s, SiC(CH3)3), 0.05 (6H, s, Si(CH3)2); 
13C NMR (75.5 MHz, 
CDCl3)  202.9, 94.3, 66.5, 64.1, 28.9, 27.3, 26.0, 18.5, 13.7, 10.4, -5.3; MS m/z (rel. 
intensity) (EI) 417 (for C18H37OSi
120Sn = M+ - Bu, 100), 415 (for C18H37OSi
118Sn = M+ - Bu, 
74), 365 (67), 363 (58), 291 (29), 289 (23), 235 (33), 233 (26), 179 (28), 177 (26), 121 (6), 
96 (4), 75 (39), 57 (5). 
 
 
tert-Butyl (2-iodophenyl)carbamate (4.117a). Following procedures described by Lamba 
and Tour,407 2-iodoaniline (5.5451 g, 0.025 mol) was added to a suspension of NaH (0.7051 
g, 0.029 mol, previously washed three times with dry hexane) in THF (300 mL). The mixture 
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was heated at reflux at 80 °C for 50 min. The mixture was cooled to room temperature, di-
tert-butyl dicarbonate (6.9471 g, 0.032 mol) was added and the reaction mixture was stirred 
for 35 min. A second portion of NaH was added (0.6451 g, 0.027 mol) and the solution was 
brought back to reflux for 9 h. The solution was cooled, quenched with water and extracted 
three times with ether and the extracts were pooled. The combined ethereal extracts were 
washed once with a saturated solution of NH4Cl, a saturated solution of NaHCO3, brine, 
dried over Na2SO4, filtered and the solvent evaporated in vacuo to give an amorphous brown 
oil. The oil was purified by silica gel chromatography (20:1 hexanes:ether) to afford 6.2953 g 
(78%) of the title compound505 as a light yellow oil: IR (NaCl, film, cm-1) νmax 3395, 2979, 
2931, 1737, 1588, 1573, 1517, 1454, 1432, 1392, 1368, 1298, 1279, 1247, 1223, 1155, 1120, 
1061, 1042, 1024, 1011, 898, 830, 768, 749, 650; 1H NMR (300 MHz, CDCl3)  8.03 (1H, d, 
J = 7.9 Hz, ArH6), 7.72 (1H, d, J = 7.7 Hz, ArH3), 7.29 (1H, dd, J = 7.7, 7.9 Hz, ArH5), 6.79 
(1H, br s, NH) overlapping with 6.74 (1H, t, J = 7.7 Hz, ArH4), 1.51 (9H, s, OC(CH3)3); 
13C 
NMR (75.5 MHz, CDCl3)  152.5, 138.8, 129.1, 124.6, 120.1, 88.7, 80.9, 28.3, 27.9; MS m/z 
(rel. intensity) (EI) 319 (M+, 56), 263 (79), 245 (9), 219 (100), 136 (24), 119 (4), 91 (14), 90 
(11), 57 (94). 
 
 
N-(2-Iodophenyl)acetamide (4.117b). Following procedures described by Sarvari and 
Sharghi,408 2-iodoaniline (4.9905 g, 0.022 mol) was added to a stirred suspension of zinc 
oxide (0.9394 g, 0.012 mol) in acetic anhydride (2.4 mL). The mixture was stirred for 45 
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min. CAUTION: the flask becomes extremely hot as the acetic anhydride is consumed. 
Dichloromethane (5 mL) was added to the reaction mixture and stirring was continued for 15 
min longer after which an additional portion of dichloromethane was added (5 mL). The 
solution was filtered, washed with a saturated solution of NaHCO3, water, brine, dried over 
Na2SO4, filtered and the solvent was evaporated under reduced pressure. The crude product 
was purified by silica gel chromatography (3:1 hexanes:ethyl acetate) to afford 5.3331 g 
(91%) of the title compound as a white solid: mp 106-107 °C (lit. value506 109-111 °C); IR 
(NaCl, film, cm-1) νmax 3273, 1659, 1582, 1575, 1532, 1464, 1532, 1464, 1433, 1369, 1294, 
1016, 751; 1H NMR (300 MHz, CDCl3)  8.18 (1H, br d, J = 7.7 Hz, ArH6), 7.76 (1H, d, J = 
7.9 Hz, ArH3), 7.39 (1H, br s, NH) overlapping with 7.32 (1H, td, J = 7.7, 1.0 Hz, ArH5), 
6.83 (1H, dd, J = 7.7, 7.9 Hz, ArH4), 2.22 (3H, s, NHC(O)CH3); 
13C NMR (75.5 MHz, 
CDCl3)  168.2, 138.7, 138.2, 129.3, 125.9, 122.1, 89.9, 24.8; MS m/z (rel. intensity) (EI) 
261 (M+, 42), 219 (100), 134 (88), 92 (30), 65 (11); HRMS (EI) calc. for C8H8INO: 




(4.118a). From a modification of the procedure described by Mukai and Takahashi,406 a 
flame dried round bottom flask was charged with the iodoaniline 4.117a (2.1154 g, 6.63 
mmol), allenylstannane 4.116 (3.4756 g, 7.34 mmol) and DMF (40 mL) . This solution was 
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degassed twice under high vacuum using freeze-thaw conditions with argon purges. While 
the reaction mixture was still frozen, tri-(2-furyl)-phosphine (0.3749 g, 1.62 mmol), 
Pd2(dba)3·CHCl3 (0.2111 g, 0.2 mmol), and CuI (0.1313 g, 0.69 mmol) were added under an 
argon atmosphere and degassed twice more and then stirred at room temperature for 16 h. 
The reaction was quenched with 10% NH4OH and extracted three times with ether and 
pooled. The pooled extracts were washed with water twice, brine once, dried over Na2SO4, 
filtered and the solvent evaporated in vacuo. The crude product was purified by flash 
chromatography (20:1 hexanes:ether) to afford 1.277 g (51%) of the allenylaniline406 as a 
light yellow oil: IR (NaCl, film, cm-1) νmax 3426, 3339, 2930, 2858, 1954, 1732, 1585, 1520, 
1449, 1392, 1367, 1300, 1238, 1159, 1048, 1024, 1007, 940, 902, 839, 777, 754, 670; 1H 
NMR (300 MHz, CDCl3)  7.99 (1H, d, J = 7.9 Hz, ArH6), 7.53 (1H, br s, NH), 7.23 (1H, td, 
J = 7.9, 1.0 Hz, ArH5), 7.16 (1H, dd, J = 1.0, 7.7 Hz, ArH3), 6.98 (1H, ddd, J = 1.0, 7.7, 7.9 
Hz, ArH4), 4.96 (2H, t, J = 2.3 Hz, C=CH2), 4.37 (2H, t, J = 2.3 Hz, SiOCH2), 1.49 (9H, s, 
OC(CH3)3), 0.87 (9H, s, SiC(CH3)3), 0.04 (6H, s, Si(CH3)2); 
13C NMR (75.5 MHz, CDCl3)  
207.4, 153.1, 136.6, 128.8, 128.3, 124.9, 122.7, 120.2, 101.9, 80.1, 76.7, 65.4, 28.4, 25.9, 
18.4, -5.4; MS m/z (rel. intensity) (CI, NH4
+) 393 (M+ + 18, 19), 376 (M+ + 1, 100), 337 (10), 









N-(2-(1-((tert-Butyldimethylsilyl)oxy)buta-2,3-dien-2-yl)phenyl)acetamide (4.118b). In 
a similar fashion to the procedure described above for 4.118a, a round bottom flask was 
charged with N-(2-iodophenyl)acetamide 4.117b (1.2097 g, 4.63 mmol), allenylstannane 
4.116 (1.8856 g, 3.98 mmol) and DMF (35 mL) under an argon atmosphere. This solution 
was degassed twice under high vacuum using freeze-thaw conditions with argon purges. 
While the reaction mixture was still frozen, tri-(2-furyl)-phosphine (0.2106 g, 0.91 mmol), 
Pd2(dba)3 (0.1099 g, 0.12 mmol), and CuI (0.0764 g, 0.4 mmol) were added under an argon 
atmosphere. The mixture was degassed twice more and stirred at room temperature for 20 h. 
The reaction was quenched with 10% NH4OH and extracted three times with ether and 
pooled. The pooled extracts were washed with water twice, brine once, dried over Na2SO4, 
filtered and the solvent evaporated in vacuo. The crude product was purified by flash 
chromatography (5:1 then 3.5:1 hexanes:ethyl acetate) to afford 1.0451 g (83%) of the title 
compound as an orange oil: IR (NaCl, film, cm-1) νmax 3301, 3060, 2930, 1953, 1682, 1583, 
1520, 1368, 1298, 1076, 833, 756; 1H NMR (300 MHz, CDCl3)  8.35 (1H, br s, NH), 8.14 
(1H, d, J = 8.2 Hz, ArH), 7.28-7.19 (2H, m, ArH), 7.05 (1H, t, J = 7.4 Hz, ArH), 4.97 (2H, 
m, C=CH2), 4.41 (2H, m, SiOCH2), 2.14 (3H, s, COCH3), 0.85 (9H, s, SiC(CH3)3), 0.03 (6H, 
s, Si(CH3)2); 
13C NMR (75.5 MHz, CDCl3)  207.9, 168.1, 135.9, 128.8, 128.3, 125.6, 124.0, 
122.0, 101.9, 76.7, 65.7. 25.8, 24.7, 18.4, -5.3; MS m/z (rel. intensity) (EI) 317 (M+, 3), 302 
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(4), 274 (31), 260 (100), 242 (4), 230 (5), 218 (14), 200 (9), 186 (11), 168 (9), 143 (58), 115 
(11), 75 (34), 73 (45); HRMS (EI) calc. for C18H27NO2Si: 317.1811, found: 317.1801. 
 
 
Synthetic efforts towards tert-Butyl (2-(1-hydroxybuta-2,3-dien-2-
yl)phenyl)carbamate (4.120a). Following a known procedure,376 glacial acetic acid (0.14 
mL, 2.43 mmol) was added to a solution of the allenylaniline 4.118a (1.1739 g, 3.13 mmol) 
in THF (20 mL) and cooled to 0 °C. Then TBAF (9.8 mL of a 1.0 M solution, 9.8 mmol) was 
added and stirring was continued at 0 °C for 4 h. The reaction was quenched with a saturated 
solution of NH4Cl and extracted three times with ethyl acetate. The extracts were pooled, 
washed with water twice, brine once, dried over Na2SO4, filtered and the solvent evaporated 
on a rotary evaporator to give 0.9283 g of the crude product as a gold oil. Purification by 
silica gel chromatography (10:1 then 3:1 hexanes:ethyl acetate) afforded 0.7006 g (86%) of 
the side product 4.119406 as a pale yellow-green oil: 
tert-Butyl 3-(hydroxymethyl)-2-methyl-1H-indole-1-carboxylate 
(4.119). 1H NMR (300 MHz, CDCl3);  8.10 (1H, d, J = 7.8 Hz, ArH), 7.57 
(1H, d, J = 7.5 Hz, ArH), 7.23 (2H, m, ArH), 4.73 (2H, s, OCH2), 2.58 (3H, 
s, CCH3), 2.04 (1H, br s, OH), 1.69 (9H, s, OC(CH3)3); 
13C NMR (75.5 MHz, CDCl3)  
150.6, 135.6, 135.4, 128.9, 123.5, 122.6, 117.9, 117.5, 115.3, 83.7, 55.1, 28.1, 13.7; MS m/z 
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tert-Butyl (2-(1-hydroxybuta-2,3-dien-2-yl)phenyl)carbamate (4.120a). The following 
procedure is a modification of that described by Perumal and coworkers.409 To a stirred 
solution of the allenylaniline 4.118a (0.6668 g, 1.78 mmol) in  75% methanol (8 mL) was 
added KHSO4 (0.2052 g, 1.51 mmol) and stirred vigorously for 7 h to which water (5 mL) 
was added and the methanol evaporated under reduced pressure. The mixture was then 
extracted with ethyl acetate twice and pooled. The pooled extracts were washed with water 
twice, dried over Na2SO4, filtered and the solvent evaporated in vacuo to give 0.4847 g of the 
crude product as a gold oil which was purified by column chromatography (silica, 10:1 then 
3:1 hexanes:ethyl acetate) to afford the title compound as a colorless oil (0.3575g, 77%): IR 
(NaCl, film, cm-1) νmax 3418, 2979, 2932, 2876, 1950, 1729, 1584, 1520, 1450, 1393, 1368, 
1303, 1245, 1159, 1047, 1025, 850, 756; 1H NMR (300 MHz, CDCl3)  7.91 (1H, d, J = 8.2 
Hz, ArH), 7.22 (3H, m, ArH, NH), 7.04 (1H, dd, J = 7.4, 7.6 Hz, ArH), 5.08 (2H, s, C=CH2), 
4.38 (2H, dd, J = 3.0 Hz, 6.1 Hz, HOCH2), 2.13 (1H, t, J = 6.1 Hz, OH), 1.49 (9H, s, 
OC(CH3)3); 
13C NMR (75.5 MHz, CDCl3)  206.4, 153.2, 136.2, 128.6, 128.2, 124.5, 123.5, 
121.3, 102.4, 80.5, 77.1, 63.6, 28.4; MS m/z (rel. intensity) (EI) 261 (M+, 1), 243 (3), 205 (3), 




N-(2-(1-Hydroxybuta-2,3-dien-2-yl)phenyl)acetamide (4.120b). In a similar fashion to 
the procedure described for 4.120a, KHSO4 (0.2939 g, 2.16 mmol) was added to a stirred 
solution of the allenylacetanilide 4.118b (0.5960 g, 1.88 mmol) in  75% methanol (12 mL) 
and stirred vigorously for 10 h to which water (5 mL) was added and the methanol 
evaporated under reduced pressure. The mixture was then extracted with ethyl acetate three 
times and the extracts were pooled. The pooled extracts were washed with water twice, brine 
once, dried over Na2SO4, filtered and the solvent evaporated under reduced pressure to give 
0.3436 g of the crude product as a yellow oil which was purified by column chromatography 
(silica, 1:4 hexanes:ethyl acetate) to afford the title compound as a light yellow oil (0.2537 g, 
67%): IR (NaCl, film, cm-1) νmax 3271, 3059, 2933, 2875, 1949, 1668, 1583, 1532, 1448, 
1371, 1307, 1012, 852, 761; 1H NMR (300 MHz, CDCl3)  8.75 (1H, br s, NH), 7.95 (1H, d, 
J = 7.5 Hz, ArH), 7.24-7.18 (2H, m, ArH), 7.05 (1H, dd, J = 7.4, 7.5 Hz, ArH), 4.93 (2H, s, 
C=CH2), 4.33 (2H, s, HOCH2), 3.93 (1H, br s, OH), 2.04 (3H, s, C(O)CH3); 
13C NMR (75.5 
MHz, CDCl3)  208.2, 169.1, 135.6, 128.7, 128.2, 126.5, 124.6, 122.7, 102.2, 76.6, 63.9, 
24.1; MS m/z (rel. intensity) (EI) 203 (M+, 6), 185 (6), 172 (3), 160 (100), 143 (96), 130 (50), 







2-(2-((tert-Butoxycarbonyl)amino)phenyl)buta-2,3-dien-1-yl acetate (4.40a). Following 
a published procedure,376 a solution of the alcohol 4.120a (0.7521 g, 2.88 mmol) in pyridine 
(8.5 mL) was cooled to 0 °C to which acetic anhydride (1.4 mL, 14.81 mmol) was added and 
stirring continued for 3 h. The reaction was quenched with a saturated solution of ammonium 
chloride and extracted with ethyl acetate. The organic layer was washed with water and dried 
over Na2SO4, filtered and the solvent evaporated on a rotary evaporator to give 0.4007 g of a 
pale yellow oil that was purified chromatographically (silica, 4:1 hexanes:ethyl acetate) 
furnishing 0.3757 g (97%) of the title compound376 as a colorless oil: IR (NaCl, film, cm-1) 
νmax 3426, 2979, 1952, 1732, 1585, 1520, 1451, 1368, 1299, 1231, 1159, 1048, 1025; 
1H 
NMR (300 MHz, CDCl3)  7.99 (1H, d, J = 7.9 Hz, ArH), 7.25 (1H, ddd, J = 1.0, 7.5, 7.9 Hz, 
ArH), 7.18 (1H, dd J = 1.0, 7.5, ArH) overlapping with  7.14 (1H, br s, NH), 7.01 (1H, td, J = 
7.5, 0.8 Hz, ArH), 5.05 (2H, t, J = 2.6 Hz, C=CH2), 4.78 (2H, t, J = 2.6 Hz, OCH2) 2.06 (3H, 
s, COCH3), 1.50 (9H, s, OC(CH3)3); 
13C NMR (75.5 MHz, CDCl3)  207.6, 170.5, 152.9, 
136.3, 128.7, 128.4, 123.3, 123.0, 120.4, 98.1, 80.3, 77.9, 64.5, 28.3, 20.8; MS m/z (rel. 
intensity) (CI, NH4








2-(2-Acetamidophenyl)buta-2,3-dien-1-yl acetate 4.40c. In a similar fashion to the 
procedure described for 4.40a, acetic anhydride (0.7 mL, 7.4 mmol) was added to a solution 
of the alcohol 4.120b (0.2470 g 1.22 mmol) in pyridine (3.75 mL, 46.4 mmol) at 0 °C and 
stirred for 1 h. The solution was then quenched with 5 mL of a saturated solution of NH4Cl 
and extracted with ethyl acetate twice and the extracts were pooled. The pooled extracts were 
washed with a saturated solution of NH4Cl, water, brine and dried over Na2SO4, filtered and 
the solvent evaporated under reduced pressure to give 0.2762 g of a gold oil that was purified 
by silica gel chromatography (1:2 hexanes:ethyl acetate) to afford 0.2502 g (84%) of the title 
compound as a light yellow oil: IR (NaCl, film, cm-1) νmax 3335, 3058, 1954, 1739, 1693, 
1584, 1526, 1450, 1376, 1297, 1233, 1027, 761; 1H NMR (300 MHz, CDCl3)  8.27 (1H, d, J 
= 7.9 Hz, ArH) overlapping with 8.23 (1H, br s, NH), 7.29-7.24 (1H, m, ArH), 7.15 (1H, d, J 
= 7.4 Hz, ArH), 7.03 (1H, t, J = 7.4 Hz, ArH), 5.01 (2H, t, J = 3.4 Hz, C=CH2), 4.66 (2H, t, J 
= 3.4 Hz, OCH2), 2.19 (3H, s, OCOCH3), 2.08 (3H, s, NHCOCH3); 
13C NMR (75.5 MHz, 
CDCl3)  206.1, 171.2, 168.7, 136.2, 128.9, 128.8, 123.8, 123.1, 121.3, 98.8, 78.4, 63.3, 24.5, 
20.8; MS m/z (rel. intensity) (EI) 245 (M+, 2), 202 (20), 185 (9), 160 (19), 143 (100), 142 







9-tert-Butyl 2,3-dimethyl 3,4-dihydro-1H-carbazole-2,3,9(2H)-tricarboxylate (4.43). 
Following a published procedure,376 K2CO3 (0.0704 g, 0.51 mmol) was added to a stirred 
solution of the allenylaniline 4.40a (0.1463 g, 0.48 mmol) and dimethyl fumarate (0.0699 g, 
0.48 mmol) in DMF (2 mL) at 0 °C. The solution was allowed to come to room temperature 
and stirred for 20 h at which time the reaction appeared complete by TLC. The reaction was 
then quenched with a saturated solution of ammonium chloride and extracted with ether three 
times. The ethereal extracts were pooled, washed with water twice, brine once and dried over 
Na2SO4 and the residue purified by silica gel chromatography (5:1 hexanes:ethyl acetate) to 
give 0.1868 g (100%) of the title compound376 as a white solid: 1H NMR (300 MHz, CDCl3) 
δ 8.06 (1H, d, J = 8.0 Hz, ArH), 7.35 (1H, d, J = 7.3 Hz, ArH),  7.27-7.17 (2H, m, ArH), 3.74 
(3H, s, CO2CH3), 3.73 (3H, s, CO2CH3), 3.58-3.51 (1H, dd, J = 3.4, 16.8 Hz), 3.18-3.08 (4H, 
m), 2.83-2.73 (1H, m), 1.65 (9H, s, CO2C(CH3)3); 
13C NMR (75.5 MHz, CDCl3) δ 174.9, 
174.6, 154.4, 135.2, 132.7, 128.3, 124.0, 122.7, 117.6, 115.6, 114.3, 83.9, 52.1, 52.1, 42.5, 










oxylate (4.121). To a stirring solution of the N-Boc protected allenyl aniline 4.40a (0.37 g, 
1.22 mmol) in DMF (5 mL) was added K2CO3 (0.1755 g, 1.27 mmol) and stirred for 17 h at 
which time the reaction was quenched with a saturated solution of NH4Cl. The solution was 
extracted three times with diethyl ether and the extracts were pooled. The pooled extracts 
were washed with water twice, once with brine, dried over Na2SO4, filtered and the solvent 
evaporated under reduced pressure to produce 0.3018 g of a light yellow solid. The crude 
residue was purified by flash silica gel chromatography (10:1 hexanes:ether) furnishing 
0.2903 g (98%) of the title compound as a clear colorless oil: 1H NMR (500 MHz, CDCl3)  
8.17 (1H, d, J = 7.9 Hz, ArH8), 7.84 (1H, d, J = 8.2 Hz, ArH7′), 7.47 (1H, dd, J = 1.0, 7.3 
Hz, ArH5), 7.31 (1H, ddd, J = 1.0, 7.4, 7.9 Hz, ArH7) overlapping with 7.27 (1H, ddd, J = 
1.2, 7.3, 7.4 Hz, ArH6), 7.21 (1H, ddd, J = 1.4, 7.5, 8.2 Hz, ArH6′), 6.96 (1H, dd, J = 1.4, 7.5 
Hz, ArH4′), 6.91 (1H, td, J = 7.5, 0.8  Hz, ArH5′), 5.72 (1H, d, J = 1.3 Hz, H2′α), 4.67 (1H, 
d, J = 1.3 Hz, H2′α), 3.40, 3.32 (2H, ABq, J = 18.5 Hz, H1a, H1b), 2.91 (1H, ddd, J = 4.9, 
5.1, 16.9 Hz, H4a), 2.80-2.74 (1H, m, H4b), 1.94 (2H, m, H3a, H3b), 1.66 (9H, s, 
OC(CH3)3), 1.65 (9H, s, OC(CH3)3); 
13C NMR (125.5 MHz, CDCl3)  153.9 (C2′), 151.7 
(carbonyl carbon), 150.5 (carbonyl carbon), 140.9 (C7′a), 136.3 (C3′a), 136.1 (C8a), 134.2 
(C9a), 128.9 (C4b), 127.8 (C6′), 123.8 (C7), 123.3 (C5′), 123.1 (C4′), 122.6 (C6), 117.9 
(C5), 116.2 (C4a), 115.54 (C7′), 115.48 (C8), 93.4 (C2′α), 83.7 (quat. C of t-Bu), 82.6 (quat. 
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C of t-Bu), 46.9 (C2/3′), 38.1 (C1), 35.2 (C3), 28.3 (methyl carbons of t-Bu), 28.2 (methyl 
carbons of t-Bu), 17.9 (C4). 
 
COSY (500 MHz, CDCl3): 
Entry Proton (δ) Correlation 
1 H1a (3.40) H1b 
2 H1b (3.32) H1a 
3 H2′α a (5.72) H2α b 
4 H2′α b (4.67) H2α a 
5 H3a (1.94) H3b, H4a, H4b 
6 H3b (1.94) H3a, H4a, H4b 
7 H4a (2.91) H3a, H3b, H4b 
8 H4b (2.80-2.74) H3a, H3b, H4a 
9 H5 (7.47) H6, H7 (v. wk.) 
10 H6 (7.27) H5, H7, H8 (v. wk.) 
11 H7 (7.31) H5 (v. wk.), H6, H8 
12 H8 (8.17) H6 (v. wk.), H7 
13 H4′ (6.96) H5′ 
14 H5′ (6.91) H4′, H6′ 
15 H6′ (7.21) H5′, H7′ 








HMQC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 38.1 (C1) 
2 H2′α 93.4 (C2′α) 
3 H3 35.2 (C3) 
4 H4 17.9 (C4) 
5 H5 117.9 (C5) 
6 H6 122.6 (C6) 
7 H7 123.8 (C7) 
8 H8 115.48 (C8) 
9 H4′ 123.1 (C4′) 
10 H5′ 123.3 (C5′) 
11 H6′ 127.8 (C6′) 
12 H7′ 115.54 (C7′) 
13 Methyl H's 28.3 (Methyl C's) 













HMBC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 153.9 (C2′), 46.9 (C2/C3′), 35.2 (C3), 136.3 (C3′a), 
17.9 (C4, v. wk.), 116.2 (C4a), 134.2 (C9a) 
2 H2′α 153.9 (C2′), 46.9 (C2/C3′), 35.2 (C3) 
3 H3 38.1 (C1), 153.9 (C2′), 46.9 (C2/C3′), 136.3 (C3′a), 
17.9 (C4), 116.2 (C4a) 
4 H4 46.9 (C2/C3′), 35.2 (C3), 116.2 (C4a), 134.2 (C9a) 
5 H5 116.2 (C4a), 128.9 (C4b, v. wk.), 123.8 (C7), 136.1 
(C8a) 
6 H6 128.9 (C4b), 115.48 (C8) 
7 H7 117.9 (C5), 136.1 (C8a) 
8 H8 128.9 (C4b), 122.6 (C6), 136.1 (C8a, v. wk.) 
9 H4′ 46.9 (C2/C3′), 127.8 (C6′), 140.9 (C7′a)  
10 H5′ 136.3 (C3′a), 127.8 (C6′, v. wk.), 115.54 (C7′) 
11 H6′ 123.1 (C4′), 115.54 (C7′, v. wk.), 140.9 (C7′a) 














(4.55). To a stirring solution of the allenyl acetanilide 4.40c (0.2475 g, 1.01 mmol) in DMF 
(4 mL) was added 0.1445 g K2CO3 (1.05 mmol). The mixture was stirred for 24 h at which 
time the reaction was quenched with 2 mL of a saturated solution of NH4Cl. The solution 
was extracted three times with diethyl ether and the extracts were pooled. The pooled 
extracts were washed three times with water, once with brine, dried over Na2SO4, filtered and 
the solvent evaporated under reduced pressure to afford 0.1458 g (78%) of the title 
compound382 as a white solid: IR (NaCl, film, cm-1) νmax 2918, 1698, 1674, 1599, 1477, 
1462, 1371, 1347, 1310, 1288, 1221, 1204, 1032, 910, 732; 1H NMR (300 MHz, CD2Cl2)  
8.01-7.98 (2H, m, ArH), 7.51 (1H, d, J = 7.8 Hz, ArH), 7.36-7.21 (3H, m, ArH), 7.09-6.99 
(2H, m, ArH), 5.11 (1H, d, J = 1.1 Hz, H2αa), 4.82 (1H, d, J = 1.1 Hz, H2αb), 3.48, 3.38 
(2H, ABq, J = 18.0 Hz, H1), 2.91-2.78 (2H, m, H4), 2.71 (3H, s, NC(O)CH3), 2.50 (3H, s, 
NC(O)CH3), 1.98-1.94 (2H, m, H3); 
1H NMR (600 MHz, CDCl3)  8.04 (1H, d, J = 8.2 Hz, 
ArH7′), 7.98 (1H, d, J = 8.1 Hz, ArH8), 7.52 (1H, dd, J = 1.2, 7.8 Hz, ArH5), 7.37 (1H, ddd, 
J = 1.2, 7.4, 8.1 Hz, ArH7), 7.33 (1H, ddd, J = 1.0, 7.4, 7.8 Hz, ArH6), 7.27 (1H, d, J = 1.8, 
7.1, 8.2 Hz, ArH6′), 7.07 (1H, dd, J = 1.8, 7.5 Hz, ArH4′), 7.04 (1H, ddd, J = 0.9, 7.1, 7.5 
Hz, ArH5′), 5.14 (1H, d, J = 2.4 Hz, H2αa), 4.85 (1H, d, J = 2.4 Hz, H2αb), 3.52, 3.43 (2H, 
ABq, J = 18.0 Hz, H1), 2.91-2.80 (2H, m, H4), 2.77 (3H, s, NC(O)CH3), 2.55 (3H, s, 
NC(O)CH3), 2.01-1.93 (2H, m, H3); 
13C NMR (75.5 MHz, CD2Cl2)  170.1, 169.71, 155.3, 
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141.9, 137.2, 136.6, 134.6, 129.9, 128.2, 124.6, 124.5, 123.4, 122.9, 118.6, 117.9, 116.9, 
115.5, 96.6, 47.9, 37.0, 33.7, 27.6, 25.7, 18.5; 13C NMR (150.9 MHz, CDCl3)  169.8 
(carbonyl carbon), 169.5 (carbonyl carbon), 154.9 (C2′), 141.4 (C7′a), 136.6 (C3′a), 136.1 
(C8a), 134.5 (C9a), 129.6 (C4b), 128.1 (C6′), 124.5 (C5′), 124.3 (C7), 123.2 (C6), 122.6 
(C4′), 118.4 (C5), 117.6 (C4a), 116.9 (C7′), 115.0 (C8), 96.6 (C2′α), 47.5 (C2/C3′), 36.7 
(C1), 33.4 (C3), 27.4 (methyl carbon), 25.6 (methyl carbon), 18.2 (C4); MS m/z (rel. 
intensity) (EI) 370 (M+, 71), 328 (31), 327 (33), 313 (9), 286 (16), 285 (44), 269 (9), 256 (4), 
241 (3), 185 (9), 144 (14), 143 (100), 115 (4), 102 (1), 77 (1); HRMS (EI) calc. for 
C24H22N2O2: 370.1681, found: 370.1672. 
 
COSY (600 MHz, CDCl3): 
Entry Proton (δ) Correlation 
1 H1a (3.52) H1b 
2 H1b (3.43) H1a 
3 H2′α a (5.14) H2α b 
4 H2′α b (4.85) H2α a 
5 H3a (2.01-1.93) H3b, H4a, H4b 
6 H3b (2.01-1.93) H3a, H4a, H4b 
7 H4a (2.91-2.80) H3a, H3b, H4b 
8 H4b (2.91-2.80) H3a, H3b, H4a 
9 H5 (7.52) H6, H7 (v. wk.) 
10 H6 (7.33) H5, H7, H8 (v. wk.) 
11 H7 (7.37) H5 (v. wk.), H6, H8 
12 H8 (7.98) H6 (v. wk.), H7 
13 H4′ (7.07) H5′, H6′ (v. wk.) 
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14 H5′ (7.04) H4′, H6′ 
15 H6′ (7.27) H4′ (v. wk.), H5′, H7′ 
16 H7′ (8.04) H6′ 
 
HMQC (600 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 36.7 (C1) 
2 H2′α 96.6 (C2′α) 
3 H3 33.4 (C3) 
4 H4 18.2 (C4) 
5 H5 118.4 (C5) 
6 H6 123.2 (C6) 
7 H7 124.3 (C7) 
8 H8 115.0 (C8) 
9 H4′ 122.6 (C4′) 
10 H5′ 124.5 (C5′) 
11 H6′ 128.1 (C6′) 











HMBC (600 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 154.9 (C2′), 47.5 (C2/C3′), 33.4 (C3), 136.6 (C3′a), 
117.6 (C4a), 136.1 (C8a), 134.5 (C9a) 
2 H2′α 154.9 (C2′), 47.5 (C2/C3′), 33.4 (C3, v. wk.) 
3 H3 36.7 (C1), 154.9 (C2′), 47.5 (C2/C3′), 136.6 (C3′a), 
18.2 (C4), 117.6 (C4a) 
4 H4 47.5 (C2/C3′), 33.4 (C3), 117.6 (C4a), 134.5 (C9a) 
5 H5 117.6 (C4a), 129.6 (C4b, v. wk.), 124.3 (C7), 115.0 
(C8, v. wk.), 136.1 (C8a) 
6 H6 129.6 (C4b), 118.4 (C5), 124.3 (C7, wk.), 115.0 (C8), 
136.1 (C8a) 
7 H7 129.6 (C4b), 118.4 (C5), 115.0 (C8), 136.1 (C8a) 
8 H8 129.6 (C4b), 118.4 (C5, v. wk.), 123.2 (C6), 136.1 
(C8a, v. wk.) 
9 H4′ 47.5 (C2/C3′, v. wk), 136.6 (C3′a), 128.1 (C6′), 116.9 
(C7′), 141.4 (C7′a) 
10 H5′ 47.5 (C2/C3′, v. wk.), 136.6 (C3′a), 122.6 (C4′, v. 
wk.), 128.1 (C6′), 116.9 (C7′), 141.4 (C7′a) 
11 H6′ 136.6 (C3′a, v. wk.), 122.6 (C4′), 124.5 (C5′, v. wk.), 
116.9 (C7′, v. wk.), 141.4 (C7′a) 









Ethyl 2-(2-iodophenyl)acetate (6.14). Following procedures described by Kim and 
coworkers,507 ethyl chloroformate (4 mL, 0.0418 mol) and DMAP (0.5113 g, 4.18 mmol) 
was added to a stirred solution of 2-iodophenylacetic acid (10.7408 g, 0.0402 mol) and 
triethylamine (6.3 mL, 0.045 mol) in dichloromethane (130 mL) at 0 °C. Stirring was 
continued for 1 h at 0 °C. The reaction solution was diluted with dichloromethane (250 mL), 
washed twice with a saturated solution of NaHCO3, once with 0.1 M HCl, once with brine, 
dried over Na2SO4, filtered and the solvent evaporated under reduced pressure. The residue 
was purified chromatographically (silica, 7:1 hexanes:ethyl acetate) to give 11.4857 g (99%) 
of the title compound508 as a white solid: IR (NaCl, film, cm-1) νmax 2981, 1736, 1587, 1564, 
1466, 1438, 1367, 1338, 1216, 1158, 1014; 1H NMR (300 MHz, CDCl3)  7.83 (1H, d, J = 
8.2 Hz, ArH), 7.33-7.24 (2H, m, ArH), 6.96-6.91 (1H, m, ArH), 4.17 (2H, q, J = 7.1 Hz, 
OCH2CH3), 3.77 (2H, s, ArCH2), 1.26 (3H, t, J = 7.1 Hz, CH2CH3); 
13C NMR (75.5 MHz, 
CDCl3)  170.5, 139.5, 137.9, 130.6, 128.8, 128.4, 100.9, 61.0, 46.3, 14.2; MS m/z (rel. 
intensity) (EI) 290 (M+, 11), 245 (4), 217 (100), 163 (79), 135 (92), 107 (8), 90 (46), 89 (23), 









Ethyl 2-(2-(1-((tert-butyldimethylsilyl)oxy)buta-2,3-dien-2-yl)phenyl)acetate (6.16). 
Following a modification of procedures published by Mukai and Takahashi,406 a round 
bottom flask was charged with the ethyl 2-(2-iodophenyl)acetate 6.14 (4.6585 g, 16.1 mmol), 
allenylstannane 6.15 (8.3944 g, 17.7 mmol) and DMF (100 mL) under argon environment. 
This mixture was degassed twice under high vacuum using freeze-thaw conditions with 
argon purges. While the reaction mixture was still frozen, tri-(2-furyl)-phosphine (1.0316 g, 
4.44 mmol), Pd2(dba)3·CHCl3 (0.5137 g, 0.99 mmol), and CuI (0.3249 g, 1.7 mmol) were 
added under argon atmosphere. The reaction mixture was then degassed twice more using 
freeze-thaw conditions and then stirred at room temperature for 10 h. The reaction mixture 
was quenched with 10% NH4OH and extracted three times with ether and pooled. The pooled 
extracts were washed with water twice, brine once, dried over Na2SO4, filtered and the 
solvent evaporated on a rotary evaporator. The crude product was purified by flash 
chromatography (15:1 hexanes:ether) to afford 4.5485 g (82%) of the title compound as a 
pale yellow oil: IR (NaCl, film, cm-1) νmax 3063, 2956, 2930, 2896, 2857, 1957, 1740, 1472, 
1464, 1368, 1333, 1253, 1208, 1156, 1080, 1033, 839, 777; 1H NMR (300 MHz, CDCl3)  
7.31-7.21 (4H, m, ArH), 4.89 (2H, t, J = 3.0 Hz, OCH2), 4.35 (2H, t, J = 3.0 Hz, C=CH2), 
4.12 (2H, q, J = 7.1 Hz, OCH2CH3), 3.73 (2H, s, C(O)CH2), 1.22 (3H, t, J = 7.1 Hz, 
OCH2CH3), 0.86 (9H, s, SiC(CH3)3), 0.02 (6H, s, Si(CH3)2); 
13C NMR (75.5 MHz, CDCl3)  
206.4, 171.7, 135.2, 132.9, 130.6, 128.8, 127.5, 127.1, 103.9, 77.1, 64.7, 60.6, 39.1, 25.8, 
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18.3, 14.2, -5.4; MS m/z (rel. intensity) (EI)  346 (M+, 11), 331 (3), 301 (14), 289 (100), 273 
(8), 243 (72), 215 (58), 197 (43), 169 (18), 141 (41), 115 (13), 84 (41), 75 (47), 51 (10); 
HRMS (EI) calc. for C20H30O3Si: 346.1964, found: 346.1956. 
 
 
Ethyl 2-(2-(1-hydroxybuta-2,3-dien-2-yl)phenyl)acetate (6.17). Following a 
modification of procedures described by Perumal and coworkers409, KHSO4 (0.7523 g, 5.53 
mmol) was added to a solution of the silyl protected alcohol 6.16 (1.4943 g, 4.31 mmol) in 
70% methanol (18 mL) and stirred at room temperature for 85 min. The methanol was then 
evaporated under reduced pressure. Water was added and the mixture was extracted with 
ethyl acetate three times. The pooled organic extracts were dried over Na2SO4, filtered and 
evaporated under reduced pressure. The residue was purified chromatographically (silica, 4:1 
hexanes:ethyl acetate) to afford the title compound as a clear, colorless oil (0.9447 g, 94%): 
IR (NaCl, film, cm-1) νmax 3435, 3062, 2982, 2936, 2873, 1952, 1732, 1490, 1452, 1416, 
1393, 1369, 1336, 1252, 1211, 1158, 1098, 1074, 1030, 852, 763; 1H NMR (300 MHz, 
CDCl3)  7.32-7.24 (4H, m, ArH), 4.95 (2H, t, J = 2.6 Hz, C=CH2), 4.38 (2H, t, J = 2.6 Hz, 
CH2OH), 4.13 (2H, q, J = 7.1 Hz, OCH2CH3), 3.76 (2H, s, ArCH2C(O)), 2.42 (1H, t, J = 5.8 
Hz, OH), 1.24 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (75.5 MHz, CDCl3)  205.3, 172.4, 
134.6, 132.9, 130.9, 128.3, 127.8, 127.6, 103.9, 77.6, 63.9, 61.0, 39.0, 14.1; MS m/z (rel. 
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intensity) (EI) 232 (M+, 88), 214 (51), 202 (68), 173 (24), 159 (43), 141 (64), 129 (100), 128 
(89), 115 (47), 84 (42), 77 (8); HRMS (EI) calc. for C14H16O3: 232.1099, found: 232.1094. 
 
 
Ethyl 2-(2-(1-acetoxybuta-2,3-dien-2-yl)phenyl)acetate (6.18). Following procedures 
described by Mukai and coworkers,376 alcohol 6.17 (0.8840 g, 3.81 mmol) was dissolved in 
pyridine (12 mL) and cooled to 0 °C. Acetic anhydride (3 mL, 31.74 mmol) was then added 
and stirred for 2 h. The reaction solution was then quenched with a saturated solution of 
ammonium chloride, extracted three times with ethyl acetate and the extracts were pooled. 
The pooled extracts were washed with water, brine and dried over Na2SO4, filtered and 
evaporated under reduced pressure. The residue was purified by silica gel chromatography 
(5:1 hexanes:ethyl acetate) to afford 0.9561 g (92%) of the title compound as a clear 
colorless oil: IR (NaCl, film, cm-1) νmax 3063, 2983, 2939, 1955, 1732, 1491, 1448, 1431, 
1377, 1335, 1226, 1158, 1098, 1060, 1029, 961, 927, 858,765; 1H NMR (300 MHz, CDCl3)  
7.28-7.24 (4H, m, ArH), 4.95 (2H, t, J = 2.6 Hz, C=CH2), 4.79 (2H, t, J = 2.6 Hz, CH2OAc), 
4.12 (2H, q, J = 7.1 Hz, OCH2CH3), 3.74 (2H, s, ArCH2C(O)), 2.03 (3H, s, C(O)CH3), 1.23 
(3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (75.5 MHz, CDCl3)  207.1, 171.5, 170.5, 134.3, 
133.1, 130.9, 128.5, 127.9, 127.4, 99.9, 77.4, 64.8, 60.7, 39.0, 20.9, 14.2; MS m/z (rel. 
intensity) (EI) 274 (M+, 5), 232 (100), 214 (3), 186 (25), 158 (76), 141 (34), 115 (27), 102 




Synthetic efforts towards 9-Ethyl 2-methyl 2,3,4,9-tetrahydro-1H-fluorene-2,9-
dicarboxylate (6.21a) and 9-Ethyl 3-methyl 2,3,4,9-tetrahydro-1H-fluorene-3,9-
dicarboxylate (6.21b). To a stirring solution of the allenyl arene 6.18 (0.0501 g, 0.18 mmol) 
and methyl acrylate (0.034 mL, 0.38 mmol) in acetonitrile (1.2 mL) was added DBU (0.06 
mL, 0.4 mmol) and stirred for 12 h at which point the solution was quenched with a saturated 
solution of ammonium chloride (2 mL). The mixture was then extracted three times with 
ethyl acetate and pooled. The pooled extracts were washed once with water, once with brine, 
dried over sodium sulfate, filtered and the solvent removed under reduced pressure to give 
0.0473 g of a yellow residue. The crude residue was purified by flash chromatography to 
return 0.0137 g (27%) of 6.18, 0.037 g of residue assumed to contain 6.20, 6.21, 6.23 and 
0.0081 g (21%) of the eneyne 6.22 as a clear colourless film: 
Ethyl 2-(2-(but-1-en-3-yn-2-yl)phenyl)acetate (6.22). 1H NMR (300 MHz, 
CDCl3) δ 7.29-7.24 (4H, m, ArH), 5.87 (1H, s, C=CH), 5.57 (1H, s, C=CH), 
4.12 (2H, q, J = 7.1 Hz, OCH2CH3), 3.81 (2H, s, ArCH2C(O)), 3.04 (1H, s, C≡CH), 1.22 
(3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (75.5 MHz, CDCl3) δ ; 171.6, 139.1, 131.7, 130.7, 
129.9, 129.1, 128.3, 127.9, 127.4, 83.3, 78.9, 60.8, 38.8, 14.2; MS m/z (rel. intensity) (EI) 
214 (M+, 58), 185 (9), 170 (23), 157 (51), 141 (100),  139(41), 129 (11), 115 (86), 89 (8), 75 





2-(2-(2-Ethoxy-2-oxoethyl)phenyl)buta-2,3-dien-1-yl pivalate (6.25). To a solution of 
the silyl protected alcohol 6.16 (1.6878 g, 4.87 mmol) in 70% methanol (19 mL) was added 
KHSO4 (0.7264 g, 5.33 mmol) and stirred at room temperature for 2 h. The rest of the 
procedure follows that as for 6.17. The residue (1.2113 g) was then purified 
chromatographically (silica, 3:1 hexanes:ethyl acetate) to afford the allenyl alcohol 6.17 as a 
yellow oil (0.2770 g, 24%). The allenyl alcohol (0.2764 g, 1.19 mmol) was then dissolved in 
pyridine (6 mL) and stirred at 0 °C to which pivaloyl chloride (0.22 mL, 1.79 mmol) was 
added and stirring continued for another 2 h. The rest of the procedure follows that as for 
6.18 producing 0.3125 g the crude residue as a dark gold oil. Chromatographic purification 
(silica, 3:1 hexanes:ethyl acetate) afforded the title compound as a clear, pale yellow oil 
(0.2006 g, 53%): IR (NaCl, film, cm-1) νmax 2979, 1956, 1733, 1480, 1460, 1430, 1397, 1368, 
1335, 1280, 1250, 1209, 1148, 1033, 958, 856, 763; 1H NMR (300 MHz, CDCl3) δ 7.29-7.24 
(4H, m, ArH), 4.94 (2H, t, J = 3.0 Hz, C=CH2), 4.78 (2H, t, J = 3.0 Hz, CH2OPv), 4.12 (2H, 
q, J = 7.1 Hz, OCH2CH3), 3.74, (2H, s, ArCH2C(O)), 1.24 (3H, t, J = 7.1 Hz, OCH2CH3) ; 
13C NMR (75.5 MHz, CDCl3) δ 206.6, 177.9, 171.6, 134.2, 133.0, 130.8, 128.6, 127.8, 127.3, 
100.2, 77.7, 64.2, 60.7, 39.1, 38.7, 27.2, 14.2; MS m/z (rel. intensity) (EI) 316 (M+, 8), 291 
(2), 271 (3), 259 (2), 232 (39), 215 (9), 186 (16), 158 (49), 141 (28), 115 (18), 85 (16), 75 





Synthetic efforts towards Diethyl 2-(2-(1-((tert-butyldimethylsilyl)oxy)buta-2,3-dien-2-
yl)phenyl)malonate (6.27). To a stirring solution of silyl protected alcohol 6.16 (0.2966 g, 
0.86 mmol) in diethyl carbonate (5 mL) was added NaH (0.1624 g, 6.77 mmol, previously 
washed twice with dry hexane) and stirred at room temperature for 50 min. The reaction 
mixture was quenched with a saturated solution of NH4Cl and extracted with ethyl acetate. 
The organic layers were pooled, washed with water, brine, dried over Na2SO4 filtered and the 
solvent removed under reduced pressure to give a gold oil (0.2304 g). Chromatographic 
purification (silica, 10:1 hexanes:ethyl acetate) provided the side products 6.26 (0.0186 g, 
10%), 6.28 (0.0128 g, 5%) and 6.29 (0.0561 g, 23%): 
Diethyl 2'-methyl-1,3,4,9-tetrahydrospiro[fluorene-2,1'-
indene]-3',9-dicarboxylate (6.26). Two diastereomers: 1H NMR 
(500 MHz, CDCl3) δ 7.89 (2H, d, J = 7.7 Hz, ArH), 7.58-7.56 
(2H, m, ArH), 7.49 (2H, d, J = 7.6 Hz, ArH), 7.29-7.24 (2H, m, ArH), 7.21-7.18 (2H, m, 
ArH), 7.13-7.08 (4H, m, ArH), 7.06-7.01 (2H, m, ArH), 4.43-4.38 (4H, m, OCH2CH3) 
overlapping with 4.40 (1H, s, H9), 4.34 (1H, s, H9) overlapping with 4.34-4.16 (4H, m, 
OCH2CH3), 2.91-2.83 (4H, m, H1, H4), 2.67-2.62 (2H, m, H4), 2.38 (3H, s, H2α′), 2.36 (3H, 
s, H2α′), 2.31-2.23 (2H, m, H1), 2.21-2.14 (2H, m, H3), 1.46-1.42 (6H, m, OCH2CH3), 1.38-
1.37 (2H, m, H3) overlapping with 1.34 (3H, t, J = 7.1 Hz, OCH2CH3), 1.31 (3H, t, J = 7.1 
Hz, OCH2CH3);
 13C NMR (125.5 MHz, CDCl3)  170.84 (ester carbonyl), 170.77 (ester 
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carbonyl), 165.40 (ester carbonyl), 165.38 (ester carbonyl), 165.0 (ester carbonyl), 164.6 
(ester carbonyl), 150.1, 150.0, 144.9, 144.8, 140.9, 140.7, 139.8, 139.6, 138.6, 138.5, 137.7, 
137.6, 127.9, 127.7, 127.6, 127.1, 127.0, 125.22, 125.16, 125.0, 123.6, 123.4, 123.3, 122.5, 
122.1, 121.9, 118.3, 118.1, 61.3 (ester methylene), 61.2 (ester methylene), 60.3 (ester 
methylene), 57.1 (C9), 56.3 (C9), 53.1 (C2/C1′), 29.3 (C3), 28.8 (C3), 27.6 (C1), 27.5 (C1), 
22.8 (C4), 22.7 (C4), 14.4 (ester methyl), 14.33 (ester methyl), 14.31 (ester methyl), 13.1 
(C2′α), 12.9 (C2′α), (Two of the signals in the δ 164.6-165.4 range are suspected to arise 
from unidentified impurities); MS m/z (rel. intensity) (EI) 428 (M+, 33), 382 (10), 354 (7), 
309 (3), 265 (9), 239 (2), 214 (100), 185 (21), 141 (39), 115 (9), 91 (1),  63 (1). 
 
COSY (500 MHz, CDCl3): 
Entry Proton Correlation 
1 H1a H1b, H3 (wk.) 
2 H1b H1a, H3 (wk.) 
3 H3a H3b, H4a, H4b, H1(wk.) 
4 H3b H3a, H4a, H4b, H1 (wk.) 
3 H4a H4b, H3a, H3b 
4 H4b H4a, H3a, H3b 
5 Ester CH2 (δ 4.43-4.38) Ester CH3 (δ 1.46-1.42) 
6 Ester CH2 (δ 4.34-4.16) Ester CH3 (δ 1.34, 1.31) 
7 Ester CH3 (δ 1.46-1.42) Ester CH2 (δ 4.43-4.38) 






HMQC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 27.6 (C1), 27.5 (C1) 
2 H2′α 13.1 (C2′α), 12.9 (C2′α) 
3 H3 29.3 (C3), 28.8 (C3) 
4 H4 22.8 (C4), 22.7 (C4) 
5 H9 57.1 (C9), 56.3 (C9) 
6 Ester CH2 61.3 (ester methylene), 61.2 (ester methylene), 60.3 
(ester methylene) 
7 Ester CH3 14.4 (ester methyl), 14.33 (ester methyl), 14.31 (ester 
methyl) 
 
HMBC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 13.1 (C2′α), 12.9 (C2′α), 29.3 (C3), 28.8 (C3) 
2a H2′α 165.40 (ester carbonyl), 165.38 (ester carbonyl), 165.0 
(ester carbonyl), 164.6 (ester carbonyl), 53.1 (C2/C1′) 
3 H9 165.40 (ester carbonyl), 165.38 (ester carbonyl), 165.0 
(ester carbonyl), 164.6 (ester carbonyl) 
4 Ester CH2 (δ 4.43-4.38) 165.40 (ester carbonyl), 165.38 (ester carbonyl), 165.0 
(ester carbonyl), 164.6 (ester carbonyl), 14.4 (ester 
methyl), 14.33 (ester methyl), 14.31 (ester methyl) 
5 Ester CH3 (δ 1.46-1.42) 60.3 (ester methylene) 
6 Ester CH3 (δ 1.34, 1.31) 61.3 (ester methylene), 61.2 (ester methylene) 







carboxylate (6.28). 1H NMR (500 MHz, CDCl3) δ 7.88 (1H, d, J = 7.7 
Hz, ArH), 7.53 (1H, d, J = 7.8 Hz, ArH), 7.47 (1H, d, J = 7.4 Hz, 
ArH), 7.30-7.24 (2H, m, ArH), 7.22-7.17 (3H, m, ArH), 4.63 (1H, td, J 
= 10.8, 3.1 Hz, C=CH), 4.36 (2H, q, J = 7.1 Hz, OCH2CH3) overlapping with 4.35 (1H, H2′), 
4.29-4.23 (2H, m, SiOCH2), 4.12 (1H, td, J = 10.8, 3.1 Hz, C=CH), 4.05-3.98 (2H, m, 
OCH2CH3), 3.43 (1H, dd, J = 3.8, 9.4 Hz, H1), 2.82-2.77 (1H, m, H1′), 2.40 (3H, s, H2α), 
1.53-1.47 (1H, m, H1′), 1.40 (3H, t, J = 7.1 Hz, OCH2CH3), 1.15 (3H, t, J = 7.1 Hz, 
OCH2CH3), 0.85 (9H, s, SiC(CH3)3), -0.02 (3H, s, Si(CH3)), -0.03 (3H, s, Si(CH3));
 13C NMR 
(125.5 MHz, CDCl3)  205.9 (=C=), 173.8 (ester carbonyl), 165.1 (ester carbonyl), 161.3, 
144.5, 141.8, 137.7 (C1′′), 134.9, 129.7, 128.5, 127.9, 127.2, 126.9, 124.6, 123.6, 122.0, 
103.2 (C2′′′), 76.8 (C4′′′), 65.0 (C1′′′), 60.8 (ester methylene), 60.1 (ester methylene), 52.6 
(C1), 44.8 (C2′), 35.7 (C1′), 25.9 (t-Bu), 18.4 (quat. C of t-Bu), 15.3 (C2α), 14.4 (ester 
methyl), 14.1 (ester methyl), -5.38 (TBDMS methyl), -5.45 (TBDMS methyl); MS m/z (rel. 
intensity) (EI) 560 (M+, 3), 503 (100), 457 (3), 429 (3), 383 (3), 355 (11), 313 (5), 289 (23), 








COSY (500 MHz, CDCl3): 
Entry Proton (δ) Correlation 
1 H1 (3.43) H1′a, H1′b 
2 H1′a (2.82-2.77) H1, H1′b, H2′ 
3 H1′b (1.53-1.47) H1, H1′a, H2′ (wk.) 
4 H1′′′ (4.29-4.23) H4′′′a, H4′′′b 
5 H2′ (4.35) H1′a, H1′b 
6 H4′′′a (4.63) H1′′′, H4′′′b 
7 H4′′′b (4.12) H1′′′, H4′′′a 
8 Ester CH2 (δ 4.36) Ester CH3 (δ 1.40) 
9 Ester CH2 (δ 4.05-3.98) Ester CH3 (δ 1.15) 
10 Ester CH3 (δ 1.40) Ester CH2 (δ 4.36) 















HMQC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 52.6 (C1) 
2 H1′a 35.7 (C1′) 
3 H1′b 35.7 (C1′) 
4 H1′′′ 65.0 (C1′′′) 
5 H2′ 44.8 (C2′) 
6 H2α 15.3 (C2α) 
7 H4′′′a 76.8 (C4′′′) 
8 H4′′′b 76.8 (C4′′′) 
9 Ester CH2 (δ 4.36) 60.1 
10 Ester CH2 (δ 4.05-3.98) 60.8 
10 Ester CH3 (δ 1.40) 14.4 
11 Ester CH3 (δ 1.15) 14.1 
12 ArH (δ 7.88) 122.0 
13 ArH (δ 7.53) 127.2 












HMBC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H2′ 165.1 (ester carbonyl), 137.7 (C1′′, wk.) 
2 H2α 52.6 (C1), 128.5, 141.8 (wk.), 161.3 
3 H4′′′a 103.2 (C2′′′) 
4 H4′′′b 103.2 (C2′′′, wk.), 65.0 (C1′′′, wk.) 
5 Ester CH2 (δ 4.36) 165.1 (ester carbonyl), 1.40 (ester CH3) or 1.15 (ester 
CH3) 
6 Ester CH2 (δ 4.05-3.98) 173.8 (ester carbonyl), 1.40 (ester CH3, wk.) or 1.15 
(ester CH3, wk.) 
7 Ester CH3 (δ 1.40) 60.1 (ester CH2) 
8 Ester CH3 (δ 1.15) 60.8 (ester CH2) 
9 ArH (δ 7.88) 144.5, 124.6 
10 ArH (δ 7.53) 134.9, 127.2 or 126.9, 44.8 (C2′, wk.) 















carboxylate (6.29). Two diastereomers: 1H NMR (500 MHz, CDCl3) δ 
7.67-7.65 (2H, m, ArH), 7.44-7.41 (2H, m, ArH), 7.32-7.27 (6H, m, 
ArH), 7.24-7.20 (4H, m, ArH), 7.16-7.11 (2H, m, ArH), 4.79 (1H, td, J 
= 10.8, 3.2 Hz, C=CH), 4.69 (1 H, td, J = 10.5, 3.1 Hz, C=CH), 4.57 (1H, td, J = 10.8, 3.2 
Hz, C=CH), 4.40 (1H, dd, J = 6.3, 9.0 Hz, H2′), 4.32-4.25 (2H, m, SiOCH2) overlapping with 
(1H, m, H2′), 4.22 (1 H, td, J = 10.5, 3.1 Hz, C=CH), 4.19-4.01 (8H, m, OCH2CH3) 
overlapping with 4.12 (1H, s, H1) overlapping with 4.02 (1H, s, H1) overlapping with (2H, 
m, SiOCH2), 3.32-3.26 (2H, m, H1′), 2.93 (1H, dd, J = 7.7, 13.8 Hz, H1′), 2.87 (1H, dd, J = 
6.3, 13.8 Hz, H1′), 1.97 (3H, s, H2α), 1.74 (3H, s, H2α), 1.23 (3H, t, J = 7.1 Hz, OCH2CH3), 
1.19 (3H, t, J = 7.1 Hz, OCH2CH3), 1.12 (3H, t, J = 7.1 Hz, OCH2CH3), 1.07 (3H, t, J = 7.1 
Hz, OCH2CH3), 0.84 (9H, s, SiC(CH3)3), 0.83 (9H, s, SiC(CH3)3), -0.033 (3H, s, Si(CH3)), -
0.046 (3H, s, Si(CH3)), -0.055 (3H, s, Si(CH3)), -0.064 (3H, s, Si(CH3)); 
13C NMR (125.5 
MHz, CDCl3)  206.0 (=C=), 205.9 (=C=), 173.7 (ester carbonyl), 173.6 (ester carbonyl), 
170.78 (ester carbonyl alpha to C1), 170.75 (ester carbonyl alpha to C1), 145.7, 145.6, 140.5, 
140.3, 138.96, 138.92, 137.2, 137.1, 136.5, 136.2, 135.7, 135.4, 129.9, 129.8, 127.82, 127.77, 
127.6, 127.49, 127.43, 126.9, 124.53, 124.47, 123.09, 123.05, 118.8, 118.6, 104.2 (C2′′′), 
103.9 (C2′′′), 76.8 (C4′′′), 76.3 (C4′′′), 64.92 (C1′′′), 64.87 (C1′′′), 60.89 (ester methylene), 
60.86 (ester methylene), 60.79 (ester methylene), 60.65 (ester methylene), 58.4 (C1), 58.3 
(C1), 45.6 (C2′), 45.5 (C2′), 30.60 (C1′), 30.57 (C1′), 25.8 (t-Bu), 18.4 (quat. C of t-Bu), 
14.19 (ester methyl), 14.17 (ester methyl), 14.01 (ester methyl), 13.97 (ester methyl), 13.2 
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(C2α), 12.8 (C2α), -5.39 (TBDMS methyl), -5.43 (TBDMS methyl), -5.46 (TBDMS methyl); 
MS m/z (rel. intensity) (EI) 560 (M+, 4), 503 (100), 457 (2), 429 (2), 383 (3), 355 (9), 313 
(4), 289 (22), 281 (14), 243 (6), 215 (12), 169 (18), 141 (28), 103 (9), 73 (24). 
 
COSY (500 MHz, CDCl3): 
Entry Proton Correlation 
1 H1′a H1′b, H2′ 
2 H1′b H1′a, H2′ 
3 H2′ H1′a, H1′b 
4 H4′′′a H4′′′b 
5 H4′′′b H4′′′a 
6 Ester CH2 Ester CH3 
7 Ester CH3 Ester CH2 
 
HMQC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 58.4 (C1), 58.3 (C1) 
2 H1′ 30.60 (C1′), 30.57 (C1′) 
3 H1′′′ 64.92 (C1′′′), 64.87 (C1′′′) 
4 H2′ 45.6 (C2′), 45.5 (C2′) 
5 H2′α 13.2 (C2α), 12.8 (C2α) 
6 H4′′′ 76.8 (C4′′′), 76.3 (C4′′′) 
7 Ester CH2 60.89, 60.86, 60.79, 60.65 





HMBC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 170.78 (ester carbonyl alpha to C1), 170.75 (ester 
carbonyl alpha to C1) 
2 H1′ 173.7 (ester carbonyl alpha to C2′), 173.6 (ester 
carbonyl alpha to C2′), 145.7, 145.6, 45.6 (C2′), 45.5 
(C2′) 
3 H2′ 173.7 (ester carbonyl alpha to C2′), 173.6 (ester 
carbonyl alpha to C2′), 30.60 (C1′), 30.57 (C1′) 
4 H2α 58.4 (C1), 58.3 (C1) 
5 H4′′′ 206.0 (=C=, wk.), 205.9 (=C=, wk.), 104.2 (C2′′′), 
103.9 (C2′′′) 
6 ArH (δ 7.67-7.65) 135.7, 135.4, 126.9, 45.6 (C2′), 45.5 (C2′) 
7 ArH (δ 7.44-7.41) 145.7, 145.6, 58.4 (C1, wk.), 58.3 (C1, wk.) 














Diethyl 2-(2-iodophenyl)malonate (6.32). From procedures described by Larock and 
coworkers,508 NaH (0.4769 g, 19.9 mmol, previously washed three times with dry hexane) 
was added to a solution of (2-iodophenyl)acetate 6.14 (1.4535g, 5 mmol) in diethyl carbonate 
(30 mL) and stirred at room temperature for 15 h. The reaction was quenched with a 
saturated solution of NH4Cl and extracted three times with dichloromethane. The organic 
extracts were pooled and dried over sodium sulfate, filtered and concentrated in vacuo to 
afford 1.3251 g of a gold oil. Purification by flash silica chromatography (6:1 hexanes:ethyl 
acetate) gave 1.2073 g (67%) of the title compound508 as a pale yellow oil: IR (NaCl, film, 
cm-1) νmax 2982, 1735, 1468, 1368, 1305, 1260, 1219, 1148, 1031, 745; 
1H NMR (300 MHz, 
CDCl3)  7.85 (1H, dd, J = 1.0, 7.9 Hz, ArH), 7.45 (1H, dd, J = 1.6, 7.8 Hz, ArH), 7.35 (1H, 
dd, J = 1.0, 7.9 Hz, ArH), 6.99 (1H, dd, J = 1.6, 7.8 Hz, ArH), 5.10 (1H, s, CH), 4.16-4.28 
(4H, m, OCH2CH3), 1.26 (6H, t, J = 7.1 Hz, CH2CH3); 
13C NMR (75.5 MHz, CDCl3)  
167.8, 139.6, 136.4, 129.8, 129.7, 128.6, 101.7, 62.2, 62.0, 14.1; MS m/z (rel. intensity) (EI) 
362 (M+, 10), 317 (6), 289 (20), 261 (4), 235 (100), 207 (39), 179 (36), 162 (45), 134 (68), 










(6.33). From a modification of the procedure described by Mukai and Takahashi,406 a flame 
dried round bottom flask was charged with the malonate 6.32 (1.0637 g, 2.94 mmol), 
stannylallene 6.15 (1.4930 g, 3.15 mmol) and DMF (30 mL). This solution was degassed 
twice under high vacuum using freeze-thaw conditions with argon purges. While still frozen, 
tri-(2-furyl)-phosphine (0.157 g, 0.68 mmol), Pd2(dba)3·CHCl3 (0.0894 g, 0.17 mmol), and 
CuI (0.0528 g, 0.277 mmol) were added under argon atmosphere. The reaction mixture was 
degassed twice more and stirred at room temperature for 20 h at which time the mixture was 
quenched with 10% NH4OH and extracted three times with ether. The ethereal extracts were 
pooled, washed with water twice, brine once, dried over Na2SO4, filtered and the solvent 
evaporated in vacuo to provide the crude product as a dark gold oil (2.2954 g). Purification of 
the target compound by flash silica chromatography (10:1 hexanes:ethyl acetate) provided 
the title compound (0.9458 g, 77%) as a yellow oil contaminated with small amounts of the 
malonate 6.32 and the ligand. Another round of flash silica chromatography (12:1 
hexanes:ethyl acetate) provided the title compound (0.0563 g, 5%) as a colourless oil: IR 
(NaCl, film, cm-1) νmax 2956, 2931, 2857, 1957, 1756, 1736, 1464, 1446, 1368, 1302, 1256, 
1214, 1145, 1078, 1034, 839, 777; 1H NMR (300 MHz, CDCl3)  7.52-7.49 (1H, m, ArH), 
7.31-7.28 (3H, m, ArH), 5.14 (1H, s, CH), 4.89 (2H, t, J = 3.0 Hz, C=CH2), 4.35 (2H, t, J = 
3.0 Hz, CH2OSi), 4.12-4.23 (4H, m, OCH2CH3), 1.22 (6H, t, J = 7.1 Hz, OCH2CH3), 0.86 
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(9H, s, SiC(CH3)3), 0.02 (6H, s, Si(CH3)2); 
13C NMR (75.5 MHz, CDCl3)  206.3, 168.5, 
135.5, 131.6, 129.3, 128.9, 127.8, 127.7, 103.5, 77.3, 64.8, 61.6, 54.3, 25.8, 18.4, 14.0, -5.4; 
MS m/z (rel. intensity) (EI) 418 (M+, 8), 373 (11), 361 (100), 315 (26), 289 (48) , 271 (8), 
259 (28), 243 (36), 231 (9), 213 (31), 199 (8), 185 (17), 169 (13), 141 (28), 115 (8), 73 (36). 
 
 
Diethyl 2-(2-(1-hydroxybuta-2,3-dien-2-yl)phenyl)malonate (6.34). To a solution of the 
silyl protected alcohol 6.33 (1.4708 g, 3.51 mmol) in 80% methanol (15 mL) was added 
KHSO4 (0.5457 g, 4.01 mmol) and stirred at room temperature for 33 h. The rest of the 
procedure follows that as for 6.17. The crude product was obtained as a yellow oil (1.1385 g) 
and was purified chromatographically (silica, 3:1then 1:1  hexanes:ethyl acetate) to afford the 
title compound (0.5974 g, 56%) as a pale yellow oil: IR (NaCl, film, cm-1) νmax 3519, 3065, 
2984, 2939, 2874, 1954, 1732, 1490, 1465, 1448, 1392, 1369, 1303, 1217, 1151, 1097, 1032, 
861, 764, 719, 655; 1H NMR (300 MHz, CDCl3)  7.54-7.50 (1H, m, ArH), 7.34-7.26 (3H, 
m, ArH), 5.16 (1H, s, CH), 4.97 (2H, t, J = 3.0 Hz, C=CH2), 4.34 (2H, br s, CH2OH), 4.27-
4.14 (4H, m, OCH2CH3), 1.92 (1H, br s, OH), 1.24 (6H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR 
(75.5 MHz, CDCl3)  205.4, 168.5, 135.0, 131.8, 129.5, 128.6, 128.3, 128.0, 103.5, 78.0, 
64.3, 61.8, 54.3, 14.0; MS m/z (rel. intensity) (EI) 304 (M+, 77), 286 (24), 274 (58), 273 (25), 
262 (10), 246 (12), 231 (19), 228 (21), 214 (26), 213 (79), 199 (37), 185 (100), 173 (22), 157 
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(55), 141 (45), 129 (99), 128 (65), 115 (50), 102 (6), 91 (9), 77 (10), 63 (4), 51 (4); HRMS 
(EI) calc. for C17H20O5: 304.1311, found: 304.1322. 
 
 
Diethyl 2-(2-(1-acetoxybuta-2,3-dien-2-yl)phenyl)malonate (6.35). TsOH·H2O (0.0028 
g) was added to a stirring solution of the allenyl alcohol 6.34 (0.0462 g, 0.15 mmol) 
dissolved in acetic anhydride (2 mL). The solution was stirred at room temperature for 24 h. 
The reaction was quenched with water and CH2Cl2 (4 mL) was added. The organic layer was 
washed with water containing one drop of a saturated solution of NaHCO3, a saturated 
solution of NH4Cl, brine, dried over Na2SO4, filtered and the solvent evaporated under 
reduced pressure. The residue (0.0514 g) was purified by silica gel chromatography (3:1 
hexanes:ethyl acetate) to afford the title compound (0.0294 g, 56%) as a clear colourless oil: 
IR (NaCl, film, cm-1) νmax 2984, 2940, 2907, 1956, 1732, 1491, 1448, 1369, 1302, 1225, 
1149, 1096, 1031, 974, 862, 767, 720; 1H NMR (300 MHz, CDCl3)  7.53-7.50 (1H, m, 
ArH), 7.33-7.28 (3H, m, ArH), 5.14 (1H, s, CH), 4.94 (2H, t, J = 2.6 Hz, C=CH2), 4.78 (2H, 
t, J = 2.6 Hz, CH2OH), 4.24-4.13 (4H, m, OCH2CH3), 1.99 (3H, s, C(O)CH3), 1.24 (6H, t, J 
= 7.1 Hz, OCH2CH3); 
13C NMR (75.5 MHz, CDCl3)  207.2, 170.5, 168.4, 134.8, 131.8, 
129.5, 128.6, 128.14, 128.07, 99.2, 77.4, 65.2, 61.7, 54.3, 20.8, 14.0; MS m/z (rel. intensity) 
(EI) 346 (M+, 7), 304 (100), 289 (13), 286 (19), 263 (4), 258 (25), 245 (5), 231 (31), 230 
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(94), 213 (46), 201 (24), 185 (85), 169 (9), 157 (77), 141 (30), 129 (36), 115 (26), 91 (3), 77 
(4), 51 (1); HRMS (EI) calc. for C19H22O6: 346.1416, found: 346.1418. 
 
 
Synthetic efforts towards 9,9-Diethyl 2-methyl-3,4-dihydro-1H-fluorene-2,9,9(2H)-
tricarboxylate (6.37a) and 9,9-Diethyl 3-methyl-3,4-dihydro-1H-fluorene-3,9,9(2H)-
tricarboxylate (6.37b). Malonate 6.35 (0.005 g, 0.0014 mmol) and methyl acrylate (0.0015-
0.033 mL, 0.0017-0.37 mmol) were typically dissolved in ethyl acetate or CH2Cl2 (0.5-2.0 
mL). The appropriate base was then added as described in Table 6.3. Reactions were 
quenched with a saturated solution of NH4Cl and extracted with either ethyl acetate or 
CH2Cl2. The organic extracts were washed with water, brine and dried over Na2SO4, filtered 
and the solvent removed in vacuo. The crude residue contained variable amounts of the target 
6.37 and 6.38 (Entries 3 and 4, Table 6.3). Flash silica gel chromatography (4:1 hexanes: 
ethyl acetate) provided a fraction containing the homodimer 6.38 (0.006 g, Entries 1 and 2, 
Table 6.3): Tetraethyl 2'-methylene-3,4-dihydrospiro[fluorene-2,1'-indene]-
3',3',9,9(1H,2'H)-tetracarboxylate (6.38). 
1H NMR (500 MHz, CDCl3)  7.68 (1H, d, J = 7.4 Hz, ArH), 
7.58-7.56 (1H, m, ArH), 7.40 (1H, dd, J = 6.8, 7.5 Hz, ArH), 7.37-
7.26 (4H, m, ArH), 7.21-7.19 (1H, m, ArH), 5.65 (1H, s, C=CH, 
H2′αa), 5.51 (1H, s, C=CH, H2′αb), 4.26-4.15 (8H, m, OCH2CH3), 2.95, 2.91 (2H, ABq, J = 
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18.5 Hz, H1), 2.72-2.66 (2H, m, H4), 1.97-1.94 (2H, m, H3), 1.34-1.23 (9H, m, OCH2CH3), 
1.16 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR (125.5 MHz, CDCl3)  169.7 (ester carbonyl), 
169.6 (ester carbonyl), 168.12 (ester carbonyl), 168.05 (ester carbonyl), 154.1 (C2′), 150.1, 
144.3, 140.61, 140.56, 137.9, 137.1, 129.1, 128.6, 127.4, 126.5, 125.8, 124.9, 123.6, 118.6, 
113.4 (C2α), 71.0 (C9), 69.1 (C3′), 62.0 (ester methylene), 61.91 (ester methylene), 61.88 
(ester methylene), 61.80 (ester methylene), 49.6 (C2/C1′), 36.4 (C1), 35.1 (C3), 20.3 (C4), 
14.04 (ester methyl), 13.97 (ester methyl), 13.85 (ester methyl); MS m/z (rel. intensity) (EI) 
572 (M+, 1), 499 (2), 452 (1), 372 (9), 346 (3), 312 (8), 286 (58), 273 (10), 252 (14), 231 (9), 
214 (44), 213 (100), 185 (74), 168 (18), 157 (18), 149 (11), 141 (21), 129 (28), 128 (14), 115 
(13), 83 (9), 57 (8); HRMS (EI) calc. for C34H36O8: 572.2410, found: 572.2401. 
 
COSY (500 MHz, CDCl3): 
Entry Proton (δ) Correlation 
1 H3 (5.65) H4 
2 H4 (5.51) H3 
 
HMQC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 36.4 (C1) 
2 H2′α 113.4 (C2′α) 
3 H3 35.1 (C3) 
4 H4 20.3 (C4) 
5 ArH (7.68) 124.9 
6 ArH (7.58-7.56) 126.5 
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7 ArH (7.40) 128.6 
8 ArH (7.37-7.26) 118.6, 125.8, 127.4, 129.1 
9 ArH (7.21-7.19) 123.6 
10 Ester CH2 61.80, 61.88, 61.91, 62.0 
11 Ester CH3 13.85, 13.97, 14.04 
 
HMBC (500 MHz, CDCl3): 
Entry Proton Correlation: 13C-Chemical Shift in ppm (Assignment) 
1 H1 35.1 (C3, wk.), 49.6 (C2/C1′), 137.9, 140.61 or 
140.56, 150.1, 154.1 (C2′) 
2 H2′αa 49.6 (C2/C1′), 69.1 (C3′), 154.1 (C2′) 
3 H2′αb 49.6 (C2/C1′), 69.1 (C3′) 
4 H3 20.3 (C4), 36.4 (C1), 49.6 (C2/C1′), 140.61 or 140.56, 
150.1, 154.1 (C2′) 
5 H4 35.1 (C3, v. wk.), 49.6 (C2/C1′, v. wk.), 137.9 (v. 
wk.), 140.61 or 140.56 (v. wk.) 
6 ArH (7.68) 128.6, 144.3 
7 ArH (7.58-7.56) 129.1, 150.1 (wk.) 
8 ArH (7.40) 118.6 (v. wk.), 124.9, 140.61 or 140.56 (v. wk.), 144.3












dicarboxylate (6.41). To stirring solution of the malonate 6.35 (0.007g, 0.02 mmol) and N-
phenylmaleimide (0.0717 g, 0.4 mmol) in CH2Cl2 (0.5 mL) was added DBU (0.006 mL 
dissolved in 1 mL CH2Cl2) via syringe pump over a 2 h period. The reaction solution was 
stirred for 15.5 h and then quenched with a saturated solution of NH4Cl (2 mL). Water and 
CH2Cl2 were added to the mixture and the mixture was washed with a saturated solution of 
NH4Cl, brine, dried over Na2SO4 and filtered. The solvent was evaporated under reduced 
pressure to give a purple solid (0.0747 g). Two rounds of flash silica gel chromatography 
(4:1, 2:1 then 1:1 hexanes:ethyl acetate) provided the title compound (0.0071 g, 77%) as a 
white solid: 1H NMR (300 MHz, CDCl3)  7.64-7.62 (1H, m, ArH), 7.41-7.21 (5H, m, ArH), 
7.17-7.15 (2H, m, ArH), 4.22 (2H, q, J = 7.1 Hz, OCH2CH3), 4.11 (2H, q, J = 7.1 Hz, 
OCH2CH3), 3.53-3.45 (2H, m, H3a, H10a), 3.32-3.26 (2H, m, H4, H10), 2.93-2.71 (2H, m, 
H4, H10), 1.27 (3H, t, J = 7.1 Hz, OCH2CH3), 1.19 (3H, t, J = 7.1 Hz, OCH2CH3); 
13C NMR 
(75.5 MHz, CDCl3)  178.5 (maleimide carbonyl), 178.4 (maleimide carbonyl), 167.4 (ester 
carbonyl), 167.1 (ester carbonyl), 143.0, 140.1, 139.9, 137.5, 131.9, 129.0, 128.7, 128.5, 
126.5, 126.4, 125.3, 118.7, 70.6 (C9), 62.4 (ester methylene), 62.2 (ester methylene), 39.5 
(C3a or C10a), 38.9 (C3a or C10a), 23.9 (C4 or C10), 21.5 (C4 or C10), 14.0 (ester methyl), 
13.9 (ester methyl); MS m/z (rel. intensity) (EI) 459 (M+, 100), 413 (6), 385 (81), 369 (11), 
357 (9), 341 (88), 340 (38), 312 (2), 238 (24), 219 (3), 209 (9), 193 (21), 181 (7), 166 (22), 
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165 (76), 152 (3), 140 (3), 120 (2), 77 (2), 57 (1); HRMS (EI) calc. for C27H25NO6: 




































Appendix B X-ray crystallographic data for N-
(diphenylmethylene)nitramide 3.7 
Figures of all X-ray crystal structures were generated using Mercury 2.2 or 2.3. 
Table B: X-ray crystal structure of N-(diphenylmethylene)nitramide 3.7. 
                  
Table B1: Crystal data and structure refinement for 3.7. 
Empirical formula                   C13H10N2O2 
Formula weight                      226.23 g/mol 
Temperature                         180(2) K 
Wavelength                          0.71073 Å  
Crystal system, space group        Triclinic, P-1 
Unit cell dimensions                a = 8.4915(14)Å, b = 9.2184(15)Å, c = 9.3932(15)Å 
     α = 93.643(3)°, β = 116.436(3)°,  = 111.577(3)° 
Volume                              589.01(17) Å3 
Z, Calculated density               2, 1.276 g/cm3 
Absorption coefficient             0.088 mm-1 
F(000)                              236 
Crystal size                        0.30 x 0.28 x 0.25 mm 
Theta range for data collection    2.47 to 26.00 ° 
Limiting indices                    -8<=h<=10, -11<=k<=11, -11<=l<=11 
Reflections collected / unique     3907 / 2297 [Rint = 0.0444] 
Completeness to theta = 26.00      98.5 % 
Absorption correction              None 
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Refinement method                  Full-matrix least-squares on F2 
Data / restraints / parameters     2297 / 0 / 156 
Goodness-of-fit on F2              1.535 
Final R indices [I>2(I)]       R1 = 0.0601, wR2 = 0.1322 
R indices (all data)                R1 = 0.0661, wR2 = 0.1344 
Extinction coefficient              0.040(7) 
Largest diff. peak and hole        0.316 and -0.274 e Å-3 
 
Table B2: Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 
x 103) for 3.7. 
_________________________________________________________________________________ 
        x                       y                     z                   Ueq 
___________________________________________________________________________ 
 O(1)                                         726(3)          3841(2)           2021(2)             49(1) 
 O(2)                                       2011(3)          1680(2)           1265(2)             52(1) 
 N(1)                                           95(3)          2902(2)            4010(2)            36(1) 
 N(2)                    -390(3)          2771(2)            2308(2)            38(1) 
 C(1)                                       1609(3)          2650(2)            4936(2)            31(1) 
 C(2)                                       2189(3)          2914(2)            6732(2)            31(1) 
 C(3)                                       1548(3)          3825(3)            7412(3)            36(1) 
 C(4)                                       1972(3)          3979(3)            9049(3)            40(1) 
 C(5)                                       3076(3)          3239(3)          10036(3)            40(1) 
 C(6)                                       3753(3)          2366(3)            9389(3)            40(1) 
 C(7)                                       3321(3)          2195(3)            7745(3)            36(1) 
 C(8)                                       2716(3)          2091(2)            4336(2)            31(1) 
 C(9)                                       1736(4)            672(3)            3035(3)            38(1) 
 C(10)                                     2796(4)            172(3)            2497(3)            47(1) 
 C(11)                                     4827(4)          1100(3)            3226(3)            50(1) 
 C(12)                                     5803(4)          2503(3)            4514(3)            48(1) 
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 C(13)                                     4777(3)          2995(3)            5089(3)            39(1) 
__________________________________________________________________________ 
 
Table B3: Hydrogen coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 3.7. 
_________________________________________________________________________________ 
         x                     y                    z                        Ueq 
___________________________________________________________________________ 
 H(3)                                           821               4339              6751                    43 
 H(4)                                         1516               4580              9493                    48 
 H(5)                                         3361               3336            11146                    48 
 H(6)                                         4514               1883            10067                    48 
 H(7)                                         3787               1596              7312                    43 
 H(9)                                           355                   55              2523                    45 
 H(10)                                       2139                -798              1637                    56 
 H(11)                                       5540                 773              2842                    59 
 H(12)                                       7180                3128             5004                    58 
 H(13)                                       5458                3938             5986                    47 
___________________________________________________________________________ 
 
Table B4: Bond lengths [Å] and angles [°] for 3.7. 
___________________________________________________________________________ 
                                    O(1)-N(2)                     1.232(3) 
                                    O(2)-N(2)                     1.234(2) 
                                    N(1)-C(1)                     1.309(3) 
                                    N(1)-N(2)                     1.447(2) 
                                    C(1)-C(8)                     1.502(3) 
                                    C(1)-C(2)                     1.506(3) 
                                    C(2)-C(3)                     1.409(3) 
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                                    C(2)-C(7)                     1.415(3) 
                                    C(3)-C(4)                     1.399(3) 
                                    C(4)-C(5)                     1.407(3) 
                                    C(5)-C(6)                     1.391(3) 
                                    C(6)-C(7)                     1.402(3) 
                                    C(8)-C(9)                     1.410(3) 
                                    C(8)-C(13)                   1.417(3) 
                                    C(9)-C(10)                   1.400(3) 
                                   C(10)-C(11)                  1.401(4) 
                                   C(11)-C(12)                  1.394(4) 
                                   C(12)-C(13)                  1.391(3) 
 
                                  C(1)-N(1)-N(2)             115.40(17) 
                                  O(1)-N(2)-O(2)             125.87(19) 
                                  O(1)-N(2)-N(1)             118.00(18) 
                                  O(2)-N(2)-N(1)             115.62(18) 
                                   N(1)-C(1)-C(8)             125.44(18) 
                                   N(1)-C(1)-C(2)             114.78(18) 
                                   C(8)-C(1)-C(2)             119.75(18) 
                                   C(3)-C(2)-C(7)             119.06(19) 
                                   C(3)-C(2)-C(1)             120.55(19) 
                                   C(7)-C(2)-C(1)             120.35(19) 
                                   C(4)-C(3)-C(2)             120.6(2) 
                                   C(3)-C(4)-C(5)             119.7(2) 
                                   C(6)-C(5)-C(4)             120.2(2) 
                                   C(5)-C(6)-C(7)             120.5(2) 
                                   C(6)-C(7)-C(2)             119.9(2) 
                                 C(9)-C(8)-C(13)             119.2(2) 
                                   C(9)-C(8)-C(1)             121.01(19) 
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                                 C(13)-C(8)-C(1)             119.77(18) 
                                 C(10)-C(9)-C(8)             120.1(2) 
                               C(9)-C(10)-C(11)             120.0(2) 
                             C(12)-C(11)-C(10)             120.1(2) 
                             C(13)-C(12)-C(11)             120.6(2) 


























Appendix C X-ray crystallographic data for Dinitrodiphenylmethane 
3.9 
 
Table C: X-ray crystal structure of Dinitrodiphenylmethane 3.9. 
 
Table C1: Crystal data and structure refinement for 3.9. 
Empirical formula                   C13H10N2O4  
Formula weight                      258.23 g/mol 
Temperature                         200(2) K  
Wavelength                          0.71073 Å 
Crystal system, space group        Monoclinic, P21/c  
Unit cell dimensions                a = 8.364(3) Å, b = 11.722(4) Å, c = 12.753(4) Å 
     β = 102.019(7) º  
Volume                              1222.8(7) Å3  
Z, Calculated density               4, 1.403 g/cm3  
Absorption coefficient             0.106 mm-1  
F(000)                              536  
Crystal size                        0.24 x 0.14 x 0.02 mm 
Theta range for data collection    3.04 to 30.00 deg.  
Limiting indices                    -11<=h<=10, -16<=k<=16, -17<=l<=17  
Reflections collected / unique     12052 / 3555 [R(int) = 0.0400]  
Completeness to theta = 30.00      99.6 %  
Absorption correction              Empirical  
Max. and min. transmission         0.9979 and 0.9749  
Refinement method                  Full-matrix least-squares on F2  
Data / restraints / parameters     3555 / 0 / 174  
Goodness-of-fit on F2              1.114  
Final R indices [I>2σ(I)]       R1 = 0.0492, wR2 = 0.0770  
R indices (all data)                R1 = 0.0896, wR2 = 0.0914  
Extinction coefficient              0.0107(11)  
Largest diff. peak and hole        0.182 and -0.191 e.Å-3 
 
 452 
Table C2: Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 
x 103) for 3.9.  
___________________________________________________________________________ 
                                x                  y                 z            U(eq) 
___________________________________________________________________________  
            O(1)        11353(2)       4668(1)       1420(1)       60(1)  
          O(2)        12737(2)       3377(1)        796(1)       63(1)  
          O(3)        12487(2)       3778(1)       3428(1)       62(1)  
          O(4)        10093(2)       3168(1)       3538(1)       68(1)  
          N(1)        11798(2)       3684(1)       1341(1)       43(1)  
          N(2)        11186(2)       3312(1)       3064(1)       45(1)  
          C(1)        10996(2)       2770(1)       1939(1)       34(1)  
          C(2)        11934(2)       1656(1)       2051(1)       35(1)  
          C(3)        12839(2)       1256(2)       3016(1)       45(1)  
          C(4)        13614(2)        205(2)       3053(2)       56(1)  
          C(5)        13508(2)       -437(2)       2143(2)       58(1)  
          C(6)        12616(2)        -40(2)       1187(2)       55(1)  
          C(7)        11820(2)        991(2)       1140(1)       45(1)  
          C(8)         9226(2)       2635(1)       1385(1)       35(1)  
          C(9)         8297(2)       1835(2)       1800(1)       46(1)  
          C(10)        6689(2)       1652(2)       1317(2)       56(1)  
          C(11)        6002(2)       2236(2)        395(2)       59(1)  
          C(12)        6921(2)       2998(2)        -37(1)       55(1)  
          C(13)        8525(2)       3213(1)        459(1)       43(1)      
___________________________________________________________________________ 
 
Table C3: Hydrogen coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 3.9. 
___________________________________________________________________________ 
                                 x                  y              z            U(eq)       
___________________________________________________________________________    
          H(3A)       12929          1699          3649          54  
          H(4A)       14223           -73           3717          67  
          H(5A)       14050         -1152          2174          69  
          H(6A)       12547          -480           554          66  
          H(7A)       11187          1251           476          54  
          H(9A)        8776          1413          2422          56  
          H(10A)       6052          1122          1617          67  
          H(11A)       4891          2110            61          71  
          H(12A)       6453          3383          -683          66  





Table C4: Bond lengths [Å] and angles [º] for 3.9.  
___________________________________________________________________________  
            O(1)-N(1)                     1.2223(17)  
            O(2)-N(1)                     1.2077(16)  
            O(3)-N(2)                     1.2193(17)  
            O(4)-N(2)                     1.2085(17)  
            N(1)-C(1)                     1.5461(19)  
            N(2)-C(1)                     1.5467(18)  
            C(1)-C(8)                     1.509(2)  
            C(1)-C(2)                     1.515(2)  
            C(2)-C(3)                     1.385(2)  
            C(2)-C(7)                     1.386(2)  
            C(3)-C(4)                     1.388(2)  
            C(4)-C(5)                     1.370(3)  
            C(5)-C(6)                     1.371(2)  
            C(6)-C(7)                     1.375(2)  
            C(8)-C(13)                    1.382(2)  
            C(8)-C(9)                     1.391(2)  
            C(9)-C(10)                    1.375(2)  
            C(10)-C(11)                   1.378(3)  
            C(11)-C(12)                   1.367(3)  
            C(12)-C(13)                   1.382(2)  
   
            O(2)-N(1)-O(1)              125.05(14)  
            O(2)-N(1)-C(1)              118.58(13)  
            O(1)-N(1)-C(1)              116.26(13)  
            O(4)-N(2)-O(3)              125.44(14)  
            O(4)-N(2)-C(1)              117.65(14)  
            O(3)-N(2)-C(1)              116.67(13)  
            C(8)-C(1)-C(2)              113.09(12)  
            C(8)-C(1)-N(1)              109.03(11)  
            C(2)-C(1)-N(1)              111.96(11)  
            C(8)-C(1)-N(2)              112.26(11)  
            C(2)-C(1)-N(2)              108.35(11)  
            N(1)-C(1)-N(2)              101.60(12)  
            C(3)-C(2)-C(7)              118.93(15)  
            C(3)-C(2)-C(1)              123.53(14)  
            C(7)-C(2)-C(1)              117.49(13)  
            C(2)-C(3)-C(4)              119.72(16)  
            C(5)-C(4)-C(3)              120.71(16)  
            C(4)-C(5)-C(6)              119.62(18)  
            C(5)-C(6)-C(7)              120.39(17)  
            C(6)-C(7)-C(2)              120.62(16)  
            C(13)-C(8)-C(9)             118.97(15)  
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            C(13)-C(8)-C(1)             123.28(14)  
            C(9)-C(8)-C(1)              117.63(13)  
            C(10)-C(9)-C(8)             120.44(16)  
            C(9)-C(10)-C(11)            120.00(18)  
            C(12)-C(11)-C(10)           119.94(17)  
            C(11)-C(12)-C(13)           120.57(17)  






















Appendix D X-ray crystallographic data for 1,1'-(2'-methylene-3,4-
dihydrospiro[carbazole-2,3'-indolin]-1',9(1H)-diyl)diethanone 4.55 
 
Table D: X-ray crystal structure of 1,1'-(2'-methylene-3,4-dihydrospiro[carbazole-2,3'-
indolin]-1',9(1H)-diyl)diethanone 4.55. 
 
Table D1: Crystal data and structure refinement for 4.55. 
Empirical formula                   C24H22N2O2  
Formula weight                      370.44  
Temperature                         296(2) K  
Wavelength                          0.71073 Å  
Crystal system, space group        Triclinic, P-1  
Unit cell dimensions                a = 8.8698(8) Å, b = 9.6311(9) Å, c = 11.2047(10) Å  
     α = 95.155(2)º, β = 98.9750(10)º ,  = 97.266(2) º  
Volume                              931.98(15) Å3  
Z, Calculated density               2, 1.320 g/cm3  
Absorption coefficient             0.085 mm-1  
F(000)                              392  
Crystal size                        0.24 x 0.12 x 0.08 mm  
Theta range for data collection    3.40 to 26.00 º  
Limiting indices                    -10<=h<=9, -11<=k<=11, -13<=l<=13  
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Reflections collected / unique     5929 / 3619 [R(int) = 0.0204]  
Completeness to theta = 26.00      98.9 %  
Absorption correction              Empirical  
Max. and min. transmission         0.9933 and 0.9800  
Refinement method                  Full-matrix least-squares on F2  
Data / restraints / parameters     3619 / 0 / 260  
Goodness-of-fit on F2              1.122  
Final R indices [I>2σ(I)]       R1 = 0.0489, wR2 = 0.0971  
R indices (all data)               R1 = 0.0781, wR2 = 0.1081  
Extinction coefficient              0.0152(17)  
Largest diff. peak and hole        0.187 and -0.174 e.Å-3 
 
 
Table D2: Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 
x 103) for 4.55. 
_______________________________________________________________________ 
                          x             y             z          U(eq)  
_______________________________________________________________________  
          C(1)         2078(2)       4672(2)       -268(2)       42(1)  
          C(2)         2736(2)       3818(2)        548(2)       43(1)  
          C(3)         2228(3)       2374(2)        422(2)       52(1)  
          C(4)         1048(3)       1822(2)       -523(2)       58(1)  
          C(5)          386(3)       2688(3)      -1321(2)       59(1)  
          C(6)          892(2)       4118(2)      -1213(2)       52(1)  
          N(7)         2811(2)       6070(2)         85(1)       42(1)  
          C(8)         3889(2)       6053(2)       1175(2)       40(1)  
          C(9)         3869(2)       4713(2)       1443(2)       44(1)  
          C(10)        4793(2)       7311(2)       1980(2)       43(1)  
          C(11)        5217(2)       6931(2)       3290(2)       40(1)  
          C(12)        5893(2)       5528(2)       3270(2)       47(1)  
          C(13)        4755(3)       4301(2)       2574(2)       52(1)  
          C(14)        3869(2)       6923(2)       3970(2)       40(1)  
          C(15)        4284(2)       7801(2)       5060(2)       40(1)  
          N(16)        5862(2)       8422(2)       5184(1)       42(1)  
          C(17)        6391(2)       8087(2)       4060(2)       44(1)  
          C(18)        2390(2)       6198(2)       3662(2)       50(1)  
          C(19)        1343(3)       6355(3)       4445(2)       60(1)  
          C(20)        1784(3)       7214(3)       5535(2)       58(1)  
          C(21)        3251(3)       7964(2)       5848(2)       51(1)  
          C(22)        6713(3)       9077(2)       6275(2)       52(1)  
          O(23)        6076(2)       9426(2)       7119(1)       68(1)  
          C(24)        8428(3)       9316(4)       6419(2)       89(1)  
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          C(25)        2535(3)       7183(2)       -608(2)       52(1)  
          O(26)        1520(2)       6995(2)      -1487(2)       78(1)  
          C(27)        3535(3)       8565(3)       -275(2)       73(1)  
          C(28)        7645(3)       8691(3)       3715(3)       64(1)  
_______________________________________________________________________ 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
 
 
Table D3: Hydrogen coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 4.55. 
_______________________________________________________________________  
                         x             y             z          U(eq)  
_______________________________________________________________________ 
          H(3A)        2671          1798           960          62  
          H(4A)         693           861          -627          69  
          H(5A)        -417          2296         -1942          70  
          H(6A)         452          4689         -1755          62  
          H(10A)       4185          8080          1982          52  
          H(10B)       5726          7616          1668          52  
          H(12A)       6813          5629          2899          57  
          H(12B)       6193          5324          4099          57  
          H(13A)       5310          3535          2358          63  
          H(13B)       4040          3964          3092          63  
          H(18A)       2100          5609          2936          60  
          H(19A)        342          5881          4238          72  
          H(20A)       1081          7289          6065          70  
          H(21A)       3534          8561          6570          61  
          H(24A)       8852          9784          7216         133  
          H(24B)       8735          9891          5818         133  
          H(24C)       8801          8427          6317         133  
          H(27A)       3206          9212          -832         109  
          H(27B)       4585          8446          -316         109  
          H(27C)       3461          8928           536         109  
          H(28A)       8360(30)      9420(30)      4200(30)      96  




Table D4: Bond lengths [Å] and angles [º] for 4.55. 
_______________________________________________________________________ 
            C(1)-C(6)                     1.386(3)  
            C(1)-C(2)                     1.394(3)  
            C(1)-N(7)                     1.412(3)  
            C(2)-C(3)                     1.395(3)  
            C(2)-C(9)                     1.439(3)  
            C(3)-C(4)                     1.383(3)  
            C(4)-C(5)                     1.391(3)  
            C(5)-C(6)                     1.382(3)  
            N(7)-C(25)                    1.403(3)  
            N(7)-C(8)                     1.431(2)  
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            C(8)-C(9)                     1.350(3)  
            C(8)-C(10)                    1.502(3)  
            C(9)-C(13)                    1.496(3)  
            C(10)-C(11)                   1.546(3)  
            C(11)-C(14)                   1.514(3)  
            C(11)-C(17)                   1.524(3)  
            C(11)-C(12)                   1.546(3)  
            C(12)-C(13)                   1.521(3)  
            C(14)-C(18)                   1.383(3)  
            C(14)-C(15)                   1.392(3)  
            C(15)-C(21)                   1.382(3)  
            C(15)-N(16)                   1.431(2)  
            N(16)-C(22)                   1.384(3)  
            N(16)-C(17)                   1.435(2)  
            C(17)-C(28)                   1.317(3)  
            C(18)-C(19)                   1.386(3)  
            C(19)-C(20)                   1.384(3)  
            C(20)-C(21)                   1.383(3)  
            C(22)-O(23)                   1.219(3)  
            C(22)-C(24)                   1.490(3)  
            C(25)-O(26)                   1.210(3)  
            C(25)-C(27)                   1.485(3)  
   
            C(6)-C(1)-C(2)              121.2(2)  
            C(6)-C(1)-N(7)              130.80(19)  
            C(2)-C(1)-N(7)              107.99(17)  
            C(1)-C(2)-C(3)              120.6(2)  
            C(1)-C(2)-C(9)              107.54(18)  
            C(3)-C(2)-C(9)              131.8(2)  
            C(4)-C(3)-C(2)              118.1(2)  
            C(3)-C(4)-C(5)              120.7(2)  
            C(6)-C(5)-C(4)              121.6(2)  
            C(5)-C(6)-C(1)              117.7(2)  
            C(25)-N(7)-C(1)             123.05(17)  
            C(25)-N(7)-C(8)             129.77(18)  
            C(1)-N(7)-C(8)              107.04(16)  
            C(9)-C(8)-N(7)              108.94(18)  
            C(9)-C(8)-C(10)             124.05(18)  
            N(7)-C(8)-C(10)             126.74(17)  
            C(8)-C(9)-C(2)              108.41(18)  
            C(8)-C(9)-C(13)             124.08(19)  
            C(2)-C(9)-C(13)             127.11(18)  
            C(8)-C(10)-C(11)            110.05(16)  
            C(14)-C(11)-C(17)           101.65(15)  
            C(14)-C(11)-C(12)           112.89(17)  
            C(17)-C(11)-C(12)           109.21(16)  
            C(14)-C(11)-C(10)           111.87(16)  
            C(17)-C(11)-C(10)           110.84(16)  
            C(12)-C(11)-C(10)           110.09(16)  
            C(13)-C(12)-C(11)           112.45(17)  
            C(9)-C(13)-C(12)            111.76(18)  
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            C(18)-C(14)-C(15)           119.55(19)  
            C(18)-C(14)-C(11)           129.92(19)  
            C(15)-C(14)-C(11)           110.53(17)  
            C(21)-C(15)-C(14)           121.5(2)  
            C(21)-C(15)-N(16)           129.14(19)  
            C(14)-C(15)-N(16)           109.40(17)  
            C(22)-N(16)-C(15)           122.95(17)  
            C(22)-N(16)-C(17)           128.27(18)  
            C(15)-N(16)-C(17)           108.37(16)  
            C(28)-C(17)-N(16)           126.8(2)  
            C(28)-C(17)-C(11)           124.9(2)  
            N(16)-C(17)-C(11)           108.32(16)  
            C(14)-C(18)-C(19)           119.5(2)  
            C(20)-C(19)-C(18)           120.2(2)  
            C(21)-C(20)-C(19)           121.1(2)  
            C(15)-C(21)-C(20)           118.2(2)  
            O(23)-C(22)-N(16)           120.7(2)  
            O(23)-C(22)-C(24)           120.1(2)  
            N(16)-C(22)-C(24)           119.1(2)  
            O(26)-C(25)-N(7)            119.7(2)  
            O(26)-C(25)-C(27)           120.9(2)  
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